data_2k0a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k0a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.403 ' SD ' HD13 ' A' ' 12' ' ' LEU . 4.5 ptp . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.149 0.499 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.6 t -53.83 -49.74 67.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.031 -172.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.764 ' HG ' ' HB3' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 51.87 43.06 30.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 172.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 50.2 mttm -95.62 -155.38 0.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.584 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.34 111.91 44.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.063 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 32.9 Cg_exo -60.1 138.58 82.68 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.244 2.629 . . . . 0.0 112.926 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.91 -140.25 11.26 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.12 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.614 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 35.3 m -98.44 -29.11 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.64 0.257 . . . . 0.0 111.209 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -69.23 125.53 26.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.95 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -82.32 142.45 32.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.827 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.8 118.55 6.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.628 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 81.8 mt -92.18 143.75 26.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 112.071 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.48 HD22 HG12 ' A' ' 59' ' ' ILE . 70.7 mt -110.33 136.57 49.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.301 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.8 p -72.59 152.39 41.83 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 53.6 mt-10 -54.97 -25.44 29.72 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 0.0 111.558 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 25.1 mtpp -72.16 -23.29 61.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.747 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 20.6 m -116.32 15.37 15.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 26.1 t70 -68.29 129.8 41.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -21.33 46.59 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.329 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 45.0 mttm -71.82 134.61 46.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.8 t -81.82 121.57 79.47 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.11 -34.15 76.95 Favored 'Trans proline' 0 CA--C 1.526 0.093 0 C-N-CA 122.441 2.094 . . . . 0.0 112.771 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.633 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 3.8 mm -76.01 -32.72 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.431 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 20.1 p -137.98 -34.46 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t0 64.35 86.86 0.12 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 t -154.36 25.35 0.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.578 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 36.79 50.11 0.82 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.303 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.19 162.81 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.346 -176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.515 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 ptp85 -42.43 128.5 2.89 Favored Pre-proline 0 N--CA 1.466 0.354 0 O-C-N 123.736 0.648 . . . . 0.0 112.63 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.524 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 2.8 Cg_exo -76.64 -154.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.421 2.747 . . . . 0.0 112.164 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -176.4 -49.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.32 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -150.12 136.08 18.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.494 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.71 134.55 56.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.926 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 16.2 m -74.03 134.42 29.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 17' ' ' VAL . 27.8 mtp85 -108.15 122.15 46.32 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -81.9 143.84 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.166 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.663 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.1 p -61.35 149.08 39.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.928 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 89.8 mt-10 -54.55 -34.49 61.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.374 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.663 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m120 -53.94 -36.25 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.759 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 66.2 m -83.82 -32.29 25.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.319 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -67.18 -49.05 66.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.066 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.578 0.228 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.897 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 34.7 m-20 -63.92 144.94 56.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.431 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.5 t -47.38 131.73 13.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.713 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 11.0 pt -75.96 -29.53 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.102 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 26' ' ' CYS . 44.1 mt -77.72 -45.7 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 28.6 p -109.4 14.28 23.72 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER 22.26 58.24 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.25 -67.61 0.12 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 0.0 110.458 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.19 139.8 38.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.897 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 8.9 p -61.65 139.56 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 110.881 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -84.07 145.21 22.26 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.628 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 68' ' ' ASN . 19.0 m -111.1 -41.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.455 ' N ' HG23 ' A' ' 67' ' ' VAL . 69.1 m-20 -114.6 135.29 54.3 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -62.12 134.49 56.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.47 147.2 40.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.589 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.524 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 9.4 m-85 -117.26 136.24 53.23 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.867 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 80.5 m-85 -67.81 128.59 37.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 1.8 p -72.25 149.08 44.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -51.08 -39.5 56.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.598 0.562 . . . . 0.0 111.7 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.27 -45.62 93.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.606 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.633 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 60.7 m -65.61 -36.65 84.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.502 0.191 . . . . 0.0 110.97 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 73.4 m -66.3 -41.81 89.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -62.84 -47.19 84.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.56 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.536 HD13 ' HE3' ' A' ' 81' ' ' LYS . 94.1 mt -66.04 -33.79 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.38 40.21 5.15 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.364 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.536 ' HE3' HD13 ' A' ' 79' ' ' LEU . 97.1 mttt -92.02 -30.93 15.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 176.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -66.89 -27.59 67.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.852 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -69.03 -8.84 48.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.329 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.764 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 70.6 m-20 -69.08 -51.21 41.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.16 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.42 -137.27 5.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.235 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 26.9 t -54.41 115.87 9.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 124.054 0.942 . . . . 0.0 111.717 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.926 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 66.0 Cg_endo -88.39 26.82 0.56 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.95 2.433 . . . . 0.0 114.177 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.759 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 30.3 mtt-85 -73.45 121.65 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.955 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.403 HG23 HD13 ' A' ' 89' ' ' ILE . 27.3 mm . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.233 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.462 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 4.7 ptp . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 121.405 0.621 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.457 ' SG ' ' HE2' ' A' ' 13' ' ' LYS . 45.5 t -52.54 -49.89 63.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.308 -175.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 54.6 mt 50.32 32.22 6.05 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HE2' ' SG ' ' A' ' 11' ' ' CYS . 27.9 mtmt -82.39 166.12 19.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.153 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.3 112.89 5.5 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 123.77 0.668 . . . . 0.0 110.451 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 50.9 Cg_endo -76.65 141.01 21.62 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.095 2.53 . . . . 0.0 113.376 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 -144.08 11.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -89.1 -24.47 5.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.132 0.491 . . . . 0.0 110.667 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -57.4 124.48 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.42 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.561 HG21 ' HD3' ' A' ' 42' ' ' LYS . 26.0 m -84.97 137.9 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.117 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.01 130.33 24.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.713 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 68' ' ' ASN . 52.5 mt -88.84 142.88 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.338 0.59 . . . . 0.0 112.358 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.692 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 81.4 mt -113.13 137.62 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.963 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.756 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 6.5 p -75.94 154.88 35.59 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 27' ' ' ASP . 39.9 mt-10 -51.97 -33.27 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.405 0.44 . . . . 0.0 111.552 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -69.0 -27.96 66.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.775 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.452 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 49.4 m -104.48 41.42 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.962 0.411 . . . . 0.0 109.916 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 9.6 t70 -66.66 119.14 11.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.01 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.73 44.67 56.2 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.613 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 26' ' ' CYS . 35.3 mtpt -120.15 139.74 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.538 -0.389 . . . . 0.0 110.992 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.67 122.75 85.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.634 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HA ' HG12 ' A' ' 60' ' ' ILE . 36.7 Cg_exo -64.49 -36.45 43.6 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.104 2.536 . . . . 0.0 113.323 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.8 mm -64.43 -41.58 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.992 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.15 -12.5 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 63.91 81.55 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.308 0.575 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 t -171.73 152.9 3.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.957 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -88.32 22.63 2.43 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.663 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.02 154.92 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.07 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 10.9 ptp180 -44.02 129.35 4.35 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.534 0.734 . . . . 0.0 112.721 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 Cg_exo -73.98 -164.54 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.37 2.713 . . . . 0.0 112.379 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.774 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -172.17 -42.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.979 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -149.66 136.42 19.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.561 ' HD3' HG21 ' A' ' 19' ' ' THR . 46.3 mttt -63.16 139.52 58.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.474 0.654 . . . . 0.0 111.698 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.818 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.2 t -70.47 133.8 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.417 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -123.6 128.34 49.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.831 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' HD2' ' A' ' 87' ' ' PRO . 28.7 m -100.83 155.88 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.043 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.4 p -67.44 145.95 54.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.93 -28.94 64.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.606 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 16.9 m-80 -59.1 -31.11 68.62 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.833 175.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.44 ' HB3' ' CD ' ' A' ' 88' ' ' ARG . 79.3 m -101.48 29.3 4.9 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 122.155 -0.341 . . . . 0.0 111.798 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 m -111.29 -28.17 8.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 109.837 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 17.0 p90 . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.56 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 14.1 mmtp . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.833 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 80.2 m-20 -67.23 150.47 49.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.901 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.756 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 36.7 t -50.11 135.1 21.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 88' ' ' ARG . 11.7 pt -77.65 -35.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.599 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 31' ' ' PRO . 43.4 mt -74.26 -47.3 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.8 p -103.07 2.81 35.29 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.847 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.532 ' OD1' ' HB ' ' A' ' 89' ' ' ILE . 1.5 p-10 36.36 47.3 0.48 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.117 0.886 . . . . 0.0 113.256 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.21 -66.27 0.37 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.044 -174.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -81.98 143.39 31.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.235 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.833 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 48.5 t -56.92 134.44 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.217 0.323 . . . . 0.0 110.545 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.87 147.29 21.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.775 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.68 -37.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.089 0.471 . . . . 0.0 110.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 6.4 m120 -82.77 173.33 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.172 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -109.92 134.41 52.12 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.686 ' HB1' HG22 ' A' ' 43' ' ' VAL . . . -77.58 151.54 34.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.28 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -126.24 135.36 51.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 173.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.818 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 76.9 m-85 -71.26 125.11 26.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.6 p -67.58 157.0 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -50.28 -40.82 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.479 0.487 . . . . 0.0 111.479 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 37.2 mt-10 -58.91 -51.96 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.604 0.24 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.618 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 98.7 m -64.38 -36.14 83.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.363 -178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.9 m -67.87 -42.83 80.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -58.8 -49.24 78.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.959 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 42.3 mt -72.06 -27.43 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.617 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.68 47.18 3.26 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.43 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -82.19 -36.43 27.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.205 0.526 . . . . 0.0 109.911 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -66.77 -28.8 68.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.997 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.9 pttp -57.07 -30.91 64.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.31 . . . . 0.0 110.465 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -61.57 -52.55 63.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.691 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.32 -127.72 3.45 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.569 -1.3 . . . . 0.0 114.669 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.4 t -58.84 109.56 1.96 Allowed Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.52 -1.34 . . . . 0.0 113.182 -171.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.568 ' HD2' HG11 ' A' ' 45' ' ' VAL . 72.0 Cg_endo -87.97 39.89 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.992 2.461 . . . . 0.0 113.716 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 59' ' ' ILE . 24.3 mtp85 -85.03 127.68 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.532 ' HB ' ' OD1' ' A' ' 62' ' ' ASN . 31.5 mm . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.541 ' SD ' HD13 ' A' ' 12' ' ' LEU . 2.3 ptp . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.425 0.631 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.405 ' CB ' ' HB2' ' A' ' 88' ' ' ARG . 44.1 t -56.15 -53.12 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.304 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.541 HD13 ' SD ' ' A' ' 10' ' ' MET . 2.3 mp 48.52 37.9 9.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -79.59 177.64 8.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.59 167.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -70.81 116.05 42.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.883 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 31.8 Cg_exo -62.91 145.23 94.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.161 2.574 . . . . 0.0 113.37 -175.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.93 -137.4 9.22 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.53 -23.28 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.445 ' O ' HG21 ' A' ' 45' ' ' VAL . 56.2 mt-30 -72.31 138.75 47.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.487 . . . . 0.0 111.718 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 43' ' ' VAL . 55.8 m -91.7 137.66 32.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.644 178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.71 132.33 31.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.268 -0.492 . . . . 0.0 112.798 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 88.1 mt -95.87 143.46 27.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.046 0.451 . . . . 0.0 111.83 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 70' ' ' ALA . 60.0 mt -113.01 140.42 47.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.263 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.3 p -78.92 154.03 30.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 40.1 mt-10 -54.69 -26.22 32.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.83 0.347 . . . . 0.0 111.67 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 35.1 mmtp -70.11 -29.36 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' O ' HD12 ' A' ' 22' ' ' LEU . 4.8 m -116.29 17.28 15.67 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 51.9 t0 -66.77 127.2 31.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.145 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.95 -22.18 42.24 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.491 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -68.26 122.07 17.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.489 0.185 . . . . 0.0 110.99 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -69.19 113.03 13.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.42 -27.37 67.67 Favored 'Trans proline' 0 N--CA 1.473 0.3 0 C-N-CA 123.372 2.715 . . . . 0.0 113.403 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 4.8 mm -66.8 -36.59 77.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.92 -176.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.58 -15.61 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 67.1 84.05 0.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.373 0.606 . . . . 0.0 109.831 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -164.57 136.02 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.148 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.68 11.76 8.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 73' ' ' CYS . 8.3 p -66.44 160.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.001 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -40.76 130.85 1.85 Allowed Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.66 0.784 . . . . 0.0 112.873 -175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 93.4 Cg_endo -78.83 -161.23 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.388 2.725 . . . . 0.0 112.771 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -171.57 -50.55 0.02 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.359 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -134.88 145.47 48.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.186 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' HG21 ' A' ' 19' ' ' THR . 59.7 mttp -68.18 140.47 56.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.825 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.7 m -74.58 127.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 111.606 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.53 114.99 29.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 18' ' ' GLN . 6.3 m -85.52 146.53 6.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.345 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p -67.04 161.23 24.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -47.36 -44.89 24.38 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.042 0.839 . . . . 0.0 111.715 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.719 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.1 m120 -61.69 -39.1 90.24 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.703 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 55.9 m -90.0 43.53 1.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.682 0.277 . . . . 0.0 110.794 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 45' ' ' VAL . 65.9 m -155.62 -38.68 0.08 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.698 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.719 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.55 0.214 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -65.92 148.47 51.73 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.34 0.59 . . . . 0.0 110.933 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 20.2 t -51.6 125.73 15.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.375 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.537 HG12 HD21 ' A' ' 22' ' ' LEU . 8.7 pt -65.52 -26.86 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.457 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.4 mt -81.12 -41.1 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 32.1 p -113.75 2.61 15.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.348 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 29.25 53.1 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.43 1.092 . . . . 0.0 113.476 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.64 -59.49 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.383 -176.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -72.48 141.27 48.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.826 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.36 133.01 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.174 0.512 . . . . 0.0 110.957 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.11 140.09 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.996 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -127.08 -39.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -117.84 137.73 52.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.89 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 19' ' ' THR . 21.2 m-20 -64.3 139.1 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.568 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 22' ' ' LEU . . . -82.39 151.33 26.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.653 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -124.73 134.15 52.93 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.838 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.825 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 68.2 m-85 -66.17 125.15 24.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -66.07 151.54 46.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -52.98 -38.0 61.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.68 -46.26 87.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.473 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 86.0 m -72.39 -38.01 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.722 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.5 t -63.97 -35.9 82.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.302 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -62.9 -41.43 99.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.334 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.03 1.41 21.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.01 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.05 84.78 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.495 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 93.3 mttt -77.72 -20.35 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' HB2' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -70.82 -23.47 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.667 175.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.47 -25.06 60.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -55.03 -57.82 10.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.61 -140.15 7.11 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.647 -1.263 . . . . 0.0 114.343 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.634 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 47.4 t -64.5 115.91 24.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.189 -1.005 . . . . 0.0 112.275 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.774 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 93.9 Cg_endo -83.17 39.59 0.84 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.211 2.607 . . . . 0.0 113.442 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.703 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 9.5 mmt180 -81.73 121.81 26.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.992 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.4 mm . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.071 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 1.4 ptp . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 121.171 0.51 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -56.98 -50.4 72.81 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.493 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.5 ' HA ' HD22 ' A' ' 12' ' ' LEU . 40.0 mt 49.5 40.65 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.015 1.116 . . . . 0.0 114.015 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -82.29 -159.8 0.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.821 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -85.18 122.94 73.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.12 133.17 48.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.852 2.368 . . . . 0.0 112.75 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -144.16 6.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.247 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 18' ' ' GLN . 11.3 p -99.38 -30.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.754 0.311 . . . . 0.0 111.401 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.507 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 70.6 mt-30 -77.96 136.37 37.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.37 0.605 . . . . 0.0 111.896 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.624 HG21 ' HD3' ' A' ' 42' ' ' LYS . 10.0 m -75.86 143.28 41.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.526 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.28 120.45 5.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.213 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 73.5 mt -91.98 147.61 22.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.492 . . . . 0.0 112.14 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.479 HD13 ' HB1' ' A' ' 70' ' ' ALA . 76.8 mt -110.89 130.11 55.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.139 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.454 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 8.5 p -71.4 160.42 32.79 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.545 ' HG3' HG22 ' A' ' 67' ' ' VAL . 54.8 mt-10 -58.25 -24.55 59.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp -74.44 -31.23 62.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.677 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -110.13 25.07 12.2 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 38.9 t70 -68.03 124.74 24.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.97 77.25 Favored Glycine 0 C--N 1.321 -0.266 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.627 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 51.3 mttm -102.7 134.51 45.97 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.448 -0.442 . . . . 0.0 110.607 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 12.6 t -70.75 117.17 53.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 11.2 Cg_endo -58.89 -31.95 96.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.818 2.346 . . . . 0.0 112.811 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HA ' ' HE2' ' A' ' 10' ' ' MET . 12.6 mm -66.4 -46.94 85.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.243 -175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -122.21 -6.06 8.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -170.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.98 75.79 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 110.091 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 t -164.33 147.52 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -89.01 41.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.058 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 73' ' ' CYS . 41.9 t -74.43 148.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.87 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.583 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 5.4 mmp_? -35.93 120.17 0.69 Allowed Pre-proline 0 C--O 1.224 -0.287 0 O-C-N 124.495 1.122 . . . . 0.0 112.554 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.58 144.37 44.56 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.597 2.198 . . . . 0.0 112.38 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 12.3 mmmm -131.7 -78.79 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -85.78 132.04 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.624 ' HD3' HG21 ' A' ' 19' ' ' THR . 40.9 ttmt -71.07 132.32 44.92 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.548 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 21.9 t -71.45 129.08 35.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.405 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -121.83 130.44 53.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 50' ' ' SER . 17.9 m -80.6 144.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.157 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.681 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.5 p -62.39 139.78 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.604 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 6.9 tp10 -60.16 -21.18 61.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.094 -174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.627 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 5.2 m120 -60.48 -31.56 70.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.7 m -87.38 -35.02 18.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.529 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.604 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 16.6 p -92.28 -22.08 19.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -172.587 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 15.6 p30 -62.15 149.26 41.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.815 0.817 . . . . 0.0 112.083 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -64.8 130.92 45.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.265 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.511 ' CD1' HG12 ' A' ' 43' ' ' VAL . 8.4 pt -62.57 -40.6 88.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 60' ' ' ILE . 43.6 mt -68.46 -38.12 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.2 p -101.73 -26.55 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.954 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 57.5 56.47 4.97 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.246 0.546 . . . . 0.0 109.611 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.86 -58.55 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.336 -170.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.4 144.0 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.752 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -64.68 138.13 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.895 0.378 . . . . 0.0 110.978 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -72.13 151.2 46.81 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.297 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 24' ' ' GLU . 61.1 t -118.74 -60.94 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.887 0.375 . . . . 0.0 111.167 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -113.45 137.55 51.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.892 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -60.3 136.72 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.473 0.483 . . . . 0.0 111.366 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.479 ' HB1' HD13 ' A' ' 22' ' ' LEU . . . -82.57 159.39 22.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.904 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -136.54 134.34 37.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.138 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.5 m-85 -66.17 128.12 34.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 1.8 p -71.87 160.15 33.06 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.002 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -49.09 -50.62 36.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.077 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.539 ' HG3' HG12 ' A' ' 37' ' ' VAL . 46.3 mt-10 -59.92 -43.15 95.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.388 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 91.6 m -68.01 -34.97 77.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.169 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 40' ' ' LYS . 81.7 m -68.63 -37.48 79.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -60.53 -47.16 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.272 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.12 -28.2 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.588 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.54 36.84 10.14 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.967 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -87.4 -10.95 50.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.919 0.39 . . . . 0.0 110.243 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -68.82 -24.46 64.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 108.988 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -73.97 -23.49 59.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.757 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB3' HD21 ' A' ' 12' ' ' LEU . 81.4 m-20 -58.16 -58.93 6.3 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 -135.01 7.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.859 -1.163 . . . . 0.0 114.261 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.681 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 24.8 t -55.99 107.35 0.86 Allowed Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 111.929 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 97.3 Cg_endo -87.95 38.25 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.772 2.315 . . . . 0.0 113.563 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' MET . 53.6 mtt180 -87.52 131.42 34.37 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.983 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.412 ' HA ' HD12 ' A' ' 89' ' ' ILE . 32.3 mm . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.176 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.462 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.405 0 CA-C-O 121.382 0.611 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.4 t -48.85 -48.46 41.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.292 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 20.9 mt 41.45 40.5 1.31 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 50.5 mttm -80.0 -160.18 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.406 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 tp-100 -82.13 111.01 23.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.381 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 77.2 Cg_endo -80.17 146.54 17.93 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.453 2.102 . . . . 0.0 112.746 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.69 -142.6 13.34 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.298 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.41 -17.87 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.096 0.474 . . . . 0.0 110.717 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.439 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.1 mp0 -64.33 142.18 58.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.756 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 42' ' ' LYS . 7.9 m -109.08 126.58 53.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.747 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.55 138.2 42.7 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.307 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.476 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 41.2 mt -78.93 154.34 29.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.869 0.842 . . . . 0.0 113.131 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.817 HD13 ' HB1' ' A' ' 70' ' ' ALA . 1.7 tp -124.47 127.68 47.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.856 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 1.4 p -81.36 149.4 28.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HG3' HG23 ' A' ' 67' ' ' VAL . 52.8 mt-10 -52.31 -35.01 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -62.22 -37.95 87.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.32 -17.37 23.66 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.49 -0.131 . . . . 0.0 110.795 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.49 110.79 0.68 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.866 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.78 -31.22 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.775 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' HD11 ' A' ' 60' ' ' ILE . 55.1 mttm -78.61 132.58 37.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.479 -0.361 . . . . 0.0 110.892 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 t -80.46 119.05 75.2 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 71.3 Cg_exo -54.59 -37.01 90.74 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 123.059 2.506 . . . . 0.0 113.761 -172.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.523 ' CG2' ' HD3' ' A' ' 81' ' ' LYS . 3.4 mm -61.47 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.4 p -106.5 -21.75 12.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -171.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 65.42 83.43 0.17 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.394 0.616 . . . . 0.0 110.292 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 t -169.34 138.88 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.39 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -80.13 45.96 0.78 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.242 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 38' ' ' ARG . 4.2 p -94.1 148.38 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.009 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.487 ' N ' HG23 ' A' ' 37' ' ' VAL . 58.9 mtt-85 -40.16 123.31 1.67 Allowed Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 77.9 Cg_endo -72.43 152.15 54.39 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.011 2.474 . . . . 0.0 111.261 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.559 ' HD2' ' HD1' ' A' ' 74' ' ' TRP . 57.6 tttp -128.81 -37.16 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.848 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.46 145.42 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.587 ' HB3' HG23 ' A' ' 19' ' ' THR . 89.1 mttt -59.93 143.07 52.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 111.557 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.776 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 31.6 m -68.39 155.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -116.19 114.81 24.95 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.485 HG21 ' SG ' ' A' ' 86' ' ' CYS . 10.0 p -93.88 139.61 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.591 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.5 p -65.79 147.75 52.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.71 -30.47 63.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.679 0.275 . . . . 0.0 110.476 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.668 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.9 m120 -55.94 -40.92 73.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.506 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 91.6 m -80.65 -24.66 38.82 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.597 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -76.95 -41.94 41.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.656 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 112.206 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 10.9 mmpt? . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.078 0.466 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 71.7 m-80 -76.23 140.17 41.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.022 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.9 t -51.68 126.57 18.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.218 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 70' ' ' ALA . 12.4 pt -68.78 -27.58 36.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.587 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.461 HG13 HD11 ' A' ' 22' ' ' LEU . 54.0 mt -75.81 -42.8 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 24.9 p -105.63 -6.99 18.79 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.23 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 42.19 45.85 3.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.981 0.801 . . . . 0.0 112.31 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 -62.43 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.142 0.496 . . . . 0.0 110.188 -177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -75.87 141.97 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.891 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 9.9 p -68.16 139.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.729 0.3 . . . . 0.0 110.591 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.25 145.1 20.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.416 HG23 ' HG3' ' A' ' 24' ' ' GLU . 12.8 m -116.33 -38.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.554 0.216 . . . . 0.0 111.478 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -104.73 -174.87 2.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.522 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -107.78 142.26 38.08 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.817 ' HB1' HD13 ' A' ' 22' ' ' LEU . . . -79.42 151.4 30.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -127.39 136.27 51.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 56.1 m-85 -68.11 127.81 34.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.4 p -71.42 161.74 30.57 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.746 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.559 ' HD1' ' HD2' ' A' ' 40' ' ' LYS . 27.8 t90 -51.99 -42.2 62.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.161 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.545 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -58.63 -55.97 28.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.116 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.78 -39.48 94.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.484 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.7 t -65.31 -41.31 94.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.454 0.169 . . . . 0.0 110.765 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.4 ttp-105 -64.15 -44.53 91.85 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.026 0.441 . . . . 0.0 110.324 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 77.3 mt -65.67 -38.2 88.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.367 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 28.18 4.11 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.308 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HD3' ' CG2' ' A' ' 32' ' ' ILE . 46.6 mttm -88.39 -4.67 58.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.869 0.366 . . . . 0.0 110.571 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 p-10 -66.83 -30.45 70.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.034 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 3.5 mmmp? -96.2 7.82 45.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.27 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -69.69 -59.65 2.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.7 -158.15 30.91 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.355 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.485 ' SG ' HG21 ' A' ' 45' ' ' VAL . 34.2 t -66.08 115.22 21.18 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.658 0.783 . . . . 0.0 111.54 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 90.0 Cg_endo -86.76 41.98 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.683 2.922 . . . . 0.0 114.047 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -87.81 130.34 34.9 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.988 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 175.153 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.621 ' SD ' HD13 ' A' ' 12' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.437 -1.108 0 CA-C-O 120.869 0.366 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -41.58 -63.11 0.76 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.328 . . . . 0.0 113.254 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.621 HD13 ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER 51.03 36.77 16.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.851 ' HE2' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -104.29 170.66 7.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 166.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.3 tp-100 -57.33 121.91 50.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 123.551 0.532 . . . . 0.0 110.693 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.9 Cg_exo -71.19 151.03 60.49 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.879 2.386 . . . . 0.0 112.688 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.625 ' H ' ' HA ' ' A' ' 46' ' ' CYS . . . -88.02 -125.98 2.37 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.529 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -105.42 -48.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -62.22 151.02 37.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.76 HG22 ' HD3' ' A' ' 42' ' ' LYS . 98.6 m -82.23 143.56 31.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.451 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.75 126.51 9.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.952 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.2 mt -95.33 136.73 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.521 HD21 HD12 ' A' ' 60' ' ' ILE . 90.7 mt -99.07 148.7 23.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.49 171.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.709 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.9 p -89.47 154.99 19.59 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -52.21 -29.54 23.04 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.423 0.452 . . . . 0.0 111.996 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.3 mmtp -69.4 -36.58 76.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.31 -0.244 . . . . 0.0 111.218 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.531 ' HB3' HD13 ' A' ' 60' ' ' ILE . 23.3 m -99.48 33.73 2.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.69 119.23 9.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.115 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.43 31.99 62.7 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.525 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 26' ' ' CYS . 24.5 mtpp -103.76 122.86 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 14.0 t -62.06 115.89 18.56 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.165 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.523 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 8.1 Cg_exo -73.29 50.16 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.63 2.887 . . . . 0.0 112.716 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mm -149.86 -48.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.3 p -112.94 -14.84 12.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.085 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 65.82 80.95 0.21 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.599 0.714 . . . . 0.0 109.939 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -165.65 146.91 7.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.99 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.72 14.1 12.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.477 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.22 150.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 16.5 ptm180 -37.5 126.98 0.89 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 124.001 0.92 . . . . 0.0 113.383 -174.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.4 Cg_exo -71.55 -163.54 0.13 Allowed 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.429 2.753 . . . . 0.0 112.478 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -169.0 -52.53 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.235 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -140.11 141.89 36.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.76 ' HD3' HG22 ' A' ' 19' ' ' THR . 39.6 ttmt -69.06 140.13 54.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.948 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.667 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 12.4 m -77.95 148.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.799 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.57 129.23 50.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.044 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.483 HG23 ' OG ' ' A' ' 50' ' ' SER . 5.1 m -93.73 146.52 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.025 0.441 . . . . 0.0 111.343 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.625 ' HA ' ' H ' ' A' ' 16' ' ' GLY . 4.6 p -69.91 165.33 21.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 49' ' ' CYS . 20.9 tt0 -59.47 -41.06 88.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.176 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.851 ' HB2' ' HE2' ' A' ' 13' ' ' LYS . 3.7 m120 -74.52 40.3 0.13 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.502 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 15.6 m -151.35 -52.3 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.75 174.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.483 ' OG ' HG23 ' A' ' 45' ' ' VAL . 51.5 m -100.21 44.17 1.03 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.737 0.779 . . . . 0.0 110.025 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.202 -178.799 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -93.35 149.74 21.0 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.769 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.709 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.8 t -48.3 129.39 15.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.922 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.404 ' HA ' HH11 ' A' ' 88' ' ' ARG . 8.5 pt -65.89 -31.6 54.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.482 -174.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 26' ' ' CYS . 51.4 mt -77.17 -47.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.74 -4.5 15.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.835 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 40.06 47.91 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.59 0.756 . . . . 0.0 112.651 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.53 -57.25 0.28 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.023 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -76.75 146.69 37.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.716 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.18 131.36 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 110.162 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.17 139.47 25.02 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.991 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.63 -40.05 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 111.447 0.165 . . . . 0.0 111.447 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.75 138.95 33.53 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.33 129.94 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.581 ' CB ' HG21 ' A' ' 43' ' ' VAL . . . -80.28 148.99 30.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.452 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 7.9 m-85 -128.01 133.77 49.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.667 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 53.7 m-85 -68.38 132.44 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -68.63 153.02 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -53.19 -38.33 62.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.789 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.82 -45.79 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.611 0.243 . . . . 0.0 111.385 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.6 m -67.68 -37.77 82.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.086 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.5 t -61.85 -42.64 99.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -57.34 -50.23 73.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.889 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.18 -27.59 62.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.576 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.17 30.71 21.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.404 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -78.99 -27.5 43.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -67.21 -41.72 85.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.096 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -85.01 26.58 0.84 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 12' ' ' LEU . 49.4 t0 -80.39 -53.65 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.461 ' N ' HD11 ' A' ' 12' ' ' LEU . . . 179.32 -149.64 8.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.451 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 30.3 t -67.26 121.05 76.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.663 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 85.3 Cg_endo -80.91 43.42 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.93 3.087 . . . . 0.0 113.446 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.5 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 14.9 mmm180 -102.14 143.7 31.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.999 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.432 ' HA ' HD12 ' A' ' 89' ' ' ILE . 50.0 mm . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.637 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 3.8 ptp . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 120.906 0.384 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -37.54 75.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.787 -174.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 53.8 mt 56.16 34.3 23.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 171.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 61.6 mttm -77.53 -169.36 1.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.533 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.24 113.63 45.23 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.514 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 27.7 Cg_exo -63.91 144.84 89.26 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.442 2.762 . . . . 0.0 112.809 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.08 -142.64 11.06 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.841 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.588 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 8.3 p -82.24 -35.65 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.127 0.489 . . . . 0.0 110.669 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.433 ' N ' HG13 ' A' ' 17' ' ' VAL . 4.8 mp0 -61.38 127.27 30.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.902 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 43' ' ' VAL . 1.0 OUTLIER -85.55 140.24 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.275 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.46 121.38 9.88 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.44 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 26.2 mt -78.53 153.82 30.95 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.548 0.69 . . . . 0.0 112.548 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.656 HD22 ' CB ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -135.81 127.01 28.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.677 -171.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.479 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 1.7 p -80.06 144.87 32.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 93.1 mt-10 -55.17 -26.06 36.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -65.51 -36.33 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.581 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.0 m -94.81 -17.98 21.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.4 t0 -52.05 121.6 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.509 -172.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.78 -32.88 5.47 Favored Glycine 0 C--N 1.316 -0.58 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.26 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -71.13 128.39 35.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.447 -0.376 . . . . 0.0 110.866 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.6 t -74.8 119.67 77.88 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.8 -36.15 90.1 Favored 'Trans proline' 0 N--CA 1.472 0.264 0 C-N-CA 123.174 2.582 . . . . 0.0 113.331 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.4 mm -65.41 -44.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.7 p -121.55 -11.49 8.68 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 62.79 72.4 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.957 0.408 . . . . 0.0 111.181 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -162.67 141.8 8.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.856 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -83.31 45.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.306 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.619 HG23 ' N ' ' A' ' 38' ' ' ARG . 5.9 p -92.79 154.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.245 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.619 ' N ' HG23 ' A' ' 37' ' ' VAL . 88.7 mtt180 -35.16 124.81 0.58 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.356 1.062 . . . . 0.0 113.584 -173.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.79 146.89 38.79 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.144 2.563 . . . . 0.0 111.825 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 57.7 tptt -127.45 -49.27 1.41 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.697 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -138.09 138.69 38.97 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.937 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.561 ' HG2' ' CE2' ' A' ' 71' ' ' PHE . 32.5 mtpt -65.25 136.04 56.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.322 0.582 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.602 ' O ' HG21 ' A' ' 19' ' ' THR . 26.0 t -79.92 124.72 38.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.162 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.588 ' NH1' ' HA ' ' A' ' 17' ' ' VAL . 72.7 mtt-85 -107.05 133.34 51.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.059 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.95 147.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.967 0.413 . . . . 0.0 110.118 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 p -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.17 -42.8 14.49 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.912 0.758 . . . . 0.0 111.721 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.3 m120 -60.28 -41.12 92.65 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.64 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 74.0 m -85.8 53.37 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 t -160.72 -46.85 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.427 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.489 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -65.75 143.34 57.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.402 0.62 . . . . 0.0 111.551 -173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.5 t -64.05 125.89 25.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.676 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -63.3 -32.43 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.3 mt -73.52 -41.3 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -173.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 6.3 p -93.5 -25.11 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.227 174.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 t30 61.43 44.59 9.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.745 0.784 . . . . 0.0 109.656 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -164.18 -59.27 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.42 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 74.9 m-80 -71.82 146.22 48.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -66.93 136.19 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.386 . . . . 0.0 111.09 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -88.51 142.34 17.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 22' ' ' LEU . 15.4 m -117.17 -38.53 2.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.685 0.279 . . . . 0.0 111.594 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' LEU . 80.5 m-20 -109.93 -168.52 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.527 ' HB3' HG22 ' A' ' 19' ' ' THR . 64.0 m-20 -115.02 145.73 41.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.025 0.441 . . . . 0.0 110.513 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.656 ' CB ' HD22 ' A' ' 22' ' ' LEU . . . -75.86 152.28 37.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.709 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' CE2' ' HG2' ' A' ' 42' ' ' LYS . 32.0 m-85 -132.08 131.47 42.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.192 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.469 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -70.67 128.75 37.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.487 ' HB2' HG13 ' A' ' 37' ' ' VAL . 7.1 p -73.6 158.4 34.85 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.868 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 27.8 t90 -47.97 -49.74 29.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.536 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 5.5 pt-20 -68.45 -36.5 79.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 34.7 m -63.23 -42.25 99.2 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.584 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 97.4 m -68.1 -41.1 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.701 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -63.26 -42.47 99.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -72.24 -30.13 64.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.248 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.83 4.29 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.033 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -96.24 -32.61 12.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 109.979 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -64.06 -34.99 79.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.614 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 7.47 2.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.953 -176.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -76.47 -56.41 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.07 -147.33 12.35 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.433 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 2.0 t -70.59 114.44 26.38 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 124.302 1.041 . . . . 0.0 112.389 -174.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.51 ' CG ' HG12 ' A' ' 43' ' ' VAL . 96.0 Cg_endo -93.33 42.11 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.073 2.515 . . . . 0.0 114.887 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.64 ' HD2' ' HB3' ' A' ' 49' ' ' CYS . 39.9 mtt-85 -74.58 128.42 35.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.024 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.8 mm . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 0.0 111.225 -178.66 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.567 ' HG3' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.72 0.771 . . . . 0.0 112.052 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.4 t -52.84 -39.75 62.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.67 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp 43.29 46.44 5.38 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 171.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -88.89 -152.66 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 46' ' ' CYS . 67.3 tp60 -86.3 115.17 61.05 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 48.9 Cg_exo -58.94 136.17 71.69 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.084 2.523 . . . . 0.0 112.852 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.69 -112.29 0.89 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.445 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 p -146.26 -26.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.781 0.324 . . . . 0.0 110.881 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 56.2 mt-30 -66.35 131.7 46.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.324 0.583 . . . . 0.0 111.45 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -76.33 135.52 39.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.888 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.2 118.72 5.66 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.233 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 91.8 mt -90.8 143.67 26.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.144 0.497 . . . . 0.0 111.648 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 HD13 ' A' ' 60' ' ' ILE . 80.9 mt -104.04 133.63 48.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.743 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.658 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.3 p -71.27 154.26 41.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -48.64 -32.27 8.02 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.484 0.49 . . . . 0.0 112.269 -176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -70.81 -43.21 69.1 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.466 ' HB3' HD11 ' A' ' 60' ' ' ILE . 33.7 m -89.72 -11.32 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -54.86 115.5 2.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.764 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.7 -31.31 5.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.6 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -77.32 127.59 32.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.4 t -68.14 118.27 57.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 3.2 Cg_endo -52.93 -41.29 72.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.221 2.614 . . . . 0.0 113.652 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.937 HG22 ' HG2' ' A' ' 81' ' ' LYS . 1.4 mm -68.75 -48.44 71.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -110.5 -7.94 14.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 58.88 71.46 0.58 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.295 0.569 . . . . 0.0 110.266 -177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.7 t -160.04 139.51 11.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.112 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -85.62 30.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 38' ' ' ARG . 7.7 p -80.51 148.82 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.444 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.534 ' N ' HG23 ' A' ' 37' ' ' VAL . 38.0 mtp85 -36.93 119.96 0.8 Allowed Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.8 Cg_endo -80.63 150.65 19.1 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.341 2.694 . . . . 0.0 112.207 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -137.59 -69.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.643 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 20.7 tpp180 -78.86 131.62 36.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.022 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -69.03 133.46 48.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.215 0.531 . . . . 0.0 110.613 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 70' ' ' ALA . 3.1 t -76.88 126.22 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.866 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -125.04 127.95 47.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.779 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 59' ' ' ILE . 6.8 m -85.53 158.44 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 0.0 111.257 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.696 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.9 p -65.45 148.79 51.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -54.02 -30.89 49.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.249 0.343 . . . . 0.0 111.686 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.662 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 64.7 m-80 -59.83 -34.2 72.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.476 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.89 35.5 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.717 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.555 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 14.8 m -140.57 -45.16 0.4 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.304 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.729 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.691 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 72.0 m-20 -61.05 142.54 56.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.658 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 42.3 t -51.03 133.39 27.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.89 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.413 HG21 ' CG1' ' A' ' 45' ' ' VAL . 7.6 pt -78.43 -26.58 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.518 -175.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.654 HD13 HD23 ' A' ' 22' ' ' LEU . 48.9 mt -78.2 -48.24 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 63' ' ' LEU . 28.2 p -103.03 -6.75 22.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.764 -0.775 . . . . 0.0 110.834 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 12.9 m-80 70.05 -36.08 0.34 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.745 0.818 . . . . 0.0 111.581 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.571 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -78.65 -63.22 1.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.559 -166.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -68.23 148.62 50.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.742 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -73.93 137.02 24.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.721 0.295 . . . . 0.0 110.688 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 144.35 27.25 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.875 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 68' ' ' ASN . 27.2 m -115.29 -47.63 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.425 ' H ' HG22 ' A' ' 67' ' ' VAL . 73.6 m-20 -114.75 135.68 53.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.289 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.89 134.62 55.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.781 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB2' HG22 ' A' ' 43' ' ' VAL . . . -77.37 153.05 34.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.475 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.461 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 11.2 m-85 -134.55 135.1 42.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.521 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -66.55 130.29 42.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.9 p -68.97 162.51 26.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -51.18 -44.03 61.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.105 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.504 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -59.82 -47.67 84.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.741 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 68.4 m -67.51 -37.92 83.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.298 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 77.0 m -62.55 -42.88 99.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.798 0.332 . . . . 0.0 110.504 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.05 -42.25 99.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 68.6 mt -70.28 -33.44 71.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.5 7.83 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.847 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.937 ' HG2' HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -66.73 -25.58 66.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.796 0.331 . . . . 0.0 111.564 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.643 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . 26.5 p-10 -65.76 -43.52 88.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.756 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -83.94 -9.0 59.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.916 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 6.4 m-20 -60.03 -49.49 77.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.12 7.92 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.041 -1.075 . . . . 0.0 113.706 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.696 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 41.4 t -69.38 117.97 57.75 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.412 -0.894 . . . . 0.0 111.85 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -86.45 24.94 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 123.201 2.601 . . . . 0.0 113.261 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' MET . 2.0 mmt180 -73.82 124.49 26.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.404 HD11 ' CE ' ' A' ' 10' ' ' MET . 27.0 mm . . . . . 0 C--N 1.32 -0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.837 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.4 t -111.14 -54.75 2.57 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.881 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 56.8 mt 48.56 33.16 3.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.047 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -86.24 -179.74 6.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mm-40 -67.93 116.05 34.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.688 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.2 Cg_exo -72.4 142.57 37.26 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.431 2.754 . . . . 0.0 112.975 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.45 -133.35 4.43 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.925 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.423 HG23 ' OE1' ' A' ' 18' ' ' GLN . 27.2 m -105.56 -27.08 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.658 0.266 . . . . 0.0 111.329 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.423 ' OE1' HG23 ' A' ' 17' ' ' VAL . 14.4 mp0 -64.6 131.65 47.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 111.163 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.69 HG22 ' HD3' ' A' ' 42' ' ' LYS . 6.6 m -83.13 140.91 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.026 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.4 133.07 14.08 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.687 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 71.7 mt -95.64 143.79 26.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.173 0.511 . . . . 0.0 112.358 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 HG12 ' A' ' 59' ' ' ILE . 53.2 mt -113.93 139.28 49.35 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.374 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.536 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 8.6 p -72.62 151.62 42.22 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -49.32 -34.67 16.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.923 0.392 . . . . 0.0 111.595 -175.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -71.46 -26.45 62.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 56.9 m -101.2 -16.08 17.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.453 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -51.94 115.77 1.85 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.258 0.552 . . . . 0.0 111.201 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 36' ' ' TYR . . . 122.29 -30.93 5.05 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.951 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 40.0 mttm -72.12 127.72 33.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.57 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 2.5 t -71.08 120.42 79.42 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HG2' HG13 ' A' ' 43' ' ' VAL . 71.8 Cg_exo -53.1 -35.54 73.05 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.827 2.351 . . . . 0.0 112.964 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mm -67.84 -46.68 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.363 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.7 p -118.46 -2.94 10.97 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.6 t70 59.13 67.8 0.88 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.284 0.564 . . . . 0.0 110.69 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.02 143.34 15.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.022 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 28' ' ' GLY . 2.1 m-85 -83.39 13.31 4.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.091 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 38' ' ' ARG . 13.1 p -60.67 149.64 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.8 ptp85 -38.88 128.77 1.18 Allowed Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.098 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 Cg_exo -74.83 -161.38 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.437 2.758 . . . . 0.0 112.724 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -167.78 -43.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.728 178.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 -153.83 142.53 20.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 111.196 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.69 ' HD3' HG22 ' A' ' 19' ' ' THR . 87.0 mttt -62.54 143.08 57.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.473 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.967 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 18.0 m -82.08 146.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -118.98 133.51 55.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.073 0.463 . . . . 0.0 110.78 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.7 m -86.9 146.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.667 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.688 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 10.2 p -66.16 151.39 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -52.02 -37.17 52.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.884 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.483 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 16.9 m-80 -64.67 -20.19 66.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 19.6 m -90.2 -41.01 11.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.274 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -68.82 -30.27 68.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.3 mttm . . . . . 0 CA--C 1.515 -0.383 0 CA-C-O 120.858 0.361 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 13.8 p30 -71.62 138.85 49.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.536 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.1 t -42.7 126.29 3.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.931 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.456 HG12 HD23 ' A' ' 22' ' ' LEU . 9.5 pt -61.21 -32.03 51.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.986 -1.007 . . . . 0.0 113.128 -171.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.99 -45.16 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -103.94 -7.35 20.46 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.684 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 42.04 51.33 4.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.708 0.803 . . . . 0.0 112.387 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HA ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -155.04 -66.13 0.13 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.085 -177.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -71.24 139.41 50.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.51 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 13.8 p -66.67 136.4 26.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.432 . . . . 0.0 111.448 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.51 141.66 25.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.381 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.1 m -118.87 -46.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -116.91 147.23 42.4 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.648 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.36 142.62 58.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.579 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.32 155.59 25.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.904 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.527 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 18.3 m-85 -127.84 137.28 52.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.595 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 91.1 m-85 -69.76 125.39 26.58 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 1.8 p -71.21 152.75 43.04 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.269 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.503 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.65 -44.19 62.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.092 -177.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -56.15 -46.8 79.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.527 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -72.6 -38.56 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.5 t -67.14 -39.98 86.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 110.397 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.27 -32.27 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.403 0.621 . . . . 0.0 109.905 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 101.82 41.21 2.53 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.106 176.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -94.74 1.26 55.46 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.279 -0.542 . . . . 0.0 110.722 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.48 -23.52 62.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.547 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -96.21 9.54 40.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.136 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -68.05 -65.91 0.63 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.96 -154.4 24.38 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.407 170.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.626 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 54.1 t -57.93 115.41 11.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.211 -0.994 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.967 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 71.8 Cg_endo -78.29 17.42 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.286 2.658 . . . . 0.0 113.312 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.555 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 14.0 mmm180 -67.98 136.41 53.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.837 ' HA ' ' HA ' ' A' ' 10' ' ' MET . 28.9 mm . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 118.408 0.549 . . . . 0.0 111.345 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.511 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.3 ptp . . . . . 0 N--CA 1.447 -0.625 0 CA-C-O 121.502 0.668 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 7.6 t -44.69 -59.9 2.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.383 -1.735 . . . . 0.0 112.625 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' A' ' 84' ' ' ASP . 81.7 mt 52.48 32.18 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.935 0.894 . . . . 0.0 113.225 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -80.75 -177.92 6.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.83 115.52 25.77 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 6.5 Cg_exo -74.99 140.1 25.09 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.991 2.461 . . . . 0.0 112.873 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.07 -145.3 10.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.214 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.6 -5.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.518 -0.401 . . . . 0.0 110.606 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.548 ' HB2' HG23 ' A' ' 45' ' ' VAL . 6.5 mm100 -62.01 130.36 45.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.177 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.409 HG22 ' HD3' ' A' ' 42' ' ' LYS . 1.3 m -79.17 137.83 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.301 -177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.26 125.66 7.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.341 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.482 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 81.9 mt -100.08 145.8 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.241 0.543 . . . . 0.0 112.407 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 70' ' ' ALA . 85.8 mt -114.04 133.01 55.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.572 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.5 p -72.14 157.95 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -53.01 -27.44 19.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.884 0.374 . . . . 0.0 111.842 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 50.7 mtpt -75.43 -24.14 57.05 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.321 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 8.9 m -119.05 18.46 13.14 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.9 129.54 40.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.763 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.52 -22.33 37.99 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.664 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 60.3 mttp -74.82 133.03 41.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.643 0.259 . . . . 0.0 111.021 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.6 t -70.9 121.01 82.76 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 12.0 Cg_endo -58.35 -34.33 98.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.976 2.451 . . . . 0.0 113.142 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 13.0 mm -69.89 -46.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.212 -175.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.5 p -122.66 -7.57 8.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 60.87 78.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.341 0.591 . . . . 0.0 110.367 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -160.54 143.95 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.398 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -94.63 26.9 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.668 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 73' ' ' CYS . 4.4 p -75.96 168.84 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.597 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 3.2 mtp-105 -50.49 129.23 25.72 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 38' ' ' ARG . 5.7 Cg_exo -73.28 158.57 48.43 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.19 2.593 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HG3' ' HE3' ' A' ' 74' ' ' TRP . 11.9 tmtt? -142.94 -49.77 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.273 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HD3' ' OD2' ' A' ' 82' ' ' ASP . 67.9 ttt180 -122.31 130.54 53.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.683 0.278 . . . . 0.0 111.071 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 19' ' ' THR . 40.2 ttmt -67.71 136.6 54.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.17 0.509 . . . . 0.0 110.648 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.585 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.2 t -75.44 134.68 28.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.984 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -124.46 130.19 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 18' ' ' GLN . 35.5 m -92.29 155.68 3.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.047 0.451 . . . . 0.0 111.249 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.5 p -66.3 151.34 47.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.222 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -53.06 -39.62 63.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.355 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.612 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.1 m120 -55.87 -44.71 78.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.256 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 33.6 m -66.95 -25.06 66.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 t -87.24 -51.01 6.21 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.628 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.612 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.306 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 11.5 mmpt? . . . . . 0 CA--C 1.519 -0.238 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 84.6 m-20 -84.35 154.46 22.86 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.733 0.777 . . . . 0.0 111.398 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.0 t -53.2 136.27 36.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.106 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 11.1 pt -77.76 -32.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.768 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.472 HD13 HG21 ' A' ' 60' ' ' ILE . 46.8 mt -73.26 -48.58 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -108.2 11.8 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.306 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 7.3 p-10 53.79 -37.11 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.951 HD13 ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -93.12 -46.75 7.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 119.665 1.121 . . . . 0.0 113.888 -171.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.951 ' H ' HD13 ' A' ' 63' ' ' LEU . 4.3 m120 -67.73 135.56 52.9 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 11.7 p -59.44 134.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 111.55 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.5 144.66 19.9 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.274 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.01 -42.57 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -113.43 139.21 49.1 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.966 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -64.36 138.16 58.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.215 0.531 . . . . 0.0 111.104 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' CG ' ' A' ' 22' ' ' LEU . . . -83.33 154.01 24.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.072 176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -131.76 135.13 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.88 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 46.3 m-85 -68.63 127.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.502 ' HB2' HG12 ' A' ' 37' ' ' VAL . 4.9 p -70.87 156.75 39.2 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.569 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.496 ' HE3' ' HG3' ' A' ' 40' ' ' LYS . 9.5 t-105 -41.17 -60.27 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.007 0.817 . . . . 0.0 112.804 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.16 -35.85 78.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.209 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 23.5 m -62.81 -35.94 81.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 111.245 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.3 m -70.99 -37.95 72.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.211 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -49.21 76.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.39 175.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.16 -32.62 71.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.771 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.9 43.92 9.55 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.504 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -95.32 -31.07 13.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.187 0.518 . . . . 0.0 110.068 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.412 ' OD2' ' HD3' ' A' ' 41' ' ' ARG . 43.7 p-10 -65.94 -30.93 71.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.429 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HD2' ' C ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -64.38 -19.12 65.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.582 -176.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.6 ' HB3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -64.62 -42.58 95.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.389 -177.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.04 -136.29 6.28 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.876 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 36.8 t -60.38 113.36 7.31 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.362 1.065 . . . . 0.0 112.159 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.448 ' HG3' HG12 ' A' ' 43' ' ' VAL . 69.4 Cg_endo -86.51 43.9 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.033 2.489 . . . . 0.0 113.827 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.626 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 45.9 mtt180 -98.67 127.88 44.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.94 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.32 -0.682 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.016 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.0 t -45.72 -53.84 8.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 111.522 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.494 ' HB2' ' HG3' ' A' ' 10' ' ' MET . 2.6 tp 41.99 41.05 1.8 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 170.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 64.0 mttm -79.65 -134.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -109.93 116.65 53.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HD3' ' HA2' ' A' ' 85' ' ' GLY . 52.0 Cg_exo -56.14 135.72 71.4 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.217 -175.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.16 -136.14 8.05 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.393 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.67 -24.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -80.86 137.44 36.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -78.25 137.91 38.35 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.988 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.75 133.22 13.25 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.491 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 64.2 mt -95.29 147.36 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 111.913 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.422 ' HA ' HD21 ' A' ' 22' ' ' LEU . 79.4 mt -117.12 132.28 56.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.376 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 6.9 p -71.9 158.24 36.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 39.8 mt-10 -55.75 -28.01 53.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.0 111.561 -176.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 55.0 mttp -71.81 -24.44 61.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.413 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.6 ' HB3' HD13 ' A' ' 60' ' ' ILE . 5.6 m -119.66 18.33 12.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 32.7 t70 -67.51 131.49 45.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.554 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.49 -27.54 6.31 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.83 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 61.9 mttp -66.75 132.02 47.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.584 0.231 . . . . 0.0 111.027 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 t -71.17 118.01 61.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HG2' HG23 ' A' ' 43' ' ' VAL . 68.0 Cg_exo -56.41 -39.85 88.51 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.157 2.571 . . . . 0.0 113.383 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.57 HG21 ' HD3' ' A' ' 81' ' ' LYS . 6.8 mm -61.54 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.209 -174.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -119.47 -16.51 8.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 66.94 77.97 0.26 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.59 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -171.34 145.86 2.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.996 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -97.45 31.23 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 73' ' ' CYS . 7.7 p -76.79 70.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 122.31 1.053 . . . . 0.0 111.83 -173.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.442 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.8 mmp_? 60.14 111.63 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.776 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.36 144.03 66.22 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.719 2.279 . . . . 0.0 112.132 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -128.68 -48.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -139.81 144.9 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.439 -0.163 . . . . 0.0 111.202 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 92.9 mttt -63.94 138.31 58.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.316 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.788 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.0 t -73.53 131.84 34.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.687 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.0 OUTLIER -113.18 124.69 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 59' ' ' ILE . 27.6 m -91.61 150.92 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.404 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 11.7 p -62.0 150.14 38.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -51.78 -34.83 41.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.103 -177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.7 m120 -58.24 -45.51 87.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.58 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 99.3 m -74.99 -15.01 60.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -85.49 -45.62 11.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.263 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.824 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.784 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.4 m-80 -78.26 158.82 28.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.3 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.5 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.397 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 45' ' ' VAL . 7.7 pt -70.62 -38.09 72.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.976 -173.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.6 HD13 ' HB3' ' A' ' 26' ' ' CYS . 43.4 mt -69.95 -54.85 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -90.36 -6.47 54.99 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.793 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 48.99 24.29 0.85 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.932 0.893 . . . . 0.0 112.393 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.91 -59.83 0.74 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.319 -170.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -76.14 140.53 41.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 42.9 t -58.56 137.76 20.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 111.107 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.88 149.17 45.87 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.049 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.4 -62.19 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.757 0.313 . . . . 0.0 111.28 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.44 143.19 45.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.28 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -60.48 136.78 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.71 156.06 23.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.325 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -128.8 133.68 48.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.14 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.788 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.3 m-85 -67.27 130.85 44.4 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.424 ' HB2' HG12 ' A' ' 37' ' ' VAL . 11.2 p -73.48 167.97 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -55.69 -49.17 73.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' CG ' ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt-20 -63.26 -39.58 95.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -175.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 69.4 m -66.25 -40.03 89.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.899 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 21.3 t -68.07 -36.99 80.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.25 0.548 . . . . 0.0 109.89 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -60.61 -44.24 96.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 79' ' ' LEU . 90.8 mt -70.05 -31.49 69.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.874 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.76 8.44 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.01 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HD3' HG21 ' A' ' 32' ' ' ILE . 43.1 mttm -87.84 7.51 30.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.708 0.766 . . . . 0.0 110.294 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -92.8 -10.94 35.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.847 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.67 -26.25 7.52 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.081 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -64.98 -54.83 24.34 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.951 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 15' ' ' PRO . . . -158.56 -158.55 9.09 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.999 -1.572 . . . . 0.0 115.152 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.617 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 1.6 t -95.17 120.04 64.75 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.792 -1.204 . . . . 0.0 111.47 -173.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.817 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 71.6 Cg_endo -75.5 47.02 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.922 3.081 . . . . 0.0 114.166 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.58 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 17.9 mmt180 -101.95 126.67 48.92 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 C--N 1.315 -0.918 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.508 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.593 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 7.1 ptp . . . . . 0 C--O 1.233 0.205 0 CA-C-O 121.37 0.605 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -42.57 -56.53 3.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.559 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.593 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 86.8 mt 52.39 41.0 30.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 84.4 mttt -77.1 -176.96 4.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 167.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.445 ' NE2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -70.09 116.11 40.99 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.725 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 28.6 Cg_endo -72.15 142.85 38.76 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.386 2.057 . . . . 0.0 112.765 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.57 -157.43 28.7 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.007 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.85 -23.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.11 0.481 . . . . 0.0 110.893 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -63.65 128.49 36.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.034 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.8 HG21 ' HD3' ' A' ' 42' ' ' LYS . 20.2 m -82.58 136.33 34.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.601 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' CA ' HG11 ' A' ' 45' ' ' VAL . . . -66.51 126.16 27.26 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.923 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.445 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 63.8 mt -80.96 141.85 34.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 112.14 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 70.2 mt -118.4 143.91 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.186 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 11.5 p -80.14 157.55 26.58 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.4 -26.55 42.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.07 0.462 . . . . 0.0 111.386 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.1 mmtt -71.52 -27.3 63.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.409 ' O ' HD12 ' A' ' 22' ' ' LEU . 34.2 m -108.84 26.22 10.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.06 127.46 31.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.4 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.61 32.84 61.32 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.421 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HE2' ' HE1' ' A' ' 36' ' ' TYR . 94.4 mttt -111.83 140.22 46.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.675 0.274 . . . . 0.0 110.902 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 10.7 t -82.36 114.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.942 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.83 -29.43 89.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.978 2.452 . . . . 0.0 112.957 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 81' ' ' LYS . 21.2 mm -65.23 -40.94 90.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.09 -12.28 6.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 t0 62.2 74.38 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -163.25 141.36 7.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.106 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.485 ' HE1' ' HE2' ' A' ' 29' ' ' LYS . 13.2 m-85 -85.75 33.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 p -78.78 158.02 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -41.51 128.85 2.31 Favored Pre-proline 0 N--CA 1.467 0.379 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 96.1 Cg_endo -82.53 154.3 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.32 2.68 . . . . 0.0 112.048 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 20.8 tptm -127.21 -40.62 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -150.45 139.68 21.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.306 -0.246 . . . . 0.0 111.166 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.8 ' HD3' HG21 ' A' ' 19' ' ' THR . 71.2 mttt -59.96 139.33 57.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 111.714 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.776 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.9 t -71.34 133.37 31.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.114 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.497 ' HB2' ' NH1' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -109.78 126.85 54.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.918 175.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG11 ' CA ' ' A' ' 20' ' ' GLY . 16.4 m -102.07 154.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.722 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -66.84 141.29 57.73 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.26 -22.61 53.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.7 -32.11 73.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.301 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.3 m -92.1 41.58 1.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.602 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -138.69 -41.98 0.49 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.556 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.732 176.627 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 21.8 mmtp . . . . . 0 CA--C 1.512 -0.505 0 CA-C-O 120.925 0.393 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.855 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.0 m-20 -68.89 140.92 55.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.467 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 10.4 t -48.54 131.53 17.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.016 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 88' ' ' ARG . 24.1 pt -70.19 -32.88 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.429 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.66 HD12 HD21 ' A' ' 22' ' ' LEU . 22.2 mt -72.64 -44.32 60.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.3 p -107.12 -3.81 19.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.984 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 41.47 45.02 2.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.415 0.686 . . . . 0.0 112.621 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.9 -60.61 0.26 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.211 0.529 . . . . 0.0 110.654 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -82.32 138.54 34.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.488 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.855 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 46.8 t -61.32 137.27 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.59 -179.41 49.5 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.148 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -174.12 -39.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.597 0.713 . . . . 0.0 109.31 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.705 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 8.1 m120 -82.83 176.75 9.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.387 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -118.92 135.48 54.56 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB3' HG22 ' A' ' 43' ' ' VAL . . . -78.38 146.25 34.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -126.55 133.02 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 64.2 m-85 -69.33 120.8 15.71 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 7.0 p -70.03 162.1 28.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.468 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 4.9 t-105 -43.4 -55.95 3.84 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 124.206 0.941 . . . . 0.0 112.1 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.81 -46.77 88.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.92 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' HG23 ' A' ' 32' ' ' ILE . 96.1 m -66.53 -40.86 89.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.079 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 t -67.51 -40.51 85.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.617 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -62.97 -43.6 98.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.881 0.372 . . . . 0.0 110.505 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.71 -27.12 62.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.067 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.07 44.46 13.81 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.564 ' O ' HG22 ' A' ' 32' ' ' ILE . 29.3 mtpp -93.12 31.41 1.45 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.955 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.39 -1.32 8.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.575 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 94.0 mttt 58.73 30.48 20.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.393 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 23.0 t70 82.42 -36.34 0.09 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.621 174.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.725 ' HA2' ' HG3' ' A' ' 15' ' ' PRO . . . -165.48 -134.15 1.62 Allowed Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 118.448 -1.834 . . . . 0.0 115.468 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 13.3 t -50.63 103.09 0.35 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 113.772 -1.214 . . . . 0.0 113.03 -169.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 57.7 Cg_endo -91.28 44.61 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.563 2.842 . . . . 0.0 113.113 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.458 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.1 ptm180 -110.94 136.7 49.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.315 -175.418 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.664 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 121.395 0.617 . . . . 0.0 111.402 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.544 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 30.9 t -50.53 -54.22 24.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.222 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.664 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 81.1 mt 48.34 40.79 15.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.544 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 50.9 mttm -79.97 -156.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 4.9 mm100 -83.16 111.17 28.58 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 171.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 59.6 Cg_endo -80.98 138.33 11.43 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.006 1.804 . . . . 0.0 112.417 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.91 -139.42 9.65 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.047 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -89.46 -16.9 8.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 110.284 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.727 ' HB2' HG13 ' A' ' 45' ' ' VAL . 3.7 mm100 -56.93 132.88 54.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.149 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.448 HG21 ' OD2' ' A' ' 69' ' ' ASP . 12.7 m -107.61 127.3 53.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.212 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 59' ' ' ILE . . . -71.7 114.67 5.21 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.256 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.683 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.1 mt -87.07 154.03 21.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.688 0.28 . . . . 0.0 110.587 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.579 HD21 HD12 ' A' ' 60' ' ' ILE . 76.8 mt -113.74 130.21 56.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p -75.2 157.03 35.18 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 51.2 mt-10 -54.9 -28.39 50.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.964 0.412 . . . . 0.0 111.69 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.7 mtpt -72.43 -27.97 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.165 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.8 31.79 6.49 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.9 t0 -73.76 133.91 43.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.343 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.85 32.29 66.68 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.035 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 22.9 mtpp -119.46 122.04 40.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 25.3 t -63.29 118.66 45.72 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.48 -37.3 97.71 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.724 HG22 ' HG3' ' A' ' 81' ' ' LYS . 10.8 mm -64.08 -46.48 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.36 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 22.5 p -123.78 -8.47 7.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.3 t0 60.91 76.47 0.37 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.812 0.815 . . . . 0.0 110.428 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -151.36 143.25 23.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.477 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 29' ' ' LYS . 5.9 m-85 -96.5 23.98 6.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 110.299 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.35 161.8 4.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.201 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HD2' ' HD2' ' A' ' 39' ' ' PRO . 23.2 tpt180 -47.25 120.24 6.71 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.443 0.697 . . . . 0.0 112.559 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 86.2 Cg_endo -82.56 161.14 16.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.415 2.743 . . . . 0.0 111.815 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.484 ' HZ1' ' HB3' ' A' ' 40' ' ' LYS . 3.3 mmmp? -130.32 -59.25 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -116.41 136.94 52.56 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.839 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -67.73 136.74 54.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.742 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.609 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 17.9 m -79.98 151.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.917 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -124.45 127.55 47.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.159 173.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 18' ' ' GLN . 0.3 OUTLIER -92.54 153.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.608 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 1.8 p -72.83 148.32 44.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 86.5 tt0 -56.56 -27.44 57.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.035 0.445 . . . . 0.0 111.068 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.543 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 7.5 m-80 -63.84 -26.69 68.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.112 177.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.487 ' HB3' ' NE ' ' A' ' 88' ' ' ARG . 87.6 m -102.68 33.1 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.22 -0.3 . . . . 0.0 111.679 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.5 ' OG ' ' HG3' ' A' ' 18' ' ' GLN . 12.0 p -160.9 -50.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.573 -173.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 124.137 0.975 . . . . 0.0 111.847 -175.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.207 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.23 141.17 39.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.376 1.084 . . . . 0.0 113.353 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.0 t -69.93 135.12 49.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.442 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.557 HG22 HG22 ' A' ' 45' ' ' VAL . 3.7 pt -71.92 -31.87 42.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.579 HD12 HD21 ' A' ' 22' ' ' LEU . 52.9 mt -70.28 -51.41 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 21.7 p -91.38 -7.4 50.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.685 176.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 6.7 p-10 47.25 40.2 9.9 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 124.436 1.085 . . . . 0.0 111.57 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HA ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -157.41 -60.63 0.09 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.525 -177.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.591 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 5.7 m120 -60.21 144.58 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 34.5 t -61.56 119.37 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 111.075 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.22 142.78 26.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.464 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 -45.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -108.2 127.86 54.2 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.87 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.448 ' OD2' HG21 ' A' ' 19' ' ' THR . 1.1 m-20 -57.56 136.83 56.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.82 0.448 . . . . 0.0 110.961 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' A' ' 59' ' ' ILE . . . -76.93 146.28 37.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.774 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.495 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 6.9 m-85 -127.52 134.55 49.77 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.182 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.483 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 95.2 m-85 -62.98 124.92 22.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.7 p -69.14 161.17 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.856 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.477 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -46.84 -50.29 18.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.067 -177.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.28 -45.65 87.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.697 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 92.3 m -64.82 -33.25 75.54 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.307 -0.246 . . . . 0.0 111.013 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 32.0 t -67.59 -40.6 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.74 -44.64 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.895 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 79' ' ' LEU . 87.1 mt -68.14 -32.59 72.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.731 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.561 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . 89.51 46.93 4.18 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.724 ' HG3' HG22 ' A' ' 32' ' ' ILE . 27.4 mmmt -73.57 -14.96 61.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 110.742 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -64.53 -32.13 73.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -73.21 -21.63 60.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.837 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.1 -55.4 35.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.58 -137.01 7.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.866 -1.159 . . . . 0.0 114.132 171.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 45' ' ' VAL . 50.2 t -64.29 113.28 9.88 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.979 0.912 . . . . 0.0 111.835 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.609 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 83.0 Cg_endo -82.58 31.55 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.956 2.437 . . . . 0.0 114.381 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.487 ' NE ' ' HB3' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.22 139.58 38.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 C--N 1.327 -0.409 0 O-C-N 123.16 0.288 . . . . 0.0 110.763 -179.559 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.635 ' SD ' HD13 ' A' ' 12' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 1.6 t -37.76 -59.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.673 -172.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.635 HD13 ' SD ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 45.77 43.47 9.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.42 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 67.8 mttm -91.74 -147.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.649 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -95.64 111.29 55.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.025 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 71.7 Cg_exo -54.67 134.79 64.28 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.233 2.622 . . . . 0.0 113.296 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.45 -142.12 12.56 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.863 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.429 HG21 ' N ' ' A' ' 18' ' ' GLN . 31.2 m -96.94 -35.93 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 50' ' ' SER . 75.4 mt-30 -76.35 138.51 40.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.472 0.653 . . . . 0.0 112.111 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 42' ' ' LYS . 30.1 m -84.44 131.17 34.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.536 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 59' ' ' ILE . . . -66.36 137.52 35.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.711 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 86.2 mt -106.31 161.69 14.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.376 . . . . 0.0 111.658 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HG ' ' HB1' ' A' ' 70' ' ' ALA . 81.7 mt -123.24 131.2 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 11.5 p -73.36 161.01 30.95 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG3' HG22 ' A' ' 67' ' ' VAL . 70.6 mt-10 -62.07 -18.16 59.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.203 0.525 . . . . 0.0 111.347 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 56.4 mttm -78.24 -36.68 46.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.609 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.9 m -106.42 32.48 4.45 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.56 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 44.2 t0 -70.93 129.66 39.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.596 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.71 28.28 61.42 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.104 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -115.91 126.64 54.17 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.658 -0.319 . . . . 0.0 110.375 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.27 117.89 34.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 78.4 Cg_exo -55.61 -37.67 94.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.987 2.458 . . . . 0.0 113.136 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.452 HG23 ' HB3' ' A' ' 81' ' ' LYS . 7.3 mm -63.21 -49.48 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.1 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.9 p -116.27 -8.44 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.6 t0 63.28 68.65 0.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.056 0.455 . . . . 0.0 109.962 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -153.42 142.98 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.459 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -87.45 2.44 50.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.318 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -60.67 152.53 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.659 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -31.08 131.86 0.25 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.434 1.094 . . . . 0.0 113.463 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 88.0 Cg_endo -76.81 -160.84 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.509 . . . . 0.0 112.431 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HG2' ' SG ' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -169.75 -50.46 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.261 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -157.35 144.24 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.718 -174.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HB3' HG22 ' A' ' 19' ' ' THR . 94.0 mttt -61.59 141.73 57.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.039 0.447 . . . . 0.0 111.5 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.9 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 25.6 m -77.82 137.78 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.281 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -106.52 119.87 40.44 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.52 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.674 HG21 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -80.67 146.39 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.525 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 7.1 p -68.38 160.45 29.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.001 -177.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 49' ' ' CYS . 36.9 tt0 -60.47 -29.63 69.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.056 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.547 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 9.0 m120 -77.68 35.94 0.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.201 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.744 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 58.0 m -157.02 -38.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.339 174.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.476 ' CB ' ' HB2' ' A' ' 18' ' ' GLN . 76.3 p -92.31 34.41 1.04 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.933 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.453 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -73.0 148.68 43.96 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.572 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.7 t -59.47 116.81 4.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.482 HG23 ' HA3' ' A' ' 20' ' ' GLY . 2.0 pt -57.59 -30.44 36.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.046 -172.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 60' ' ' ILE . 31.2 mt -72.35 -44.1 63.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.7 p -101.04 -12.97 18.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.346 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 56.38 17.72 3.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.45 1.1 . . . . 0.0 111.723 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 -61.42 0.85 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 -172.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -71.79 142.25 49.68 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.56 133.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -73.62 139.22 26.14 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.714 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.603 HG22 ' HG3' ' A' ' 24' ' ' GLU . 45.3 t -109.94 -57.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.258 0.552 . . . . 0.0 111.07 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.14 136.81 43.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.303 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.435 ' HB3' HG21 ' A' ' 19' ' ' THR . 2.1 m-20 -64.08 128.87 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' A' ' 43' ' ' VAL . . . -74.26 144.27 44.69 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.973 0.416 . . . . 0.0 111.753 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -115.87 135.33 54.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.371 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.747 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 86.9 m-85 -64.98 132.62 49.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB2' HG12 ' A' ' 37' ' ' VAL . 3.5 p -74.65 154.83 38.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.532 ' HA ' ' SG ' ' A' ' 77' ' ' CYS . 56.5 t90 -53.2 -41.41 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.442 0.464 . . . . 0.0 111.659 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.496 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 50.0 mt-10 -59.62 -42.99 93.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.976 0.417 . . . . 0.0 110.542 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.443 ' SG ' HG21 ' A' ' 32' ' ' ILE . 59.4 m -67.67 -39.76 84.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.57 ' SG ' ' HG2' ' A' ' 40' ' ' LYS . 21.5 p -72.63 -34.2 67.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -63.38 -45.17 92.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 83.7 mt -73.93 -39.46 63.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.606 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.47 28.54 3.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.749 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.625 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 4.5 mttp -82.98 -25.24 32.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.138 0.494 . . . . 0.0 110.431 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.35 -32.33 73.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.272 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -94.84 8.39 42.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.212 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.625 ' OD2' ' HA ' ' A' ' 81' ' ' LYS . 2.6 m-20 -71.06 -48.15 54.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.99 -143.7 9.71 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.916 173.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.74 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 52.6 t -68.93 123.65 88.55 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 123.842 0.857 . . . . 0.0 111.42 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.9 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 69.3 Cg_endo -89.28 25.26 0.61 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.656 2.238 . . . . 0.0 114.945 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.744 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 50.4 mtt180 -80.18 141.4 35.71 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.006 -0.433 . . . . 0.0 111.231 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.8 mm . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.066 173.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.514 ' HG3' ' CD1' ' A' ' 12' ' ' LEU . 2.2 ptm . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 120.788 0.327 . . . . 0.0 111.547 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 9.1 t -54.14 -53.91 46.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.179 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.514 ' CD1' ' HG3' ' A' ' 10' ' ' MET . 0.9 OUTLIER 40.23 49.41 2.46 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 174.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 59.7 mttm -91.63 -149.56 0.24 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 170.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -100.3 122.57 49.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.336 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 70.1 Cg_exo -53.93 132.89 52.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.244 2.629 . . . . 0.0 112.535 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.87 -63.6 1.81 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.337 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 18' ' ' GLN . 7.4 p -176.53 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.414 ' N ' HG11 ' A' ' 17' ' ' VAL . 9.3 pt20 -71.25 145.65 49.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.778 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.458 HG22 ' HD3' ' A' ' 42' ' ' LYS . 28.4 m -78.97 139.07 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.778 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.65 129.4 13.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.356 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.652 HD13 ' HE2' ' A' ' 56' ' ' LYS . 95.0 mt -100.14 142.78 31.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.274 0.559 . . . . 0.0 111.717 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -107.5 134.98 49.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.012 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 4.2 p -72.47 150.99 42.8 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 69.4 mt-10 -50.22 -30.63 11.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.17 0.51 . . . . 0.0 111.63 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.4 mttm -69.82 -22.39 63.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.485 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.1 m -116.07 0.91 13.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.159 0.504 . . . . 0.0 109.735 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 31.9 t0 -56.16 136.45 52.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.816 -172.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.18 -28.59 10.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.91 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.523 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 36.2 mtmt -74.18 128.11 34.7 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.126 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 1.8 t -66.42 115.54 25.04 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -55.45 -28.96 66.61 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 123.074 2.516 . . . . 0.0 113.159 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' A' ' 76' ' ' CYS . 7.2 mm -64.46 -42.29 94.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.881 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 35' ' ' SER . 31.5 p -128.72 -11.84 4.89 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -170.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 65.59 58.28 0.82 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.61 . . . . 0.0 110.645 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.486 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 41.8 t -153.96 141.37 19.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.585 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.523 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 3.4 m-85 -91.31 34.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 37' ' ' VAL . 7.4 p -81.7 76.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.178 0.989 . . . . 0.0 111.547 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 63.5 mtp85 59.73 91.43 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.62 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 39.9 Cg_endo -62.42 145.24 95.72 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.365 2.043 . . . . 0.0 111.366 174.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -132.56 -51.1 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.46 140.82 48.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.744 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' HD3' HG22 ' A' ' 19' ' ' THR . 72.2 mttt -66.36 136.1 55.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG1' ' HG3' ' A' ' 87' ' ' PRO . 58.2 t -85.86 133.04 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.851 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -109.29 128.02 54.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 m -77.13 155.4 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.334 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.77 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 2.1 p -66.49 164.06 17.23 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.426 0.632 . . . . 0.0 111.744 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.537 ' HG2' ' CE2' ' A' ' 51' ' ' PHE . 67.8 tt0 -55.05 -50.8 68.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.102 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 2.5 m-80 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.487 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.616 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 96.0 m -70.84 -24.12 62.47 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -78.68 -38.76 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.142 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.537 ' CE2' ' HG2' ' A' ' 47' ' ' GLU . 1.7 p90 . . . . . 0 C--N 1.33 -0.283 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.652 ' HE2' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 1.9 m120 -61.22 136.84 58.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.28 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 29.8 t -55.16 125.9 22.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.126 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 3.5 pt -66.88 -34.39 69.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.672 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -71.63 -37.59 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.551 ' O ' HD11 ' A' ' 63' ' ' LEU . 27.3 p -113.45 -0.35 14.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.421 -0.799 . . . . 0.0 110.482 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 36.56 59.58 0.98 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.432 1.493 . . . . 0.0 114.829 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.732 ' CD1' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.88 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.056 171.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.732 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 72.2 m-80 -61.19 142.55 56.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.9 t -75.52 132.45 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.15 148.36 31.29 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.158 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.45 -41.85 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -113.25 131.91 55.73 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 110.956 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.22 138.18 56.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.415 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.19 144.57 50.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.708 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.89 133.05 52.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.697 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.418 ' CE2' HG21 ' A' ' 43' ' ' VAL . 97.6 m-85 -65.45 126.72 29.16 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 3.9 p -74.65 165.21 25.6 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.272 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -47.95 -59.56 3.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 54.2 mt-10 -58.17 -43.1 87.28 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.216 -171.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.44 ' SG ' HG23 ' A' ' 32' ' ' ILE . 85.5 m -66.14 -32.51 73.99 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.055 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.7 m -68.7 -36.98 79.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.81 -45.1 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.218 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 94.2 mt -63.0 -33.79 76.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.784 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.08 31.24 9.3 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.041 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.56 26.95 3.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.286 0.565 . . . . 0.0 109.971 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -78.43 -15.96 58.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.695 173.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -4.32 38.85 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.325 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.418 ' C ' HD13 ' A' ' 12' ' ' LEU . 83.5 m-20 -81.95 77.35 8.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.91 -86.4 0.02 OUTLIER Glycine 0 C--O 1.227 -0.282 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.374 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 10.8 t -78.37 108.67 8.25 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.715 0.293 . . . . 0.0 110.571 -174.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 43.0 Cg_endo -93.5 36.74 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.523 2.149 . . . . 0.0 113.785 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.616 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 33.3 mtt180 -75.63 114.51 14.3 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.083 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 50.5 mm . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.71 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 8.1 ptm . . . . . 0 N--CA 1.442 -0.842 0 CA-C-O 120.801 0.334 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 t -48.35 -59.82 3.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.912 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.71 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 81.5 mt 48.58 35.65 6.41 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -81.73 -171.34 3.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.07 117.39 57.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -83.45 138.87 8.79 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.05 2.5 . . . . 0.0 112.773 -178.41 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.3 -138.79 9.02 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.477 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -95.53 -14.54 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.541 0.686 . . . . 0.0 109.749 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.591 ' HB2' HG11 ' A' ' 45' ' ' VAL . 6.2 mm100 -59.49 136.98 58.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.137 -178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -105.42 136.66 44.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.423 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.77 133.69 13.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.714 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 85.7 mt -90.58 145.76 24.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 70' ' ' ALA . 53.7 mt -109.09 134.92 51.06 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.097 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.5 p -71.61 151.98 43.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HG2' HG13 ' A' ' 67' ' ' VAL . 37.8 mt-10 -48.73 -32.91 9.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 111.789 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -71.81 -27.65 63.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -102.75 1.38 34.24 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.953 -0.467 . . . . 0.0 110.162 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -59.46 112.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.71 -26.8 7.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.851 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -73.45 130.59 40.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.765 0.317 . . . . 0.0 111.329 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.22 122.14 86.72 Favored Pre-proline 0 C--N 1.319 -0.717 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 168.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HG3' HG11 ' A' ' 43' ' ' VAL . 6.1 Cg_endo -53.15 -35.5 73.39 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.663 2.909 . . . . 0.0 113.872 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.671 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 14.1 mm -69.5 -44.17 80.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.2 p -112.08 -20.88 11.78 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 68.49 72.82 0.29 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.554 0.693 . . . . 0.0 110.337 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -163.31 145.81 10.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.756 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -82.16 40.18 0.62 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.174 0.511 . . . . 0.0 110.318 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.561 HG23 ' N ' ' A' ' 38' ' ' ARG . 8.4 p -87.02 153.44 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.078 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.561 ' N ' HG23 ' A' ' 37' ' ' VAL . 6.8 mmp_? -39.79 110.56 0.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -171.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 91.0 Cg_endo -79.6 151.61 22.4 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.286 2.658 . . . . 0.0 111.85 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -140.97 -58.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.694 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -90.15 131.28 36.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.266 -0.174 . . . . 0.0 111.192 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -70.65 136.29 48.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.736 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 32.8 m -71.03 139.73 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.449 0.642 . . . . 0.0 111.728 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -112.74 114.84 27.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.76 175.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -83.94 148.88 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.777 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 3.5 p -68.96 145.89 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -56.45 -27.99 58.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.292 0.567 . . . . 0.0 110.349 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.777 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 52.9 m-80 -60.37 -32.34 71.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.655 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 99.1 m -94.54 36.44 1.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.626 0.25 . . . . 0.0 111.117 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.8 t -139.86 -52.25 0.51 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 . . . . . 0 C--O 1.235 0.324 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.624 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.102 0 CA-C-O 120.546 0.212 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.972 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 76.0 m-20 -61.15 152.88 27.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.888 0.851 . . . . 0.0 111.59 -176.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.651 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -59.42 131.07 49.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.307 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.477 HG23 ' HG2' ' A' ' 88' ' ' ARG . 11.9 pt -73.62 -32.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.975 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.517 HG22 HD12 ' A' ' 60' ' ' ILE . 22.3 mt -72.01 -48.66 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.546 ' C ' ' H ' ' A' ' 63' ' ' LEU . 29.5 p -102.13 -9.3 20.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.85 -28.25 0.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.581 0.752 . . . . 0.0 112.56 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.546 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -75.74 -60.14 2.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -91.91 150.77 20.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.179 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.972 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 16.7 t -63.37 136.14 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.386 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 23' ' ' CYS . . . -82.19 -167.21 39.45 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.491 HG13 ' HG2' ' A' ' 24' ' ' GLU . 7.4 p -162.06 -50.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.822 0.344 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -105.26 138.75 40.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.928 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.53 134.76 51.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' A' ' 22' ' ' LEU . . . -77.72 153.97 32.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.151 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.94 135.66 45.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.982 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.703 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 43.9 m-85 -71.62 133.58 45.8 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 6.1 p -70.76 158.24 36.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.494 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.575 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -55.13 -41.06 71.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.907 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -58.42 -51.75 68.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 97.0 m -65.54 -38.0 88.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.054 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.463 ' HB3' ' HE3' ' A' ' 74' ' ' TRP . 36.9 t -66.25 -41.41 90.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -67.77 -46.84 70.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.452 HD21 ' HE2' ' A' ' 81' ' ' LYS . 8.6 mp -64.14 -30.97 72.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.24 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 96.76 45.08 2.75 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.992 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.452 ' HE2' HD21 ' A' ' 79' ' ' LEU . 67.6 mttm -103.2 -24.5 13.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.533 . . . . 0.0 110.072 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -69.59 -25.18 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 15.9 pttp -63.33 -27.98 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.294 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -52.28 -48.12 65.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.033 -173.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.06 -139.65 8.3 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.851 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.7 t -55.35 117.65 15.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.401 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.736 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 88.9 Cg_endo -82.23 22.02 0.91 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.932 2.421 . . . . 0.0 113.307 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.53 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.0 mmt180 -77.54 122.31 25.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.322 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 10' ' ' MET . 12.7 mm . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.782 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 11.3 ptp . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.307 0.575 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.599 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -54.71 -42.13 71.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.646 -173.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 93.0 mt 48.99 45.7 22.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 172.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.599 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 34.6 mttm -88.65 -155.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.035 172.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 52.1 mm-40 -77.75 114.6 42.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 110.856 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 8.9 Cg_exo -71.53 142.48 40.49 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.136 2.557 . . . . 0.0 112.741 -177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.73 -139.72 6.4 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.508 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -101.57 -25.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.335 . . . . 0.0 110.438 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -61.19 128.87 38.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.683 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -76.22 140.35 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.39 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.21 114.33 5.98 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.256 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 84.3 mt -77.5 149.49 34.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.706 HD22 HD12 ' A' ' 60' ' ' ILE . 64.7 mt -122.42 138.41 54.55 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.644 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.514 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 7.8 p -76.25 142.68 41.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -47.62 -28.25 2.26 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 76.7 mttt -65.54 -39.33 91.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.42 ' SG ' HG22 ' A' ' 60' ' ' ILE . 61.3 m -93.05 -14.59 27.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 122.113 -0.367 . . . . 0.0 110.225 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.91 120.4 5.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.278 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.19 -34.1 3.47 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.966 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -72.92 131.18 41.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.934 -0.133 . . . . 0.0 110.711 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.5 t -71.94 117.53 58.81 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.69 -31.45 94.87 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.858 2.372 . . . . 0.0 112.74 -173.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.541 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 1.6 mm -72.15 -43.13 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.322 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.6 -8.24 7.4 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.21 73.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.113 0.482 . . . . 0.0 110.797 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -165.94 139.73 4.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.3 33.56 0.81 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.029 0.442 . . . . 0.0 110.866 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.38 152.88 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.796 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -44.05 126.7 4.39 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.8 Cg_exo -77.54 -167.14 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.457 2.771 . . . . 0.0 111.698 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -170.98 -49.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.167 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -116.9 139.18 50.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -71.23 133.64 46.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.315 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.956 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 29.2 m -72.32 143.79 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.704 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -128.63 126.74 40.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -81.46 146.02 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.731 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.3 p -70.94 146.18 49.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.572 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 56.6 mt-10 -54.98 -37.25 66.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.432 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.635 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 4.5 m120 -51.38 -39.52 57.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.3 m -81.55 -36.36 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 28.8 p -72.87 -48.79 34.48 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.53 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.089 0.471 . . . . 0.0 110.432 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 8.9 mptt . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 60.9 m-20 -77.09 149.77 35.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.816 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 4.5 t -53.42 123.02 10.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.602 175.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 70' ' ' ALA . 13.2 pt -62.44 -29.86 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.706 HD12 HD22 ' A' ' 22' ' ' LEU . 47.1 mt -73.45 -44.9 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.4 p -100.31 -11.38 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.311 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 44.46 44.92 7.35 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.155 0.982 . . . . 0.0 110.941 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.67 -61.36 0.15 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.375 -172.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -73.06 140.14 47.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 6.0 p -66.64 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.108 0.48 . . . . 0.0 111.243 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.77 159.21 53.77 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.054 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.461 HG13 ' HA ' ' A' ' 23' ' ' CYS . 2.0 p -157.55 -48.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.289 0.566 . . . . 0.0 110.226 -178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.33 -176.25 4.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.357 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -124.49 142.89 50.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.57 0.224 . . . . 0.0 110.685 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB3' HG12 ' A' ' 43' ' ' VAL . . . -87.88 154.68 20.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.104 0.478 . . . . 0.0 111.13 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -130.39 134.07 46.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.479 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.713 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.4 m-85 -68.92 122.74 19.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 5.9 p -70.25 149.81 47.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -55.6 -31.21 62.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.041 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 66.8 mm-40 -59.9 -44.91 93.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.867 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 38.0 m -68.64 -37.06 79.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.46 -40.79 96.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.054 177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.66 96.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.105 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.55 -35.08 72.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.694 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.6 38.46 6.59 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.491 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -93.72 -30.21 15.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.436 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.76 -29.88 71.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.126 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -63.32 -20.65 65.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.076 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.484 ' HB2' HD23 ' A' ' 12' ' ' LEU . 44.7 m-20 -67.19 -44.86 78.57 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 15' ' ' PRO . . . 126.4 -119.9 3.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.562 -1.304 . . . . 0.0 114.664 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.731 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 19.3 t -43.14 105.5 0.43 Allowed Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 113.12 -171.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.956 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 75.1 Cg_endo -85.15 22.48 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.204 2.603 . . . . 0.0 112.674 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -73.16 124.0 24.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 89' ' ' ILE . 12.1 mm . . . . . 0 C--N 1.32 -0.709 0 C-N-CA 122.533 0.333 . . . . 0.0 111.816 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 121.326 0.584 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.3 t -42.08 -46.35 4.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.04 -1.437 . . . . 0.0 111.637 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HA ' ' N ' ' A' ' 86' ' ' CYS . 1.2 mp 42.76 52.23 5.04 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -95.53 -145.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 170.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -91.65 113.8 59.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.571 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 52.3 Cg_exo -57.63 129.11 32.02 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.878 2.385 . . . . 0.0 112.47 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.08 -131.34 6.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.607 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 18' ' ' GLN . 11.7 p -112.57 -36.75 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.454 ' N ' HG13 ' A' ' 17' ' ' VAL . 54.2 mt-30 -63.11 125.41 23.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.47 0.652 . . . . 0.0 111.556 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.3 m -74.8 130.92 40.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.717 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.06 129.64 26.7 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.017 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 65.7 mt -102.14 145.31 29.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.164 0.507 . . . . 0.0 112.009 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.545 HD21 HG12 ' A' ' 59' ' ' ILE . 74.5 mt -113.36 144.01 43.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.168 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 2.9 p -78.07 154.47 31.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 50.3 mt-10 -57.53 -26.7 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.901 0.381 . . . . 0.0 111.453 -176.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.6 mmtt -69.15 -24.12 64.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.81 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 m -115.72 25.21 10.93 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 33.4 t70 -72.49 131.36 42.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.22 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.29 62.68 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.807 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -111.76 131.64 55.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.3 119.16 73.26 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.26 -38.3 95.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.266 2.644 . . . . 0.0 113.359 -174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.499 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 6.9 mm -64.44 -56.8 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 28.1 p -100.82 -19.78 15.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -169.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 33' ' ' CYS . 13.4 t70 68.59 85.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.225 0.536 . . . . 0.0 110.397 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -174.58 145.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.312 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.35 33.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.71 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.4 p -78.62 158.23 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.313 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -50.83 126.02 23.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.382 0.673 . . . . 0.0 112.543 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.6 Cg_exo -70.45 -166.62 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.605 2.87 . . . . 0.0 112.169 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 25.7 tptp -166.91 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -143.65 140.2 29.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.059 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 33.8 mtpt -62.03 136.26 57.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 111.117 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.543 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 11.5 t -75.85 131.94 34.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.94 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -121.19 128.73 52.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.723 0.296 . . . . 0.0 110.205 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 18' ' ' GLN . 35.2 m -75.22 151.26 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.062 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.712 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 9.6 p -59.7 153.77 19.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -54.94 -37.03 65.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.625 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 6.8 m120 -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.341 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 m -71.39 -27.01 63.03 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.451 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 89.3 p -77.16 -39.44 49.1 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.942 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 4.0 p90 . . . . . 0 C--N 1.327 -0.392 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.7 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? . . . . . 0 CA--C 1.513 -0.456 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 6.9 p30 -62.18 142.7 57.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 40.9 t -46.71 111.08 0.34 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.816 -175.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.545 HG12 HD21 ' A' ' 22' ' ' LEU . 6.0 pt -60.43 -26.0 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.398 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.64 -42.96 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -117.43 5.76 12.55 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.137 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 5.4 p-10 38.64 43.49 0.69 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.76 -58.59 0.22 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.834 -173.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -86.76 17.75 3.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -167.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.824 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 2.6 t 59.67 137.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.113 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.53 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -82.36 162.23 41.76 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.548 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 22' ' ' LEU . 6.3 p -149.8 -44.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.259 -0.471 . . . . 0.0 110.367 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -106.03 131.39 53.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.01 133.36 56.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.955 0.407 . . . . 0.0 110.752 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HB3' HD11 ' A' ' 59' ' ' ILE . . . -74.21 150.5 40.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 9.2 m-85 -128.62 131.93 48.12 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.477 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 98.4 m-85 -67.97 127.79 34.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 8.5 p -73.68 158.78 34.06 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.232 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.493 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.39 -46.2 62.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.138 -178.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.69 -44.51 93.62 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.611 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.797 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 58.6 m -64.72 -43.41 93.51 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.224 -0.297 . . . . 0.0 111.018 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 58.4 m -64.24 -34.59 78.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -58.33 -49.88 75.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.927 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.52 -47.0 24.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.521 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.67 34.55 0.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.556 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' CYS . 18.9 mmtp -76.13 -23.69 54.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.23 0.538 . . . . 0.0 110.531 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.23 -42.13 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.892 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -85.54 -15.24 43.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.597 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.518 ' OD2' HD22 ' A' ' 12' ' ' LEU . 25.2 t0 -56.47 -51.13 69.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.899 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.91 34.43 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.211 -1.471 . . . . 0.0 114.926 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.3 t -72.56 113.5 21.66 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 113.691 -1.254 . . . . 0.0 111.751 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -81.98 43.87 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.228 2.619 . . . . 0.0 113.405 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 10' ' ' MET . 6.5 mmm180 -87.97 131.24 34.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.597 177.867 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.967 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 t -51.91 -54.0 34.45 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.478 -167.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.967 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 34.1 mt 44.86 37.86 2.58 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -82.42 170.71 14.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 7.1 tp-100 -67.69 119.65 67.69 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 34.6 Cg_exo -62.29 145.47 96.01 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.754 2.303 . . . . 0.0 112.814 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.9 -66.46 1.62 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.977 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p 176.64 -32.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.792 0.329 . . . . 0.0 110.586 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.527 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 26.1 mt-30 -64.38 133.28 52.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.692 -175.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -74.71 137.26 41.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.35 133.48 14.88 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.996 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 80.1 mt -100.12 143.34 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 70' ' ' ALA . 63.7 mt -111.93 138.56 48.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.44 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 3.5 p -81.88 148.92 28.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HA ' ' CB ' ' A' ' 27' ' ' ASP . 46.6 mt-10 -54.39 -27.58 37.62 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.64 -29.98 70.62 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.656 0.265 . . . . 0.0 111.378 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 34.6 m -105.37 -12.63 15.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.878 0.37 . . . . 0.0 110.206 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CB ' ' HA ' ' A' ' 24' ' ' GLU . 11.7 t70 -59.89 115.75 3.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.075 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.02 -33.02 4.19 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 47.2 mttp -77.55 136.75 38.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.63 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.3 t -79.98 121.98 82.69 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.82 -41.26 79.21 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.228 2.619 . . . . 0.0 113.648 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.602 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 5.8 mm -63.73 -49.09 83.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 p -111.47 -17.09 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 t0 63.04 74.89 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.543 0.687 . . . . 0.0 110.366 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -160.24 146.32 15.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.312 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -87.19 30.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.322 . . . . 0.0 111.159 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 38' ' ' ARG . 3.6 p -76.64 150.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.866 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 37' ' ' VAL . 90.5 mtt180 -49.08 124.64 13.48 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 87.9 Cg_endo -79.62 149.35 21.0 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.526 2.817 . . . . 0.0 112.114 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -132.16 -62.37 0.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.4 mtp-105 -102.39 141.99 34.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -69.18 137.57 53.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.183 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.868 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -78.84 145.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.127 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -131.7 119.48 21.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 50' ' ' SER . 28.5 m -86.83 155.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.893 -173.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 6.2 p -71.13 160.24 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.599 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -53.57 -39.74 65.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.194 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.01 -35.51 75.22 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.551 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 60.4 m -98.48 33.3 2.28 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.151 -0.343 . . . . 0.0 111.493 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.565 ' HB3' HG21 ' A' ' 45' ' ' VAL . 53.6 p -156.81 -28.06 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.9 p90 . . . . . 0 N--CA 1.465 0.304 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -170.681 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 51.7 mmtt . . . . . 0 CA--C 1.516 -0.327 0 CA-C-O 121.063 0.458 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 21.4 p30 -66.2 143.37 57.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.4 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.44 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -55.23 130.27 41.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.453 -177.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 9.9 pt -62.44 -26.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -171.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 HD11 HD21 ' A' ' 22' ' ' LEU . 45.9 mt -80.0 -42.65 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.924 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -109.51 -11.38 14.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.645 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 54.03 28.52 8.86 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.513 . . . . 0.0 111.264 175.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.26 -64.27 0.61 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.375 -169.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -79.74 140.17 37.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.921 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 21.2 t -64.07 135.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 111.045 -176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.6 141.73 27.97 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.5 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.66 -42.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -115.19 141.58 47.83 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.585 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.87 136.38 57.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.625 ' CB ' HG22 ' A' ' 43' ' ' VAL . . . -79.05 160.09 27.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.065 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.526 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 12.8 m-85 -132.21 134.6 45.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.628 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.722 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 74.6 m-85 -68.65 127.81 34.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.4 p -68.22 163.38 22.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.952 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -51.81 -45.88 64.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.234 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -60.26 -48.25 82.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.544 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 66.5 m -65.56 -37.91 88.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.411 0.148 . . . . 0.0 111.243 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.18 -43.46 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 110.005 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -66.06 -42.83 88.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.94 -34.48 78.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.47 30.21 14.4 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.857 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.75 -22.44 27.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -66.35 -42.43 88.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.713 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.3 -16.54 60.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.551 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.75 -50.35 67.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.82 -139.41 5.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 118.643 -1.742 . . . . 0.0 115.688 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 44.4 t -62.06 119.47 49.05 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 113.104 -1.548 . . . . 0.0 112.687 -170.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.868 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 64.4 Cg_endo -84.16 51.28 3.31 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.691 2.927 . . . . 0.0 113.068 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.551 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.0 mmt180 -99.58 127.27 45.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.54 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 89' ' ' ILE . 46.3 mm . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.458 0.647 . . . . 0.0 109.434 172.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.472 ' SD ' HD12 ' A' ' 12' ' ' LEU . 4.8 ptp . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 2.0 t -46.12 -47.02 17.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.603 -1.181 . . . . 0.0 112.812 -174.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.472 HD12 ' SD ' ' A' ' 10' ' ' MET . 1.3 mp 46.35 40.23 7.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 62.4 mttm -80.02 -162.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.819 0.342 . . . . 0.0 110.345 169.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -85.99 110.58 31.7 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.367 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 36.9 Cg_endo -70.75 143.56 46.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.495 2.13 . . . . 0.0 113.018 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.68 -101.5 0.47 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.206 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.49 -31.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HB2' HG21 ' A' ' 45' ' ' VAL . 62.9 mt-30 -57.9 132.41 53.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 111.477 -177.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 69' ' ' ASP . 5.9 m -83.26 138.53 33.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.714 -176.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.29 133.79 13.35 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.809 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 94.3 mt -96.91 151.47 19.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 0.0 112.084 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 59' ' ' ILE . 93.9 mt -120.0 141.52 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.17 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.473 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 5.7 p -78.78 154.74 29.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.65 -32.21 50.6 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.262 0.351 . . . . 0.0 111.847 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.0 mmtp -63.65 -43.91 95.36 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.95 -15.93 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -53.59 108.99 0.4 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.471 0.653 . . . . 0.0 110.585 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.3 -35.12 1.69 Allowed Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.02 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -87.96 128.36 35.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.798 -0.201 . . . . 0.0 111.496 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.13 118.58 65.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.86 -39.41 68.3 Favored 'Trans proline' 0 N--CA 1.474 0.357 0 C-N-CA 123.051 2.501 . . . . 0.0 114.169 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.529 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mm -63.94 -40.79 90.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.06 -18.85 8.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t0 66.06 76.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.284 0.564 . . . . 0.0 110.013 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.9 t -162.43 147.06 12.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.874 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -90.45 22.72 3.28 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.033 0.444 . . . . 0.0 111.143 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG12 ' CB ' ' A' ' 73' ' ' CYS . 2.5 p -69.43 148.85 11.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.135 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -40.19 113.07 0.9 Allowed Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.6 Cg_endo -78.71 148.12 22.49 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.202 2.601 . . . . 0.0 112.011 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.569 ' HE2' ' HB2' ' A' ' 74' ' ' TRP . 61.9 mttm -139.17 -53.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 99.5 mtt180 -101.05 138.21 38.39 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -64.8 132.42 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.497 . . . . 0.0 111.04 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.822 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 15.7 t -74.16 125.18 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.354 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.9 136.99 36.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.984 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.891 HG11 HH21 ' A' ' 88' ' ' ARG . 2.1 m -91.84 150.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.6 p -81.29 145.7 30.77 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.445 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 1.5 tp10 -58.11 -24.3 58.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -173.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.511 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 41.9 m-80 -66.08 -20.99 66.34 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.383 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.473 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 78.4 m -110.27 39.0 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.119 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.708 ' HB3' HG23 ' A' ' 45' ' ' VAL . 84.8 p -147.78 -49.43 0.17 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.618 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' HZ2' ' HB2' ' A' ' 56' ' ' LYS . 9.9 mtmp? . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 120.691 0.282 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.506 ' C ' HD21 ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.6 149.75 48.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.372 0.606 . . . . 0.0 110.588 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 11.8 t -54.1 124.12 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.829 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.543 HD12 ' NH1' ' A' ' 88' ' ' ARG . 28.0 pt -69.33 -23.07 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.576 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 22' ' ' LEU . 37.4 mt -78.71 -49.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -95.28 -8.28 36.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.33 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.87 46.67 6.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.702 0.801 . . . . 0.0 111.663 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -61.56 0.13 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.236 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -70.06 141.75 52.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.723 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.8 132.72 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.207 0.317 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.53 176.93 54.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.702 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' LEU . 3.2 p -161.34 -52.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -97.4 122.7 40.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.677 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.3 m-20 -59.16 134.08 56.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.993 0.425 . . . . 0.0 110.482 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . . . -73.26 142.73 47.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.591 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 7.6 m-85 -124.79 130.09 51.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.271 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.822 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.6 m-85 -66.26 129.94 41.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.0 p -69.75 161.86 28.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.775 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.569 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 26.6 t90 -53.75 -39.82 65.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.603 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -60.99 -48.25 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.723 0.297 . . . . 0.0 110.946 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 84.2 m -67.97 -32.76 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.58 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.12 -44.02 97.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.583 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 -60.77 -46.65 89.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.536 HD12 ' HE3' ' A' ' 81' ' ' LYS . 86.0 mt -68.76 -32.62 72.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.825 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.71 38.57 10.43 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.344 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.536 ' HE3' HD12 ' A' ' 79' ' ' LEU . 87.5 mttt -78.76 -9.14 59.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.681 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.07 -35.73 72.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.36 0.6 . . . . 0.0 109.597 173.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -81.74 -9.17 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.061 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 81' ' ' LYS . 23.5 t0 -70.1 -42.9 72.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.76 -175.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . 172.09 178.52 42.39 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.626 -1.273 . . . . 0.0 114.029 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.689 ' SG ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -72.42 110.68 8.62 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 111.326 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' HG2' HH12 ' A' ' 88' ' ' ARG . 56.6 Cg_endo -78.12 41.44 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.436 2.758 . . . . 0.0 115.279 -172.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.891 HH21 HG11 ' A' ' 45' ' ' VAL . 7.0 mmt-85 -79.98 134.41 36.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 121.217 0.532 . . . . 0.0 112.126 -175.005 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 79.54 -142.39 24.73 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.973 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m 53.56 43.1 31.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.348 0.594 . . . . 0.0 110.61 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -167.13 -121.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.312 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -88.52 51.75 2.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.409 0.623 . . . . 0.0 111.42 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -152.11 36.86 0.54 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.495 ' C ' ' H ' ' A' ' 7' ' ' ASP . 31.3 tt0 -80.26 -34.0 37.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.05 -171.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.524 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 20.2 t80 77.36 -23.21 0.25 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.176 -173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 5' ' ' GLN . 1.5 m-20 61.5 39.82 14.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.66 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.524 ' HB3' ' CD2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -73.94 51.99 0.42 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.151 178.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.666 ' HB ' ' HB3' ' A' ' 91' ' ' ASN . 1.7 mp -61.06 98.79 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.281 0.562 . . . . 0.0 109.813 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 8' ' ' LEU . 4.5 ptp -114.24 156.68 23.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.276 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.581 ' HA ' HD13 ' A' ' 90' ' ' LEU . 42.6 t -53.83 -49.74 67.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.031 -172.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.764 ' HG ' ' HB3' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 51.87 43.06 30.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 172.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 50.2 mttm -95.62 -155.38 0.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.584 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.34 111.91 44.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.063 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 32.9 Cg_exo -60.1 138.58 82.68 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.244 2.629 . . . . 0.0 112.926 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.91 -140.25 11.26 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.12 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.614 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 35.3 m -98.44 -29.11 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.64 0.257 . . . . 0.0 111.209 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -69.23 125.53 26.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.95 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -82.32 142.45 32.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.827 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.8 118.55 6.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.628 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 81.8 mt -92.18 143.75 26.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 112.071 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.48 HD22 HG12 ' A' ' 59' ' ' ILE . 70.7 mt -110.33 136.57 49.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.301 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.8 p -72.59 152.39 41.83 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 53.6 mt-10 -54.97 -25.44 29.72 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 0.0 111.558 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 25.1 mtpp -72.16 -23.29 61.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.747 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 20.6 m -116.32 15.37 15.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 26.1 t70 -68.29 129.8 41.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -21.33 46.59 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.329 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 45.0 mttm -71.82 134.61 46.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.8 t -81.82 121.57 79.47 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.11 -34.15 76.95 Favored 'Trans proline' 0 CA--C 1.526 0.093 0 C-N-CA 122.441 2.094 . . . . 0.0 112.771 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.633 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 3.8 mm -76.01 -32.72 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.431 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 20.1 p -137.98 -34.46 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t0 64.35 86.86 0.12 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 t -154.36 25.35 0.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.578 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 36.79 50.11 0.82 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.303 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.19 162.81 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.346 -176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.515 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 ptp85 -42.43 128.5 2.89 Favored Pre-proline 0 N--CA 1.466 0.354 0 O-C-N 123.736 0.648 . . . . 0.0 112.63 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.524 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 2.8 Cg_exo -76.64 -154.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.421 2.747 . . . . 0.0 112.164 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -176.4 -49.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.32 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -150.12 136.08 18.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.494 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.71 134.55 56.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.926 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 16.2 m -74.03 134.42 29.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 17' ' ' VAL . 27.8 mtp85 -108.15 122.15 46.32 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -81.9 143.84 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.166 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.663 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.1 p -61.35 149.08 39.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.928 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 89.8 mt-10 -54.55 -34.49 61.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.374 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.663 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m120 -53.94 -36.25 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.759 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 66.2 m -83.82 -32.29 25.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.319 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -67.18 -49.05 66.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.066 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 -95.36 28.52 2.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.65 38.91 2.02 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.957 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 69.48 -48.8 0.61 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.517 0.727 . . . . 0.0 112.664 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -78.26 70.33 4.6 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.215 0.531 . . . . 0.0 110.956 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -117.21 -54.59 2.39 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.351 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -81.97 -29.81 31.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.897 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 34.7 m-20 -63.92 144.94 56.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.431 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.5 t -47.38 131.73 13.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.713 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 11.0 pt -75.96 -29.53 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.102 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 26' ' ' CYS . 44.1 mt -77.72 -45.7 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.596 ' HA ' HD21 ' A' ' 92' ' ' LEU . 28.6 p -109.4 14.28 23.72 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER 22.26 58.24 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.25 -67.61 0.12 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 0.0 110.458 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.19 139.8 38.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.897 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 8.9 p -61.65 139.56 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 110.881 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -84.07 145.21 22.26 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.628 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 68' ' ' ASN . 19.0 m -111.1 -41.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.455 ' N ' HG23 ' A' ' 67' ' ' VAL . 69.1 m-20 -114.6 135.29 54.3 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -62.12 134.49 56.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.47 147.2 40.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.589 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.524 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 9.4 m-85 -117.26 136.24 53.23 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.867 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 80.5 m-85 -67.81 128.59 37.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 1.8 p -72.25 149.08 44.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -51.08 -39.5 56.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.598 0.562 . . . . 0.0 111.7 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.27 -45.62 93.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.606 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.633 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 60.7 m -65.61 -36.65 84.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.502 0.191 . . . . 0.0 110.97 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 73.4 m -66.3 -41.81 89.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -62.84 -47.19 84.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.56 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.536 HD13 ' HE3' ' A' ' 81' ' ' LYS . 94.1 mt -66.04 -33.79 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.38 40.21 5.15 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.364 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.536 ' HE3' HD13 ' A' ' 79' ' ' LEU . 97.1 mttt -92.02 -30.93 15.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 176.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -66.89 -27.59 67.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.852 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -69.03 -8.84 48.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.329 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.764 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 70.6 m-20 -69.08 -51.21 41.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.16 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.42 -137.27 5.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.235 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 26.9 t -54.41 115.87 9.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 124.054 0.942 . . . . 0.0 111.717 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.926 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 66.0 Cg_endo -88.39 26.82 0.56 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.95 2.433 . . . . 0.0 114.177 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.759 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 30.3 mtt-85 -73.45 121.65 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.955 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.519 HG23 ' ND2' ' A' ' 91' ' ' ASN . 27.3 mm -74.46 116.89 17.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.233 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.581 HD13 ' HA ' ' A' ' 11' ' ' CYS . 29.6 mt -99.86 -32.82 10.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.021 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.666 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 15.4 p30 -56.58 -29.82 62.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.963 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 61' ' ' CYS . 15.1 tp -75.66 96.47 3.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.837 -173.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.84 -40.47 4.64 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -153.22 178.96 9.18 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.587 ' ND2' ' HA ' ' A' ' 99' ' ' ARG . 2.7 m120 62.42 70.62 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.924 0.393 . . . . 0.0 110.879 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.737 ' HD2' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -48.2 -32.53 7.22 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.774 -176.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.737 ' N ' ' HD2' ' A' ' 96' ' ' ARG . 4.2 pp -162.67 139.66 7.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 55.11 -135.05 1.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.855 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.587 ' HA ' ' ND2' ' A' ' 95' ' ' ASN . 1.3 mpt_? -139.11 47.0 1.92 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -136.36 131.36 34.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.423 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.529 ' HA ' HH21 ' A' ' 96' ' ' ARG . 9.8 p90 -105.81 -37.11 6.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 167.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 49.97 68.32 0.77 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.112 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 52.55 49.16 21.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.138 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -145.0 40.13 1.24 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.313 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? 69.18 -60.98 0.44 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.748 0.819 . . . . 0.0 111.847 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? 178.77 -30.77 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.3 p . . . . . 0 C--N 1.31 -1.151 0 CA-C-N 113.353 -1.748 . . . . 0.0 108.462 176.462 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 156.8 51.2 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.083 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 m -72.19 70.54 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 m 71.27 -47.05 0.65 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.538 0.735 . . . . 0.0 112.284 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 7.4 tpm_? 63.22 50.56 2.97 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.724 0.774 . . . . 0.0 109.999 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -77.83 137.82 38.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.144 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -173.56 136.73 0.6 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.616 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -99.9 -15.78 18.23 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -73.51 61.24 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.925 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.485 ' HB3' HD12 ' A' ' 89' ' ' ILE . 10.5 mt -80.74 80.18 7.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.97 0.414 . . . . 0.0 110.744 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.543 HD13 ' N ' ' A' ' 9' ' ' ILE . 1.6 mp -78.93 71.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.462 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 4.7 ptp -73.45 149.32 42.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.693 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.457 ' SG ' ' HE2' ' A' ' 13' ' ' LYS . 45.5 t -52.54 -49.89 63.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.308 -175.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 54.6 mt 50.32 32.22 6.05 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HE2' ' SG ' ' A' ' 11' ' ' CYS . 27.9 mtmt -82.39 166.12 19.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.153 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.3 112.89 5.5 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 123.77 0.668 . . . . 0.0 110.451 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 50.9 Cg_endo -76.65 141.01 21.62 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.095 2.53 . . . . 0.0 113.376 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 -144.08 11.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -89.1 -24.47 5.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.132 0.491 . . . . 0.0 110.667 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -57.4 124.48 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.42 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.561 HG21 ' HD3' ' A' ' 42' ' ' LYS . 26.0 m -84.97 137.9 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.117 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.01 130.33 24.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.713 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 68' ' ' ASN . 52.5 mt -88.84 142.88 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.338 0.59 . . . . 0.0 112.358 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.692 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 81.4 mt -113.13 137.62 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.963 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.756 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 6.5 p -75.94 154.88 35.59 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 27' ' ' ASP . 39.9 mt-10 -51.97 -33.27 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.405 0.44 . . . . 0.0 111.552 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -69.0 -27.96 66.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.775 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 49.4 m -104.48 41.42 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.962 0.411 . . . . 0.0 109.916 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 9.6 t70 -66.66 119.14 11.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.01 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.73 44.67 56.2 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.613 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HD3' ' HB3' ' A' ' 26' ' ' CYS . 35.3 mtpt -120.15 139.74 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.538 -0.389 . . . . 0.0 110.992 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.67 122.75 85.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.634 173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HA ' HG12 ' A' ' 60' ' ' ILE . 36.7 Cg_exo -64.49 -36.45 43.6 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.104 2.536 . . . . 0.0 113.323 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.8 mm -64.43 -41.58 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.992 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.15 -12.5 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 63.91 81.55 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.308 0.575 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 t -171.73 152.9 3.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.957 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -88.32 22.63 2.43 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.663 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.02 154.92 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.07 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 10.9 ptp180 -44.02 129.35 4.35 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.534 0.734 . . . . 0.0 112.721 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 Cg_exo -73.98 -164.54 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.37 2.713 . . . . 0.0 112.379 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.774 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -172.17 -42.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.979 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -149.66 136.42 19.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.561 ' HD3' HG21 ' A' ' 19' ' ' THR . 46.3 mttt -63.16 139.52 58.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.474 0.654 . . . . 0.0 111.698 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.818 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.2 t -70.47 133.8 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.417 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -123.6 128.34 49.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.831 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' HD2' ' A' ' 87' ' ' PRO . 28.7 m -100.83 155.88 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.043 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.4 p -67.44 145.95 54.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.93 -28.94 64.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.606 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 16.9 m-80 -59.1 -31.11 68.62 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.833 175.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.44 ' HB3' ' CD ' ' A' ' 88' ' ' ARG . 79.3 m -101.48 29.3 4.9 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 122.155 -0.341 . . . . 0.0 111.798 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 m -111.29 -28.17 8.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 109.837 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 17.0 p90 -97.4 149.19 22.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.56 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.22 -176.49 35.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.166 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -48.81 54.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.666 0.386 . . . . 0.0 111.388 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -77.28 55.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.428 0.632 . . . . 0.0 110.762 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.24 -53.37 0.74 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.913 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 14.1 mmtp -79.08 -18.2 53.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.778 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.833 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 80.2 m-20 -67.23 150.47 49.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.901 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.756 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 36.7 t -50.11 135.1 21.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 88' ' ' ARG . 11.7 pt -77.65 -35.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.599 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 31' ' ' PRO . 43.4 mt -74.26 -47.3 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 19.8 p -103.07 2.81 35.29 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.847 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.725 HD21 ' HA2' ' A' ' 93' ' ' GLY . 1.5 p-10 36.36 47.3 0.48 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.117 0.886 . . . . 0.0 113.256 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.21 -66.27 0.37 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.044 -174.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -81.98 143.39 31.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.235 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.833 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 48.5 t -56.92 134.44 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.217 0.323 . . . . 0.0 110.545 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.87 147.29 21.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.775 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.68 -37.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.089 0.471 . . . . 0.0 110.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 6.4 m120 -82.77 173.33 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.172 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -109.92 134.41 52.12 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.686 ' HB1' HG22 ' A' ' 43' ' ' VAL . . . -77.58 151.54 34.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.28 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -126.24 135.36 51.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 173.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.818 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 76.9 m-85 -71.26 125.11 26.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.6 p -67.58 157.0 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -50.28 -40.82 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.479 0.487 . . . . 0.0 111.479 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 37.2 mt-10 -58.91 -51.96 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.604 0.24 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.618 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 98.7 m -64.38 -36.14 83.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.363 -178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.9 m -67.87 -42.83 80.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -58.8 -49.24 78.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.959 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 42.3 mt -72.06 -27.43 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.617 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.68 47.18 3.26 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.43 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -82.19 -36.43 27.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.205 0.526 . . . . 0.0 109.911 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -66.77 -28.8 68.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.997 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.9 pttp -57.07 -30.91 64.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.31 . . . . 0.0 110.465 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -61.57 -52.55 63.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.691 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.32 -127.72 3.45 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.569 -1.3 . . . . 0.0 114.669 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.4 t -58.84 109.56 1.96 Allowed Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.52 -1.34 . . . . 0.0 113.182 -171.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.568 ' HD2' HG11 ' A' ' 45' ' ' VAL . 72.0 Cg_endo -87.97 39.89 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.992 2.461 . . . . 0.0 113.716 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.441 ' HG2' HG21 ' A' ' 59' ' ' ILE . 24.3 mtp85 -85.03 127.68 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.532 ' HB ' ' OD1' ' A' ' 62' ' ' ASN . 31.5 mm -81.28 126.14 39.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 9' ' ' ILE . 17.0 mt -89.09 -37.45 15.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.031 -170.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -63.25 125.92 25.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.375 0.607 . . . . 0.0 111.902 -171.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.34 45.75 26.55 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.643 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.725 ' HA2' HD21 ' A' ' 62' ' ' ASN . . . -80.21 53.5 4.43 Favored Glycine 0 C--N 1.33 0.217 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m 74.26 -43.39 0.53 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.844 0.858 . . . . 0.0 110.479 -170.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 93' ' ' GLY . 35.3 t-20 -66.8 129.75 40.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.957 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 35.25 1.78 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.823 0.821 . . . . 0.0 109.35 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.8 mt -142.08 67.68 1.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.532 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -47.6 -45.98 27.98 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.059 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -111.98 126.79 55.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.417 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -78.82 124.43 28.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.728 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -70.78 -47.85 57.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.363 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 64.93 -59.78 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.122 0.889 . . . . 0.0 111.149 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -83.1 137.93 33.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.776 172.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? 60.95 -144.05 0.48 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.416 0.448 . . . . 0.0 110.689 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.632 ' HB3' HG23 ' A' ' 107' ' ' VAL . 37.1 mtmm -146.92 135.95 22.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.594 0.235 . . . . 0.0 110.591 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -95.84 38.92 1.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.406 0.622 . . . . 0.0 109.667 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 105' ' ' LYS . 71.7 t . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.331 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 65.92 -141.55 41.93 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.14 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.498 ' HB3' ' HG2' ' A' ' 3' ' ' ARG . 50.3 m 67.69 -60.06 0.4 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.503 0.721 . . . . 0.0 112.069 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t 51.34 50.06 19.72 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.263 0.554 . . . . 0.0 109.922 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.498 ' HG2' ' HB3' ' A' ' 1' ' ' SER . 30.2 mmt180 -74.13 126.76 31.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.39 -173.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -126.38 59.91 1.33 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 7' ' ' ASP . 7.5 pt20 -144.92 163.08 35.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.748 -169.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -76.1 34.67 0.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.15 0.976 . . . . 0.0 110.096 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 5' ' ' GLN . 71.9 m-20 60.18 53.89 4.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.611 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mt -85.44 74.68 10.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.531 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' A' ' 91' ' ' ASN . 1.6 mp -68.94 79.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.729 0.776 . . . . 0.0 109.935 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.541 ' SD ' HD13 ' A' ' 12' ' ' LEU . 2.3 ptp -80.8 153.96 27.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.577 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.494 ' HA ' HD13 ' A' ' 90' ' ' LEU . 44.1 t -56.15 -53.12 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.304 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.541 HD13 ' SD ' ' A' ' 10' ' ' MET . 2.3 mp 48.52 37.9 9.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -79.59 177.64 8.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.59 167.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -70.81 116.05 42.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.883 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 31.8 Cg_exo -62.91 145.23 94.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.161 2.574 . . . . 0.0 113.37 -175.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.93 -137.4 9.22 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.53 -23.28 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.445 ' O ' HG21 ' A' ' 45' ' ' VAL . 56.2 mt-30 -72.31 138.75 47.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.487 . . . . 0.0 111.718 -178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 43' ' ' VAL . 55.8 m -91.7 137.66 32.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.644 178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.71 132.33 31.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.268 -0.492 . . . . 0.0 112.798 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 88.1 mt -95.87 143.46 27.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.046 0.451 . . . . 0.0 111.83 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 70' ' ' ALA . 60.0 mt -113.01 140.42 47.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.263 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.3 p -78.92 154.03 30.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 40.1 mt-10 -54.69 -26.22 32.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.83 0.347 . . . . 0.0 111.67 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 35.1 mmtp -70.11 -29.36 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.422 ' O ' HD12 ' A' ' 22' ' ' LEU . 4.8 m -116.29 17.28 15.67 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 51.9 t0 -66.77 127.2 31.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.145 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.95 -22.18 42.24 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.491 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -68.26 122.07 17.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.489 0.185 . . . . 0.0 110.99 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -69.19 113.03 13.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.42 -27.37 67.67 Favored 'Trans proline' 0 N--CA 1.473 0.3 0 C-N-CA 123.372 2.715 . . . . 0.0 113.403 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 4.8 mm -66.8 -36.59 77.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.92 -176.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.58 -15.61 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 67.1 84.05 0.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.373 0.606 . . . . 0.0 109.831 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -164.57 136.02 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.148 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.68 11.76 8.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 73' ' ' CYS . 8.3 p -66.44 160.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.001 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -40.76 130.85 1.85 Allowed Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.66 0.784 . . . . 0.0 112.873 -175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 93.4 Cg_endo -78.83 -161.23 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.388 2.725 . . . . 0.0 112.771 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -171.57 -50.55 0.02 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.359 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -134.88 145.47 48.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.186 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' HG21 ' A' ' 19' ' ' THR . 59.7 mttp -68.18 140.47 56.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.825 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.7 m -74.58 127.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 111.606 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.53 114.99 29.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 18' ' ' GLN . 6.3 m -85.52 146.53 6.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.345 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p -67.04 161.23 24.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -47.36 -44.89 24.38 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.042 0.839 . . . . 0.0 111.715 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.719 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.1 m120 -61.69 -39.1 90.24 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.703 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 55.9 m -90.0 43.53 1.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.682 0.277 . . . . 0.0 110.794 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 45' ' ' VAL . 65.9 m -155.62 -38.68 0.08 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.698 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.719 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -59.68 -23.1 62.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -175.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.37 145.58 7.27 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.833 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HG3' ' H ' ' A' ' 54' ' ' GLN . 54.3 pttt 52.99 -59.46 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.414 1.886 . . . . 0.0 115.208 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.415 ' H ' ' HG3' ' A' ' 53' ' ' LYS . 1.4 tp-100 -77.05 44.64 0.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.152 -0.343 . . . . 0.0 111.87 -173.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.79 -45.32 0.73 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.989 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -66.13 -46.51 77.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.148 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -65.92 148.47 51.73 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.34 0.59 . . . . 0.0 110.933 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 20.2 t -51.6 125.73 15.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.375 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.537 HG12 HD21 ' A' ' 22' ' ' LEU . 8.7 pt -65.52 -26.86 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.457 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.4 mt -81.12 -41.1 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 32.1 p -113.75 2.61 15.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.348 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 29.25 53.1 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.43 1.092 . . . . 0.0 113.476 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.64 -59.49 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.383 -176.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -72.48 141.27 48.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.826 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.36 133.01 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.174 0.512 . . . . 0.0 110.957 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.11 140.09 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.996 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -127.08 -39.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -117.84 137.73 52.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.89 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 19' ' ' THR . 21.2 m-20 -64.3 139.1 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.568 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HB2' HD13 ' A' ' 22' ' ' LEU . . . -82.39 151.33 26.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.653 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -124.73 134.15 52.93 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.838 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.825 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 68.2 m-85 -66.17 125.15 24.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -66.07 151.54 46.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -52.98 -38.0 61.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.68 -46.26 87.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.473 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 86.0 m -72.39 -38.01 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.722 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.5 t -63.97 -35.9 82.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.302 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -62.9 -41.43 99.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.334 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.03 1.41 21.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.01 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.05 84.78 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.495 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 93.3 mttt -77.72 -20.35 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' HB2' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -70.82 -23.47 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.667 175.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.47 -25.06 60.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -55.03 -57.82 10.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.61 -140.15 7.11 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.647 -1.263 . . . . 0.0 114.343 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.634 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 47.4 t -64.5 115.91 24.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.189 -1.005 . . . . 0.0 112.275 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.774 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 93.9 Cg_endo -83.17 39.59 0.84 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.211 2.607 . . . . 0.0 113.442 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.703 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 9.5 mmt180 -81.73 121.81 26.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.992 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.488 HG23 ' OD1' ' A' ' 91' ' ' ASN . 36.4 mm -78.42 113.12 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 11' ' ' CYS . 25.0 mt -105.26 -27.69 11.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.78 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.488 ' OD1' HG23 ' A' ' 89' ' ' ILE . 11.9 p-10 -60.3 -27.01 66.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.543 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.56 124.45 22.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.39 . . . . 0.0 110.926 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.4 50.83 3.88 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.649 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 16.9 m 55.23 61.33 2.95 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.679 0.276 . . . . 0.0 110.527 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 94' ' ' SER . 6.2 m120 74.21 -71.91 0.12 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.269 -174.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -174.06 -73.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.371 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.4 mt -156.46 120.38 4.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.82 0.343 . . . . 0.0 110.748 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.555 ' OD1' ' HG3' ' A' ' 99' ' ' ARG . 10.1 t70 -78.81 138.31 38.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.555 ' HG3' ' OD1' ' A' ' 98' ' ' ASP . 56.1 mtm-85 66.82 65.86 0.45 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.108 0.48 . . . . 0.0 110.494 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -51.45 127.94 21.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.492 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -70.22 69.86 0.37 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.316 0.579 . . . . 0.0 110.59 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.12 135.28 4.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.628 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 178.77 -46.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.005 173.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 65.9 mttm -102.74 39.12 1.58 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.028 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 62.97 69.52 0.58 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.524 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp 65.98 34.02 7.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.604 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 104' ' ' LYS . 86.7 t . . . . . 0 C--O 1.247 0.935 0 CA-C-O 117.441 -1.266 . . . . 0.0 107.869 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -159.93 126.79 1.69 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.719 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.5 p -169.4 41.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.001 0.429 . . . . 0.0 110.875 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m -86.51 32.02 0.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.924 0.392 . . . . 0.0 111.12 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -90.65 121.03 32.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.805 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -163.18 130.43 3.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.029 0.443 . . . . 0.0 111.258 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.556 HE22 HD11 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -76.71 -46.01 27.14 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.4 t80 55.42 -108.7 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -139.48 42.97 2.02 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 5' ' ' GLN . 1.4 mt -78.93 46.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.873 -174.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.694 HG22 HG23 ' A' ' 89' ' ' ILE . 2.3 mp -86.4 43.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 123.248 1.499 . . . . 0.0 108.471 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.498 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 1.4 ptp -127.29 143.83 51.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.544 173.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -56.98 -50.4 72.81 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.493 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.5 ' HA ' HD22 ' A' ' 12' ' ' LEU . 40.0 mt 49.5 40.65 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.015 1.116 . . . . 0.0 114.015 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -82.29 -159.8 0.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.821 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -85.18 122.94 73.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.12 133.17 48.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.852 2.368 . . . . 0.0 112.75 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -144.16 6.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.247 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 18' ' ' GLN . 11.3 p -99.38 -30.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.754 0.311 . . . . 0.0 111.401 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.507 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 70.6 mt-30 -77.96 136.37 37.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.37 0.605 . . . . 0.0 111.896 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.624 HG21 ' HD3' ' A' ' 42' ' ' LYS . 10.0 m -75.86 143.28 41.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.526 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.28 120.45 5.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.213 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 73.5 mt -91.98 147.61 22.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.492 . . . . 0.0 112.14 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.479 HD13 ' HB1' ' A' ' 70' ' ' ALA . 76.8 mt -110.89 130.11 55.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.139 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.454 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 8.5 p -71.4 160.42 32.79 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.545 ' HG3' HG22 ' A' ' 67' ' ' VAL . 54.8 mt-10 -58.25 -24.55 59.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp -74.44 -31.23 62.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.677 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -110.13 25.07 12.2 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 38.9 t70 -68.03 124.74 24.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.97 77.25 Favored Glycine 0 C--N 1.321 -0.266 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.627 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 51.3 mttm -102.7 134.51 45.97 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.448 -0.442 . . . . 0.0 110.607 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 12.6 t -70.75 117.17 53.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 11.2 Cg_endo -58.89 -31.95 96.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.818 2.346 . . . . 0.0 112.811 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HA ' ' HE2' ' A' ' 10' ' ' MET . 12.6 mm -66.4 -46.94 85.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.243 -175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -122.21 -6.06 8.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -170.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.98 75.79 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 110.091 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 t -164.33 147.52 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -89.01 41.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.058 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 73' ' ' CYS . 41.9 t -74.43 148.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.87 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.583 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 5.4 mmp_? -35.93 120.17 0.69 Allowed Pre-proline 0 C--O 1.224 -0.287 0 O-C-N 124.495 1.122 . . . . 0.0 112.554 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.58 144.37 44.56 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.597 2.198 . . . . 0.0 112.38 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 12.3 mmmm -131.7 -78.79 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -85.78 132.04 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.624 ' HD3' HG21 ' A' ' 19' ' ' THR . 40.9 ttmt -71.07 132.32 44.92 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.548 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 21.9 t -71.45 129.08 35.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.405 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -121.83 130.44 53.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 50' ' ' SER . 17.9 m -80.6 144.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.157 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.681 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.5 p -62.39 139.78 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.604 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 6.9 tp10 -60.16 -21.18 61.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.094 -174.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.627 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 5.2 m120 -60.48 -31.56 70.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.7 m -87.38 -35.02 18.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.529 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.604 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 16.6 p -92.28 -22.08 19.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -57.67 -32.87 67.74 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.01 140.69 5.23 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.642 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 39.0 ttmt 69.91 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.477 0.711 . . . . 0.0 111.701 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.489 HE21 ' HB2' ' A' ' 54' ' ' GLN . 6.3 mt-30 58.98 33.49 23.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.241 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.07 35.09 1.97 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.069 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 -22.4 0.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.796 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 15.6 p30 -62.15 149.26 41.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.815 0.817 . . . . 0.0 112.083 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -64.8 130.92 45.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.265 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.511 ' CD1' HG12 ' A' ' 43' ' ' VAL . 8.4 pt -62.57 -40.6 88.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 60' ' ' ILE . 43.6 mt -68.46 -38.12 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.2 p -101.73 -26.55 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.954 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 57.5 56.47 4.97 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.246 0.546 . . . . 0.0 109.611 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.86 -58.55 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.336 -170.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.4 144.0 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.752 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -64.68 138.13 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.895 0.378 . . . . 0.0 110.978 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -72.13 151.2 46.81 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.297 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 24' ' ' GLU . 61.1 t -118.74 -60.94 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.887 0.375 . . . . 0.0 111.167 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -113.45 137.55 51.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.892 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -60.3 136.72 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.473 0.483 . . . . 0.0 111.366 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.479 ' HB1' HD13 ' A' ' 22' ' ' LEU . . . -82.57 159.39 22.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.904 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -136.54 134.34 37.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.138 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.5 m-85 -66.17 128.12 34.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 1.8 p -71.87 160.15 33.06 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.002 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -49.09 -50.62 36.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.077 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.539 ' HG3' HG12 ' A' ' 37' ' ' VAL . 46.3 mt-10 -59.92 -43.15 95.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.388 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 91.6 m -68.01 -34.97 77.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.169 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 40' ' ' LYS . 81.7 m -68.63 -37.48 79.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -60.53 -47.16 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.272 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.12 -28.2 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.588 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.54 36.84 10.14 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.967 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -87.4 -10.95 50.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.919 0.39 . . . . 0.0 110.243 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -68.82 -24.46 64.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 108.988 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -73.97 -23.49 59.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.757 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB3' HD21 ' A' ' 12' ' ' LEU . 81.4 m-20 -58.16 -58.93 6.3 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 -135.01 7.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.859 -1.163 . . . . 0.0 114.261 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.681 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 24.8 t -55.99 107.35 0.86 Allowed Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 111.929 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 97.3 Cg_endo -87.95 38.25 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.772 2.315 . . . . 0.0 113.563 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 10' ' ' MET . 53.6 mtt180 -87.52 131.42 34.37 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.983 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.694 HG23 HG22 ' A' ' 9' ' ' ILE . 32.3 mm -69.71 121.35 19.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.176 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pp -173.71 -33.4 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.846 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.806 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 13.8 t-20 61.01 106.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.884 0.874 . . . . 0.0 111.18 -173.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.806 ' HG ' ' O ' ' A' ' 91' ' ' ASN . 3.0 pp 61.82 -40.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.195 1.398 . . . . 0.0 113.28 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.32 15.42 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.781 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.6 m 55.57 52.03 11.75 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.243 0.544 . . . . 0.0 110.799 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -151.96 33.52 0.54 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.491 0.663 . . . . 0.0 109.982 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -153.35 121.44 6.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.427 175.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 97' ' ' LEU . 82.8 mt 58.35 47.73 13.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.424 0.63 . . . . 0.0 110.019 -173.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -147.95 -129.43 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.047 -176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.49 74.66 4.05 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 171.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.549 ' HB3' ' HG2' ' A' ' 102' ' ' GLU . 4.0 t-160 -156.78 137.65 13.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.702 -172.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.638 ' HB2' ' HA ' ' A' ' 106' ' ' LYS . 49.0 p90 -61.12 -40.25 93.09 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.901 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.549 ' HG2' ' HB3' ' A' ' 100' ' ' HIS . 55.9 mm-40 52.66 -112.4 0.68 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 175.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -122.12 -48.86 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 111.23 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -87.87 -62.82 1.41 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.432 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -79.67 56.66 2.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.03 -175.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.638 ' HA ' ' HB2' ' A' ' 101' ' ' PHE . 50.9 mtmt -80.55 45.35 0.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.067 0.461 . . . . 0.0 111.392 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.476 177.242 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.864 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 161.45 -43.25 0.39 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.037 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.4 t 61.09 -143.11 0.48 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 122.851 0.46 . . . . 0.0 110.65 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.3 t -171.32 -133.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 59.66 56.46 3.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 110.919 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -126.52 123.63 38.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.478 0.656 . . . . 0.0 111.378 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -106.08 167.33 9.88 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.52 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.8 t80 61.74 -126.07 0.79 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -119.06 32.52 6.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.284 0.564 . . . . 0.0 109.572 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.87 145.72 55.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.368 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.977 HD12 ' H ' ' A' ' 91' ' ' ASN . 0.4 OUTLIER -151.81 43.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.934 -164.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.462 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -63.39 136.59 57.73 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.904 -176.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.4 t -48.85 -48.46 41.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.292 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.462 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 20.9 mt 41.45 40.5 1.31 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 50.5 mttm -80.0 -160.18 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.406 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 tp-100 -82.13 111.01 23.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.381 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 77.2 Cg_endo -80.17 146.54 17.93 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.453 2.102 . . . . 0.0 112.746 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.69 -142.6 13.34 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.298 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.41 -17.87 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.096 0.474 . . . . 0.0 110.717 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.439 ' O ' HG13 ' A' ' 45' ' ' VAL . 10.1 mp0 -64.33 142.18 58.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.756 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 42' ' ' LYS . 7.9 m -109.08 126.58 53.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.747 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.55 138.2 42.7 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.307 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.476 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 41.2 mt -78.93 154.34 29.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.869 0.842 . . . . 0.0 113.131 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.817 HD13 ' HB1' ' A' ' 70' ' ' ALA . 1.7 tp -124.47 127.68 47.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.856 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 1.4 p -81.36 149.4 28.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HG3' HG23 ' A' ' 67' ' ' VAL . 52.8 mt-10 -52.31 -35.01 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -62.22 -37.95 87.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.32 -17.37 23.66 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.49 -0.131 . . . . 0.0 110.795 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.49 110.79 0.68 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.866 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.78 -31.22 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.775 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' HD11 ' A' ' 60' ' ' ILE . 55.1 mttm -78.61 132.58 37.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.479 -0.361 . . . . 0.0 110.892 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 t -80.46 119.05 75.2 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 71.3 Cg_exo -54.59 -37.01 90.74 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 123.059 2.506 . . . . 0.0 113.761 -172.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.523 ' CG2' ' HD3' ' A' ' 81' ' ' LYS . 3.4 mm -61.47 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.4 p -106.5 -21.75 12.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -171.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 65.42 83.43 0.17 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.394 0.616 . . . . 0.0 110.292 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 t -169.34 138.88 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.39 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -80.13 45.96 0.78 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.242 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 38' ' ' ARG . 4.2 p -94.1 148.38 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.009 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.487 ' N ' HG23 ' A' ' 37' ' ' VAL . 58.9 mtt-85 -40.16 123.31 1.67 Allowed Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 77.9 Cg_endo -72.43 152.15 54.39 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.011 2.474 . . . . 0.0 111.261 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.559 ' HD2' ' HD1' ' A' ' 74' ' ' TRP . 57.6 tttp -128.81 -37.16 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.848 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.46 145.42 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.587 ' HB3' HG23 ' A' ' 19' ' ' THR . 89.1 mttt -59.93 143.07 52.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 111.557 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.776 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 31.6 m -68.39 155.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -116.19 114.81 24.95 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.485 HG21 ' SG ' ' A' ' 86' ' ' CYS . 10.0 p -93.88 139.61 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.591 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.5 p -65.79 147.75 52.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.71 -30.47 63.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.679 0.275 . . . . 0.0 110.476 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.668 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.9 m120 -55.94 -40.92 73.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.506 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 91.6 m -80.65 -24.66 38.82 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.597 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -76.95 -41.94 41.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.656 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -79.61 41.05 0.47 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 112.206 -175.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -163.87 159.74 32.52 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -61.68 -11.49 12.05 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -57.94 -40.4 80.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.22 75.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.585 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 10.9 mmpt? -64.18 -30.32 71.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.254 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 71.7 m-80 -76.23 140.17 41.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.022 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.9 t -51.68 126.57 18.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.218 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 70' ' ' ALA . 12.4 pt -68.78 -27.58 36.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.587 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.461 HG13 HD11 ' A' ' 22' ' ' LEU . 54.0 mt -75.81 -42.8 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.982 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 24.9 p -105.63 -6.99 18.79 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.23 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 42.19 45.85 3.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.981 0.801 . . . . 0.0 112.31 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 -62.43 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.142 0.496 . . . . 0.0 110.188 -177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -75.87 141.97 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.891 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 9.9 p -68.16 139.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.729 0.3 . . . . 0.0 110.591 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.25 145.1 20.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.416 HG23 ' HG3' ' A' ' 24' ' ' GLU . 12.8 m -116.33 -38.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.554 0.216 . . . . 0.0 111.478 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -104.73 -174.87 2.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.522 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -107.78 142.26 38.08 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.817 ' HB1' HD13 ' A' ' 22' ' ' LEU . . . -79.42 151.4 30.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -127.39 136.27 51.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 56.1 m-85 -68.11 127.81 34.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.4 p -71.42 161.74 30.57 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.746 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.559 ' HD1' ' HD2' ' A' ' 40' ' ' LYS . 27.8 t90 -51.99 -42.2 62.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.161 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.545 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -58.63 -55.97 28.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.116 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.78 -39.48 94.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.484 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.7 t -65.31 -41.31 94.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.454 0.169 . . . . 0.0 110.765 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.4 ttp-105 -64.15 -44.53 91.85 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.026 0.441 . . . . 0.0 110.324 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 77.3 mt -65.67 -38.2 88.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.367 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 28.18 4.11 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.308 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HD3' ' CG2' ' A' ' 32' ' ' ILE . 46.6 mttm -88.39 -4.67 58.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.869 0.366 . . . . 0.0 110.571 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 p-10 -66.83 -30.45 70.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.034 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 3.5 mmmp? -96.2 7.82 45.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.27 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -69.69 -59.65 2.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.7 -158.15 30.91 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.355 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.485 ' SG ' HG21 ' A' ' 45' ' ' VAL . 34.2 t -66.08 115.22 21.18 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.658 0.783 . . . . 0.0 111.54 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.584 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 90.0 Cg_endo -86.76 41.98 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.683 2.922 . . . . 0.0 114.047 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -87.81 130.34 34.9 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.988 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.0 mm -84.29 115.81 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 9' ' ' ILE . 18.1 mt -85.45 -46.63 10.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.816 -174.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.977 ' H ' HD12 ' A' ' 9' ' ' ILE . 12.9 p30 -59.81 -69.82 0.19 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.6 tp 177.54 136.03 0.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.982 ' HA3' ' HA ' ' A' ' 61' ' ' CYS . . . -58.64 151.38 33.08 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.019 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -71.77 47.39 0.14 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.063 0.459 . . . . 0.0 111.858 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.621 HD22 ' HB2' ' A' ' 61' ' ' CYS . 70.0 m-80 -65.92 -41.13 91.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.669 ' HD2' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -110.1 -151.8 0.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.964 173.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HG ' ' HD2' ' A' ' 96' ' ' ARG . 96.3 mt 64.59 32.55 11.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.419 0.628 . . . . 0.0 109.712 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.6 -30.21 22.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.942 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -66.74 123.38 19.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.021 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -79.03 76.73 5.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.278 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -76.67 45.27 0.4 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.322 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.9 -37.87 85.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.948 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -56.84 136.08 55.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.235 -176.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 68.07 -57.82 0.46 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.22 1.008 . . . . 0.0 113.29 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -170.48 115.56 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -79.29 -32.32 43.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.009 0.433 . . . . 0.0 111.736 -175.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 106' ' ' LYS . 11.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.656 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -171.21 161.22 33.75 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.1 m -74.62 45.62 0.25 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.915 0.388 . . . . 0.0 111.933 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.6 m -159.32 -54.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 38.67 62.11 1.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.201 1.0 . . . . 0.0 113.485 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -82.54 49.23 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 109.251 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.506 ' HG3' ' H ' ' A' ' 6' ' ' PHE . 53.6 tp60 -169.68 -121.34 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.777 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.506 ' H ' ' HG3' ' A' ' 5' ' ' GLN . 28.6 t80 -171.61 161.67 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -73.73 58.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 111.285 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.551 ' C ' HD11 ' A' ' 9' ' ' ILE . 61.6 mt -77.34 39.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.518 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.642 ' HA ' ' CB ' ' A' ' 91' ' ' ASN . 3.7 mp -131.9 26.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 124.083 1.897 . . . . 0.0 106.275 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.621 ' SD ' HD13 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -109.25 140.45 42.87 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.129 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -41.58 -63.11 0.76 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.328 . . . . 0.0 113.254 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.621 HD13 ' SD ' ' A' ' 10' ' ' MET . 0.0 OUTLIER 51.03 36.77 16.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.851 ' HE2' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -104.29 170.66 7.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 166.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.3 tp-100 -57.33 121.91 50.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 123.551 0.532 . . . . 0.0 110.693 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.9 Cg_exo -71.19 151.03 60.49 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.879 2.386 . . . . 0.0 112.688 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.625 ' H ' ' HA ' ' A' ' 46' ' ' CYS . . . -88.02 -125.98 2.37 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.529 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -105.42 -48.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -62.22 151.02 37.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.76 HG22 ' HD3' ' A' ' 42' ' ' LYS . 98.6 m -82.23 143.56 31.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.451 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.75 126.51 9.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.952 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.2 mt -95.33 136.73 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.521 HD21 HD12 ' A' ' 60' ' ' ILE . 90.7 mt -99.07 148.7 23.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.49 171.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.709 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.9 p -89.47 154.99 19.59 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -52.21 -29.54 23.04 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.423 0.452 . . . . 0.0 111.996 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.3 mmtp -69.4 -36.58 76.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.31 -0.244 . . . . 0.0 111.218 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.531 ' HB3' HD13 ' A' ' 60' ' ' ILE . 23.3 m -99.48 33.73 2.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.69 119.23 9.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.115 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.43 31.99 62.7 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.525 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 26' ' ' CYS . 24.5 mtpp -103.76 122.86 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 14.0 t -62.06 115.89 18.56 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.165 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.523 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 8.1 Cg_exo -73.29 50.16 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.63 2.887 . . . . 0.0 112.716 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mm -149.86 -48.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.3 p -112.94 -14.84 12.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.085 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 65.82 80.95 0.21 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.599 0.714 . . . . 0.0 109.939 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -165.65 146.91 7.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.99 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.72 14.1 12.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.477 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.22 150.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.44 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 16.5 ptm180 -37.5 126.98 0.89 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 124.001 0.92 . . . . 0.0 113.383 -174.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.4 Cg_exo -71.55 -163.54 0.13 Allowed 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.429 2.753 . . . . 0.0 112.478 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -169.0 -52.53 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.235 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -140.11 141.89 36.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.76 ' HD3' HG22 ' A' ' 19' ' ' THR . 39.6 ttmt -69.06 140.13 54.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.948 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.667 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 12.4 m -77.95 148.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.799 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.57 129.23 50.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.044 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.483 HG23 ' OG ' ' A' ' 50' ' ' SER . 5.1 m -93.73 146.52 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.025 0.441 . . . . 0.0 111.343 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.625 ' HA ' ' H ' ' A' ' 16' ' ' GLY . 4.6 p -69.91 165.33 21.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 49' ' ' CYS . 20.9 tt0 -59.47 -41.06 88.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.176 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.851 ' HB2' ' HE2' ' A' ' 13' ' ' LYS . 3.7 m120 -74.52 40.3 0.13 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.502 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.5 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 15.6 m -151.35 -52.3 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.75 174.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.483 ' OG ' HG23 ' A' ' 45' ' ' VAL . 51.5 m -100.21 44.17 1.03 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.737 0.779 . . . . 0.0 110.025 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -72.08 -33.68 68.09 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.202 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.47 -68.85 0.13 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.266 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.41 142.84 39.04 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.768 -0.086 . . . . 0.0 110.768 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' HB2' ' ND2' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 40.37 49.42 2.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.809 0.844 . . . . 0.0 111.527 -177.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 50' ' ' SER . . . -92.41 -41.93 10.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.083 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -90.39 27.53 1.67 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.578 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 54' ' ' GLN . 22.9 p30 -93.35 149.74 21.0 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.769 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.709 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.8 t -48.3 129.39 15.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.922 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.404 ' HA ' HH11 ' A' ' 88' ' ' ARG . 8.5 pt -65.89 -31.6 54.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.482 -174.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 26' ' ' CYS . 51.4 mt -77.17 -47.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.74 -4.5 15.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.835 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 40.06 47.91 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.59 0.756 . . . . 0.0 112.651 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.53 -57.25 0.28 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.023 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -76.75 146.69 37.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.716 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.18 131.36 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 110.162 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.17 139.47 25.02 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.991 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.63 -40.05 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 111.447 0.165 . . . . 0.0 111.447 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.75 138.95 33.53 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.33 129.94 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.581 ' CB ' HG21 ' A' ' 43' ' ' VAL . . . -80.28 148.99 30.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.452 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 7.9 m-85 -128.01 133.77 49.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.667 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 53.7 m-85 -68.38 132.44 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -68.63 153.02 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -53.19 -38.33 62.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.789 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.82 -45.79 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.611 0.243 . . . . 0.0 111.385 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.6 m -67.68 -37.77 82.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.086 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.5 t -61.85 -42.64 99.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -57.34 -50.23 73.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.889 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.18 -27.59 62.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.576 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.17 30.71 21.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.404 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -78.99 -27.5 43.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -67.21 -41.72 85.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.096 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -85.01 26.58 0.84 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 12' ' ' LEU . 49.4 t0 -80.39 -53.65 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.461 ' N ' HD11 ' A' ' 12' ' ' LEU . . . 179.32 -149.64 8.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.451 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 30.3 t -67.26 121.05 76.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.663 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 85.3 Cg_endo -80.91 43.42 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.93 3.087 . . . . 0.0 113.446 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.5 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 14.9 mmm180 -102.14 143.7 31.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.999 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.432 ' HA ' HD12 ' A' ' 89' ' ' ILE . 50.0 mm -94.99 123.62 47.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.501 HD23 ' SG ' ' A' ' 11' ' ' CYS . 1.3 pt? -168.12 -31.77 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.642 ' CB ' ' HA ' ' A' ' 9' ' ' ILE . 6.5 t-20 -23.17 -64.61 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.516 1.127 . . . . 0.0 113.699 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.44 HD12 ' HB3' ' A' ' 91' ' ' ASN . 0.2 OUTLIER -164.82 141.64 6.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.13 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.08 122.78 7.71 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.558 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.5 m 71.81 -49.2 0.69 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.633 0.773 . . . . 0.0 111.732 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -63.29 135.92 57.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.483 ' HB3' ' H ' ' A' ' 97' ' ' LEU . 5.0 mmt85 -124.8 -154.99 0.65 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.16 0.505 . . . . 0.0 111.385 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.483 ' H ' ' HB3' ' A' ' 96' ' ' ARG . 32.1 mt -87.52 30.03 0.83 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.516 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -77.25 136.49 38.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.349 174.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.8 ttp-105 62.04 37.08 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.795 0.807 . . . . 0.0 109.628 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 21.3 m80 -123.93 -44.6 2.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.239 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 63.11 -94.45 0.04 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.365 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 59.4 36.39 23.24 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.753 0.787 . . . . 0.0 110.33 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -144.07 -49.26 0.29 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.284 -1.325 . . . . 0.0 107.651 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 9.9 mtmp? -123.21 153.15 40.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.173 169.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 105' ' ' LYS . 12.3 mptt -66.17 124.27 22.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.099 0.476 . . . . 0.0 110.994 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -81.56 139.93 34.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.377 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.943 179.238 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.812 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -69.12 133.25 26.35 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.388 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.4 p -80.29 43.04 0.61 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.995 0.426 . . . . 0.0 111.913 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -75.15 -27.5 59.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.446 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 66.6 44.05 2.35 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.434 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -146.26 9.81 1.11 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.863 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.699 ' HG2' ' HD1' ' A' ' 6' ' ' PHE . 42.4 tt0 -62.49 -70.4 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.306 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.699 ' HD1' ' HG2' ' A' ' 5' ' ' GLN . 3.5 m-85 -103.78 9.67 36.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.814 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.72 ' O ' HD11 ' A' ' 9' ' ' ILE . 8.7 m-20 52.68 48.36 22.69 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.586 -172.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD13 ' H ' ' A' ' 6' ' ' PHE . 3.3 mp -63.72 121.56 14.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.187 -173.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.843 ' HA ' ' HB2' ' A' ' 91' ' ' ASN . 1.3 mp -90.16 50.13 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-O 122.357 1.075 . . . . 0.0 109.386 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.637 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 3.8 ptp -143.77 136.77 27.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.522 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HB2' HD22 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -58.32 -37.54 75.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.787 -174.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 53.8 mt 56.16 34.3 23.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 171.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 61.6 mttm -77.53 -169.36 1.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.533 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.24 113.63 45.23 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.514 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 27.7 Cg_exo -63.91 144.84 89.26 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.442 2.762 . . . . 0.0 112.809 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.08 -142.64 11.06 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.841 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.588 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 8.3 p -82.24 -35.65 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.127 0.489 . . . . 0.0 110.669 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.433 ' N ' HG13 ' A' ' 17' ' ' VAL . 4.8 mp0 -61.38 127.27 30.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.902 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 43' ' ' VAL . 1.0 OUTLIER -85.55 140.24 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.275 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.46 121.38 9.88 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.44 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 26.2 mt -78.53 153.82 30.95 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.548 0.69 . . . . 0.0 112.548 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.656 HD22 ' CB ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -135.81 127.01 28.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.677 -171.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.479 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 1.7 p -80.06 144.87 32.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 93.1 mt-10 -55.17 -26.06 36.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -65.51 -36.33 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.581 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.0 m -94.81 -17.98 21.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.4 t0 -52.05 121.6 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.509 -172.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.78 -32.88 5.47 Favored Glycine 0 C--N 1.316 -0.58 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.26 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -71.13 128.39 35.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.447 -0.376 . . . . 0.0 110.866 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.6 t -74.8 119.67 77.88 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.8 -36.15 90.1 Favored 'Trans proline' 0 N--CA 1.472 0.264 0 C-N-CA 123.174 2.582 . . . . 0.0 113.331 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.5 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.4 mm -65.41 -44.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.7 p -121.55 -11.49 8.68 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 62.79 72.4 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.957 0.408 . . . . 0.0 111.181 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -162.67 141.8 8.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.856 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -83.31 45.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.306 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.619 HG23 ' N ' ' A' ' 38' ' ' ARG . 5.9 p -92.79 154.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.245 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.619 ' N ' HG23 ' A' ' 37' ' ' VAL . 88.7 mtt180 -35.16 124.81 0.58 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.356 1.062 . . . . 0.0 113.584 -173.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.79 146.89 38.79 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.144 2.563 . . . . 0.0 111.825 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 57.7 tptt -127.45 -49.27 1.41 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.697 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -138.09 138.69 38.97 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.937 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.561 ' HG2' ' CE2' ' A' ' 71' ' ' PHE . 32.5 mtpt -65.25 136.04 56.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.322 0.582 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.602 ' O ' HG21 ' A' ' 19' ' ' THR . 26.0 t -79.92 124.72 38.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.162 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.588 ' NH1' ' HA ' ' A' ' 17' ' ' VAL . 72.7 mtt-85 -107.05 133.34 51.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.059 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.95 147.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.967 0.413 . . . . 0.0 110.118 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 p -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.17 -42.8 14.49 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.912 0.758 . . . . 0.0 111.721 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.3 m120 -60.28 -41.12 92.65 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.64 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 74.0 m -85.8 53.37 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 t -160.72 -46.85 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.427 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.57 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 -73.73 136.01 43.67 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.489 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.08 -42.92 1.41 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 116.013 -0.539 . . . . 0.0 114.115 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.764 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -165.74 172.15 12.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.961 0.381 . . . . 0.0 110.933 -174.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.764 ' HG3' ' HG2' ' A' ' 53' ' ' LYS . 17.1 mt-30 61.92 46.13 6.94 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.703 0.627 . . . . 0.0 111.307 176.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -118.45 -42.11 2.79 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.354 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -84.33 -35.28 23.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.083 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -65.75 143.34 57.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.402 0.62 . . . . 0.0 111.551 -173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.5 t -64.05 125.89 25.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.676 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -63.3 -32.43 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.3 mt -73.52 -41.3 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -173.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 6.3 p -93.5 -25.11 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.227 174.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 t30 61.43 44.59 9.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.745 0.784 . . . . 0.0 109.656 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -164.18 -59.27 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.42 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 74.9 m-80 -71.82 146.22 48.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -66.93 136.19 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.386 . . . . 0.0 111.09 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -88.51 142.34 17.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 22' ' ' LEU . 15.4 m -117.17 -38.53 2.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.685 0.279 . . . . 0.0 111.594 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' LEU . 80.5 m-20 -109.93 -168.52 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.527 ' HB3' HG22 ' A' ' 19' ' ' THR . 64.0 m-20 -115.02 145.73 41.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.025 0.441 . . . . 0.0 110.513 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.656 ' CB ' HD22 ' A' ' 22' ' ' LEU . . . -75.86 152.28 37.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.709 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' CE2' ' HG2' ' A' ' 42' ' ' LYS . 32.0 m-85 -132.08 131.47 42.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.192 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.469 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -70.67 128.75 37.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.487 ' HB2' HG13 ' A' ' 37' ' ' VAL . 7.1 p -73.6 158.4 34.85 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.868 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 27.8 t90 -47.97 -49.74 29.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.536 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 5.5 pt-20 -68.45 -36.5 79.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.5 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 34.7 m -63.23 -42.25 99.2 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.584 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 97.4 m -68.1 -41.1 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.701 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -63.26 -42.47 99.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -72.24 -30.13 64.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.248 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.83 4.29 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.033 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -96.24 -32.61 12.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 109.979 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -64.06 -34.99 79.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.614 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 7.47 2.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.953 -176.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -76.47 -56.41 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.07 -147.33 12.35 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.433 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 2.0 t -70.59 114.44 26.38 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 124.302 1.041 . . . . 0.0 112.389 -174.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.51 ' CG ' HG12 ' A' ' 43' ' ' VAL . 96.0 Cg_endo -93.33 42.11 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.073 2.515 . . . . 0.0 114.887 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.64 ' HD2' ' HB3' ' A' ' 49' ' ' CYS . 39.9 mtt-85 -74.58 128.42 35.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.024 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.694 HG23 HG22 ' A' ' 9' ' ' ILE . 17.8 mm -67.34 118.79 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 0.0 111.225 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.565 ' H ' HG23 ' A' ' 9' ' ' ILE . 2.1 pp -169.75 -40.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.935 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.843 ' HB2' ' HA ' ' A' ' 9' ' ' ILE . 20.9 t-20 65.76 -67.2 0.14 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.772 0.829 . . . . 0.0 110.763 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.34 -60.12 1.77 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.98 -61.44 0.75 Allowed Glycine 0 C--N 1.33 0.209 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.45 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.6 t -173.96 -140.82 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.5 m120 58.69 37.11 25.21 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 122.714 0.405 . . . . 0.0 111.233 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.2 -28.0 0.74 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.683 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.19 149.33 44.74 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 t70 62.39 46.54 5.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.326 0.584 . . . . 0.0 109.655 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 70.7 -69.04 0.19 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.351 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -170.38 143.88 2.4 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.185 0.594 . . . . 0.0 109.554 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -77.01 72.93 3.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.05 0.452 . . . . 0.0 109.795 175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.552 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 5.9 tp10 -161.99 145.17 11.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.02 -174.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.552 ' HG2' ' HG3' ' A' ' 102' ' ' GLU . 34.7 mmtp 72.91 -57.79 0.62 Allowed 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.098 0.874 . . . . 0.0 111.309 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -84.58 126.01 32.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.16 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp 62.23 -134.16 0.52 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.426 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HZ2' ' CD ' ' A' ' 102' ' ' GLU . 82.3 tttt 64.14 48.25 3.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.882 0.849 . . . . 0.0 110.545 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.66 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -70.32 126.06 15.47 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.237 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.8 t 53.33 -130.86 2.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.432 0.293 . . . . 0.0 110.395 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m 71.5 -47.8 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.828 0.851 . . . . 0.0 112.501 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.48 -27.3 66.89 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.3 -50.51 67.16 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.293 0.568 . . . . 0.0 110.398 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.7 ' HB2' HD22 ' A' ' 8' ' ' LEU . 3.2 pt20 -96.42 -138.84 0.26 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.538 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.614 ' HE2' ' HD3' ' A' ' 103' ' ' LYS . 1.2 t80 64.2 17.24 10.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.402 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -92.11 25.95 2.68 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 159.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.7 HD22 ' HB2' ' A' ' 5' ' ' GLN . 1.6 mt -76.2 95.17 3.65 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.759 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 8' ' ' LEU . 1.9 tp 173.27 178.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -172.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.567 ' HG3' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -55.87 137.73 49.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.72 0.771 . . . . 0.0 112.052 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.4 t -52.84 -39.75 62.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.67 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp 43.29 46.44 5.38 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 171.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -88.89 -152.66 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 46' ' ' CYS . 67.3 tp60 -86.3 115.17 61.05 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 48.9 Cg_exo -58.94 136.17 71.69 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.084 2.523 . . . . 0.0 112.852 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.69 -112.29 0.89 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.445 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 p -146.26 -26.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.781 0.324 . . . . 0.0 110.881 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 56.2 mt-30 -66.35 131.7 46.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.324 0.583 . . . . 0.0 111.45 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -76.33 135.52 39.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.888 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.2 118.72 5.66 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.233 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 91.8 mt -90.8 143.67 26.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.144 0.497 . . . . 0.0 111.648 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 HD13 ' A' ' 60' ' ' ILE . 80.9 mt -104.04 133.63 48.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.743 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.658 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.3 p -71.27 154.26 41.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -48.64 -32.27 8.02 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.484 0.49 . . . . 0.0 112.269 -176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -70.81 -43.21 69.1 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.466 ' HB3' HD11 ' A' ' 60' ' ' ILE . 33.7 m -89.72 -11.32 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -54.86 115.5 2.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.764 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.7 -31.31 5.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.6 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -77.32 127.59 32.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.4 t -68.14 118.27 57.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 3.2 Cg_endo -52.93 -41.29 72.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.221 2.614 . . . . 0.0 113.652 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.937 HG22 ' HG2' ' A' ' 81' ' ' LYS . 1.4 mm -68.75 -48.44 71.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -110.5 -7.94 14.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 58.88 71.46 0.58 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.295 0.569 . . . . 0.0 110.266 -177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.7 t -160.04 139.51 11.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.112 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -85.62 30.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.534 HG23 ' N ' ' A' ' 38' ' ' ARG . 7.7 p -80.51 148.82 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.444 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.534 ' N ' HG23 ' A' ' 37' ' ' VAL . 38.0 mtp85 -36.93 119.96 0.8 Allowed Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -170.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.674 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.8 Cg_endo -80.63 150.65 19.1 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.341 2.694 . . . . 0.0 112.207 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -137.59 -69.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.643 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 20.7 tpp180 -78.86 131.62 36.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.022 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -69.03 133.46 48.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.215 0.531 . . . . 0.0 110.613 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 70' ' ' ALA . 3.1 t -76.88 126.22 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.866 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -125.04 127.95 47.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.779 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 59' ' ' ILE . 6.8 m -85.53 158.44 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 0.0 111.257 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.696 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.9 p -65.45 148.79 51.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -54.02 -30.89 49.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.249 0.343 . . . . 0.0 111.686 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.662 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 64.7 m-80 -59.83 -34.2 72.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.476 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.89 35.5 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.717 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.555 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 14.8 m -140.57 -45.16 0.4 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.304 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -87.69 -18.43 29.55 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.729 178.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.78 -150.16 6.8 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.903 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -82.41 38.07 0.54 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.23 0.538 . . . . 0.0 111.239 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -166.03 142.07 4.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.724 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -174.03 -49.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.379 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.691 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -96.83 -26.63 15.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.178 177.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 72.0 m-20 -61.05 142.54 56.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.658 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 42.3 t -51.03 133.39 27.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.89 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.413 HG21 ' CG1' ' A' ' 45' ' ' VAL . 7.6 pt -78.43 -26.58 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.518 -175.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.654 HD13 HD23 ' A' ' 22' ' ' LEU . 48.9 mt -78.2 -48.24 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 63' ' ' LEU . 28.2 p -103.03 -6.75 22.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.764 -0.775 . . . . 0.0 110.834 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 12.9 m-80 70.05 -36.08 0.34 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.745 0.818 . . . . 0.0 111.581 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.571 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -78.65 -63.22 1.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.559 -166.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -68.23 148.62 50.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.742 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -73.93 137.02 24.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.721 0.295 . . . . 0.0 110.688 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 144.35 27.25 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.875 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 68' ' ' ASN . 27.2 m -115.29 -47.63 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.425 ' H ' HG22 ' A' ' 67' ' ' VAL . 73.6 m-20 -114.75 135.68 53.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.289 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.89 134.62 55.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.781 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB2' HG22 ' A' ' 43' ' ' VAL . . . -77.37 153.05 34.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.475 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.461 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 11.2 m-85 -134.55 135.1 42.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.521 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.414 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -66.55 130.29 42.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.9 p -68.97 162.51 26.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -51.18 -44.03 61.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.105 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.504 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -59.82 -47.67 84.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.741 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 68.4 m -67.51 -37.92 83.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.298 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 77.0 m -62.55 -42.88 99.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.798 0.332 . . . . 0.0 110.504 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.05 -42.25 99.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 68.6 mt -70.28 -33.44 71.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.5 7.83 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.847 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.937 ' HG2' HG22 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -66.73 -25.58 66.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.796 0.331 . . . . 0.0 111.564 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.643 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . 26.5 p-10 -65.76 -43.52 88.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.756 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -83.94 -9.0 59.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.916 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 6.4 m-20 -60.03 -49.49 77.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.12 7.92 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.041 -1.075 . . . . 0.0 113.706 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.696 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 41.4 t -69.38 117.97 57.75 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.412 -0.894 . . . . 0.0 111.85 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -86.45 24.94 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 123.201 2.601 . . . . 0.0 113.261 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' MET . 2.0 mmt180 -73.82 124.49 26.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.404 HD11 ' CE ' ' A' ' 10' ' ' MET . 27.0 mm -77.69 110.6 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 68.2 mt -83.02 -26.2 31.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 7.3 t-20 -64.64 -143.74 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.797 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -160.25 -141.68 0.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.98 -51.15 57.66 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.579 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.5 m -155.83 124.29 5.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.708 0.254 . . . . 0.0 110.48 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 179.16 50.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.623 ' HD3' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -160.87 -143.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.838 -176.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.623 ' HG ' ' HD3' ' A' ' 96' ' ' ARG . 91.6 mt 66.79 31.07 7.64 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 122.775 0.43 . . . . 0.0 111.203 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -77.5 130.61 37.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' NE ' ' HA ' ' A' ' 99' ' ' ARG . 5.3 mmp_? -94.76 -20.17 19.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.865 0.364 . . . . 0.0 110.964 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -125.08 47.98 2.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.136 0.494 . . . . 0.0 110.65 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -65.82 117.23 7.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.806 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -168.96 62.2 0.06 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.614 ' HD3' ' HE2' ' A' ' 6' ' ' PHE . 26.2 mtpp -111.3 76.23 0.96 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.081 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER 74.34 -40.71 0.46 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.292 -175.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 103' ' ' LYS . 20.8 pttp -133.35 152.62 51.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.273 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -151.65 131.78 13.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.348 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.979 -0.534 . . . . 0.0 110.025 178.725 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 169.95 60.92 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.4 m 62.3 -131.78 0.57 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.423 0.289 . . . . 0.0 110.315 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.0 m -159.37 140.46 12.72 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 67.37 -85.01 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.875 0.734 . . . . 0.0 110.965 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -97.98 -145.21 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 6' ' ' PHE . 1.9 pt20 -87.65 -11.79 47.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 21.4 t80 79.22 23.5 0.53 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 124.404 1.065 . . . . 0.0 110.032 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.65 54.7 9.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.211 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.632 ' HB2' ' CG2' ' A' ' 89' ' ' ILE . 3.7 mt -58.89 142.27 51.13 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.221 0.534 . . . . 0.0 111.654 -174.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.888 HG22 ' HB3' ' A' ' 92' ' ' LEU . 3.8 mp -104.36 45.54 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.12 -162.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.837 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 42.19 -170.33 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.484 -1.235 . . . . 0.0 113.46 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.459 ' HB2' ' CD2' ' A' ' 90' ' ' LEU . 16.4 t -111.14 -54.75 2.57 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.881 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 56.8 mt 48.56 33.16 3.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.047 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -86.24 -179.74 6.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mm-40 -67.93 116.05 34.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.688 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.2 Cg_exo -72.4 142.57 37.26 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.431 2.754 . . . . 0.0 112.975 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.45 -133.35 4.43 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.925 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.423 HG23 ' OE1' ' A' ' 18' ' ' GLN . 27.2 m -105.56 -27.08 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.658 0.266 . . . . 0.0 111.329 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.423 ' OE1' HG23 ' A' ' 17' ' ' VAL . 14.4 mp0 -64.6 131.65 47.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 111.163 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.69 HG22 ' HD3' ' A' ' 42' ' ' LYS . 6.6 m -83.13 140.91 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.026 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.4 133.07 14.08 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.687 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 71.7 mt -95.64 143.79 26.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.173 0.511 . . . . 0.0 112.358 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 HG12 ' A' ' 59' ' ' ILE . 53.2 mt -113.93 139.28 49.35 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.374 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.536 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 8.6 p -72.62 151.62 42.22 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -49.32 -34.67 16.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.923 0.392 . . . . 0.0 111.595 -175.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -71.46 -26.45 62.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 56.9 m -101.2 -16.08 17.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.453 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -51.94 115.77 1.85 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.258 0.552 . . . . 0.0 111.201 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 36' ' ' TYR . . . 122.29 -30.93 5.05 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.951 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 40.0 mttm -72.12 127.72 33.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.57 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 2.5 t -71.08 120.42 79.42 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HG2' HG13 ' A' ' 43' ' ' VAL . 71.8 Cg_exo -53.1 -35.54 73.05 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.827 2.351 . . . . 0.0 112.964 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mm -67.84 -46.68 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.363 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.7 p -118.46 -2.94 10.97 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.6 t70 59.13 67.8 0.88 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.284 0.564 . . . . 0.0 110.69 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.02 143.34 15.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.022 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 28' ' ' GLY . 2.1 m-85 -83.39 13.31 4.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.091 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 38' ' ' ARG . 13.1 p -60.67 149.64 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.8 ptp85 -38.88 128.77 1.18 Allowed Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.098 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 Cg_exo -74.83 -161.38 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.437 2.758 . . . . 0.0 112.724 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -167.78 -43.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.728 178.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 -153.83 142.53 20.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 111.196 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.69 ' HD3' HG22 ' A' ' 19' ' ' THR . 87.0 mttt -62.54 143.08 57.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.473 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.967 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 18.0 m -82.08 146.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -118.98 133.51 55.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.073 0.463 . . . . 0.0 110.78 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.7 m -86.9 146.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.667 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.688 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 10.2 p -66.16 151.39 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -52.02 -37.17 52.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.884 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.483 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 16.9 m-80 -64.67 -20.19 66.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.555 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 19.6 m -90.2 -41.01 11.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.274 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -68.82 -30.27 68.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -63.46 -21.76 66.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -173.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.85 -148.87 18.91 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.169 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HE3' ' CZ ' ' A' ' 51' ' ' PHE . 22.3 pttp 52.83 -59.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.173 1.789 . . . . 0.0 114.455 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -162.61 115.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.516 0.598 . . . . 0.0 111.299 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -165.87 -35.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.647 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -66.76 -29.37 69.32 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.11 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 13.8 p30 -71.62 138.85 49.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.536 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.1 t -42.7 126.29 3.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.931 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.456 HG12 HD23 ' A' ' 22' ' ' LEU . 9.5 pt -61.21 -32.03 51.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.986 -1.007 . . . . 0.0 113.128 -171.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.99 -45.16 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -103.94 -7.35 20.46 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.684 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 42.04 51.33 4.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.708 0.803 . . . . 0.0 112.387 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HA ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -155.04 -66.13 0.13 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.085 -177.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -71.24 139.41 50.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.51 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 13.8 p -66.67 136.4 26.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.432 . . . . 0.0 111.448 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.51 141.66 25.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.381 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.1 m -118.87 -46.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -116.91 147.23 42.4 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.648 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.36 142.62 58.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.579 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.32 155.59 25.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.904 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.527 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 18.3 m-85 -127.84 137.28 52.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.595 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 91.1 m-85 -69.76 125.39 26.58 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 1.8 p -71.21 152.75 43.04 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.269 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.503 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.65 -44.19 62.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.092 -177.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -56.15 -46.8 79.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.527 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -72.6 -38.56 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.5 t -67.14 -39.98 86.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 110.397 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.27 -32.27 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.403 0.621 . . . . 0.0 109.905 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 101.82 41.21 2.53 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.106 176.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -94.74 1.26 55.46 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.279 -0.542 . . . . 0.0 110.722 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.48 -23.52 62.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.547 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -96.21 9.54 40.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.136 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -68.05 -65.91 0.63 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.96 -154.4 24.38 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.407 170.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.626 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 54.1 t -57.93 115.41 11.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.211 -0.994 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.967 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 71.8 Cg_endo -78.29 17.42 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.286 2.658 . . . . 0.0 113.312 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.555 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 14.0 mmm180 -67.98 136.41 53.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.837 ' HA ' ' HA ' ' A' ' 10' ' ' MET . 28.9 mm -92.31 119.55 40.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 118.408 0.549 . . . . 0.0 111.345 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -153.84 -62.59 0.14 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.698 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER 169.97 154.61 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.365 0.666 . . . . 0.0 110.009 -173.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.888 ' HB3' HG22 ' A' ' 9' ' ' ILE . 60.2 tp -159.56 -24.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.57 37.95 39.11 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.5 t -167.98 44.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -69.27 127.85 34.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.279 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -145.14 -122.12 0.08 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.69 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 92.4 mt 73.37 141.12 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.972 0.509 . . . . 0.0 111.282 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.91 59.86 1.61 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.607 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -67.61 138.28 56.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.013 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -156.12 51.9 0.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.462 0.648 . . . . 0.0 110.306 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -99.08 42.28 1.11 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.58 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -96.43 36.02 1.41 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.948 -175.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -95.21 -169.59 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -68.29 -33.07 73.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 25.2 mmmt -79.52 130.07 35.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.438 172.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -159.32 -36.6 0.06 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.623 0.725 . . . . 0.0 109.228 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 48.6 t . . . . . 0 C--N 1.31 -1.116 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.755 173.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 173.0 -35.84 0.13 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.926 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.8 t 60.1 30.67 20.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.793 0.437 . . . . 0.0 111.201 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.431 ' H ' ' HB3' ' A' ' 92' ' ' LEU . 5.0 m 54.63 32.4 17.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.811 176.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -75.84 142.54 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.033 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -75.54 55.43 0.82 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.669 ' HB3' ' HB2' ' A' ' 8' ' ' LEU . 57.4 mt-30 -67.76 144.91 55.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.33 72.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.468 0.651 . . . . 0.0 111.137 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 55.8 28.3 12.13 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.725 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 5' ' ' GLN . 62.4 mt -91.02 46.48 1.32 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.133 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.805 ' HA ' ' HB2' ' A' ' 91' ' ' ASN . 2.5 mp -110.52 13.27 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 123.157 1.456 . . . . 0.0 107.427 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.511 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.3 ptp -95.07 144.98 25.29 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 111.868 -2.424 . . . . 0.0 111.425 170.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.476 ' SG ' HD23 ' A' ' 90' ' ' LEU . 7.6 t -44.69 -59.9 2.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.383 -1.735 . . . . 0.0 112.625 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' A' ' 84' ' ' ASP . 81.7 mt 52.48 32.18 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.935 0.894 . . . . 0.0 113.225 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -80.75 -177.92 6.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.83 115.52 25.77 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 6.5 Cg_exo -74.99 140.1 25.09 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.991 2.461 . . . . 0.0 112.873 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.07 -145.3 10.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.214 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.6 -5.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.518 -0.401 . . . . 0.0 110.606 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.548 ' HB2' HG23 ' A' ' 45' ' ' VAL . 6.5 mm100 -62.01 130.36 45.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.177 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.409 HG22 ' HD3' ' A' ' 42' ' ' LYS . 1.3 m -79.17 137.83 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.301 -177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.26 125.66 7.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.341 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.482 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 81.9 mt -100.08 145.8 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.241 0.543 . . . . 0.0 112.407 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 70' ' ' ALA . 85.8 mt -114.04 133.01 55.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.572 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.5 p -72.14 157.95 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -53.01 -27.44 19.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.884 0.374 . . . . 0.0 111.842 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 50.7 mtpt -75.43 -24.14 57.05 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.321 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 8.9 m -119.05 18.46 13.14 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.9 129.54 40.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.763 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.52 -22.33 37.99 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.664 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 60.3 mttp -74.82 133.03 41.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.643 0.259 . . . . 0.0 111.021 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 22.6 t -70.9 121.01 82.76 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 12.0 Cg_endo -58.35 -34.33 98.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.976 2.451 . . . . 0.0 113.142 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 13.0 mm -69.89 -46.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.212 -175.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.5 p -122.66 -7.57 8.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 60.87 78.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.341 0.591 . . . . 0.0 110.367 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -160.54 143.95 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.398 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -94.63 26.9 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.668 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 73' ' ' CYS . 4.4 p -75.96 168.84 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.597 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 3.2 mtp-105 -50.49 129.23 25.72 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 38' ' ' ARG . 5.7 Cg_exo -73.28 158.57 48.43 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.19 2.593 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HG3' ' HE3' ' A' ' 74' ' ' TRP . 11.9 tmtt? -142.94 -49.77 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.273 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HD3' ' OD2' ' A' ' 82' ' ' ASP . 67.9 ttt180 -122.31 130.54 53.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.683 0.278 . . . . 0.0 111.071 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 19' ' ' THR . 40.2 ttmt -67.71 136.6 54.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.17 0.509 . . . . 0.0 110.648 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.585 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.2 t -75.44 134.68 28.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.984 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -124.46 130.19 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 18' ' ' GLN . 35.5 m -92.29 155.68 3.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.047 0.451 . . . . 0.0 111.249 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.683 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.5 p -66.3 151.34 47.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.222 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -53.06 -39.62 63.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.355 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.612 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.1 m120 -55.87 -44.71 78.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.256 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 33.6 m -66.95 -25.06 66.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 t -87.24 -51.01 6.21 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.628 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.612 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -65.22 -21.3 66.73 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.306 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.61 155.45 52.94 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.656 172.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -51.51 -37.77 50.84 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -79.4 48.76 0.92 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.921 0.391 . . . . 0.0 111.467 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.72 -54.71 23.59 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 11.5 mmpt? -97.76 16.83 19.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -171.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 84.6 m-20 -84.35 154.46 22.86 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.733 0.777 . . . . 0.0 111.398 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.0 t -53.2 136.27 36.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.106 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 11.1 pt -77.76 -32.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.768 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.472 HD13 HG21 ' A' ' 60' ' ' ILE . 46.8 mt -73.26 -48.58 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -108.2 11.8 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.306 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 7.3 p-10 53.79 -37.11 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.951 HD13 ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -93.12 -46.75 7.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 119.665 1.121 . . . . 0.0 113.888 -171.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.951 ' H ' HD13 ' A' ' 63' ' ' LEU . 4.3 m120 -67.73 135.56 52.9 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 11.7 p -59.44 134.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 111.55 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.5 144.66 19.9 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.274 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.01 -42.57 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -113.43 139.21 49.1 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.966 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -64.36 138.16 58.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.215 0.531 . . . . 0.0 111.104 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' CG ' ' A' ' 22' ' ' LEU . . . -83.33 154.01 24.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.072 176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -131.76 135.13 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.88 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 46.3 m-85 -68.63 127.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.502 ' HB2' HG12 ' A' ' 37' ' ' VAL . 4.9 p -70.87 156.75 39.2 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.569 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.496 ' HE3' ' HG3' ' A' ' 40' ' ' LYS . 9.5 t-105 -41.17 -60.27 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.007 0.817 . . . . 0.0 112.804 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.16 -35.85 78.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.209 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 23.5 m -62.81 -35.94 81.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 111.245 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.3 m -70.99 -37.95 72.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.211 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -49.21 76.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.39 175.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.16 -32.62 71.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.771 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.9 43.92 9.55 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.504 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -95.32 -31.07 13.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.187 0.518 . . . . 0.0 110.068 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' OD2' ' HD3' ' A' ' 41' ' ' ARG . 43.7 p-10 -65.94 -30.93 71.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.429 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HD2' ' C ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -64.38 -19.12 65.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.582 -176.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.6 ' HB3' HD23 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -64.62 -42.58 95.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.389 -177.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.04 -136.29 6.28 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.876 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 36.8 t -60.38 113.36 7.31 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.362 1.065 . . . . 0.0 112.159 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.448 ' HG3' HG12 ' A' ' 43' ' ' VAL . 69.4 Cg_endo -86.51 43.9 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.033 2.489 . . . . 0.0 113.827 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.626 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 45.9 mtt180 -98.67 127.88 44.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.94 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.611 HG23 HG22 ' A' ' 9' ' ' ILE . 50.4 mm -74.18 114.27 13.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' ' 11' ' ' CYS . 0.8 OUTLIER -158.62 -0.72 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -177.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.805 ' HB2' ' HA ' ' A' ' 9' ' ' ILE . 91.2 m-20 -78.81 -118.96 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.168 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 91' ' ' ASN . 4.2 tp -172.3 128.17 0.56 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.57 -140.1 4.15 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.016 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.6 m -68.41 115.86 8.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.194 0.521 . . . . 0.0 110.789 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 176.41 -41.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.734 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -142.55 146.07 34.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.609 -1.632 . . . . 0.0 107.44 170.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 96' ' ' ARG . 5.1 mt 172.56 -21.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.17 0.919 . . . . 0.0 110.843 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.7 t70 61.41 47.13 7.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.871 0.843 . . . . 0.0 109.954 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 100' ' ' HIS . 89.8 mtt-85 -148.04 -147.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.736 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.471 ' C ' ' H ' ' A' ' 102' ' ' GLU . 58.4 t60 56.25 36.78 28.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.0 t80 72.09 -28.56 0.19 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.144 0.577 . . . . 0.0 112.053 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 103' ' ' LYS . 41.2 tt0 -54.74 132.89 46.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.846 0.459 . . . . 0.0 111.771 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HG2' ' HG2' ' A' ' 102' ' ' GLU . 14.5 mmmm 70.84 -50.95 0.68 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.182 0.993 . . . . 0.0 111.98 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -77.93 -134.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.288 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.54 ' HB3' ' NZ ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -168.34 179.41 4.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -146.93 127.69 14.34 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.815 -177.601 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -179.44 -133.13 1.9 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.755 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 m -92.13 37.89 0.99 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.126 0.489 . . . . 0.0 110.459 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -82.27 47.16 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.298 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -143.55 128.59 18.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.063 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -87.12 -44.28 11.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.283 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 67.1 127.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.956 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 1.004 ' HA ' HD11 ' A' ' 8' ' ' LEU . 1.8 t80 -136.05 24.77 3.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.295 1.045 . . . . 0.0 108.798 173.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 1.021 ' HB3' HD13 ' A' ' 9' ' ' ILE . 25.6 m-20 -89.48 -50.86 5.85 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.242 168.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.004 HD11 ' HA ' ' A' ' 6' ' ' PHE . 1.1 mp 48.76 73.97 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.685 173.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 1.021 HD13 ' HB3' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -176.83 -172.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 123.969 0.908 . . . . 0.0 109.389 -177.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -76.15 142.38 41.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 164.009 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.0 t -45.72 -53.84 8.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 111.522 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.494 ' HB2' ' HG3' ' A' ' 10' ' ' MET . 2.6 tp 41.99 41.05 1.8 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 170.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 64.0 mttm -79.65 -134.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -109.93 116.65 53.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HD3' ' HA2' ' A' ' 85' ' ' GLY . 52.0 Cg_exo -56.14 135.72 71.4 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.217 -175.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.16 -136.14 8.05 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.393 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.67 -24.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -80.86 137.44 36.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -78.25 137.91 38.35 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.988 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.75 133.22 13.25 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.491 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 64.2 mt -95.29 147.36 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 111.913 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.422 ' HA ' HD21 ' A' ' 22' ' ' LEU . 79.4 mt -117.12 132.28 56.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.376 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 6.9 p -71.9 158.24 36.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 39.8 mt-10 -55.75 -28.01 53.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.0 111.561 -176.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 55.0 mttp -71.81 -24.44 61.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.413 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.6 ' HB3' HD13 ' A' ' 60' ' ' ILE . 5.6 m -119.66 18.33 12.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.496 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 32.7 t70 -67.51 131.49 45.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.554 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.49 -27.54 6.31 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.83 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 61.9 mttp -66.75 132.02 47.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.584 0.231 . . . . 0.0 111.027 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 t -71.17 118.01 61.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HG2' HG23 ' A' ' 43' ' ' VAL . 68.0 Cg_exo -56.41 -39.85 88.51 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.157 2.571 . . . . 0.0 113.383 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.57 HG21 ' HD3' ' A' ' 81' ' ' LYS . 6.8 mm -61.54 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.209 -174.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -119.47 -16.51 8.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 66.94 77.97 0.26 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.59 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -171.34 145.86 2.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.996 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -97.45 31.23 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 73' ' ' CYS . 7.7 p -76.79 70.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 122.31 1.053 . . . . 0.0 111.83 -173.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.442 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.8 mmp_? 60.14 111.63 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.776 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.36 144.03 66.22 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.719 2.279 . . . . 0.0 112.132 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -128.68 -48.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -139.81 144.9 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.439 -0.163 . . . . 0.0 111.202 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 92.9 mttt -63.94 138.31 58.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.316 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.788 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.0 t -73.53 131.84 34.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.687 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.0 OUTLIER -113.18 124.69 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 59' ' ' ILE . 27.6 m -91.61 150.92 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.404 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 11.7 p -62.0 150.14 38.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -51.78 -34.83 41.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.103 -177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.7 m120 -58.24 -45.51 87.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.58 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 99.3 m -74.99 -15.01 60.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -85.49 -45.62 11.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.263 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER -81.36 -20.88 39.65 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.824 -179.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -70.5 158.59 53.61 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.278 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.92 -24.96 67.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.395 0.617 . . . . 0.0 110.054 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HA ' ' ND2' ' A' ' 57' ' ' ASN . 7.0 mp0 -53.83 -30.83 47.02 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.431 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 52' ' ' GLY . . . -48.04 -35.43 11.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.791 -1.095 . . . . 0.0 113.013 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -70.59 -36.33 73.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.01 0.433 . . . . 0.0 110.582 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.784 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.4 m-80 -78.26 158.82 28.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.3 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.5 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.397 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 45' ' ' VAL . 7.7 pt -70.62 -38.09 72.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.976 -173.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.6 HD13 ' HB3' ' A' ' 26' ' ' CYS . 43.4 mt -69.95 -54.85 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -90.36 -6.47 54.99 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.793 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 48.99 24.29 0.85 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.932 0.893 . . . . 0.0 112.393 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.91 -59.83 0.74 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.319 -170.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -76.14 140.53 41.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.784 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 42.9 t -58.56 137.76 20.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 111.107 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.88 149.17 45.87 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.049 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.4 -62.19 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.757 0.313 . . . . 0.0 111.28 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.44 143.19 45.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.28 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -60.48 136.78 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.71 156.06 23.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.325 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -128.8 133.68 48.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.14 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.788 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.3 m-85 -67.27 130.85 44.4 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.424 ' HB2' HG12 ' A' ' 37' ' ' VAL . 11.2 p -73.48 167.97 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -55.69 -49.17 73.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' CG ' ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt-20 -63.26 -39.58 95.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -175.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 69.4 m -66.25 -40.03 89.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.899 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 21.3 t -68.07 -36.99 80.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.25 0.548 . . . . 0.0 109.89 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -60.61 -44.24 96.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 79' ' ' LEU . 90.8 mt -70.05 -31.49 69.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.874 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.76 8.44 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.01 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.57 ' HD3' HG21 ' A' ' 32' ' ' ILE . 43.1 mttm -87.84 7.51 30.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.708 0.766 . . . . 0.0 110.294 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -92.8 -10.94 35.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.847 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.67 -26.25 7.52 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.081 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -64.98 -54.83 24.34 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.951 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 15' ' ' PRO . . . -158.56 -158.55 9.09 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.999 -1.572 . . . . 0.0 115.152 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.617 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 1.6 t -95.17 120.04 64.75 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.792 -1.204 . . . . 0.0 111.47 -173.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.817 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 71.6 Cg_endo -75.5 47.02 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.922 3.081 . . . . 0.0 114.166 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.58 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 17.9 mmt180 -101.95 126.67 48.92 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mm -86.88 118.68 33.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.508 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.53 -44.5 7.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.82 ' HB3' ' N ' ' A' ' 9' ' ' ILE . 4.0 t30 -126.03 159.4 32.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.3 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -39.33 -38.84 0.58 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.04 -57.18 0.29 Allowed Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.96 174.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.501 ' HB2' HG22 ' A' ' 9' ' ' ILE . 49.5 m 55.68 37.35 28.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.643 0.735 . . . . 0.0 109.766 -176.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -166.99 25.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.606 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' A' ' 98' ' ' ASP . 19.7 ttt85 -67.5 135.5 53.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.133 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.1 mt 72.45 -25.38 0.18 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.128 0.571 . . . . 0.0 111.523 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 96' ' ' ARG . 31.0 t70 61.83 22.04 12.71 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.905 0.882 . . . . 0.0 111.493 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -94.8 41.63 1.09 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.309 0.576 . . . . 0.0 110.564 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.57 141.43 31.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.058 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.74 45.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.27 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.426 ' HG3' ' HG3' ' A' ' 103' ' ' LYS . 46.2 tp10 -68.29 122.46 18.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.76 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HG3' ' HG3' ' A' ' 102' ' ' GLU . 34.1 mtmm 62.1 -135.29 0.52 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.977 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.71 -35.02 45.55 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 122.208 -0.308 . . . . 0.0 111.371 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -67.18 129.5 40.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.777 0.323 . . . . 0.0 110.53 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.508 ' HZ1' ' HB2' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -92.37 10.68 28.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.327 0.584 . . . . 0.0 109.721 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.2 t . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.624 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 77.17 48.57 8.18 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.311 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.7 m -65.13 -38.32 90.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.528 0.204 . . . . 0.0 110.469 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t 55.12 48.34 19.84 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.79 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -95.84 53.52 1.42 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.426 0.632 . . . . 0.0 109.714 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.509 ' C ' ' H ' ' A' ' 6' ' ' PHE . 61.7 m170 -84.55 142.54 29.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.168 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.618 ' C ' ' H ' ' A' ' 7' ' ' ASP . 19.7 pt20 -79.76 35.13 0.29 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.333 169.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.543 ' HB2' ' CD1' ' A' ' 8' ' ' LEU . 34.1 m-85 69.56 -20.36 0.17 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.325 1.05 . . . . 0.0 109.705 -169.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.618 ' H ' ' C ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER 64.73 44.01 3.94 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.783 176.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.581 ' HB3' HD11 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -85.16 56.15 3.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.168 0.509 . . . . 0.0 110.516 175.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 91' ' ' ASN . 1.8 mp -74.05 69.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.379 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.593 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 7.1 ptp -50.44 151.69 2.13 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.367 -172.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -42.57 -56.53 3.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.559 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.593 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 86.8 mt 52.39 41.0 30.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 84.4 mttt -77.1 -176.96 4.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 167.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.463 ' HB3' ' HD3' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -70.09 116.11 40.99 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.725 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 28.6 Cg_endo -72.15 142.85 38.76 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.386 2.057 . . . . 0.0 112.765 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.57 -157.43 28.7 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.007 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.85 -23.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.11 0.481 . . . . 0.0 110.893 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -63.65 128.49 36.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.034 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.8 HG21 ' HD3' ' A' ' 42' ' ' LYS . 20.2 m -82.58 136.33 34.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.601 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' CA ' HG11 ' A' ' 45' ' ' VAL . . . -66.51 126.16 27.26 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.923 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.445 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 63.8 mt -80.96 141.85 34.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 112.14 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 70.2 mt -118.4 143.91 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.186 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 11.5 p -80.14 157.55 26.58 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.4 -26.55 42.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.07 0.462 . . . . 0.0 111.386 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.1 mmtt -71.52 -27.3 63.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.409 ' O ' HD12 ' A' ' 22' ' ' LEU . 34.2 m -108.84 26.22 10.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.06 127.46 31.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.4 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.61 32.84 61.32 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.421 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HE2' ' HE1' ' A' ' 36' ' ' TYR . 94.4 mttt -111.83 140.22 46.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.675 0.274 . . . . 0.0 110.902 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 10.7 t -82.36 114.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.942 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.83 -29.43 89.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.978 2.452 . . . . 0.0 112.957 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 81' ' ' LYS . 21.2 mm -65.23 -40.94 90.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.09 -12.28 6.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 t0 62.2 74.38 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -163.25 141.36 7.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.106 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.485 ' HE1' ' HE2' ' A' ' 29' ' ' LYS . 13.2 m-85 -85.75 33.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 p -78.78 158.02 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -41.51 128.85 2.31 Favored Pre-proline 0 N--CA 1.467 0.379 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 96.1 Cg_endo -82.53 154.3 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.32 2.68 . . . . 0.0 112.048 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 20.8 tptm -127.21 -40.62 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -150.45 139.68 21.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.306 -0.246 . . . . 0.0 111.166 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.8 ' HD3' HG21 ' A' ' 19' ' ' THR . 71.2 mttt -59.96 139.33 57.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 111.714 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.776 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.9 t -71.34 133.37 31.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.114 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.497 ' HB2' ' NH1' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -109.78 126.85 54.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.918 175.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG11 ' CA ' ' A' ' 20' ' ' GLY . 16.4 m -102.07 154.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.722 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -66.84 141.29 57.73 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.26 -22.61 53.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.7 -32.11 73.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.301 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.3 m -92.1 41.58 1.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.602 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.4 ' CA ' ' HB1' ' A' ' 55' ' ' ALA . 17.3 m -138.69 -41.98 0.49 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.556 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -127.07 28.32 5.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.732 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.44 -148.8 10.69 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.343 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -67.08 -42.63 84.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -130.88 130.27 43.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HB1' ' CA ' ' A' ' 50' ' ' SER . . . -161.94 -44.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.458 -172.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 21.8 mmtp -70.95 -33.32 70.36 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.338 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.855 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.0 m-20 -68.89 140.92 55.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.467 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 10.4 t -48.54 131.53 17.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.016 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 88' ' ' ARG . 24.1 pt -70.19 -32.88 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.429 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.66 HD12 HD21 ' A' ' 22' ' ' LEU . 22.2 mt -72.64 -44.32 60.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.3 p -107.12 -3.81 19.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.984 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 41.47 45.02 2.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.415 0.686 . . . . 0.0 112.621 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.9 -60.61 0.26 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.211 0.529 . . . . 0.0 110.654 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -82.32 138.54 34.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.488 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.855 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 46.8 t -61.32 137.27 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.59 -179.41 49.5 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.148 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -174.12 -39.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.597 0.713 . . . . 0.0 109.31 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.705 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 8.1 m120 -82.83 176.75 9.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.387 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -118.92 135.48 54.56 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.527 ' HB3' HG22 ' A' ' 43' ' ' VAL . . . -78.38 146.25 34.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -126.55 133.02 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 64.2 m-85 -69.33 120.8 15.71 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 7.0 p -70.03 162.1 28.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.468 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 4.9 t-105 -43.4 -55.95 3.84 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 124.206 0.941 . . . . 0.0 112.1 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.81 -46.77 88.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.92 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' HG23 ' A' ' 32' ' ' ILE . 96.1 m -66.53 -40.86 89.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.079 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 t -67.51 -40.51 85.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.617 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -62.97 -43.6 98.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.881 0.372 . . . . 0.0 110.505 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.71 -27.12 62.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.067 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.07 44.46 13.81 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.564 ' O ' HG22 ' A' ' 32' ' ' ILE . 29.3 mtpp -93.12 31.41 1.45 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.955 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.39 -1.32 8.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.575 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 94.0 mttt 58.73 30.48 20.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.393 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.508 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 23.0 t70 82.42 -36.34 0.09 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.621 174.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.725 ' HA2' ' HG3' ' A' ' 15' ' ' PRO . . . -165.48 -134.15 1.62 Allowed Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 118.448 -1.834 . . . . 0.0 115.468 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 13.3 t -50.63 103.09 0.35 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 113.772 -1.214 . . . . 0.0 113.03 -169.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 57.7 Cg_endo -91.28 44.61 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.563 2.842 . . . . 0.0 113.113 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.458 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.1 ptm180 -110.94 136.7 49.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 8' ' ' LEU . 42.9 mm -76.13 139.72 18.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.315 -175.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pp -171.5 -37.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER 56.65 -149.95 0.45 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.395 169.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 96' ' ' ARG . 13.1 tp -173.65 134.75 0.5 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.695 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.24 -44.13 4.46 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.8 m -157.78 170.9 21.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.0 m120 70.46 63.48 0.2 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.501 0.5 . . . . 0.0 111.061 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.478 HH22 HG23 ' A' ' 9' ' ' ILE . 18.2 tpp180 -66.35 135.14 53.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.331 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 HD11 ' HA ' ' A' ' 100' ' ' HIS . 3.0 pp -56.66 141.34 43.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -74.44 118.18 17.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.331 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 102' ' ' GLU . 65.9 mtp180 66.03 -77.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.758 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.451 ' HA ' HD11 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -165.84 -60.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -169.67 35.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.405 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.641 ' HG3' ' HG3' ' A' ' 103' ' ' LYS . 6.9 tp10 -76.54 140.18 41.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.359 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.641 ' HG3' ' HG3' ' A' ' 102' ' ' GLU . 66.0 mttm 61.3 45.82 8.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.988 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -172.22 -38.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.449 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 66.58 -149.85 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.997 -174.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.463 ' HD3' ' HB3' ' A' ' 14' ' ' GLN . 33.2 mtmm -115.0 51.75 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.131 0.491 . . . . 0.0 110.672 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.214 -0.898 . . . . 0.0 109.345 179.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.622 ' HA3' ' HZ ' ' A' ' 6' ' ' PHE . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.196 -0.362 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 109.56 23.41 6.28 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.066 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.0 m -158.42 137.09 11.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 m -136.1 121.21 18.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.161 0.505 . . . . 0.0 111.138 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -105.13 -17.82 14.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.658 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -148.73 -137.07 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -80.23 115.95 20.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.622 ' HZ ' ' HA3' ' A' ' -1' ' ' GLY . 47.6 t80 -83.16 29.14 0.49 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.637 -176.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 p30 38.62 53.57 1.88 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.702 0.801 . . . . 0.0 112.529 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.722 ' HB3' HD13 ' A' ' 89' ' ' ILE . 1.2 mm? -63.97 -41.68 97.47 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.854 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.722 ' HB ' ' HB3' ' A' ' 91' ' ' ASN . 1.5 mp 58.32 77.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.195 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.664 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -84.44 145.66 28.05 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.402 -171.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.544 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 30.9 t -50.53 -54.22 24.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.222 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.664 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 81.1 mt 48.34 40.79 15.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.544 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 50.9 mttm -79.97 -156.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 4.9 mm100 -83.16 111.17 28.58 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 171.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 59.6 Cg_endo -80.98 138.33 11.43 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.006 1.804 . . . . 0.0 112.417 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.91 -139.42 9.65 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.047 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -89.46 -16.9 8.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 110.284 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.727 ' HB2' HG13 ' A' ' 45' ' ' VAL . 3.7 mm100 -56.93 132.88 54.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.149 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.448 HG21 ' OD2' ' A' ' 69' ' ' ASP . 12.7 m -107.61 127.3 53.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.212 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' CA ' HG21 ' A' ' 59' ' ' ILE . . . -71.7 114.67 5.21 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.256 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.683 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.1 mt -87.07 154.03 21.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.688 0.28 . . . . 0.0 110.587 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.579 HD21 HD12 ' A' ' 60' ' ' ILE . 76.8 mt -113.74 130.21 56.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p -75.2 157.03 35.18 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 51.2 mt-10 -54.9 -28.39 50.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.964 0.412 . . . . 0.0 111.69 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.7 mtpt -72.43 -27.97 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.165 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.8 31.79 6.49 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.559 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.9 t0 -73.76 133.91 43.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.343 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.85 32.29 66.68 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.035 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 22.9 mtpp -119.46 122.04 40.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 25.3 t -63.29 118.66 45.72 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.48 -37.3 97.71 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.724 HG22 ' HG3' ' A' ' 81' ' ' LYS . 10.8 mm -64.08 -46.48 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.36 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 22.5 p -123.78 -8.47 7.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.3 t0 60.91 76.47 0.37 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.812 0.815 . . . . 0.0 110.428 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -151.36 143.25 23.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.477 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 29' ' ' LYS . 5.9 m-85 -96.5 23.98 6.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 110.299 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.35 161.8 4.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.201 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HD2' ' HD2' ' A' ' 39' ' ' PRO . 23.2 tpt180 -47.25 120.24 6.71 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.443 0.697 . . . . 0.0 112.559 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 86.2 Cg_endo -82.56 161.14 16.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.415 2.743 . . . . 0.0 111.815 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.484 ' HZ1' ' HB3' ' A' ' 40' ' ' LYS . 3.3 mmmp? -130.32 -59.25 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -116.41 136.94 52.56 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.839 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -67.73 136.74 54.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.742 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.609 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 17.9 m -79.98 151.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.917 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -124.45 127.55 47.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.159 173.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.727 HG13 ' HB2' ' A' ' 18' ' ' GLN . 0.3 OUTLIER -92.54 153.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.608 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 1.8 p -72.83 148.32 44.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 86.5 tt0 -56.56 -27.44 57.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.035 0.445 . . . . 0.0 111.068 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.543 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 7.5 m-80 -63.84 -26.69 68.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.112 177.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.487 ' HB3' ' NE ' ' A' ' 88' ' ' ARG . 87.6 m -102.68 33.1 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.22 -0.3 . . . . 0.0 111.679 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.5 ' OG ' ' HG3' ' A' ' 18' ' ' GLN . 12.0 p -160.9 -50.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.573 -173.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 49.71 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.137 0.975 . . . . 0.0 111.847 -175.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.66 76.07 1.76 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.191 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 18' ' ' GLN . 67.6 mttm 67.51 -74.97 0.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.676 0.79 . . . . 0.0 112.246 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -155.34 28.22 0.4 Allowed 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 44.24 27.47 0.22 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.939 171.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER 41.02 44.81 2.12 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.672 0.789 . . . . 0.0 111.65 -176.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.23 141.17 39.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.376 1.084 . . . . 0.0 113.353 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.683 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.0 t -69.93 135.12 49.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.442 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.557 HG22 HG22 ' A' ' 45' ' ' VAL . 3.7 pt -71.92 -31.87 42.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.579 HD12 HD21 ' A' ' 22' ' ' LEU . 52.9 mt -70.28 -51.41 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 21.7 p -91.38 -7.4 50.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.685 176.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 6.7 p-10 47.25 40.2 9.9 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 124.436 1.085 . . . . 0.0 111.57 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HA ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -157.41 -60.63 0.09 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.525 -177.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.591 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 5.7 m120 -60.21 144.58 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 34.5 t -61.56 119.37 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 111.075 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.22 142.78 26.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.464 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 -45.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -108.2 127.86 54.2 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.87 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' OD2' HG21 ' A' ' 19' ' ' THR . 1.1 m-20 -57.56 136.83 56.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.82 0.448 . . . . 0.0 110.961 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' A' ' 59' ' ' ILE . . . -76.93 146.28 37.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.774 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.495 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 6.9 m-85 -127.52 134.55 49.77 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.182 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.483 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 95.2 m-85 -62.98 124.92 22.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.7 p -69.14 161.17 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.856 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.477 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -46.84 -50.29 18.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.067 -177.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.28 -45.65 87.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.697 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 92.3 m -64.82 -33.25 75.54 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.307 -0.246 . . . . 0.0 111.013 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 32.0 t -67.59 -40.6 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.74 -44.64 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.895 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 79' ' ' LEU . 87.1 mt -68.14 -32.59 72.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.731 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.561 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . 89.51 46.93 4.18 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.724 ' HG3' HG22 ' A' ' 32' ' ' ILE . 27.4 mmmt -73.57 -14.96 61.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 110.742 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -64.53 -32.13 73.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -73.21 -21.63 60.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.837 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.1 -55.4 35.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.58 -137.01 7.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.866 -1.159 . . . . 0.0 114.132 171.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 45' ' ' VAL . 50.2 t -64.29 113.28 9.88 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.979 0.912 . . . . 0.0 111.835 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.609 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 83.0 Cg_endo -82.58 31.55 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.956 2.437 . . . . 0.0 114.381 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.487 ' NE ' ' HB3' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.22 139.58 38.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.722 HD13 ' HB3' ' A' ' 8' ' ' LEU . 33.5 mm -92.83 132.09 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 123.16 0.288 . . . . 0.0 110.763 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 11' ' ' CYS . 1.2 pt? -165.6 54.69 0.11 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.722 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 9.7 p30 -72.07 -29.98 64.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 171.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 94' ' ' SER . 64.8 tp -160.78 -58.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.571 174.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.13 22.32 49.21 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.258 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.482 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 t 54.89 40.28 31.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.985 0.514 . . . . 0.0 110.455 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -160.05 -57.97 0.06 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -71.87 127.11 31.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.081 -176.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.405 ' HA ' HD21 ' A' ' 97' ' ' LEU . 58.9 mt 51.14 37.0 17.03 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.547 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -76.91 -41.68 42.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 45.5 ttt-85 167.31 -37.42 0.0 OUTLIER 'General case' 0 C--O 1.231 0.086 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.843 175.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -63.55 136.93 57.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.583 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.804 ' HB2' ' HA ' ' A' ' 106' ' ' LYS . 40.9 p90 -150.35 122.27 8.18 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 171.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -142.37 -42.23 0.33 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.174 -166.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.671 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 55.4 mtpt -75.32 91.5 2.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.471 -173.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 70.67 -54.2 0.65 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.064 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -138.9 -130.94 0.12 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.625 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.804 ' HA ' ' HB2' ' A' ' 101' ' ' PHE . 12.4 mmmm -80.7 54.27 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.094 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' ' 103' ' ' LYS . 36.9 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.042 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 161.41 -32.32 0.35 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t -163.63 139.96 6.82 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 71.25 142.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.789 0.68 . . . . 0.0 111.785 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -66.27 141.6 57.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.665 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -66.21 -49.31 67.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.442 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -78.59 128.22 33.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.6 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -79.67 -110.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.413 ' HA ' ' CD1' ' A' ' 9' ' ' ILE . 86.0 m-20 -87.28 17.89 4.1 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.401 0.619 . . . . 0.0 110.153 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mt -86.01 55.37 3.5 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.694 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.8 mp -62.37 87.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.67 -173.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.635 ' SD ' HD13 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -66.26 136.0 55.23 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.041 -171.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 1.6 t -37.76 -59.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.673 -172.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.635 HD13 ' SD ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 45.77 43.47 9.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.42 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 67.8 mttm -91.74 -147.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.649 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -95.64 111.29 55.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.025 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 71.7 Cg_exo -54.67 134.79 64.28 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.233 2.622 . . . . 0.0 113.296 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.45 -142.12 12.56 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.863 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.429 HG21 ' N ' ' A' ' 18' ' ' GLN . 31.2 m -96.94 -35.93 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 50' ' ' SER . 75.4 mt-30 -76.35 138.51 40.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.472 0.653 . . . . 0.0 112.111 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 42' ' ' LYS . 30.1 m -84.44 131.17 34.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.536 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 59' ' ' ILE . . . -66.36 137.52 35.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.711 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 86.2 mt -106.31 161.69 14.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.376 . . . . 0.0 111.658 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HG ' ' HB1' ' A' ' 70' ' ' ALA . 81.7 mt -123.24 131.2 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 11.5 p -73.36 161.01 30.95 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG3' HG22 ' A' ' 67' ' ' VAL . 70.6 mt-10 -62.07 -18.16 59.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.203 0.525 . . . . 0.0 111.347 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 56.4 mttm -78.24 -36.68 46.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.609 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.9 m -106.42 32.48 4.45 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.56 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 44.2 t0 -70.93 129.66 39.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.596 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.71 28.28 61.42 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.104 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -115.91 126.64 54.17 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.658 -0.319 . . . . 0.0 110.375 175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.27 117.89 34.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.537 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 78.4 Cg_exo -55.61 -37.67 94.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.987 2.458 . . . . 0.0 113.136 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.452 HG23 ' HB3' ' A' ' 81' ' ' LYS . 7.3 mm -63.21 -49.48 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.1 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.9 p -116.27 -8.44 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.6 t0 63.28 68.65 0.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.056 0.455 . . . . 0.0 109.962 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -153.42 142.98 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.459 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -87.45 2.44 50.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.318 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -60.67 152.53 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.659 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -31.08 131.86 0.25 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.434 1.094 . . . . 0.0 113.463 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 88.0 Cg_endo -76.81 -160.84 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.509 . . . . 0.0 112.431 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HG2' ' SG ' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -169.75 -50.46 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.261 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -157.35 144.24 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.718 -174.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HB3' HG22 ' A' ' 19' ' ' THR . 94.0 mttt -61.59 141.73 57.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.039 0.447 . . . . 0.0 111.5 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.9 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 25.6 m -77.82 137.78 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.281 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -106.52 119.87 40.44 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.52 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.674 HG21 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -80.67 146.39 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.525 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.74 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 7.1 p -68.38 160.45 29.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.001 -177.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 49' ' ' CYS . 36.9 tt0 -60.47 -29.63 69.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.056 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.547 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 9.0 m120 -77.68 35.94 0.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.201 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.744 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 58.0 m -157.02 -38.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.339 174.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.476 ' CB ' ' HB2' ' A' ' 18' ' ' GLN . 76.3 p -92.31 34.41 1.04 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.933 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -32.44 58.7 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.453 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.25 -71.22 0.27 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.544 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.622 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 1.4 tpmt? -74.17 123.97 25.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 66.13 51.62 1.26 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.588 0.709 . . . . 0.0 110.544 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.37 -32.47 8.13 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.336 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -95.41 14.2 23.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.62 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -73.0 148.68 43.96 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.572 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.7 t -59.47 116.81 4.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.482 HG23 ' HA3' ' A' ' 20' ' ' GLY . 2.0 pt -57.59 -30.44 36.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.046 -172.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 60' ' ' ILE . 31.2 mt -72.35 -44.1 63.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.7 p -101.04 -12.97 18.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.346 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 56.38 17.72 3.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.45 1.1 . . . . 0.0 111.723 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 -61.42 0.85 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 -172.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -71.79 142.25 49.68 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.56 133.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -73.62 139.22 26.14 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.714 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG22 ' HG3' ' A' ' 24' ' ' GLU . 45.3 t -109.94 -57.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.258 0.552 . . . . 0.0 111.07 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.14 136.81 43.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.303 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.435 ' HB3' HG21 ' A' ' 19' ' ' THR . 2.1 m-20 -64.08 128.87 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' A' ' 43' ' ' VAL . . . -74.26 144.27 44.69 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.973 0.416 . . . . 0.0 111.753 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -115.87 135.33 54.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.371 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.747 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 86.9 m-85 -64.98 132.62 49.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB2' HG12 ' A' ' 37' ' ' VAL . 3.5 p -74.65 154.83 38.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.532 ' HA ' ' SG ' ' A' ' 77' ' ' CYS . 56.5 t90 -53.2 -41.41 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.442 0.464 . . . . 0.0 111.659 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.496 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 50.0 mt-10 -59.62 -42.99 93.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.976 0.417 . . . . 0.0 110.542 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.443 ' SG ' HG21 ' A' ' 32' ' ' ILE . 59.4 m -67.67 -39.76 84.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.57 ' SG ' ' HG2' ' A' ' 40' ' ' LYS . 21.5 p -72.63 -34.2 67.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -63.38 -45.17 92.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 83.7 mt -73.93 -39.46 63.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.606 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.47 28.54 3.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.749 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.625 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 4.5 mttp -82.98 -25.24 32.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.138 0.494 . . . . 0.0 110.431 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.35 -32.33 73.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.272 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -94.84 8.39 42.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.212 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.625 ' OD2' ' HA ' ' A' ' 81' ' ' LYS . 2.6 m-20 -71.06 -48.15 54.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.99 -143.7 9.71 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.916 173.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.74 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 52.6 t -68.93 123.65 88.55 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 123.842 0.857 . . . . 0.0 111.42 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.9 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 69.3 Cg_endo -89.28 25.26 0.61 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.656 2.238 . . . . 0.0 114.945 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.744 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 50.4 mtt180 -80.18 141.4 35.71 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.006 -0.433 . . . . 0.0 111.231 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.8 mm -99.07 104.6 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.066 173.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.35 -6.53 2.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.232 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 66.07 -130.89 0.21 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -174.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -148.25 139.73 23.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.0 0.428 . . . . 0.0 111.086 178.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.17 46.12 3.49 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.762 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.517 ' H ' HD23 ' A' ' 92' ' ' LEU . 16.3 m 59.9 41.79 17.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.031 0.532 . . . . 0.0 111.4 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.72 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 17.6 p-10 -166.2 -52.8 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.108 176.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.72 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 6.3 ppt_? 58.25 -39.75 0.06 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.649 1.58 . . . . 0.0 114.56 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.471 HD21 ' NH1' ' A' ' 96' ' ' ARG . 58.4 mt -67.21 130.78 44.19 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.967 -0.458 . . . . 0.0 110.633 177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.86 37.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.67 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.511 ' C ' ' H ' ' A' ' 101' ' ' PHE . 99.6 mtt180 -81.85 57.21 3.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -72.68 31.09 0.06 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.92 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.511 ' H ' ' C ' ' A' ' 99' ' ' ARG . 15.8 m-85 -96.45 52.08 1.22 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 172.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.67 -46.37 88.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.945 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -79.33 125.6 29.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.301 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 mttp 56.6 47.74 17.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.373 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.24 -175.99 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 101' ' ' PHE . 3.6 mppt? -83.04 133.76 35.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.977 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.522 -178.171 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 63.91 -116.69 9.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.929 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t -156.65 -146.09 0.16 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -153.97 158.8 41.18 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -63.58 104.07 0.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.801 0.81 . . . . 0.0 110.833 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.0 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.404 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -63.86 160.45 17.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.891 168.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.925 ' HB2' HD12 ' A' ' 8' ' ' LEU . 33.5 m-85 -71.86 -134.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -132.23 38.55 3.48 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.678 -0.639 . . . . 0.0 111.939 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.925 HD12 ' HB2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -91.35 55.92 2.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.201 0.524 . . . . 0.0 110.637 174.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.612 HD13 ' N ' ' A' ' 9' ' ' ILE . 1.7 mp -77.97 79.94 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.514 ' HG3' ' CD1' ' A' ' 12' ' ' LEU . 2.2 ptm -109.39 169.74 8.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.547 -167.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.602 ' HA ' HD12 ' A' ' 90' ' ' LEU . 9.1 t -54.14 -53.91 46.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.179 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' CD1' ' HG3' ' A' ' 10' ' ' MET . 0.9 OUTLIER 40.23 49.41 2.46 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 174.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 59.7 mttm -91.63 -149.56 0.24 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 170.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -100.3 122.57 49.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.336 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 70.1 Cg_exo -53.93 132.89 52.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.244 2.629 . . . . 0.0 112.535 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.87 -63.6 1.81 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.337 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 18' ' ' GLN . 7.4 p -176.53 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.414 ' N ' HG11 ' A' ' 17' ' ' VAL . 9.3 pt20 -71.25 145.65 49.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.778 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.458 HG22 ' HD3' ' A' ' 42' ' ' LYS . 28.4 m -78.97 139.07 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.778 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.65 129.4 13.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.356 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.652 HD13 ' HE2' ' A' ' 56' ' ' LYS . 95.0 mt -100.14 142.78 31.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.274 0.559 . . . . 0.0 111.717 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -107.5 134.98 49.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.012 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 4.2 p -72.47 150.99 42.8 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 69.4 mt-10 -50.22 -30.63 11.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.17 0.51 . . . . 0.0 111.63 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.4 mttm -69.82 -22.39 63.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.485 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.1 m -116.07 0.91 13.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.159 0.504 . . . . 0.0 109.735 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 31.9 t0 -56.16 136.45 52.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.816 -172.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.18 -28.59 10.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.91 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.523 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 36.2 mtmt -74.18 128.11 34.7 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.126 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 1.8 t -66.42 115.54 25.04 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -55.45 -28.96 66.61 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 123.074 2.516 . . . . 0.0 113.159 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' A' ' 76' ' ' CYS . 7.2 mm -64.46 -42.29 94.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.881 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 35' ' ' SER . 31.5 p -128.72 -11.84 4.89 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -170.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 65.59 58.28 0.82 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.61 . . . . 0.0 110.645 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.486 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 41.8 t -153.96 141.37 19.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.585 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.523 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 3.4 m-85 -91.31 34.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 37' ' ' VAL . 7.4 p -81.7 76.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.178 0.989 . . . . 0.0 111.547 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 63.5 mtp85 59.73 91.43 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.62 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 39.9 Cg_endo -62.42 145.24 95.72 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.365 2.043 . . . . 0.0 111.366 174.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -132.56 -51.1 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.46 140.82 48.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.744 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' HD3' HG22 ' A' ' 19' ' ' THR . 72.2 mttt -66.36 136.1 55.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG1' ' HG3' ' A' ' 87' ' ' PRO . 58.2 t -85.86 133.04 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.851 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -109.29 128.02 54.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 m -77.13 155.4 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.334 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.77 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 2.1 p -66.49 164.06 17.23 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.426 0.632 . . . . 0.0 111.744 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.537 ' HG2' ' CE2' ' A' ' 51' ' ' PHE . 67.8 tt0 -55.05 -50.8 68.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.102 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 2.5 m-80 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.487 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.616 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 96.0 m -70.84 -24.12 62.47 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -78.68 -38.76 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.142 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.537 ' CE2' ' HG2' ' A' ' 47' ' ' GLU . 1.7 p90 -96.63 -26.01 15.37 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -82.76 52.76 4.76 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.782 -174.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 61.5 pttt 52.29 178.23 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.377 1.071 . . . . 0.0 112.533 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 2.5 pt20 42.74 35.19 0.66 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.074 0.95 . . . . 0.0 112.515 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.79 79.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.109 0.48 . . . . 0.0 111.085 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.652 ' HE2' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -66.58 -15.53 63.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.441 -178.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 1.9 m120 -61.22 136.84 58.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.28 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 29.8 t -55.16 125.9 22.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.126 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 88' ' ' ARG . 3.5 pt -66.88 -34.39 69.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.672 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -71.63 -37.59 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.762 ' HB2' ' HB2' ' A' ' 94' ' ' SER . 27.3 p -113.45 -0.35 14.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.421 -0.799 . . . . 0.0 110.482 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 36.56 59.58 0.98 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.432 1.493 . . . . 0.0 114.829 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.732 ' CD1' ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.88 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.056 171.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.732 ' H ' ' CD1' ' A' ' 63' ' ' LEU . 72.2 m-80 -61.19 142.55 56.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.9 t -75.52 132.45 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.15 148.36 31.29 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.158 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.45 -41.85 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -113.25 131.91 55.73 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 110.956 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.22 138.18 56.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.415 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.19 144.57 50.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.708 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.89 133.05 52.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.697 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.418 ' CE2' HG21 ' A' ' 43' ' ' VAL . 97.6 m-85 -65.45 126.72 29.16 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 3.9 p -74.65 165.21 25.6 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.272 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -47.95 -59.56 3.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 54.2 mt-10 -58.17 -43.1 87.28 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.216 -171.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.44 ' SG ' HG23 ' A' ' 32' ' ' ILE . 85.5 m -66.14 -32.51 73.99 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.055 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.7 m -68.7 -36.98 79.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.81 -45.1 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.218 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 94.2 mt -63.0 -33.79 76.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.784 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.08 31.24 9.3 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.041 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.56 26.95 3.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.286 0.565 . . . . 0.0 109.971 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -78.43 -15.96 58.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.695 173.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -4.32 38.85 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.325 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.418 ' C ' HD13 ' A' ' 12' ' ' LEU . 83.5 m-20 -81.95 77.35 8.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.5 ' O ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.91 -86.4 0.02 OUTLIER Glycine 0 C--O 1.227 -0.282 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.374 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 10.8 t -78.37 108.67 8.25 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.715 0.293 . . . . 0.0 110.571 -174.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 43.0 Cg_endo -93.5 36.74 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.523 2.149 . . . . 0.0 113.785 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.616 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 33.3 mtt180 -75.63 114.51 14.3 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.083 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 50.5 mm -75.43 87.56 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 -178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 11' ' ' CYS . 16.0 mt -66.88 -43.42 83.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.903 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -69.1 128.37 36.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.421 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 71.08 -43.47 0.56 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.133 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.34 -126.72 22.89 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.762 ' HB2' ' HB2' ' A' ' 61' ' ' CYS . 48.4 t -108.0 18.86 20.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.13 0.491 . . . . 0.0 109.955 173.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -83.43 50.97 1.88 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.625 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.458 ' HB2' ' H ' ' A' ' 97' ' ' LEU . 3.2 ppt_? -163.32 -140.96 0.05 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.638 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 97' ' ' LEU . 4.3 pp -59.04 140.49 55.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.105 0.479 . . . . 0.0 110.935 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -126.14 28.76 5.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.581 0.705 . . . . 0.0 109.334 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.7 mmt-85 -148.13 142.71 26.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.736 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -80.95 114.81 20.08 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 174.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.7 ' HB3' ' HA ' ' A' ' 106' ' ' LYS . 9.2 p90 -66.71 126.38 28.81 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.081 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -170.57 -52.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.267 -172.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -70.08 -59.05 3.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.01 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -177.84 128.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.427 ' HB3' HG23 ' A' ' 107' ' ' VAL . 65.4 mttm 70.35 143.85 0.05 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.871 0.732 . . . . 0.0 111.617 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.7 ' HA ' ' HB3' ' A' ' 101' ' ' PHE . 48.0 mtmt -87.17 44.61 1.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.605 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.427 HG23 ' HB3' ' A' ' 105' ' ' LYS . 19.6 m . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.66 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -160.84 48.65 0.38 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 m -67.46 -39.01 85.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.692 -0.254 . . . . 0.0 110.972 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m 57.39 45.9 19.15 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.74 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.8 mtm-85 -66.47 138.54 57.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.351 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -76.55 -135.93 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 171.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -76.81 77.39 3.42 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.908 -0.495 . . . . 0.0 110.002 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.583 ' HA ' HD21 ' A' ' 8' ' ' LEU . 22.0 m-85 -120.21 27.39 8.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.557 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -86.48 58.68 5.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 164.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.583 HD21 ' HA ' ' A' ' 6' ' ' PHE . 3.7 mt -65.69 -133.12 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.975 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.926 HG23 ' H ' ' A' ' 92' ' ' LEU . 1.9 mp 61.24 49.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 123.499 1.618 . . . . 0.0 107.466 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.71 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 8.1 ptm -72.53 148.32 45.11 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 112.855 -1.975 . . . . 0.0 110.19 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 t -48.35 -59.82 3.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.912 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.71 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 81.5 mt 48.58 35.65 6.41 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -81.73 -171.34 3.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.07 117.39 57.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -83.45 138.87 8.79 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.05 2.5 . . . . 0.0 112.773 -178.41 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.3 -138.79 9.02 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.477 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -95.53 -14.54 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.541 0.686 . . . . 0.0 109.749 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.591 ' HB2' HG11 ' A' ' 45' ' ' VAL . 6.2 mm100 -59.49 136.98 58.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.137 -178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -105.42 136.66 44.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.423 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.77 133.69 13.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.714 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 85.7 mt -90.58 145.76 24.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 70' ' ' ALA . 53.7 mt -109.09 134.92 51.06 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.097 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.5 p -71.61 151.98 43.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HG2' HG13 ' A' ' 67' ' ' VAL . 37.8 mt-10 -48.73 -32.91 9.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 111.789 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -71.81 -27.65 63.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -102.75 1.38 34.24 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.953 -0.467 . . . . 0.0 110.162 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -59.46 112.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.71 -26.8 7.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.851 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -73.45 130.59 40.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.765 0.317 . . . . 0.0 111.329 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.22 122.14 86.72 Favored Pre-proline 0 C--N 1.319 -0.717 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 168.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HG3' HG11 ' A' ' 43' ' ' VAL . 6.1 Cg_endo -53.15 -35.5 73.39 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.663 2.909 . . . . 0.0 113.872 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.671 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 14.1 mm -69.5 -44.17 80.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.2 p -112.08 -20.88 11.78 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 68.49 72.82 0.29 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.554 0.693 . . . . 0.0 110.337 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -163.31 145.81 10.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.756 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -82.16 40.18 0.62 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.174 0.511 . . . . 0.0 110.318 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.561 HG23 ' N ' ' A' ' 38' ' ' ARG . 8.4 p -87.02 153.44 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.078 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.561 ' N ' HG23 ' A' ' 37' ' ' VAL . 6.8 mmp_? -39.79 110.56 0.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -171.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 91.0 Cg_endo -79.6 151.61 22.4 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.286 2.658 . . . . 0.0 111.85 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -140.97 -58.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.694 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -90.15 131.28 36.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.266 -0.174 . . . . 0.0 111.192 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -70.65 136.29 48.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.736 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 32.8 m -71.03 139.73 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.449 0.642 . . . . 0.0 111.728 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -112.74 114.84 27.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.76 175.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -83.94 148.88 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.777 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 3.5 p -68.96 145.89 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -56.45 -27.99 58.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.292 0.567 . . . . 0.0 110.349 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.777 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 52.9 m-80 -60.37 -32.34 71.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.655 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 99.1 m -94.54 36.44 1.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.626 0.25 . . . . 0.0 111.117 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.8 t -139.86 -52.25 0.51 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 -69.21 137.77 53.48 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.624 179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.77 -134.59 7.73 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.156 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -157.32 27.0 0.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -148.8 33.54 0.76 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.394 0.616 . . . . 0.0 110.402 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.96 0.06 45.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.49 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -22.39 54.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.972 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 76.0 m-20 -61.15 152.88 27.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.888 0.851 . . . . 0.0 111.59 -176.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.651 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -59.42 131.07 49.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.307 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.477 HG23 ' HG2' ' A' ' 88' ' ' ARG . 11.9 pt -73.62 -32.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.975 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.517 HG22 HD12 ' A' ' 60' ' ' ILE . 22.3 mt -72.01 -48.66 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.546 ' C ' ' H ' ' A' ' 63' ' ' LEU . 29.5 p -102.13 -9.3 20.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.85 -28.25 0.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.581 0.752 . . . . 0.0 112.56 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -75.74 -60.14 2.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -91.91 150.77 20.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.179 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.972 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 16.7 t -63.37 136.14 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.386 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 23' ' ' CYS . . . -82.19 -167.21 39.45 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.491 HG13 ' HG2' ' A' ' 24' ' ' GLU . 7.4 p -162.06 -50.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.822 0.344 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -105.26 138.75 40.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.928 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.53 134.76 51.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' A' ' 22' ' ' LEU . . . -77.72 153.97 32.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.151 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.94 135.66 45.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.982 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.703 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 43.9 m-85 -71.62 133.58 45.8 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 6.1 p -70.76 158.24 36.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.494 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.575 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -55.13 -41.06 71.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.907 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -58.42 -51.75 68.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 97.0 m -65.54 -38.0 88.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.054 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.463 ' HB3' ' HE3' ' A' ' 74' ' ' TRP . 36.9 t -66.25 -41.41 90.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -67.77 -46.84 70.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.452 HD21 ' HE2' ' A' ' 81' ' ' LYS . 8.6 mp -64.14 -30.97 72.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.24 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 96.76 45.08 2.75 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.992 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.452 ' HE2' HD21 ' A' ' 79' ' ' LEU . 67.6 mttm -103.2 -24.5 13.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.533 . . . . 0.0 110.072 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -69.59 -25.18 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 15.9 pttp -63.33 -27.98 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.294 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -52.28 -48.12 65.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.033 -173.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.06 -139.65 8.3 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.851 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.7 t -55.35 117.65 15.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.401 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.736 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 88.9 Cg_endo -82.23 22.02 0.91 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.932 2.421 . . . . 0.0 113.307 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.53 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.0 mmt180 -77.54 122.31 25.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.322 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 10' ' ' MET . 12.7 mm -78.98 131.37 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -163.97 45.32 0.11 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.883 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.77 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 21.5 t-20 -38.88 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.533 -175.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.926 ' H ' HG23 ' A' ' 9' ' ' ILE . 21.6 tp 162.51 120.82 0.0 OUTLIER 'General case' 0 C--O 1.234 0.279 0 O-C-N 124.471 1.107 . . . . 0.0 108.934 175.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.03 -49.91 73.42 Favored Glycine 0 CA--C 1.515 0.079 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.45 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -158.85 127.02 5.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.14 106.6 10.14 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.933 ' HG2' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -77.61 172.49 13.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.105 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.933 ' HG ' ' HG2' ' A' ' 96' ' ' ARG . 76.9 mt 63.39 38.39 10.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.198 0.523 . . . . 0.0 110.719 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -93.38 148.57 21.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.042 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -79.43 65.59 4.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.531 0.681 . . . . 0.0 110.704 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.405 ' O ' ' HB2' ' A' ' 101' ' ' PHE . 74.3 t60 -147.1 -57.52 0.26 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.085 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 100' ' ' HIS . 8.4 m-85 69.86 138.01 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 O-C-N 124.274 0.984 . . . . 0.0 110.681 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -151.55 38.28 0.61 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.304 1.05 . . . . 0.0 108.862 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -103.15 -142.81 0.36 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.842 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -94.01 35.08 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.714 0.768 . . . . 0.0 109.05 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -173.43 122.95 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.124 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -167.07 39.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.429 0.633 . . . . 0.0 110.185 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.293 179.021 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.622 ' HA2' HD21 ' A' ' 63' ' ' LEU . . . 76.48 -128.15 9.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.117 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.4 p 51.43 46.3 26.7 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.436 0.694 . . . . 0.0 111.28 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.81 136.09 52.2 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.955 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.415 ' HG3' ' CD2' ' A' ' 4' ' ' HIS . 11.6 ptm180 -174.29 159.75 3.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -177.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.415 ' CD2' ' HG3' ' A' ' 3' ' ' ARG . 84.1 m-70 72.58 152.86 0.13 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.056 0.848 . . . . 0.0 110.341 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -158.99 35.63 0.21 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.223 0.535 . . . . 0.0 110.254 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 45.4 m-85 -59.58 -54.4 46.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 109.656 177.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 27.1 t0 167.21 68.52 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.976 ' HB2' HG22 ' A' ' 89' ' ' ILE . 38.3 mt -70.49 64.86 0.29 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.018 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.711 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.3 mp 26.54 78.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 112.263 -2.244 . . . . 0.0 112.53 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.782 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 11.3 ptp -68.89 144.15 54.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.807 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.599 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -54.71 -42.13 71.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.646 -173.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 93.0 mt 48.99 45.7 22.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 172.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.599 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 34.6 mttm -88.65 -155.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.035 172.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 52.1 mm-40 -77.75 114.6 42.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 110.856 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 8.9 Cg_exo -71.53 142.48 40.49 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.136 2.557 . . . . 0.0 112.741 -177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.73 -139.72 6.4 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.508 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -101.57 -25.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.335 . . . . 0.0 110.438 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -61.19 128.87 38.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.683 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -76.22 140.35 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.39 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.21 114.33 5.98 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.256 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 84.3 mt -77.5 149.49 34.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.706 HD22 HD12 ' A' ' 60' ' ' ILE . 64.7 mt -122.42 138.41 54.55 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.644 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.514 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 7.8 p -76.25 142.68 41.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -47.62 -28.25 2.26 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 76.7 mttt -65.54 -39.33 91.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.42 ' SG ' HG22 ' A' ' 60' ' ' ILE . 61.3 m -93.05 -14.59 27.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 122.113 -0.367 . . . . 0.0 110.225 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.91 120.4 5.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.278 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.19 -34.1 3.47 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.966 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -72.92 131.18 41.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.934 -0.133 . . . . 0.0 110.711 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.5 t -71.94 117.53 58.81 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.69 -31.45 94.87 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.858 2.372 . . . . 0.0 112.74 -173.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.541 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 1.6 mm -72.15 -43.13 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.322 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.6 -8.24 7.4 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.21 73.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.113 0.482 . . . . 0.0 110.797 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -165.94 139.73 4.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.3 33.56 0.81 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.029 0.442 . . . . 0.0 110.866 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.38 152.88 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.796 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -44.05 126.7 4.39 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.8 Cg_exo -77.54 -167.14 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.457 2.771 . . . . 0.0 111.698 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -170.98 -49.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.167 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -116.9 139.18 50.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -71.23 133.64 46.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.315 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.956 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 29.2 m -72.32 143.79 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.704 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -128.63 126.74 40.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -81.46 146.02 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.731 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.3 p -70.94 146.18 49.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.572 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 56.6 mt-10 -54.98 -37.25 66.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.432 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.635 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 4.5 m120 -51.38 -39.52 57.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.3 m -81.55 -36.36 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 28.8 p -72.87 -48.79 34.48 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.53 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -74.04 -17.13 61.01 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.089 0.471 . . . . 0.0 110.432 178.128 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.73 -114.63 0.4 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.421 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -147.6 153.91 40.01 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 65.36 55.44 1.07 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.912 0.758 . . . . 0.0 111.358 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.88 -28.57 2.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.769 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 8.9 mptt -74.75 -14.48 60.72 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.625 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 60.9 m-20 -77.09 149.77 35.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.816 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 4.5 t -53.42 123.02 10.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.602 175.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 70' ' ' ALA . 13.2 pt -62.44 -29.86 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.706 HD12 HD22 ' A' ' 22' ' ' LEU . 47.1 mt -73.45 -44.9 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.4 p -100.31 -11.38 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.311 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 44.46 44.92 7.35 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.155 0.982 . . . . 0.0 110.941 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.622 HD21 ' HA2' ' A' ' 0' ' ' GLY . 0.8 OUTLIER -152.67 -61.36 0.15 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.375 -172.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -73.06 140.14 47.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 6.0 p -66.64 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.108 0.48 . . . . 0.0 111.243 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.77 159.21 53.77 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.054 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.461 HG13 ' HA ' ' A' ' 23' ' ' CYS . 2.0 p -157.55 -48.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.289 0.566 . . . . 0.0 110.226 -178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.33 -176.25 4.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.357 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -124.49 142.89 50.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.57 0.224 . . . . 0.0 110.685 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB3' HG12 ' A' ' 43' ' ' VAL . . . -87.88 154.68 20.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.104 0.478 . . . . 0.0 111.13 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -130.39 134.07 46.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.479 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.713 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.4 m-85 -68.92 122.74 19.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 5.9 p -70.25 149.81 47.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -55.6 -31.21 62.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.041 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 66.8 mm-40 -59.9 -44.91 93.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.867 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 38.0 m -68.64 -37.06 79.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.46 -40.79 96.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.054 177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.66 96.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.105 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.55 -35.08 72.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.694 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.6 38.46 6.59 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.491 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -93.72 -30.21 15.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.436 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.76 -29.88 71.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.126 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -63.32 -20.65 65.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.076 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.484 ' HB2' HD23 ' A' ' 12' ' ' LEU . 44.7 m-20 -67.19 -44.86 78.57 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 15' ' ' PRO . . . 126.4 -119.9 3.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.562 -1.304 . . . . 0.0 114.664 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.731 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 19.3 t -43.14 105.5 0.43 Allowed Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 113.12 -171.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.956 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 75.1 Cg_endo -85.15 22.48 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.204 2.603 . . . . 0.0 112.674 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -73.16 124.0 24.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.976 HG22 ' HB2' ' A' ' 8' ' ' LEU . 12.1 mm -83.12 133.62 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 122.533 0.333 . . . . 0.0 111.816 -176.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 11' ' ' CYS . 1.5 pt? -169.61 38.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.711 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -50.98 142.64 11.59 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.839 0.352 . . . . 0.0 111.148 177.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 96' ' ' ARG . 13.2 tp -50.34 117.9 2.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.157 -173.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -130.08 56.87 0.73 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.1 m 68.96 49.59 0.65 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.377 0.608 . . . . 0.0 110.04 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -130.62 22.25 5.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.932 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.508 HH11 HD21 ' A' ' 97' ' ' LEU . 4.9 tmt_? -67.41 -33.68 75.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.319 0.581 . . . . 0.0 109.803 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.508 HD21 HH11 ' A' ' 96' ' ' ARG . 0.4 OUTLIER -151.28 59.62 0.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.747 177.134 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.93 127.34 31.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.15 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -155.53 55.5 0.62 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -69.23 137.91 53.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.63 -175.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.92 43.16 1.24 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.169 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.57 -35.3 79.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.408 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.858 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -73.78 163.24 28.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.023 174.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -77.44 54.54 1.16 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.592 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.497 ' HE2' ' HG3' ' A' ' 103' ' ' LYS . 60.9 pttt -167.61 145.4 4.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 110.316 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -142.58 -45.7 0.32 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.415 0.626 . . . . 0.0 110.527 -177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.309 -1.188 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.871 178.594 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -165.46 137.45 4.69 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.85 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.8 m 58.63 40.14 23.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.494 0.664 . . . . 0.0 110.589 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -93.21 -27.69 16.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.579 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 70.99 139.77 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.81 0.694 . . . . 0.0 111.476 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.505 ' NE2' ' HA ' ' A' ' 94' ' ' SER . 49.2 p-80 -177.74 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.756 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -160.69 170.29 21.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.65 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.535 ' HB3' HD13 ' A' ' 8' ' ' LEU . 27.3 t80 -68.33 -20.72 64.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.594 172.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.958 ' HB3' HD22 ' A' ' 91' ' ' ASN . 11.3 m-20 72.49 74.41 0.15 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.425 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD13 ' HB3' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -74.96 124.04 26.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.095 -170.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.928 HG12 ' HB3' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -169.76 46.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 C-N-CA 123.317 0.647 . . . . 0.0 110.651 174.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -64.31 131.94 48.74 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.75 -174.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.3 t -42.08 -46.35 4.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.04 -1.437 . . . . 0.0 111.637 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' HA ' ' N ' ' A' ' 86' ' ' CYS . 1.2 mp 42.76 52.23 5.04 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -95.53 -145.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 170.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -91.65 113.8 59.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.571 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 52.3 Cg_exo -57.63 129.11 32.02 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.878 2.385 . . . . 0.0 112.47 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.08 -131.34 6.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.607 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 18' ' ' GLN . 11.7 p -112.57 -36.75 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.454 ' N ' HG13 ' A' ' 17' ' ' VAL . 54.2 mt-30 -63.11 125.41 23.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.47 0.652 . . . . 0.0 111.556 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.3 m -74.8 130.92 40.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.717 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.06 129.64 26.7 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.017 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 65.7 mt -102.14 145.31 29.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.164 0.507 . . . . 0.0 112.009 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.545 HD21 HG12 ' A' ' 59' ' ' ILE . 74.5 mt -113.36 144.01 43.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.168 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 2.9 p -78.07 154.47 31.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 50.3 mt-10 -57.53 -26.7 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.901 0.381 . . . . 0.0 111.453 -176.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.6 mmtt -69.15 -24.12 64.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.81 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 m -115.72 25.21 10.93 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 33.4 t70 -72.49 131.36 42.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.22 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.29 62.68 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.807 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -111.76 131.64 55.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.3 119.16 73.26 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.26 -38.3 95.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.266 2.644 . . . . 0.0 113.359 -174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.499 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 6.9 mm -64.44 -56.8 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 28.1 p -100.82 -19.78 15.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -169.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 33' ' ' CYS . 13.4 t70 68.59 85.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.225 0.536 . . . . 0.0 110.397 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -174.58 145.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.312 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.35 33.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.71 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.543 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.4 p -78.62 158.23 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.313 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -50.83 126.02 23.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.382 0.673 . . . . 0.0 112.543 -176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.6 Cg_exo -70.45 -166.62 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.605 2.87 . . . . 0.0 112.169 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 25.7 tptp -166.91 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -143.65 140.2 29.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.059 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 33.8 mtpt -62.03 136.26 57.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 111.117 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.543 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 11.5 t -75.85 131.94 34.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.94 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -121.19 128.73 52.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.723 0.296 . . . . 0.0 110.205 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.59 HG22 ' HB1' ' A' ' 55' ' ' ALA . 35.2 m -75.22 151.26 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.062 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.712 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 9.6 p -59.7 153.77 19.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -54.94 -37.03 65.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.625 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 6.8 m120 -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.341 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 33.8 m -71.39 -27.01 63.03 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.451 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 89.3 p -77.16 -39.44 49.1 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.942 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 4.0 p90 -90.43 -31.21 16.92 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.7 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.88 30.42 7.53 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.89 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 3.7 mptp? 60.87 -178.24 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.813 0.445 . . . . 0.0 111.125 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER 63.76 56.94 1.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.428 0.633 . . . . 0.0 111.127 179.3 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HB1' HG22 ' A' ' 45' ' ' VAL . . . -138.6 -30.67 0.76 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.978 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -78.91 -37.2 40.55 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.404 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 6.9 p30 -62.18 142.7 57.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 40.9 t -46.71 111.08 0.34 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.816 -175.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.545 HG12 HD21 ' A' ' 22' ' ' LEU . 6.0 pt -60.43 -26.0 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.398 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.64 -42.96 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -117.43 5.76 12.55 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.137 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 5.4 p-10 38.64 43.49 0.69 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.76 -58.59 0.22 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.834 -173.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -86.76 17.75 3.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -167.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.824 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 2.6 t 59.67 137.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.113 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.53 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -82.36 162.23 41.76 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.548 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 22' ' ' LEU . 6.3 p -149.8 -44.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.259 -0.471 . . . . 0.0 110.367 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -106.03 131.39 53.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.01 133.36 56.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.955 0.407 . . . . 0.0 110.752 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HB3' HD11 ' A' ' 59' ' ' ILE . . . -74.21 150.5 40.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 9.2 m-85 -128.62 131.93 48.12 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.477 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.543 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 98.4 m-85 -67.97 127.79 34.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 8.5 p -73.68 158.78 34.06 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.232 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.493 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.39 -46.2 62.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.138 -178.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.69 -44.51 93.62 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.611 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.797 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 58.6 m -64.72 -43.41 93.51 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.224 -0.297 . . . . 0.0 111.018 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 58.4 m -64.24 -34.59 78.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -58.33 -49.88 75.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.927 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.52 -47.0 24.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.521 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.67 34.55 0.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.556 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' CYS . 18.9 mmtp -76.13 -23.69 54.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.23 0.538 . . . . 0.0 110.531 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.23 -42.13 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.892 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -85.54 -15.24 43.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.597 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.518 ' OD2' HD22 ' A' ' 12' ' ' LEU . 25.2 t0 -56.47 -51.13 69.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.899 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.91 34.43 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.211 -1.471 . . . . 0.0 114.926 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.3 t -72.56 113.5 21.66 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 113.691 -1.254 . . . . 0.0 111.751 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -81.98 43.87 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.228 2.619 . . . . 0.0 113.405 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 10' ' ' MET . 6.5 mmm180 -87.97 131.24 34.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.544 HG22 HD11 ' A' ' 9' ' ' ILE . 28.6 mm -91.91 115.84 31.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.597 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.62 50.79 1.66 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.958 HD22 ' HB3' ' A' ' 7' ' ' ASP . 22.5 p30 -92.32 -124.23 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.47 -0.769 . . . . 0.0 111.423 169.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.464 ' N ' HD21 ' A' ' 92' ' ' LEU . 2.3 pt? -159.04 14.8 0.16 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.984 0.421 . . . . 0.0 110.056 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' C ' ' HG ' ' A' ' 94' ' ' SER . . . 77.0 136.83 0.79 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.154 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.505 ' HA ' ' NE2' ' A' ' 4' ' ' HIS . 51.2 p 54.01 69.9 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.429 0.692 . . . . 0.0 112.405 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.458 HD22 ' ND2' ' A' ' 91' ' ' ASN . 78.7 m-20 -62.96 132.94 53.75 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 174.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -151.97 -135.68 0.06 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.208 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.471 ' H ' ' HB2' ' A' ' 96' ' ' ARG . 98.2 mt 65.96 28.83 10.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.376 0.608 . . . . 0.0 110.801 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.11 -26.02 15.12 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.3 mmm-85 -133.99 119.46 19.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.437 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -169.23 -46.93 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.102 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 1.7 t80 61.41 69.36 0.66 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.525 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -92.17 21.09 5.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 103' ' ' LYS . 3.8 mppt? 57.66 44.01 21.37 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.845 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -82.97 -51.24 7.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.99 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -149.1 58.72 1.03 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.545 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp 61.49 34.71 17.91 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.6 0.714 . . . . 0.0 109.077 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 9.9 p . . . . . 0 C--O 1.244 0.807 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.183 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 77.58 47.85 8.49 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.736 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.6 t -152.66 47.76 0.73 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.716 0.769 . . . . 0.0 109.353 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 m -81.2 53.15 1.96 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.347 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -61.81 -47.15 86.41 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -84.13 -68.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.863 168.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.491 ' HG3' HD11 ' A' ' 8' ' ' LEU . 3.8 tp60 178.29 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.92 176.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.598 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 9.8 t80 -146.42 26.44 1.17 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.807 0.813 . . . . 0.0 109.481 174.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -92.23 47.69 1.35 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.959 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.598 ' CD2' ' HA ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -157.56 39.49 0.29 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.745 -171.591 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.894 HD12 ' HB2' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -77.57 147.22 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.632 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.967 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -143.57 131.55 21.67 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 t -51.91 -54.0 34.45 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.478 -167.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.967 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 34.1 mt 44.86 37.86 2.58 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -82.42 170.71 14.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 7.1 tp-100 -67.69 119.65 67.69 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 34.6 Cg_exo -62.29 145.47 96.01 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.754 2.303 . . . . 0.0 112.814 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.9 -66.46 1.62 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.977 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p 176.64 -32.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.792 0.329 . . . . 0.0 110.586 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.527 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 26.1 mt-30 -64.38 133.28 52.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.692 -175.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -74.71 137.26 41.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.35 133.48 14.88 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.996 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 80.1 mt -100.12 143.34 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 70' ' ' ALA . 63.7 mt -111.93 138.56 48.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.44 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 3.5 p -81.88 148.92 28.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HA ' ' CB ' ' A' ' 27' ' ' ASP . 46.6 mt-10 -54.39 -27.58 37.62 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.64 -29.98 70.62 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.656 0.265 . . . . 0.0 111.378 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 34.6 m -105.37 -12.63 15.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.878 0.37 . . . . 0.0 110.206 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CB ' ' HA ' ' A' ' 24' ' ' GLU . 11.7 t70 -59.89 115.75 3.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.075 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.02 -33.02 4.19 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 47.2 mttp -77.55 136.75 38.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.63 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.3 t -79.98 121.98 82.69 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.82 -41.26 79.21 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.228 2.619 . . . . 0.0 113.648 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.602 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 5.8 mm -63.73 -49.09 83.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 p -111.47 -17.09 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 t0 63.04 74.89 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.543 0.687 . . . . 0.0 110.366 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -160.24 146.32 15.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.312 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -87.19 30.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.322 . . . . 0.0 111.159 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 38' ' ' ARG . 3.6 p -76.64 150.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.866 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.498 ' N ' HG22 ' A' ' 37' ' ' VAL . 90.5 mtt180 -49.08 124.64 13.48 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 87.9 Cg_endo -79.62 149.35 21.0 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.526 2.817 . . . . 0.0 112.114 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -132.16 -62.37 0.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.4 mtp-105 -102.39 141.99 34.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -69.18 137.57 53.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.183 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.868 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -78.84 145.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.127 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -131.7 119.48 21.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 50' ' ' SER . 28.5 m -86.83 155.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.893 -173.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 6.2 p -71.13 160.24 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.599 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -53.57 -39.74 65.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.194 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.01 -35.51 75.22 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.551 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 60.4 m -98.48 33.3 2.28 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.151 -0.343 . . . . 0.0 111.493 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.565 ' HB3' HG21 ' A' ' 45' ' ' VAL . 53.6 p -156.81 -28.06 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -50.98 -41.31 59.44 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.38 157.12 15.08 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.56 -1.305 . . . . 0.0 113.754 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 22.1 pttp 44.21 34.23 0.97 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.124 1.37 . . . . 0.0 113.904 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 2.7 tt0 176.95 46.88 0.0 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.098 0.475 . . . . 0.0 110.438 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.5 -29.58 1.96 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.969 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 51.7 mmtt -71.31 -29.76 65.42 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.063 0.458 . . . . 0.0 110.809 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 21.4 p30 -66.2 143.37 57.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.4 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.44 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 0.6 OUTLIER -55.23 130.27 41.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.453 -177.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 9.9 pt -62.44 -26.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -171.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 HD11 HD21 ' A' ' 22' ' ' LEU . 45.9 mt -80.0 -42.65 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.924 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -109.51 -11.38 14.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.645 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 54.03 28.52 8.86 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.513 . . . . 0.0 111.264 175.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.26 -64.27 0.61 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.375 -169.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -79.74 140.17 37.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.921 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 21.2 t -64.07 135.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 111.045 -176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.6 141.73 27.97 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.5 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.66 -42.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -115.19 141.58 47.83 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.585 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.87 136.38 57.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.625 ' CB ' HG22 ' A' ' 43' ' ' VAL . . . -79.05 160.09 27.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.065 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.526 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 12.8 m-85 -132.21 134.6 45.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.628 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.722 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 74.6 m-85 -68.65 127.81 34.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.4 p -68.22 163.38 22.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.952 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -51.81 -45.88 64.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.234 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -60.26 -48.25 82.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.544 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 66.5 m -65.56 -37.91 88.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.411 0.148 . . . . 0.0 111.243 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.18 -43.46 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 110.005 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -66.06 -42.83 88.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.94 -34.48 78.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.47 30.21 14.4 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.857 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.75 -22.44 27.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -66.35 -42.43 88.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.713 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.3 -16.54 60.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.551 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.75 -50.35 67.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.82 -139.41 5.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 118.643 -1.742 . . . . 0.0 115.688 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 44.4 t -62.06 119.47 49.05 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 113.104 -1.548 . . . . 0.0 112.687 -170.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.868 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 64.4 Cg_endo -84.16 51.28 3.31 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.691 2.927 . . . . 0.0 113.068 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.551 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.0 mmt180 -99.58 127.27 45.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.54 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 89' ' ' ILE . 46.3 mm -90.9 88.42 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.458 0.647 . . . . 0.0 109.434 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.894 ' HB2' HD12 ' A' ' 9' ' ' ILE . 3.9 mt -66.74 -27.18 67.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.557 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -41.24 142.95 0.47 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.301 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 94' ' ' SER . 30.4 tp -63.23 130.87 46.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.554 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.82 55.84 4.76 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.555 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.456 ' HB2' HD21 ' A' ' 92' ' ' LEU . 11.9 t -65.5 -32.12 73.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.424 0.29 . . . . 0.0 110.666 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.96 49.12 2.88 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.304 0.573 . . . . 0.0 110.432 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.411 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 5.9 ppt_? -127.28 28.53 5.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.288 0.566 . . . . 0.0 110.797 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.33 118.89 36.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.198 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 68.99 140.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.948 0.78 . . . . 0.0 110.806 -173.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -78.35 59.42 2.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.952 0.406 . . . . 0.0 111.169 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -66.88 130.15 42.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.375 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.535 ' HB2' ' HG3' ' A' ' 106' ' ' LYS . 37.0 p90 -99.58 -23.67 14.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.868 0.366 . . . . 0.0 110.248 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -75.97 69.47 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.691 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.32 175.23 11.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.861 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -55.32 118.54 4.5 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.473 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 68.05 124.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.13 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HG3' ' HB2' ' A' ' 101' ' ' PHE . 4.0 ttmp? -75.58 51.21 0.58 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.588 0.708 . . . . 0.0 110.571 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.301 177.514 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -169.77 130.75 2.1 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.9 m -160.55 -130.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -70.21 -41.56 73.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.934 0.397 . . . . 0.0 110.062 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 58.87 41.22 21.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.752 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -94.81 -38.39 10.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.091 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -135.88 171.8 13.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.314 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 3.5 m-85 -62.3 -22.14 65.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.796 -173.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER 81.54 81.88 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 123.971 0.794 . . . . 0.0 110.039 -171.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.81 60.05 1.12 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.342 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 1.077 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.7 mp -78.03 63.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 122.595 1.188 . . . . 0.0 109.589 -171.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.472 ' SD ' HD12 ' A' ' 12' ' ' LEU . 4.8 ptp -90.05 149.33 22.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.496 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 2.0 t -46.12 -47.02 17.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.603 -1.181 . . . . 0.0 112.812 -174.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.472 HD12 ' SD ' ' A' ' 10' ' ' MET . 1.3 mp 46.35 40.23 7.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 62.4 mttm -80.02 -162.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.819 0.342 . . . . 0.0 110.345 169.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -85.99 110.58 31.7 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.367 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 36.9 Cg_endo -70.75 143.56 46.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.495 2.13 . . . . 0.0 113.018 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.68 -101.5 0.47 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.206 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.49 -31.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.568 ' HB2' HG21 ' A' ' 45' ' ' VAL . 62.9 mt-30 -57.9 132.41 53.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 111.477 -177.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 69' ' ' ASP . 5.9 m -83.26 138.53 33.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.714 -176.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.29 133.79 13.35 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.809 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 94.3 mt -96.91 151.47 19.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 0.0 112.084 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 59' ' ' ILE . 93.9 mt -120.0 141.52 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.17 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.473 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 5.7 p -78.78 154.74 29.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.65 -32.21 50.6 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.262 0.351 . . . . 0.0 111.847 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.0 mmtp -63.65 -43.91 95.36 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.95 -15.93 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -53.59 108.99 0.4 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.471 0.653 . . . . 0.0 110.585 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.3 -35.12 1.69 Allowed Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.02 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -87.96 128.36 35.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.798 -0.201 . . . . 0.0 111.496 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.13 118.58 65.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.86 -39.41 68.3 Favored 'Trans proline' 0 N--CA 1.474 0.357 0 C-N-CA 123.051 2.501 . . . . 0.0 114.169 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mm -63.94 -40.79 90.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.06 -18.85 8.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t0 66.06 76.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.284 0.564 . . . . 0.0 110.013 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.9 t -162.43 147.06 12.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.874 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -90.45 22.72 3.28 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.033 0.444 . . . . 0.0 111.143 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG12 ' CB ' ' A' ' 73' ' ' CYS . 2.5 p -69.43 148.85 11.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.135 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -40.19 113.07 0.9 Allowed Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.6 Cg_endo -78.71 148.12 22.49 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.202 2.601 . . . . 0.0 112.011 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.569 ' HE2' ' HB2' ' A' ' 74' ' ' TRP . 61.9 mttm -139.17 -53.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 99.5 mtt180 -101.05 138.21 38.39 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -64.8 132.42 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.497 . . . . 0.0 111.04 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.822 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 15.7 t -74.16 125.18 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.354 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.9 136.99 36.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.984 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.891 HG11 HH21 ' A' ' 88' ' ' ARG . 2.1 m -91.84 150.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.6 p -81.29 145.7 30.77 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.445 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 1.5 tp10 -58.11 -24.3 58.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -173.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.511 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 41.9 m-80 -66.08 -20.99 66.34 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.383 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.473 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 78.4 m -110.27 39.0 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.119 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.708 ' HB3' HG23 ' A' ' 45' ' ' VAL . 84.8 p -147.78 -49.43 0.17 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.618 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.03 40.2 0.53 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.01 -51.44 0.13 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.423 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.549 ' HD3' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -132.48 165.0 25.32 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.549 ' HG2' ' HD3' ' A' ' 53' ' ' LYS . 85.9 mm-40 62.32 -138.81 0.45 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.667 0.605 . . . . 0.0 110.41 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.61 -60.15 0.39 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.873 0.869 . . . . 0.0 112.204 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' HZ2' ' HB2' ' A' ' 56' ' ' LYS . 9.9 mtmp? -83.11 -46.48 12.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.851 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.506 ' C ' HD21 ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.6 149.75 48.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.372 0.606 . . . . 0.0 110.588 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 11.8 t -54.1 124.12 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.829 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.543 HD12 ' NH1' ' A' ' 88' ' ' ARG . 28.0 pt -69.33 -23.07 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.576 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 22' ' ' LEU . 37.4 mt -78.71 -49.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -95.28 -8.28 36.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.33 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.87 46.67 6.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.702 0.801 . . . . 0.0 111.663 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -61.56 0.13 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.236 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -70.06 141.75 52.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.723 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.8 132.72 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.207 0.317 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.53 176.93 54.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.702 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 22' ' ' LEU . 3.2 p -161.34 -52.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -97.4 122.7 40.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.677 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' HB3' HG23 ' A' ' 19' ' ' THR . 1.3 m-20 -59.16 134.08 56.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.993 0.425 . . . . 0.0 110.482 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . . . -73.26 142.73 47.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.591 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 7.6 m-85 -124.79 130.09 51.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.271 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.822 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.6 m-85 -66.26 129.94 41.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.0 p -69.75 161.86 28.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.775 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.569 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 26.6 t90 -53.75 -39.82 65.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.603 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -60.99 -48.25 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.723 0.297 . . . . 0.0 110.946 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 84.2 m -67.97 -32.76 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.58 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.12 -44.02 97.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.583 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 -60.77 -46.65 89.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.536 HD12 ' HE3' ' A' ' 81' ' ' LYS . 86.0 mt -68.76 -32.62 72.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.825 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.71 38.57 10.43 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.344 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.536 ' HE3' HD12 ' A' ' 79' ' ' LEU . 87.5 mttt -78.76 -9.14 59.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.681 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.07 -35.73 72.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.36 0.6 . . . . 0.0 109.597 173.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -81.74 -9.17 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.061 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 81' ' ' LYS . 23.5 t0 -70.1 -42.9 72.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.76 -175.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . 172.09 178.52 42.39 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.626 -1.273 . . . . 0.0 114.029 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.689 ' SG ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -72.42 110.68 8.62 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 111.326 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' HG2' HH12 ' A' ' 88' ' ' ARG . 56.6 Cg_endo -78.12 41.44 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.436 2.758 . . . . 0.0 115.279 -172.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.891 HH21 HG11 ' A' ' 45' ' ' VAL . 7.0 mmt-85 -79.98 134.41 36.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.487 HG23 ' OD1' ' A' ' 91' ' ' ASN . 33.7 mm -85.24 126.34 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.217 0.532 . . . . 0.0 112.126 -175.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.4 46.0 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.683 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 1.077 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 5.7 m120 -57.17 124.24 18.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.513 -173.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.1 tp 173.16 -48.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.828 177.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.3 -75.41 0.39 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.6 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 98' ' ' ASP . 35.3 t 174.08 -67.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.964 -0.618 . . . . 0.0 109.658 172.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m120 70.17 -31.57 0.22 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.823 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -155.56 160.56 40.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.624 -175.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 94.1 mt 75.81 -56.2 0.6 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.65 0.78 . . . . 0.0 113.057 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.55 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 44.1 m-20 -81.48 43.9 0.77 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.101 0.477 . . . . 0.0 111.283 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -135.36 35.16 2.99 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.837 ' HB3' ' HG3' ' A' ' 102' ' ' GLU . 4.1 m170 -148.86 134.13 18.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.229 -177.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -71.21 -41.85 69.71 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.684 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.837 ' HG3' ' HB3' ' A' ' 100' ' ' HIS . 97.3 mt-10 43.67 60.88 2.47 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.673 0.608 . . . . 0.0 111.768 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.8 mttt 67.34 -130.55 0.14 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.059 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.9 tptm 67.95 -64.55 0.28 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.37 0.668 . . . . 0.0 111.537 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -148.55 39.99 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -67.39 127.27 32.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.007 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.121 177.409 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.501 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.5 ptp . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.149 0.499 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.6 t -53.83 -49.74 67.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.031 -172.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.787 ' HG ' ' HB3' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 51.87 43.06 30.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 172.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 50.2 mttm -95.62 -155.38 0.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.584 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -87.34 111.91 44.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.063 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 32.9 Cg_exo -60.1 138.58 82.68 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.244 2.629 . . . . 0.0 112.926 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.91 -140.25 11.26 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.12 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.612 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 35.3 m -98.44 -29.11 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.64 0.257 . . . . 0.0 111.209 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 59.5 mt-30 -69.23 125.53 26.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.95 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -82.32 142.45 32.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.827 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.8 118.55 6.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.628 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 81.8 mt -92.18 143.75 26.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 112.071 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 70.7 mt -110.33 136.57 49.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.301 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.8 p -72.59 152.39 41.83 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 53.6 mt-10 -54.97 -25.44 29.72 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 0.0 111.558 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 25.1 mtpp -72.16 -23.29 61.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.747 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 20.6 m -116.32 15.37 15.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 26.1 t70 -68.29 129.8 41.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -21.33 46.59 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.329 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 45.0 mttm -71.82 134.61 46.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.8 t -81.82 121.57 79.47 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HG2' HG11 ' A' ' 43' ' ' VAL . 72.7 Cg_exo -54.11 -34.15 76.95 Favored 'Trans proline' 0 CA--C 1.526 0.093 0 C-N-CA 122.441 2.094 . . . . 0.0 112.771 -175.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 3.8 mm -76.01 -32.72 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.431 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 20.1 p -137.98 -34.46 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t0 64.35 86.86 0.12 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 t -154.36 25.35 0.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.578 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 36.79 50.11 0.82 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.303 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 73' ' ' CYS . 7.9 p -118.19 162.81 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.346 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 ptp85 -42.43 128.5 2.89 Favored Pre-proline 0 N--CA 1.466 0.354 0 O-C-N 123.736 0.648 . . . . 0.0 112.63 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.547 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 2.8 Cg_exo -76.64 -154.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.421 2.747 . . . . 0.0 112.164 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -176.4 -49.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.32 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -150.12 136.08 18.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.494 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.71 134.55 56.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.957 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 16.2 m -74.03 134.42 29.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.612 ' NH2' ' HA ' ' A' ' 17' ' ' VAL . 27.8 mtp85 -108.15 122.15 46.32 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -81.9 143.84 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.166 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.1 p -61.35 149.08 39.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.928 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 89.8 mt-10 -54.55 -34.49 61.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.374 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m120 -53.94 -36.25 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.765 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 66.2 m -83.82 -32.29 25.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.319 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.418 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 4.5 m -67.18 -49.05 66.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.066 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.529 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.578 0.228 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.931 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 34.7 m-20 -63.92 144.94 56.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.431 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.5 t -47.38 131.73 13.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.719 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 11.0 pt -75.96 -29.53 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.102 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -77.72 -45.7 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 28.6 p -109.4 14.28 23.72 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 44.7 p30 22.26 58.24 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.25 -67.61 0.12 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 0.0 110.458 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -78.19 139.8 38.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.931 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 8.9 p -61.65 139.56 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 110.881 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -84.07 145.21 22.26 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.628 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.0 m -111.1 -41.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.6 135.29 54.3 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -62.12 134.49 56.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -75.47 147.2 40.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.589 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.547 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 9.4 m-85 -117.26 136.24 53.23 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.867 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 80.5 m-85 -67.81 128.59 37.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.58 ' HB2' HG13 ' A' ' 37' ' ' VAL . 1.8 p -72.25 149.08 44.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -51.08 -39.5 56.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.598 0.562 . . . . 0.0 111.7 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.27 -45.62 93.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.606 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 60.7 m -65.61 -36.65 84.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.502 0.191 . . . . 0.0 110.97 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 73.4 m -66.3 -41.81 89.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -62.84 -47.19 84.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.56 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.04 -33.79 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.38 40.21 5.15 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.364 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.02 -30.93 15.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -66.89 -27.59 67.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.852 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -69.03 -8.84 48.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.329 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.787 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 70.6 m-20 -69.08 -51.21 41.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.16 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.42 -137.27 5.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.235 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 26.9 t -54.41 115.87 9.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 124.054 0.942 . . . . 0.0 111.717 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.957 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 66.0 Cg_endo -88.39 26.82 0.56 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.95 2.433 . . . . 0.0 114.177 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.765 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 30.3 mtt-85 -73.45 121.65 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.955 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 mm . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.233 177.705 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.522 ' HE1' HD13 ' A' ' 32' ' ' ILE . 4.7 ptp . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 121.405 0.621 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.478 ' SG ' ' HE2' ' A' ' 13' ' ' LYS . 45.5 t -52.54 -49.89 63.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.308 -175.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 54.6 mt 50.32 32.22 6.05 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HE2' ' SG ' ' A' ' 11' ' ' CYS . 27.9 mtmt -82.39 166.12 19.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.153 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.3 112.89 5.5 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 123.77 0.668 . . . . 0.0 110.451 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 50.9 Cg_endo -76.65 141.01 21.62 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.095 2.53 . . . . 0.0 113.376 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 -144.08 11.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -89.1 -24.47 5.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.132 0.491 . . . . 0.0 110.667 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -57.4 124.48 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.42 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 m -84.97 137.9 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.117 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -69.01 130.33 24.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.713 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 68' ' ' ASN . 52.5 mt -88.84 142.88 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.338 0.59 . . . . 0.0 112.358 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.712 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 81.4 mt -113.13 137.62 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.963 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 6.5 p -75.94 154.88 35.59 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 27' ' ' ASP . 39.9 mt-10 -51.97 -33.27 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.405 0.44 . . . . 0.0 111.552 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -69.0 -27.96 66.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.775 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 49.4 m -104.48 41.42 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.962 0.411 . . . . 0.0 109.916 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 9.6 t70 -66.66 119.14 11.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.01 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.73 44.67 56.2 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.613 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD3' ' HB3' ' A' ' 26' ' ' CYS . 35.3 mtpt -120.15 139.74 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.538 -0.389 . . . . 0.0 110.992 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 37.1 t -78.67 122.75 85.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.634 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.724 ' HG2' HG21 ' A' ' 43' ' ' VAL . 36.7 Cg_exo -64.49 -36.45 43.6 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.104 2.536 . . . . 0.0 113.323 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.62 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.8 mm -64.43 -41.58 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.992 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.15 -12.5 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 63.91 81.55 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.308 0.575 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 t -171.73 152.9 3.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.957 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -88.32 22.63 2.43 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.663 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 73' ' ' CYS . 10.0 p -68.02 154.92 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.07 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 10.9 ptp180 -44.02 129.35 4.35 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.534 0.734 . . . . 0.0 112.721 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.712 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 Cg_exo -73.98 -164.54 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.37 2.713 . . . . 0.0 112.379 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.786 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -172.17 -42.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.979 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -149.66 136.42 19.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -63.16 139.52 58.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.474 0.654 . . . . 0.0 111.698 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.828 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.2 t -70.47 133.8 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.417 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -123.6 128.34 49.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.831 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG12 ' HD2' ' A' ' 87' ' ' PRO . 28.7 m -100.83 155.88 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.043 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.4 p -67.44 145.95 54.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.93 -28.94 64.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.625 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 16.9 m-80 -59.1 -31.11 68.62 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.833 175.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.443 ' HB3' ' CD ' ' A' ' 88' ' ' ARG . 79.3 m -101.48 29.3 4.9 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 122.155 -0.341 . . . . 0.0 111.798 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 m -111.29 -28.17 8.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 109.837 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 17.0 p90 . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.56 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 14.1 mmtp . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.849 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 80.2 m-20 -67.23 150.47 49.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.901 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 36.7 t -50.11 135.1 21.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.608 HG22 ' HG2' ' A' ' 88' ' ' ARG . 11.7 pt -77.65 -35.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.599 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.26 -47.3 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.8 p -103.07 2.81 35.29 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.847 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.541 ' OD1' ' HB ' ' A' ' 89' ' ' ILE . 1.5 p-10 36.36 47.3 0.48 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.117 0.886 . . . . 0.0 113.256 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.21 -66.27 0.37 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.044 -174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -81.98 143.39 31.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.235 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 48.5 t -56.92 134.44 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.217 0.323 . . . . 0.0 110.545 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.87 147.29 21.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.775 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.68 -37.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.089 0.471 . . . . 0.0 110.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.712 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 6.4 m120 -82.77 173.33 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.172 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -109.92 134.41 52.12 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.531 ' CB ' HD11 ' A' ' 59' ' ' ILE . . . -77.58 151.54 34.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.28 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.404 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 16.3 m-85 -126.24 135.36 51.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.828 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 76.9 m-85 -71.26 125.11 26.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.6 p -67.58 157.0 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -50.28 -40.82 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.479 0.487 . . . . 0.0 111.479 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 37.2 mt-10 -58.91 -51.96 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.604 0.24 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.62 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 98.7 m -64.38 -36.14 83.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.363 -178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 72' ' ' TYR . 84.9 m -67.87 -42.83 80.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -58.8 -49.24 78.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.959 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 42.3 mt -72.06 -27.43 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.68 47.18 3.26 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.43 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.494 ' CB ' HG21 ' A' ' 32' ' ' ILE . 29.7 mmmt -82.19 -36.43 27.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.205 0.526 . . . . 0.0 109.911 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -66.77 -28.8 68.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.997 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.9 pttp -57.07 -30.91 64.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.31 . . . . 0.0 110.465 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB2' HD22 ' A' ' 12' ' ' LEU . 86.9 m-20 -61.57 -52.55 63.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.691 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.32 -127.72 3.45 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.569 -1.3 . . . . 0.0 114.669 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.4 t -58.84 109.56 1.96 Allowed Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.52 -1.34 . . . . 0.0 113.182 -171.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.461 ' CG ' HG13 ' A' ' 43' ' ' VAL . 72.0 Cg_endo -87.97 39.89 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.992 2.461 . . . . 0.0 113.716 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 59' ' ' ILE . 24.3 mtp85 -85.03 127.68 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HB ' ' OD1' ' A' ' 62' ' ' ASN . 31.5 mm . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.544 ' HE1' ' HA ' ' A' ' 32' ' ' ILE . 2.3 ptp . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.425 0.631 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 88' ' ' ARG . 44.1 t -56.15 -53.12 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.304 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mp 48.52 37.9 9.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -79.59 177.64 8.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.59 167.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -70.81 116.05 42.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.883 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 31.8 Cg_exo -62.91 145.23 94.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.161 2.574 . . . . 0.0 113.37 -175.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.93 -137.4 9.22 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.53 -23.28 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -72.31 138.75 47.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.487 . . . . 0.0 111.718 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 m -91.7 137.66 32.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.644 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.524 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -66.71 132.33 31.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.268 -0.492 . . . . 0.0 112.798 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 88.1 mt -95.87 143.46 27.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.046 0.451 . . . . 0.0 111.83 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 60.0 mt -113.01 140.42 47.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.263 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.3 p -78.92 154.03 30.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 40.1 mt-10 -54.69 -26.22 32.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.83 0.347 . . . . 0.0 111.67 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 35.1 mmtp -70.11 -29.36 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.432 ' O ' HD13 ' A' ' 22' ' ' LEU . 4.8 m -116.29 17.28 15.67 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.564 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 51.9 t0 -66.77 127.2 31.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.145 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.95 -22.18 42.24 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.491 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -68.26 122.07 17.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.489 0.185 . . . . 0.0 110.99 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -69.19 113.03 13.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.42 -27.37 67.67 Favored 'Trans proline' 0 N--CA 1.473 0.3 0 C-N-CA 123.372 2.715 . . . . 0.0 113.403 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.544 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 4.8 mm -66.8 -36.59 77.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.92 -176.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.58 -15.61 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 67.1 84.05 0.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.373 0.606 . . . . 0.0 109.831 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -164.57 136.02 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.148 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.68 11.76 8.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 73' ' ' CYS . 8.3 p -66.44 160.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.001 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -40.76 130.85 1.85 Allowed Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.66 0.784 . . . . 0.0 112.873 -175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 93.4 Cg_endo -78.83 -161.23 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.388 2.725 . . . . 0.0 112.771 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -171.57 -50.55 0.02 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.359 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -134.88 145.47 48.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.186 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 59.7 mttp -68.18 140.47 56.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.836 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.7 m -74.58 127.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 111.606 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.53 114.99 29.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.52 146.53 6.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.345 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p -67.04 161.23 24.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -47.36 -44.89 24.38 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.042 0.839 . . . . 0.0 111.715 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.731 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.1 m120 -61.69 -39.1 90.24 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.709 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 55.9 m -90.0 43.53 1.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.682 0.277 . . . . 0.0 110.794 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.9 m -155.62 -38.68 0.08 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.698 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.731 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.55 0.214 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -65.92 148.47 51.73 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.34 0.59 . . . . 0.0 110.933 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 20.2 t -51.6 125.73 15.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.375 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.5 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 8.7 pt -65.52 -26.86 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.457 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.4 mt -81.12 -41.1 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 32.1 p -113.75 2.61 15.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.348 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.1 p30 29.25 53.1 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.43 1.092 . . . . 0.0 113.476 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.64 -59.49 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.383 -176.315 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -72.48 141.27 48.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.826 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.36 133.01 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.174 0.512 . . . . 0.0 110.957 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.415 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.11 140.09 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.996 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -127.08 -39.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -117.84 137.73 52.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.89 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.3 139.1 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.568 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.699 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -82.39 151.33 26.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.653 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 7.7 m-85 -124.73 134.15 52.93 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.838 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.836 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 68.2 m-85 -66.17 125.15 24.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -66.07 151.54 46.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -52.98 -38.0 61.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.68 -46.26 87.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.473 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 86.0 m -72.39 -38.01 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.722 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.5 t -63.97 -35.9 82.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.302 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -62.9 -41.43 99.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.334 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.03 1.41 21.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.01 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.05 84.78 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.495 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 93.3 mttt -77.72 -20.35 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HB2' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -70.82 -23.47 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.667 175.474 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.47 -25.06 60.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -55.03 -57.82 10.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.61 -140.15 7.11 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.647 -1.263 . . . . 0.0 114.343 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.643 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 47.4 t -64.5 115.91 24.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.189 -1.005 . . . . 0.0 112.275 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.811 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 93.9 Cg_endo -83.17 39.59 0.84 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.211 2.607 . . . . 0.0 113.442 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.709 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 9.5 mmt180 -81.73 121.81 26.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.992 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.4 mm . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.071 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 1.4 ptp . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 121.171 0.51 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -56.98 -50.4 72.81 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.493 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 84' ' ' ASP . 40.0 mt 49.5 40.65 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.015 1.116 . . . . 0.0 114.015 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HB3' ' H ' ' A' ' 14' ' ' GLN . 47.4 mttm -82.29 -159.8 0.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.821 169.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 15.6 tm0? -85.18 122.94 73.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.12 133.17 48.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.852 2.368 . . . . 0.0 112.75 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -144.16 6.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.247 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG12 ' OE1' ' A' ' 47' ' ' GLU . 11.3 p -99.38 -30.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.754 0.311 . . . . 0.0 111.401 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.499 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 70.6 mt-30 -77.96 136.37 37.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.37 0.605 . . . . 0.0 111.896 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 m -75.86 143.28 41.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.526 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.28 120.45 5.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.213 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 73.5 mt -91.98 147.61 22.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.492 . . . . 0.0 112.14 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.653 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 76.8 mt -110.89 130.11 55.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.139 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.446 ' H ' ' CB ' ' A' ' 58' ' ' CYS . 8.5 p -71.4 160.42 32.79 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.705 ' HG3' HG21 ' A' ' 67' ' ' VAL . 54.8 mt-10 -58.25 -24.55 59.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp -74.44 -31.23 62.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.677 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -110.13 25.07 12.2 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 38.9 t70 -68.03 124.74 24.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.97 77.25 Favored Glycine 0 C--N 1.321 -0.266 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.627 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 51.3 mttm -102.7 134.51 45.97 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.448 -0.442 . . . . 0.0 110.607 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 12.6 t -70.75 117.17 53.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 11.2 Cg_endo -58.89 -31.95 96.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.818 2.346 . . . . 0.0 112.811 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 12.6 mm -66.4 -46.94 85.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.243 -175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -122.21 -6.06 8.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -170.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.98 75.79 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 110.091 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 t -164.33 147.52 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -89.01 41.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.058 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 73' ' ' CYS . 41.9 t -74.43 148.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.87 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.557 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 5.4 mmp_? -35.93 120.17 0.69 Allowed Pre-proline 0 C--O 1.224 -0.287 0 O-C-N 124.495 1.122 . . . . 0.0 112.554 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.58 144.37 44.56 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.597 2.198 . . . . 0.0 112.38 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 12.3 mmmm -131.7 -78.79 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -85.78 132.04 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.07 132.32 44.92 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 21.9 t -71.45 129.08 35.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.405 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -121.83 130.44 53.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.9 m -80.6 144.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.157 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.5 p -62.39 139.78 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.611 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 6.9 tp10 -60.16 -21.18 61.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.094 -174.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.628 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 5.2 m120 -60.48 -31.56 70.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.7 m -87.38 -35.02 18.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.529 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 16.6 p -92.28 -22.08 19.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -172.587 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 15.6 p30 -62.15 149.26 41.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.815 0.817 . . . . 0.0 112.083 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -64.8 130.92 45.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.265 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' CD1' HG11 ' A' ' 43' ' ' VAL . 8.4 pt -62.57 -40.6 88.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.46 -38.12 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.2 p -101.73 -26.55 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.954 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 57.5 56.47 4.97 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.246 0.546 . . . . 0.0 109.611 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.86 -58.55 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.336 -170.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.4 144.0 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.752 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -64.68 138.13 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.895 0.378 . . . . 0.0 110.978 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -72.13 151.2 46.81 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.297 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.705 HG21 ' HG3' ' A' ' 24' ' ' GLU . 61.1 t -118.74 -60.94 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.887 0.375 . . . . 0.0 111.167 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -113.45 137.55 51.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.892 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -60.3 136.72 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.473 0.483 . . . . 0.0 111.366 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.653 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -82.57 159.39 22.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.904 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -136.54 134.34 37.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.138 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.5 m-85 -66.17 128.12 34.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 1.8 p -71.87 160.15 33.06 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.002 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -49.09 -50.62 36.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.077 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HG3' HG11 ' A' ' 37' ' ' VAL . 46.3 mt-10 -59.92 -43.15 95.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.388 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 91.6 m -68.01 -34.97 77.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.169 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 40' ' ' LYS . 81.7 m -68.63 -37.48 79.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -60.53 -47.16 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.272 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.12 -28.2 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.588 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.54 36.84 10.14 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.967 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 81' ' ' LYS . 21.6 mtpp -87.4 -10.95 50.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.919 0.39 . . . . 0.0 110.243 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -68.82 -24.46 64.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 108.988 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -73.97 -23.49 59.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.757 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' HD13 ' A' ' 12' ' ' LEU . 81.4 m-20 -58.16 -58.93 6.3 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 -135.01 7.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.859 -1.163 . . . . 0.0 114.261 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 24.8 t -55.99 107.35 0.86 Allowed Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 111.929 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 97.3 Cg_endo -87.95 38.25 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.772 2.315 . . . . 0.0 113.563 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 10' ' ' MET . 53.6 mtt180 -87.52 131.42 34.37 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.983 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mm . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.176 178.746 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.471 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.405 0 CA-C-O 121.382 0.611 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.4 t -48.85 -48.46 41.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.292 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' N ' ' A' ' 86' ' ' CYS . 20.9 mt 41.45 40.5 1.31 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 50.5 mttm -80.0 -160.18 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 34.0 tp60 -82.13 111.01 23.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.381 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 77.2 Cg_endo -80.17 146.54 17.93 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.453 2.102 . . . . 0.0 112.746 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.69 -142.6 13.34 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.298 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.41 -17.87 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.096 0.474 . . . . 0.0 110.717 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -64.33 142.18 58.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.9 m -109.08 126.58 53.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.747 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -63.55 138.2 42.7 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.307 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 56' ' ' LYS . 41.2 mt -78.93 154.34 29.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.869 0.842 . . . . 0.0 113.131 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' A' ' 70' ' ' ALA . 1.7 tp -124.47 127.68 47.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.856 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 1.4 p -81.36 149.4 28.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -52.31 -35.01 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -62.22 -37.95 87.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.32 -17.37 23.66 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.49 -0.131 . . . . 0.0 110.795 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' HA ' HD23 ' A' ' 22' ' ' LEU . 13.0 t70 -54.49 110.79 0.68 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.866 -172.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.78 -31.22 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.775 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.542 ' HB2' HD13 ' A' ' 60' ' ' ILE . 55.1 mttm -78.61 132.58 37.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.479 -0.361 . . . . 0.0 110.892 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 t -80.46 119.05 75.2 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 71.3 Cg_exo -54.59 -37.01 90.74 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 123.059 2.506 . . . . 0.0 113.761 -172.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.604 HG21 ' HD3' ' A' ' 81' ' ' LYS . 3.4 mm -61.47 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.4 p -106.5 -21.75 12.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -171.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 65.42 83.43 0.17 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.394 0.616 . . . . 0.0 110.292 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 t -169.34 138.88 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.39 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -80.13 45.96 0.78 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.242 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 73' ' ' CYS . 4.2 p -94.1 148.38 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.009 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -40.16 123.31 1.67 Allowed Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 77.9 Cg_endo -72.43 152.15 54.39 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.011 2.474 . . . . 0.0 111.261 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HD2' ' HD1' ' A' ' 74' ' ' TRP . 57.6 tttp -128.81 -37.16 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.848 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.46 145.42 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.93 143.07 52.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 111.557 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.779 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 31.6 m -68.39 155.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -116.19 114.81 24.95 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.536 HG22 ' HB2' ' A' ' 49' ' ' CYS . 10.0 p -93.88 139.61 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.591 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.5 p -65.79 147.75 52.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.71 -30.47 63.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.679 0.275 . . . . 0.0 110.476 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.685 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.9 m120 -55.94 -40.92 73.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.506 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.536 ' HB2' HG22 ' A' ' 45' ' ' VAL . 91.6 m -80.65 -24.66 38.82 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.597 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -76.95 -41.94 41.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.667 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 112.206 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.9 mmpt? . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.078 0.466 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 71.7 m-80 -76.23 140.17 41.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.022 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.9 t -51.68 126.57 18.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.218 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD11 ' CB ' ' A' ' 70' ' ' ALA . 12.4 pt -68.78 -27.58 36.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.587 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' ' 29' ' ' LYS . 54.0 mt -75.81 -42.8 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 24.9 p -105.63 -6.99 18.79 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.23 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 42.19 45.85 3.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.981 0.801 . . . . 0.0 112.31 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 -62.43 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.142 0.496 . . . . 0.0 110.188 -177.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -75.87 141.97 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.891 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 9.9 p -68.16 139.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.729 0.3 . . . . 0.0 110.591 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.25 145.1 20.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.8 m -116.33 -38.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.554 0.216 . . . . 0.0 111.478 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -104.73 -174.87 2.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.522 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.411 ' HB3' HG21 ' A' ' 19' ' ' THR . 44.3 m-20 -107.78 142.26 38.08 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 22' ' ' LEU . . . -79.42 151.4 30.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -127.39 136.27 51.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.779 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 56.1 m-85 -68.11 127.81 34.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 37' ' ' VAL . 12.4 p -71.42 161.74 30.57 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.746 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.578 ' HD1' ' HD2' ' A' ' 40' ' ' LYS . 27.8 t90 -51.99 -42.2 62.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.161 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -58.63 -55.97 28.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.116 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.78 -39.48 94.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.484 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.7 t -65.31 -41.31 94.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.454 0.169 . . . . 0.0 110.765 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.4 ttp-105 -64.15 -44.53 91.85 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.026 0.441 . . . . 0.0 110.324 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 77.3 mt -65.67 -38.2 88.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.367 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 28.18 4.11 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.308 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.604 ' HD3' HG21 ' A' ' 32' ' ' ILE . 46.6 mttm -88.39 -4.67 58.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.869 0.366 . . . . 0.0 110.571 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 p-10 -66.83 -30.45 70.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.034 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.474 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 3.5 mmmp? -96.2 7.82 45.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.27 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -69.69 -59.65 2.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.7 -158.15 30.91 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.355 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.474 ' N ' ' HA ' ' A' ' 12' ' ' LEU . 34.2 t -66.08 115.22 21.18 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.658 0.783 . . . . 0.0 111.54 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.619 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 90.0 Cg_endo -86.76 41.98 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.683 2.922 . . . . 0.0 114.047 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -87.81 130.34 34.9 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.988 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 175.153 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.81 ' HG2' HD22 ' A' ' 12' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.437 -1.108 0 CA-C-O 120.869 0.366 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -41.58 -63.11 0.76 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.328 . . . . 0.0 113.254 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.81 HD22 ' HG2' ' A' ' 10' ' ' MET . 0.0 OUTLIER 51.03 36.77 16.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.873 ' HE2' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -104.29 170.66 7.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 166.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.3 tp-100 -57.33 121.91 50.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 123.551 0.532 . . . . 0.0 110.693 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.9 Cg_exo -71.19 151.03 60.49 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.879 2.386 . . . . 0.0 112.688 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.652 ' H ' ' HA ' ' A' ' 46' ' ' CYS . . . -88.02 -125.98 2.37 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.529 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -105.42 -48.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -62.22 151.02 37.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.522 HG21 ' HD3' ' A' ' 42' ' ' LYS . 98.6 m -82.23 143.56 31.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.451 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.75 126.51 9.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.952 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.2 mt -95.33 136.73 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.674 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 90.7 mt -99.07 148.7 23.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.49 171.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.9 p -89.47 154.99 19.59 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 67' ' ' VAL . 62.5 mm-40 -52.21 -29.54 23.04 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.423 0.452 . . . . 0.0 111.996 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.3 mmtp -69.4 -36.58 76.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.31 -0.244 . . . . 0.0 111.218 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 23.3 m -99.48 33.73 2.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.69 119.23 9.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.115 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.43 31.99 62.7 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.525 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 26' ' ' CYS . 24.5 mtpp -103.76 122.86 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 14.0 t -62.06 115.89 18.56 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.165 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.714 ' HG2' HG11 ' A' ' 43' ' ' VAL . 8.1 Cg_exo -73.29 50.16 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.63 2.887 . . . . 0.0 112.716 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mm -149.86 -48.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.3 p -112.94 -14.84 12.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.085 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 65.82 80.95 0.21 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.599 0.714 . . . . 0.0 109.939 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -165.65 146.91 7.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.99 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.72 14.1 12.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.477 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -65.22 150.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 16.5 ptm180 -37.5 126.98 0.89 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 124.001 0.92 . . . . 0.0 113.383 -174.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.4 Cg_exo -71.55 -163.54 0.13 Allowed 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.429 2.753 . . . . 0.0 112.478 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -169.0 -52.53 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.235 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -140.11 141.89 36.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HD3' HG21 ' A' ' 19' ' ' THR . 39.6 ttmt -69.06 140.13 54.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.948 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.714 HG11 ' HG2' ' A' ' 31' ' ' PRO . 12.4 m -77.95 148.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.799 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.57 129.23 50.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.044 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 m -93.73 146.52 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.025 0.441 . . . . 0.0 111.343 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.665 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p -69.91 165.33 21.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -59.47 -41.06 88.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.176 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.873 ' HB2' ' HE2' ' A' ' 13' ' ' LYS . 63.0 m-20 -74.52 40.3 0.13 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.502 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.498 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 15.6 m -151.35 -52.3 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.75 174.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.5 m -100.21 44.17 1.03 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.737 0.779 . . . . 0.0 110.025 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.202 -178.799 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -93.35 149.74 21.0 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.769 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.719 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.8 t -48.3 129.39 15.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.922 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.619 HG22 ' HD3' ' A' ' 88' ' ' ARG . 8.5 pt -65.89 -31.6 54.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.482 -174.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 26' ' ' CYS . 51.4 mt -77.17 -47.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.74 -4.5 15.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.835 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 40.06 47.91 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.59 0.756 . . . . 0.0 112.651 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.53 -57.25 0.28 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.023 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -76.75 146.69 37.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.716 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.18 131.36 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 110.162 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.17 139.47 25.02 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.991 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 24' ' ' GLU . 16.2 m -131.63 -40.05 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 111.447 0.165 . . . . 0.0 111.447 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.75 138.95 33.53 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.33 129.94 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.674 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -80.28 148.99 30.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 7.9 m-85 -128.01 133.77 49.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.674 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 53.7 m-85 -68.38 132.44 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -68.63 153.02 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -53.19 -38.33 62.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.789 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.82 -45.79 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.611 0.243 . . . . 0.0 111.385 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.6 m -67.68 -37.77 82.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.086 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.5 t -61.85 -42.64 99.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -57.34 -50.23 73.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.889 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.18 -27.59 62.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.576 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.17 30.71 21.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.404 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -78.99 -27.5 43.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -67.21 -41.72 85.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.096 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -85.01 26.58 0.84 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' CG ' ' HG ' ' A' ' 12' ' ' LEU . 49.4 t0 -80.39 -53.65 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . 179.32 -149.64 8.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.451 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 30.3 t -67.26 121.05 76.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.697 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 85.3 Cg_endo -80.91 43.42 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.93 3.087 . . . . 0.0 113.446 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.619 ' HD3' HG22 ' A' ' 59' ' ' ILE . 14.9 mmm180 -102.14 143.7 31.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.999 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.0 mm . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.807 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 3.8 ptp . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 120.906 0.384 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -37.54 75.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.787 -174.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 53.8 mt 56.16 34.3 23.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 171.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 61.6 mttm -77.53 -169.36 1.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.533 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.24 113.63 45.23 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.514 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.782 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 27.7 Cg_exo -63.91 144.84 89.26 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.442 2.762 . . . . 0.0 112.809 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.08 -142.64 11.06 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.841 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.595 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 8.3 p -82.24 -35.65 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.127 0.489 . . . . 0.0 110.669 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.38 127.27 30.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.902 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.55 140.24 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.275 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.46 121.38 9.88 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.44 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 56' ' ' LYS . 26.2 mt -78.53 153.82 30.95 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.548 0.69 . . . . 0.0 112.548 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.744 HD11 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.81 127.01 28.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.677 -171.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 1.7 p -80.06 144.87 32.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 93.1 mt-10 -55.17 -26.06 36.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -65.51 -36.33 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.581 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.0 m -94.81 -17.98 21.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.4 t0 -52.05 121.6 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.509 -172.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.78 -32.88 5.47 Favored Glycine 0 C--N 1.316 -0.58 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.26 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -71.13 128.39 35.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.447 -0.376 . . . . 0.0 110.866 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.6 t -74.8 119.67 77.88 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 8.8 Cg_endo -54.8 -36.15 90.1 Favored 'Trans proline' 0 N--CA 1.472 0.264 0 C-N-CA 123.174 2.582 . . . . 0.0 113.331 -174.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.495 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.4 mm -65.41 -44.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.7 p -121.55 -11.49 8.68 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 62.79 72.4 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.957 0.408 . . . . 0.0 111.181 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -162.67 141.8 8.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.856 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -83.31 45.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.306 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.66 HG13 ' HB2' ' A' ' 73' ' ' CYS . 5.9 p -92.79 154.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.245 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -35.16 124.81 0.58 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.356 1.062 . . . . 0.0 113.584 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.79 146.89 38.79 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.144 2.563 . . . . 0.0 111.825 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 57.7 tptt -127.45 -49.27 1.41 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.697 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -138.09 138.69 38.97 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.937 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HG2' ' CE2' ' A' ' 71' ' ' PHE . 32.5 mtpt -65.25 136.04 56.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.322 0.582 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 26.0 t -79.92 124.72 38.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.162 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.595 ' NH1' ' HA ' ' A' ' 17' ' ' VAL . 72.7 mtt-85 -107.05 133.34 51.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.059 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.95 147.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.967 0.413 . . . . 0.0 110.118 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.782 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 p -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.17 -42.8 14.49 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.912 0.758 . . . . 0.0 111.721 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.3 m120 -60.28 -41.12 92.65 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 74.0 m -85.8 53.37 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 t -160.72 -46.85 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.427 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.489 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 21' ' ' LEU . 35.4 mtmm . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 p30 -65.75 143.34 57.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.402 0.62 . . . . 0.0 111.551 -173.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.5 t -64.05 125.89 25.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.676 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 70' ' ' ALA . 18.4 pt -63.3 -32.43 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.744 HD12 HD11 ' A' ' 22' ' ' LEU . 49.3 mt -73.52 -41.3 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -173.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 6.3 p -93.5 -25.11 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.227 174.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 t30 61.43 44.59 9.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.745 0.784 . . . . 0.0 109.656 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 63' ' ' LEU . 1.4 tm? -164.18 -59.27 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.418 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 74.9 m-80 -71.82 146.22 48.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.4 p -66.93 136.19 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.386 . . . . 0.0 111.09 -177.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -88.51 142.34 17.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.4 m -117.17 -38.53 2.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.685 0.279 . . . . 0.0 111.594 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' LEU . 80.5 m-20 -109.93 -168.52 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -115.02 145.73 41.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.025 0.441 . . . . 0.0 110.513 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . . . -75.86 152.28 37.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.709 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CE2' ' HG2' ' A' ' 42' ' ' LYS . 32.0 m-85 -132.08 131.47 42.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.192 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -70.67 128.75 37.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.66 ' HB2' HG13 ' A' ' 37' ' ' VAL . 7.1 p -73.6 158.4 34.85 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.868 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 27.8 t90 -47.97 -49.74 29.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.536 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 5.5 pt-20 -68.45 -36.5 79.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 34.7 m -63.23 -42.25 99.2 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.584 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 97.4 m -68.1 -41.1 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.701 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -63.26 -42.47 99.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -72.24 -30.13 64.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.248 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.83 4.29 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.033 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -96.24 -32.61 12.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 109.979 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -64.06 -34.99 79.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.614 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 7.47 2.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.953 -176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -76.47 -56.41 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.07 -147.33 12.35 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.433 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 2.0 t -70.59 114.44 26.38 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 124.302 1.041 . . . . 0.0 112.389 -174.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 10' ' ' MET . 96.0 Cg_endo -93.33 42.11 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.073 2.515 . . . . 0.0 114.887 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' ' 10' ' ' MET . 39.9 mtt-85 -74.58 128.42 35.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.024 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 89' ' ' ILE . 17.8 mm . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 0.0 111.225 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.781 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.72 0.771 . . . . 0.0 112.052 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.4 t -52.84 -39.75 62.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.67 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 10' ' ' MET . 1.1 mp 43.29 46.44 5.38 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -88.89 -152.66 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 46' ' ' CYS . 11.9 tp-100 -86.3 115.17 61.05 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 48.9 Cg_exo -58.94 136.17 71.69 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.084 2.523 . . . . 0.0 112.852 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.69 -112.29 0.89 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.445 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 p -146.26 -26.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.781 0.324 . . . . 0.0 110.881 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.569 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 56.2 mt-30 -66.35 131.7 46.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.324 0.583 . . . . 0.0 111.45 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -76.33 135.52 39.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.888 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.2 118.72 5.66 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.233 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 91.8 mt -90.8 143.67 26.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.144 0.497 . . . . 0.0 111.648 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 80.9 mt -104.04 133.63 48.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.743 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.3 p -71.27 154.26 41.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HG2' HG21 ' A' ' 67' ' ' VAL . 37.1 mt-10 -48.64 -32.27 8.02 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.484 0.49 . . . . 0.0 112.269 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -70.81 -43.21 69.1 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.652 ' HB3' HD12 ' A' ' 60' ' ' ILE . 33.7 m -89.72 -11.32 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -54.86 115.5 2.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.764 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.7 -31.31 5.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.6 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 62.5 mttp -77.32 127.59 32.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.4 t -68.14 118.27 57.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 3.2 Cg_endo -52.93 -41.29 72.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.221 2.614 . . . . 0.0 113.652 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.963 HG21 ' HG2' ' A' ' 81' ' ' LYS . 1.4 mm -68.75 -48.44 71.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -110.5 -7.94 14.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 58.88 71.46 0.58 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.295 0.569 . . . . 0.0 110.266 -177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.7 t -160.04 139.51 11.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.112 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.405 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.3 m-85 -85.62 30.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 73' ' ' CYS . 7.7 p -80.51 148.82 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.444 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -36.93 119.96 0.8 Allowed Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.8 Cg_endo -80.63 150.65 19.1 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.341 2.694 . . . . 0.0 112.207 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 52.2 mtpt -137.59 -69.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.668 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 20.7 tpp180 -78.86 131.62 36.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.022 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -69.03 133.46 48.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.215 0.531 . . . . 0.0 110.613 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.655 HG13 ' HG3' ' A' ' 87' ' ' PRO . 3.1 t -76.88 126.22 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.866 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -125.04 127.95 47.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.779 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 m -85.53 158.44 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 0.0 111.257 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.9 p -65.45 148.79 51.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -54.02 -30.89 49.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.249 0.343 . . . . 0.0 111.686 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.668 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 64.7 m-80 -59.83 -34.2 72.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.476 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.89 35.5 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.717 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 14.8 m -140.57 -45.16 0.4 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.304 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.729 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.695 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 72.0 m-20 -61.05 142.54 56.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.3 t -51.03 133.39 27.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.89 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' CD1' HG11 ' A' ' 43' ' ' VAL . 7.6 pt -78.43 -26.58 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.518 -175.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 26' ' ' CYS . 48.9 mt -78.2 -48.24 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.549 ' C ' ' H ' ' A' ' 63' ' ' LEU . 28.2 p -103.03 -6.75 22.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.764 -0.775 . . . . 0.0 110.834 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 12.9 m-80 70.05 -36.08 0.34 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.745 0.818 . . . . 0.0 111.581 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -78.65 -63.22 1.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.559 -166.379 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -68.23 148.62 50.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.742 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -73.93 137.02 24.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.721 0.295 . . . . 0.0 110.688 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 144.35 27.25 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.875 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' HG2' ' A' ' 24' ' ' GLU . 27.2 m -115.29 -47.63 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -114.75 135.68 53.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.289 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.89 134.62 55.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.781 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -77.37 153.05 34.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.475 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 11.2 m-85 -134.55 135.1 42.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.521 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -66.55 130.29 42.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.9 p -68.97 162.51 26.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -51.18 -44.03 61.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.105 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -59.82 -47.67 84.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.741 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 68.4 m -67.51 -37.92 83.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.298 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 77.0 m -62.55 -42.88 99.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.798 0.332 . . . . 0.0 110.504 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.05 -42.25 99.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 68.6 mt -70.28 -33.44 71.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.5 7.83 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.847 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.963 ' HG2' HG21 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -66.73 -25.58 66.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.796 0.331 . . . . 0.0 111.564 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.668 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . 26.5 p-10 -65.76 -43.52 88.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.756 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -83.94 -9.0 59.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.916 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 6.4 m-20 -60.03 -49.49 77.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.12 7.92 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.041 -1.075 . . . . 0.0 113.706 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 41.4 t -69.38 117.97 57.75 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.412 -0.894 . . . . 0.0 111.85 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.655 ' HG3' HG13 ' A' ' 43' ' ' VAL . 75.6 Cg_endo -86.45 24.94 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 123.201 2.601 . . . . 0.0 113.261 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 10' ' ' MET . 2.0 mmt180 -73.82 124.49 26.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm . . . . . 0 C--N 1.32 -0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.546 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.876 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.4 t -111.14 -54.75 2.57 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.881 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.556 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 56.8 mt 48.56 33.16 3.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.047 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -86.24 -179.74 6.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mm-40 -67.93 116.05 34.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.2 Cg_exo -72.4 142.57 37.26 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.431 2.754 . . . . 0.0 112.975 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.45 -133.35 4.43 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.925 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.56 -27.08 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.658 0.266 . . . . 0.0 111.329 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -64.6 131.65 47.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 111.163 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.668 HG21 ' HD3' ' A' ' 42' ' ' LYS . 6.6 m -83.13 140.91 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.026 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.4 133.07 14.08 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.687 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 71.7 mt -95.64 143.79 26.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.173 0.511 . . . . 0.0 112.358 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 53.2 mt -113.93 139.28 49.35 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.374 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 8.6 p -72.62 151.62 42.22 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.606 ' HG2' HG21 ' A' ' 67' ' ' VAL . 21.4 mt-10 -49.32 -34.67 16.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.923 0.392 . . . . 0.0 111.595 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -71.46 -26.45 62.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 56.9 m -101.2 -16.08 17.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.453 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -51.94 115.77 1.85 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.258 0.552 . . . . 0.0 111.201 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 36' ' ' TYR . . . 122.29 -30.93 5.05 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.951 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 40.0 mttm -72.12 127.72 33.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.57 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 2.5 t -71.08 120.42 79.42 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HG2' HG11 ' A' ' 43' ' ' VAL . 71.8 Cg_exo -53.1 -35.54 73.05 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.827 2.351 . . . . 0.0 112.964 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mm -67.84 -46.68 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.363 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.7 p -118.46 -2.94 10.97 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.6 t70 59.13 67.8 0.88 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.284 0.564 . . . . 0.0 110.69 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.02 143.34 15.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.022 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 28' ' ' GLY . 2.1 m-85 -83.39 13.31 4.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.091 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 73' ' ' CYS . 13.1 p -60.67 149.64 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.8 ptp85 -38.88 128.77 1.18 Allowed Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.098 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.732 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 Cg_exo -74.83 -161.38 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.437 2.758 . . . . 0.0 112.724 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.836 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -167.78 -43.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.728 178.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 -153.83 142.53 20.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 111.196 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.668 ' HD3' HG21 ' A' ' 19' ' ' THR . 87.0 mttt -62.54 143.08 57.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.473 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.994 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 18.0 m -82.08 146.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -118.98 133.51 55.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.073 0.463 . . . . 0.0 110.78 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.7 m -86.9 146.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.667 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.769 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 10.2 p -66.16 151.39 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -52.02 -37.17 52.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.884 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.495 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 16.9 m-80 -64.67 -20.19 66.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.554 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 19.6 m -90.2 -41.01 11.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.274 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -68.82 -30.27 68.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.3 mttm . . . . . 0 CA--C 1.515 -0.383 0 CA-C-O 120.858 0.361 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 13.8 p30 -71.62 138.85 49.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.1 t -42.7 126.29 3.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.931 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.432 HG12 HD23 ' A' ' 22' ' ' LEU . 9.5 pt -61.21 -32.03 51.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.986 -1.007 . . . . 0.0 113.128 -171.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.99 -45.16 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -103.94 -7.35 20.46 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.684 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 42.04 51.33 4.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.708 0.803 . . . . 0.0 112.387 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 -66.13 0.13 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.085 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -71.24 139.41 50.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.51 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 13.8 p -66.67 136.4 26.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.432 . . . . 0.0 111.448 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.51 141.66 25.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.381 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 ' HG2' ' A' ' 24' ' ' GLU . 19.1 m -118.87 -46.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -116.91 147.23 42.4 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.648 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.36 142.62 58.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.579 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . . . -81.32 155.59 25.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.904 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 18.3 m-85 -127.84 137.28 52.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 91.1 m-85 -69.76 125.39 26.58 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 1.8 p -71.21 152.75 43.04 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.269 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.534 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.65 -44.19 62.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.092 -177.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -56.15 -46.8 79.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.527 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -72.6 -38.56 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.5 t -67.14 -39.98 86.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 110.397 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.27 -32.27 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.403 0.621 . . . . 0.0 109.905 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 101.82 41.21 2.53 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.106 176.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -94.74 1.26 55.46 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.279 -0.542 . . . . 0.0 110.722 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.48 -23.52 62.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.547 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -96.21 9.54 40.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.136 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -68.05 -65.91 0.63 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.96 -154.4 24.38 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.407 170.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 54.1 t -57.93 115.41 11.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.211 -0.994 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.994 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 71.8 Cg_endo -78.29 17.42 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.286 2.658 . . . . 0.0 113.312 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 14.0 mmm180 -67.98 136.41 53.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.876 ' HA ' ' HA ' ' A' ' 10' ' ' MET . 28.9 mm . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 118.408 0.549 . . . . 0.0 111.345 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.668 ' HE1' HD13 ' A' ' 32' ' ' ILE . 4.3 ptp . . . . . 0 N--CA 1.447 -0.625 0 CA-C-O 121.502 0.668 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 7.6 t -44.69 -59.9 2.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.383 -1.735 . . . . 0.0 112.625 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 84' ' ' ASP . 81.7 mt 52.48 32.18 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.935 0.894 . . . . 0.0 113.225 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -80.75 -177.92 6.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 9.3 tm0? -66.83 115.52 25.77 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 6.5 Cg_exo -74.99 140.1 25.09 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.991 2.461 . . . . 0.0 112.873 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.07 -145.3 10.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.214 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.6 -5.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.518 -0.401 . . . . 0.0 110.606 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -62.01 130.36 45.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.177 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -79.17 137.83 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.301 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.26 125.66 7.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.341 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 81.9 mt -100.08 145.8 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.241 0.543 . . . . 0.0 112.407 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.614 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 85.8 mt -114.04 133.01 55.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.572 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.5 p -72.14 157.95 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -53.01 -27.44 19.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.884 0.374 . . . . 0.0 111.842 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 50.7 mtpt -75.43 -24.14 57.05 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.321 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.441 ' HB3' HD12 ' A' ' 60' ' ' ILE . 8.9 m -119.05 18.46 13.14 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.9 129.54 40.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.763 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.52 -22.33 37.99 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.664 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 60.3 mttp -74.82 133.03 41.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.643 0.259 . . . . 0.0 111.021 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t -70.9 121.01 82.76 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 12.0 Cg_endo -58.35 -34.33 98.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.976 2.451 . . . . 0.0 113.142 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.668 HD13 ' HE1' ' A' ' 10' ' ' MET . 13.0 mm -69.89 -46.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.212 -175.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.5 p -122.66 -7.57 8.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 60.87 78.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.341 0.591 . . . . 0.0 110.367 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -160.54 143.95 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.398 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 25.5 m-85 -94.63 26.9 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.668 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG22 ' H ' ' A' ' 38' ' ' ARG . 4.4 p -75.96 168.84 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.602 ' NH1' ' HB3' ' A' ' 38' ' ' ARG . 3.2 mtp-105 -50.49 129.23 25.72 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.7 Cg_exo -73.28 158.57 48.43 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.19 2.593 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.512 ' HG3' ' HE3' ' A' ' 74' ' ' TRP . 11.9 tmtt? -142.94 -49.77 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.273 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HD3' ' OD2' ' A' ' 82' ' ' ASP . 67.9 ttt180 -122.31 130.54 53.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.683 0.278 . . . . 0.0 111.071 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.71 136.6 54.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.17 0.509 . . . . 0.0 110.648 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.2 t -75.44 134.68 28.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.984 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -124.46 130.19 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.5 m -92.29 155.68 3.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.047 0.451 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.5 p -66.3 151.34 47.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.222 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -53.06 -39.62 63.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.355 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.624 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 5.1 m120 -55.87 -44.71 78.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.256 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 33.6 m -66.95 -25.06 66.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 t -87.24 -51.01 6.21 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.628 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.306 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 11.5 mmpt? . . . . . 0 CA--C 1.519 -0.238 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 84.6 m-20 -84.35 154.46 22.86 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.733 0.777 . . . . 0.0 111.398 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.0 t -53.2 136.27 36.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.106 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.516 HD11 ' CB ' ' A' ' 70' ' ' ALA . 11.1 pt -77.76 -32.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.768 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 26' ' ' CYS . 46.8 mt -73.26 -48.58 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -108.2 11.8 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.306 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 7.3 p-10 53.79 -37.11 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -93.12 -46.75 7.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 119.665 1.121 . . . . 0.0 113.888 -171.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.742 ' H ' HD12 ' A' ' 63' ' ' LEU . 4.3 m120 -67.73 135.56 52.9 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 11.7 p -59.44 134.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 111.55 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.5 144.66 19.9 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.274 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.01 -42.57 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -113.43 139.21 49.1 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.966 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -64.36 138.16 58.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.215 0.531 . . . . 0.0 111.104 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.614 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -83.33 154.01 24.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.072 176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 11.6 m-85 -131.76 135.13 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.88 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 46.3 m-85 -68.63 127.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 4.9 p -70.87 156.75 39.2 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.569 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.512 ' HE3' ' HG3' ' A' ' 40' ' ' LYS . 9.5 t-105 -41.17 -60.27 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.007 0.817 . . . . 0.0 112.804 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.16 -35.85 78.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.209 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 23.5 m -62.81 -35.94 81.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 111.245 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.3 m -70.99 -37.95 72.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.211 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -49.21 76.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.39 175.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.16 -32.62 71.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.771 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . 79.9 43.92 9.55 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.504 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -95.32 -31.07 13.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.187 0.518 . . . . 0.0 110.068 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.435 ' OD2' ' HD3' ' A' ' 41' ' ' ARG . 43.7 p-10 -65.94 -30.93 71.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.429 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.488 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -64.38 -19.12 65.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.582 -176.072 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.721 ' HB3' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -64.62 -42.58 95.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.389 -177.609 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.04 -136.29 6.28 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.876 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 36.8 t -60.38 113.36 7.31 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.362 1.065 . . . . 0.0 112.159 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 69.4 Cg_endo -86.51 43.9 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.033 2.489 . . . . 0.0 113.827 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.643 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 45.9 mtt180 -98.67 127.88 44.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.94 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.32 -0.682 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.016 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.86 ' SD ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.0 t -45.72 -53.84 8.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 111.522 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.515 ' HB2' ' HG3' ' A' ' 10' ' ' MET . 2.6 tp 41.99 41.05 1.8 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 170.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 64.0 mttm -79.65 -134.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.93 116.65 53.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD3' ' HA2' ' A' ' 85' ' ' GLY . 52.0 Cg_exo -56.14 135.72 71.4 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.217 -175.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.16 -136.14 8.05 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.393 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.67 -24.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -80.86 137.44 36.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -78.25 137.91 38.35 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.988 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.75 133.22 13.25 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.491 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 64.2 mt -95.29 147.36 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 111.913 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.645 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 79.4 mt -117.12 132.28 56.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.376 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.593 ' HA ' HG23 ' A' ' 67' ' ' VAL . 6.9 p -71.9 158.24 36.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HG3' HG21 ' A' ' 67' ' ' VAL . 39.8 mt-10 -55.75 -28.01 53.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.0 111.561 -176.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 55.0 mttp -71.81 -24.44 61.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.413 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.478 ' HB3' HD12 ' A' ' 60' ' ' ILE . 5.6 m -119.66 18.33 12.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 32.7 t70 -67.51 131.49 45.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.554 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.49 -27.54 6.31 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.83 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 61.9 mttp -66.75 132.02 47.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.584 0.231 . . . . 0.0 111.027 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 t -71.17 118.01 61.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 68.0 Cg_exo -56.41 -39.85 88.51 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.157 2.571 . . . . 0.0 113.383 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.586 HG21 ' HD3' ' A' ' 81' ' ' LYS . 6.8 mm -61.54 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.209 -174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -119.47 -16.51 8.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 66.94 77.97 0.26 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.59 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -171.34 145.86 2.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.996 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -97.45 31.23 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.79 70.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 122.31 1.053 . . . . 0.0 111.83 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.428 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 4.8 mmp_? 60.14 111.63 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.776 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.36 144.03 66.22 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.719 2.279 . . . . 0.0 112.132 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -128.68 -48.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -139.81 144.9 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.439 -0.163 . . . . 0.0 111.202 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 92.9 mttt -63.94 138.31 58.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.316 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.805 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.0 t -73.53 131.84 34.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.687 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.0 OUTLIER -113.18 124.69 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.61 150.92 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.404 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.633 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 11.7 p -62.0 150.14 38.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -51.78 -34.83 41.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.103 -177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.7 m120 -58.24 -45.51 87.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.574 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 99.3 m -74.99 -15.01 60.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -85.49 -45.62 11.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.263 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.645 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.824 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.804 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.4 m-80 -78.26 158.82 28.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.3 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.5 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.397 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.615 HG22 ' NE ' ' A' ' 88' ' ' ARG . 7.7 pt -70.62 -38.09 72.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.976 -173.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 26' ' ' CYS . 43.4 mt -69.95 -54.85 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -90.36 -6.47 54.99 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.793 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 48.99 24.29 0.85 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.932 0.893 . . . . 0.0 112.393 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.91 -59.83 0.74 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.319 -170.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -76.14 140.53 41.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.804 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 42.9 t -58.56 137.76 20.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 111.107 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.88 149.17 45.87 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.049 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 23' ' ' CYS . 47.3 t -122.4 -62.19 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.757 0.313 . . . . 0.0 111.28 -177.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.44 143.19 45.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.28 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -60.48 136.78 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -82.71 156.06 23.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.325 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -128.8 133.68 48.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.14 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.805 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.3 m-85 -67.27 130.85 44.4 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.416 ' SG ' ' CG ' ' A' ' 75' ' ' GLU . 11.2 p -73.48 167.97 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -55.69 -49.17 73.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' CG ' ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt-20 -63.26 -39.58 95.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 69.4 m -66.25 -40.03 89.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.899 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 21.3 t -68.07 -36.99 80.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.25 0.548 . . . . 0.0 109.89 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -60.61 -44.24 96.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.05 -31.49 69.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.874 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.76 8.44 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.01 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HD3' HG21 ' A' ' 32' ' ' ILE . 43.1 mttm -87.84 7.51 30.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.708 0.766 . . . . 0.0 110.294 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -92.8 -10.94 35.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.847 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.67 -26.25 7.52 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.081 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -64.98 -54.83 24.34 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.951 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.449 ' HA2' ' HD3' ' A' ' 15' ' ' PRO . . . -158.56 -158.55 9.09 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.999 -1.572 . . . . 0.0 115.152 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 1.6 t -95.17 120.04 64.75 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.792 -1.204 . . . . 0.0 111.47 -173.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.86 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 71.6 Cg_endo -75.5 47.02 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.922 3.081 . . . . 0.0 114.166 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.615 ' NE ' HG22 ' A' ' 59' ' ' ILE . 17.9 mmt180 -101.95 126.67 48.92 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 10' ' ' MET . 2.8 mm . . . . . 0 C--N 1.315 -0.918 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.508 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.592 ' SD ' ' HD2' ' A' ' 83' ' ' LYS . 7.1 ptp . . . . . 0 C--O 1.233 0.205 0 CA-C-O 121.37 0.605 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -42.57 -56.53 3.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.559 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 86.8 mt 52.39 41.0 30.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.508 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 84.4 mttt -77.1 -176.96 4.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 167.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.09 116.11 40.99 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.722 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 28.6 Cg_endo -72.15 142.85 38.76 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.386 2.057 . . . . 0.0 112.765 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.57 -157.43 28.7 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.007 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.85 -23.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.11 0.481 . . . . 0.0 110.893 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -63.65 128.49 36.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.034 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.576 HG21 ' HD3' ' A' ' 42' ' ' LYS . 20.2 m -82.58 136.33 34.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.601 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.546 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -66.51 126.16 27.26 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.923 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 63.8 mt -80.96 141.85 34.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 112.14 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 70.2 mt -118.4 143.91 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.186 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 11.5 p -80.14 157.55 26.58 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.4 -26.55 42.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.07 0.462 . . . . 0.0 111.386 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.1 mmtt -71.52 -27.3 63.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.2 m -108.84 26.22 10.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.06 127.46 31.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.4 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.61 32.84 61.32 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.421 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE2' ' HE1' ' A' ' 36' ' ' TYR . 94.4 mttt -111.83 140.22 46.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.675 0.274 . . . . 0.0 110.902 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 10.7 t -82.36 114.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.942 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HG3' HG21 ' A' ' 43' ' ' VAL . 12.0 Cg_endo -58.83 -29.43 89.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.978 2.452 . . . . 0.0 112.957 -176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 81' ' ' LYS . 21.2 mm -65.23 -40.94 90.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.09 -12.28 6.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 t0 62.2 74.38 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -163.25 141.36 7.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.106 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.502 ' HE1' ' HE2' ' A' ' 29' ' ' LYS . 13.2 m-85 -85.75 33.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 73' ' ' CYS . 5.1 p -78.78 158.02 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -41.51 128.85 2.31 Favored Pre-proline 0 N--CA 1.467 0.379 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 96.1 Cg_endo -82.53 154.3 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.32 2.68 . . . . 0.0 112.048 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 20.8 tptm -127.21 -40.62 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -150.45 139.68 21.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.306 -0.246 . . . . 0.0 111.166 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HD3' HG21 ' A' ' 19' ' ' THR . 71.2 mttt -59.96 139.33 57.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 111.714 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.786 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.9 t -71.34 133.37 31.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.114 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' NH1' ' HB2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -109.78 126.85 54.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.918 175.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.4 m -102.07 154.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.733 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -66.84 141.29 57.73 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.26 -22.61 53.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.7 -32.11 73.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.301 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.3 m -92.1 41.58 1.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.602 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -138.69 -41.98 0.49 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.556 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.732 176.627 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 21.8 mmtp . . . . . 0 CA--C 1.512 -0.505 0 CA-C-O 120.925 0.393 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.877 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.0 m-20 -68.89 140.92 55.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.467 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 10.4 t -48.54 131.53 17.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.016 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 ' HA3' ' A' ' 20' ' ' GLY . 24.1 pt -70.19 -32.88 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.429 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 mt -72.64 -44.32 60.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.3 p -107.12 -3.81 19.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.984 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 41.47 45.02 2.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.415 0.686 . . . . 0.0 112.621 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.9 -60.61 0.26 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.211 0.529 . . . . 0.0 110.654 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -82.32 138.54 34.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.488 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.877 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 46.8 t -61.32 137.27 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.59 -179.41 49.5 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.148 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -174.12 -39.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.597 0.713 . . . . 0.0 109.31 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 8.1 m120 -82.83 176.75 9.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.387 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -118.92 135.48 54.56 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB2' HD21 ' A' ' 22' ' ' LEU . . . -78.38 146.25 34.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -126.55 133.02 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.786 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 64.2 m-85 -69.33 120.8 15.71 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 7.0 p -70.03 162.1 28.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.468 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 4.9 t-105 -43.4 -55.95 3.84 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 124.206 0.941 . . . . 0.0 112.1 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.81 -46.77 88.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.92 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.1 m -66.53 -40.86 89.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.079 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 t -67.51 -40.51 85.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.617 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -62.97 -43.6 98.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.881 0.372 . . . . 0.0 110.505 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.71 -27.12 62.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.067 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.07 44.46 13.81 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.533 ' O ' HD12 ' A' ' 32' ' ' ILE . 29.3 mtpp -93.12 31.41 1.45 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.955 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.39 -1.32 8.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.592 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 94.0 mttt 58.73 30.48 20.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.393 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 23.0 t70 82.42 -36.34 0.09 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.621 174.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.722 ' HA2' ' HG3' ' A' ' 15' ' ' PRO . . . -165.48 -134.15 1.62 Allowed Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 118.448 -1.834 . . . . 0.0 115.468 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 13.3 t -50.63 103.09 0.35 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 113.772 -1.214 . . . . 0.0 113.03 -169.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 57.7 Cg_endo -91.28 44.61 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.563 2.842 . . . . 0.0 113.113 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.1 ptm180 -110.94 136.7 49.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.315 -175.418 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.664 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 121.395 0.617 . . . . 0.0 111.402 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 30.9 t -50.53 -54.22 24.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.222 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.664 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 81.1 mt 48.34 40.79 15.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 50.9 mttm -79.97 -156.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -83.16 111.17 28.58 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 59.6 Cg_endo -80.98 138.33 11.43 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.006 1.804 . . . . 0.0 112.417 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.91 -139.42 9.65 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.047 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -89.46 -16.9 8.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 110.284 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.729 ' HB2' HG12 ' A' ' 45' ' ' VAL . 3.7 mm100 -56.93 132.88 54.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.149 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.402 HG21 ' HD3' ' A' ' 42' ' ' LYS . 12.7 m -107.61 127.3 53.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.212 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.744 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -71.7 114.67 5.21 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.256 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.1 mt -87.07 154.03 21.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.688 0.28 . . . . 0.0 110.587 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 76.8 mt -113.74 130.21 56.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p -75.2 157.03 35.18 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 51.2 mt-10 -54.9 -28.39 50.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.964 0.412 . . . . 0.0 111.69 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.7 mtpt -72.43 -27.97 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.165 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.8 31.79 6.49 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.9 t0 -73.76 133.91 43.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.343 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.85 32.29 66.68 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.035 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 22.9 mtpp -119.46 122.04 40.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 25.3 t -63.29 118.66 45.72 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.48 -37.3 97.71 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.762 HG21 ' HG3' ' A' ' 81' ' ' LYS . 10.8 mm -64.08 -46.48 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.36 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 22.5 p -123.78 -8.47 7.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.3 t0 60.91 76.47 0.37 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.812 0.815 . . . . 0.0 110.428 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -151.36 143.25 23.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.477 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 29' ' ' LYS . 5.9 m-85 -96.5 23.98 6.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 110.299 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 73' ' ' CYS . 9.9 p -76.35 161.8 4.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.201 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.599 ' HD2' ' HD2' ' A' ' 39' ' ' PRO . 23.2 tpt180 -47.25 120.24 6.71 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.443 0.697 . . . . 0.0 112.559 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 86.2 Cg_endo -82.56 161.14 16.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.415 2.743 . . . . 0.0 111.815 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HG3' ' CE3' ' A' ' 74' ' ' TRP . 3.3 mmmp? -130.32 -59.25 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -116.41 136.94 52.56 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.839 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HD3' HG21 ' A' ' 19' ' ' THR . 38.9 ttmt -67.73 136.74 54.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.742 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 17.9 m -79.98 151.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.917 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -124.45 127.55 47.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.159 173.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.729 HG12 ' HB2' ' A' ' 18' ' ' GLN . 0.3 OUTLIER -92.54 153.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.608 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 p -72.83 148.32 44.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 86.5 tt0 -56.56 -27.44 57.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.035 0.445 . . . . 0.0 111.068 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.56 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 7.5 m-80 -63.84 -26.69 68.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.112 177.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HB3' ' NE ' ' A' ' 88' ' ' ARG . 87.6 m -102.68 33.1 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.22 -0.3 . . . . 0.0 111.679 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.488 ' OG ' ' HG3' ' A' ' 18' ' ' GLN . 12.0 p -160.9 -50.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.573 -173.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 124.137 0.975 . . . . 0.0 111.847 -175.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.207 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.23 141.17 39.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.376 1.084 . . . . 0.0 113.353 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.0 t -69.93 135.12 49.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.442 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.744 HD13 ' HA3' ' A' ' 20' ' ' GLY . 3.7 pt -71.92 -31.87 42.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -70.28 -51.41 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 21.7 p -91.38 -7.4 50.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.685 176.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 6.7 p-10 47.25 40.2 9.9 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 124.436 1.085 . . . . 0.0 111.57 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -157.41 -60.63 0.09 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.525 -177.071 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.581 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 5.7 m120 -60.21 144.58 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 34.5 t -61.56 119.37 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 111.075 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.22 142.78 26.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.464 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 -45.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -108.2 127.86 54.2 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.87 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.56 136.83 56.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.82 0.448 . . . . 0.0 110.961 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -76.93 146.28 37.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.774 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 6.9 m-85 -127.52 134.55 49.77 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.182 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.487 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 95.2 m-85 -62.98 124.92 22.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.7 p -69.14 161.17 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.856 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.499 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -46.84 -50.29 18.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.067 -177.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.28 -45.65 87.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.697 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 92.3 m -64.82 -33.25 75.54 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.307 -0.246 . . . . 0.0 111.013 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 32.0 t -67.59 -40.6 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.74 -44.64 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.895 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.14 -32.59 72.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.731 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . 89.51 46.93 4.18 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.762 ' HG3' HG21 ' A' ' 32' ' ' ILE . 27.4 mmmt -73.57 -14.96 61.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 110.742 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -64.53 -32.13 73.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -73.21 -21.63 60.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.837 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.437 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.3 m-20 -58.1 -55.4 35.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.58 -137.01 7.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.866 -1.159 . . . . 0.0 114.132 171.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.628 ' SG ' HG22 ' A' ' 45' ' ' VAL . 50.2 t -64.29 113.28 9.88 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.979 0.912 . . . . 0.0 111.835 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.636 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 83.0 Cg_endo -82.58 31.55 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.956 2.437 . . . . 0.0 114.381 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.483 ' NE ' ' HB3' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.22 139.58 38.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 C--N 1.327 -0.409 0 O-C-N 123.16 0.288 . . . . 0.0 110.763 -179.559 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.711 ' CG ' HD13 ' A' ' 12' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 1.6 t -37.76 -59.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.673 -172.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD13 ' CG ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 45.77 43.47 9.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.42 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 67.8 mttm -91.74 -147.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.649 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -95.64 111.29 55.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.025 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 71.7 Cg_exo -54.67 134.79 64.28 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.233 2.622 . . . . 0.0 113.296 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.45 -142.12 12.56 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.863 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -96.94 -35.93 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' ' CB ' ' A' ' 50' ' ' SER . 75.4 mt-30 -76.35 138.51 40.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.472 0.653 . . . . 0.0 112.111 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.492 HG21 ' HD3' ' A' ' 42' ' ' LYS . 30.1 m -84.44 131.17 34.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.536 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.36 137.52 35.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 86.2 mt -106.31 161.69 14.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.376 . . . . 0.0 111.658 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.714 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 81.7 mt -123.24 131.2 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 11.5 p -73.36 161.01 30.95 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HG3' HG21 ' A' ' 67' ' ' VAL . 70.6 mt-10 -62.07 -18.16 59.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.203 0.525 . . . . 0.0 111.347 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 56.4 mttm -78.24 -36.68 46.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.609 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 3.9 m -106.42 32.48 4.45 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.584 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 44.2 t0 -70.93 129.66 39.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.596 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.71 28.28 61.42 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.104 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 26' ' ' CYS . 40.0 mtmt -115.91 126.64 54.17 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.658 -0.319 . . . . 0.0 110.375 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.27 117.89 34.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 78.4 Cg_exo -55.61 -37.67 94.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.987 2.458 . . . . 0.0 113.136 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.603 HG21 ' HB3' ' A' ' 81' ' ' LYS . 7.3 mm -63.21 -49.48 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.1 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.9 p -116.27 -8.44 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.6 t0 63.28 68.65 0.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.056 0.455 . . . . 0.0 109.962 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -153.42 142.98 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.459 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -87.45 2.44 50.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.318 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -60.67 152.53 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.659 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -31.08 131.86 0.25 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.434 1.094 . . . . 0.0 113.463 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 88.0 Cg_endo -76.81 -160.84 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.509 . . . . 0.0 112.431 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.566 ' HG2' ' SG ' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -169.75 -50.46 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.261 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -157.35 144.24 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.718 -174.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HD3' HG21 ' A' ' 19' ' ' THR . 94.0 mttt -61.59 141.73 57.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.039 0.447 . . . . 0.0 111.5 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.938 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 25.6 m -77.82 137.78 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.281 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -106.52 119.87 40.44 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.52 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.528 HG22 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -80.67 146.39 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.525 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 7.1 p -68.38 160.45 29.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.001 -177.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' CYS . 36.9 tt0 -60.47 -29.63 69.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.056 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.551 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 9.0 m120 -77.68 35.94 0.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.201 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.748 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 58.0 m -157.02 -38.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.339 174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' A' ' 18' ' ' GLN . 76.3 p -92.31 34.41 1.04 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.933 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.453 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -73.0 148.68 43.96 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.572 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.7 t -59.47 116.81 4.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' A' ' 43' ' ' VAL . 2.0 pt -57.59 -30.44 36.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.046 -172.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.35 -44.1 63.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.7 p -101.04 -12.97 18.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.346 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 56.38 17.72 3.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.45 1.1 . . . . 0.0 111.723 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 -61.42 0.85 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 -172.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -71.79 142.25 49.68 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.56 133.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -73.62 139.22 26.14 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.714 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.719 HG21 ' HG3' ' A' ' 24' ' ' GLU . 45.3 t -109.94 -57.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.258 0.552 . . . . 0.0 111.07 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.14 136.81 43.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.303 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.439 ' HA ' HD23 ' A' ' 21' ' ' LEU . 2.1 m-20 -64.08 128.87 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.714 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -74.26 144.27 44.69 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.973 0.416 . . . . 0.0 111.753 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -115.87 135.33 54.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.371 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.753 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 86.9 m-85 -64.98 132.62 49.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.5 p -74.65 154.83 38.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.536 ' HA ' ' SG ' ' A' ' 77' ' ' CYS . 56.5 t90 -53.2 -41.41 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.442 0.464 . . . . 0.0 111.659 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 50.0 mt-10 -59.62 -42.99 93.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.976 0.417 . . . . 0.0 110.542 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 59.4 m -67.67 -39.76 84.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.566 ' SG ' ' HG2' ' A' ' 40' ' ' LYS . 21.5 p -72.63 -34.2 67.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -63.38 -45.17 92.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 83.7 mt -73.93 -39.46 63.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.606 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.47 28.54 3.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.749 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.637 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 4.5 mttp -82.98 -25.24 32.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.138 0.494 . . . . 0.0 110.431 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.35 -32.33 73.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.272 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -94.84 8.39 42.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.212 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.637 ' OD2' ' HA ' ' A' ' 81' ' ' LYS . 2.6 m-20 -71.06 -48.15 54.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.99 -143.7 9.71 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.916 173.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 52.6 t -68.93 123.65 88.55 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 123.842 0.857 . . . . 0.0 111.42 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.938 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 69.3 Cg_endo -89.28 25.26 0.61 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.656 2.238 . . . . 0.0 114.945 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.748 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 50.4 mtt180 -80.18 141.4 35.71 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.006 -0.433 . . . . 0.0 111.231 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.8 mm . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.066 173.914 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . 1.004 ' HG3' HD13 ' A' ' 12' ' ' LEU . 2.2 ptm . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 120.788 0.327 . . . . 0.0 111.547 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 9.1 t -54.14 -53.91 46.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.179 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.004 HD13 ' HG3' ' A' ' 10' ' ' MET . 0.9 OUTLIER 40.23 49.41 2.46 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 174.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 59.7 mttm -91.63 -149.56 0.24 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 170.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -100.3 122.57 49.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.336 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 70.1 Cg_exo -53.93 132.89 52.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.244 2.629 . . . . 0.0 112.535 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.87 -63.6 1.81 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.337 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.53 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HG3' ' CG2' ' A' ' 45' ' ' VAL . 14.8 pt20 -71.25 145.65 49.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.778 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.657 HG21 ' HD3' ' A' ' 42' ' ' LYS . 28.4 m -78.97 139.07 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.778 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.65 129.4 13.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.356 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 95.0 mt -100.14 142.78 31.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.274 0.559 . . . . 0.0 111.717 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -107.5 134.98 49.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.012 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 4.2 p -72.47 150.99 42.8 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 69.4 mt-10 -50.22 -30.63 11.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.17 0.51 . . . . 0.0 111.63 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.4 mttm -69.82 -22.39 63.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.485 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.1 m -116.07 0.91 13.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.159 0.504 . . . . 0.0 109.735 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 31.9 t0 -56.16 136.45 52.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.816 -172.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.18 -28.59 10.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.91 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 36.2 mtmt -74.18 128.11 34.7 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.126 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 1.8 t -66.42 115.54 25.04 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -55.45 -28.96 66.61 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 123.074 2.516 . . . . 0.0 113.159 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.48 HD11 ' HE1' ' A' ' 72' ' ' TYR . 7.2 mm -64.46 -42.29 94.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.881 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 35' ' ' SER . 31.5 p -128.72 -11.84 4.89 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -170.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 65.59 58.28 0.82 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.61 . . . . 0.0 110.645 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.503 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 41.8 t -153.96 141.37 19.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.585 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 3.4 m-85 -91.31 34.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 37' ' ' VAL . 7.4 p -81.7 76.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.178 0.989 . . . . 0.0 111.547 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.445 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 63.5 mtp85 59.73 91.43 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.62 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 39.9 Cg_endo -62.42 145.24 95.72 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.365 2.043 . . . . 0.0 111.366 174.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -132.56 -51.1 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.46 140.82 48.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.744 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.657 ' HD3' HG21 ' A' ' 19' ' ' THR . 72.2 mttt -66.36 136.1 55.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.941 HG11 ' HG3' ' A' ' 87' ' ' PRO . 58.2 t -85.86 133.04 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.851 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -109.29 128.02 54.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' CG2' ' HG3' ' A' ' 18' ' ' GLN . 25.0 m -77.13 155.4 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.334 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.781 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 2.1 p -66.49 164.06 17.23 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.426 0.632 . . . . 0.0 111.744 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HG2' ' CE2' ' A' ' 51' ' ' PHE . 67.8 tt0 -55.05 -50.8 68.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.102 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 2.5 m-80 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.487 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.624 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 96.0 m -70.84 -24.12 62.47 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -78.68 -38.76 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.142 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.541 ' CE2' ' HG2' ' A' ' 47' ' ' GLU . 1.7 p90 . . . . . 0 C--N 1.33 -0.283 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 22.4 m-20 -61.22 136.84 58.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.28 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 29.8 t -55.16 125.9 22.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.126 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.878 HD12 ' HG2' ' A' ' 87' ' ' PRO . 3.5 pt -66.88 -34.39 69.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.672 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -71.63 -37.59 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.78 ' O ' HD12 ' A' ' 63' ' ' LEU . 27.3 p -113.45 -0.35 14.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.421 -0.799 . . . . 0.0 110.482 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 36.56 59.58 0.98 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.432 1.493 . . . . 0.0 114.829 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.006 HD13 ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.88 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.056 171.376 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 1.006 ' H ' HD13 ' A' ' 63' ' ' LEU . 72.2 m-80 -61.19 142.55 56.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.9 t -75.52 132.45 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.15 148.36 31.29 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.158 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.45 -41.85 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -113.25 131.91 55.73 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 110.956 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.22 138.18 56.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.415 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB2' HD11 ' A' ' 59' ' ' ILE . . . -71.19 144.57 50.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.708 175.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.89 133.05 52.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.697 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.48 ' HE1' HD11 ' A' ' 32' ' ' ILE . 97.6 m-85 -65.45 126.72 29.16 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 3.9 p -74.65 165.21 25.6 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.272 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -47.95 -59.56 3.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.537 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 54.2 mt-10 -58.17 -43.1 87.28 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.216 -171.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.14 -32.51 73.99 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.055 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.7 m -68.7 -36.98 79.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.81 -45.1 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.218 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 94.2 mt -63.0 -33.79 76.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.784 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.08 31.24 9.3 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.041 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.56 26.95 3.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.286 0.565 . . . . 0.0 109.971 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -78.43 -15.96 58.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.695 173.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -4.32 38.85 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.325 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.719 ' HB3' HD11 ' A' ' 12' ' ' LEU . 83.5 m-20 -81.95 77.35 8.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.91 -86.4 0.02 OUTLIER Glycine 0 C--O 1.227 -0.282 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.374 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.781 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 10.8 t -78.37 108.67 8.25 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.715 0.293 . . . . 0.0 110.571 -174.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.941 ' HG3' HG11 ' A' ' 43' ' ' VAL . 43.0 Cg_endo -93.5 36.74 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.523 2.149 . . . . 0.0 113.785 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.624 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 33.3 mtt180 -75.63 114.51 14.3 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.083 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 -178.179 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.722 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 8.1 ptm . . . . . 0 N--CA 1.442 -0.842 0 CA-C-O 120.801 0.334 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 t -48.35 -59.82 3.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.912 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.722 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 81.5 mt 48.58 35.65 6.41 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -81.73 -171.34 3.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.0 tm0? -72.07 117.39 57.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -83.45 138.87 8.79 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.05 2.5 . . . . 0.0 112.773 -178.41 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.3 -138.79 9.02 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.477 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -95.53 -14.54 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.541 0.686 . . . . 0.0 109.749 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.601 ' HB2' HG12 ' A' ' 45' ' ' VAL . 6.2 mm100 -59.49 136.98 58.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.137 -178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -105.42 136.66 44.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.423 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.682 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -77.77 133.69 13.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.714 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 85.7 mt -90.58 145.76 24.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 53.7 mt -109.09 134.92 51.06 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.097 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.5 p -71.61 151.98 43.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HG2' HG11 ' A' ' 67' ' ' VAL . 37.8 mt-10 -48.73 -32.91 9.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 111.789 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -71.81 -27.65 63.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -102.75 1.38 34.24 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.953 -0.467 . . . . 0.0 110.162 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -59.46 112.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.71 -26.8 7.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.851 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -73.45 130.59 40.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.765 0.317 . . . . 0.0 111.329 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.22 122.14 86.72 Favored Pre-proline 0 C--N 1.319 -0.717 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 168.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HG3' HG11 ' A' ' 43' ' ' VAL . 6.1 Cg_endo -53.15 -35.5 73.39 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.663 2.909 . . . . 0.0 113.872 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 14.1 mm -69.5 -44.17 80.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.2 p -112.08 -20.88 11.78 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 68.49 72.82 0.29 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.554 0.693 . . . . 0.0 110.337 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -163.31 145.81 10.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.756 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -82.16 40.18 0.62 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.174 0.511 . . . . 0.0 110.318 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.532 HG13 ' CB ' ' A' ' 73' ' ' CYS . 8.4 p -87.02 153.44 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.078 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -39.79 110.56 0.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -171.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 91.0 Cg_endo -79.6 151.61 22.4 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.286 2.658 . . . . 0.0 111.85 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -140.97 -58.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.694 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -90.15 131.28 36.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.266 -0.174 . . . . 0.0 111.192 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -70.65 136.29 48.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.766 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 32.8 m -71.03 139.73 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.449 0.642 . . . . 0.0 111.728 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -112.74 114.84 27.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.76 175.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -83.94 148.88 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.788 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 3.5 p -68.96 145.89 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -56.45 -27.99 58.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.292 0.567 . . . . 0.0 110.349 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.788 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 52.9 m-80 -60.37 -32.34 71.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.655 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.481 ' HB2' HG22 ' A' ' 45' ' ' VAL . 99.1 m -94.54 36.44 1.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.626 0.25 . . . . 0.0 111.117 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.8 t -139.86 -52.25 0.51 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 . . . . . 0 C--O 1.235 0.324 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.624 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.102 0 CA-C-O 120.546 0.212 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 1.003 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 76.0 m-20 -61.15 152.88 27.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.888 0.851 . . . . 0.0 111.59 -176.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -59.42 131.07 49.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.307 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.682 HD13 ' HA3' ' A' ' 20' ' ' GLY . 11.9 pt -73.62 -32.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.975 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.01 -48.66 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 63' ' ' LEU . 29.5 p -102.13 -9.3 20.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.85 -28.25 0.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.581 0.752 . . . . 0.0 112.56 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -75.74 -60.14 2.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.678 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -91.91 150.77 20.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.179 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.003 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 16.7 t -63.37 136.14 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.386 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 23' ' ' CYS . . . -82.19 -167.21 39.45 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.463 HG11 ' HG2' ' A' ' 24' ' ' GLU . 7.4 p -162.06 -50.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.822 0.344 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.449 ' N ' HG13 ' A' ' 67' ' ' VAL . 79.2 m-20 -105.26 138.75 40.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.928 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.53 134.76 51.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -77.72 153.97 32.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.151 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.94 135.66 45.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.982 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.71 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 43.9 m-85 -71.62 133.58 45.8 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 6.1 p -70.76 158.24 36.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.494 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -55.13 -41.06 71.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.907 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' OE2' HG21 ' A' ' 37' ' ' VAL . 48.4 mt-10 -58.42 -51.75 68.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.666 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 97.0 m -65.54 -38.0 88.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.054 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' ' HE3' ' A' ' 74' ' ' TRP . 36.9 t -66.25 -41.41 90.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -67.77 -46.84 70.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' HE2' ' A' ' 81' ' ' LYS . 8.6 mp -64.14 -30.97 72.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.24 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 96.76 45.08 2.75 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.992 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HE2' HD23 ' A' ' 79' ' ' LEU . 67.6 mttm -103.2 -24.5 13.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.533 . . . . 0.0 110.072 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -69.59 -25.18 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 15.9 pttp -63.33 -27.98 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.294 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB3' HD13 ' A' ' 12' ' ' LEU . 76.6 m-20 -52.28 -48.12 65.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.033 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.06 -139.65 8.3 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.851 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.7 t -55.35 117.65 15.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.401 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.766 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 88.9 Cg_endo -82.23 22.02 0.91 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.932 2.421 . . . . 0.0 113.307 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.0 mmt180 -77.54 122.31 25.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.322 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 10' ' ' MET . 12.7 mm . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.782 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 11.3 ptp . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.307 0.575 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -54.71 -42.13 71.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.646 -173.206 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 93.0 mt 48.99 45.7 22.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 172.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.59 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 34.6 mttm -88.65 -155.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.035 172.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 52.1 mm-40 -77.75 114.6 42.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 110.856 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 8.9 Cg_exo -71.53 142.48 40.49 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.136 2.557 . . . . 0.0 112.741 -177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.73 -139.72 6.4 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.508 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -101.57 -25.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.335 . . . . 0.0 110.438 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -61.19 128.87 38.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.683 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -76.22 140.35 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.39 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -68.21 114.33 5.98 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.256 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 84.3 mt -77.5 149.49 34.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.707 HD21 ' HB2' ' A' ' 70' ' ' ALA . 64.7 mt -122.42 138.41 54.55 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.644 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.608 ' HA ' HG12 ' A' ' 67' ' ' VAL . 7.8 p -76.25 142.68 41.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HG3' HG11 ' A' ' 67' ' ' VAL . 48.6 mt-10 -47.62 -28.25 2.26 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 76.7 mttt -65.54 -39.33 91.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.05 -14.59 27.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 122.113 -0.367 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.91 120.4 5.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.278 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.19 -34.1 3.47 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.966 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HB2' HD13 ' A' ' 60' ' ' ILE . 20.8 mtpp -72.92 131.18 41.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.934 -0.133 . . . . 0.0 110.711 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 44.5 t -71.94 117.53 58.81 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 11.3 Cg_endo -58.69 -31.45 94.87 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.858 2.372 . . . . 0.0 112.74 -173.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.595 HD13 ' SD ' ' A' ' 10' ' ' MET . 1.6 mm -72.15 -43.13 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.322 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.6 -8.24 7.4 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.21 73.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.113 0.482 . . . . 0.0 110.797 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -165.94 139.73 4.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.3 33.56 0.81 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.029 0.442 . . . . 0.0 110.866 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.9 p -76.38 152.88 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.796 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.7 ptp180 -44.05 126.7 4.39 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.8 Cg_exo -77.54 -167.14 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.457 2.771 . . . . 0.0 111.698 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -170.98 -49.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.167 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -116.9 139.18 50.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -71.23 133.64 46.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.315 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.977 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 29.2 m -72.32 143.79 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.704 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -128.63 126.74 40.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -81.46 146.02 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.736 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.3 p -70.94 146.18 49.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 56.6 mt-10 -54.98 -37.25 66.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.432 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.638 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 4.5 m120 -51.38 -39.52 57.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.3 m -81.55 -36.36 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.583 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 28.8 p -72.87 -48.79 34.48 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.53 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.089 0.471 . . . . 0.0 110.432 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 8.9 mptt . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 60.9 m-20 -77.09 149.77 35.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.816 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.5 t -53.42 123.02 10.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.602 175.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.453 HD11 ' CB ' ' A' ' 70' ' ' ALA . 13.2 pt -62.44 -29.86 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 29' ' ' LYS . 47.1 mt -73.45 -44.9 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.4 p -100.31 -11.38 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.311 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 44.46 44.92 7.35 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.155 0.982 . . . . 0.0 110.941 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -152.67 -61.36 0.15 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.375 -172.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -73.06 140.14 47.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 6.0 p -66.64 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.108 0.48 . . . . 0.0 111.243 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.77 159.21 53.77 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.054 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 23' ' ' CYS . 2.0 p -157.55 -48.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.289 0.566 . . . . 0.0 110.226 -178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' H ' HG13 ' A' ' 67' ' ' VAL . 3.1 m120 -92.33 -176.25 4.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.357 174.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -124.49 142.89 50.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.57 0.224 . . . . 0.0 110.685 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.749 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -87.88 154.68 20.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.104 0.478 . . . . 0.0 111.13 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.408 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 20.0 m-85 -130.39 134.07 46.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.479 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.723 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.4 m-85 -68.92 122.74 19.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 5.9 p -70.25 149.81 47.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -55.6 -31.21 62.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.041 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 66.8 mm-40 -59.9 -44.91 93.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.867 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.535 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 38.0 m -68.64 -37.06 79.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.46 -40.79 96.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.054 177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.66 96.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.105 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.55 -35.08 72.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.694 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.6 38.46 6.59 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.491 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -93.72 -30.21 15.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.436 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.76 -29.88 71.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.126 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -63.32 -20.65 65.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.076 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.48 ' HB2' HD22 ' A' ' 12' ' ' LEU . 44.7 m-20 -67.19 -44.86 78.57 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.519 ' HA3' ' HG3' ' A' ' 15' ' ' PRO . . . 126.4 -119.9 3.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.562 -1.304 . . . . 0.0 114.664 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 19.3 t -43.14 105.5 0.43 Allowed Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 113.12 -171.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.977 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 75.1 Cg_endo -85.15 22.48 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.204 2.603 . . . . 0.0 112.674 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -73.16 124.0 24.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.1 mm . . . . . 0 C--N 1.32 -0.709 0 C-N-CA 122.533 0.333 . . . . 0.0 111.816 -176.734 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.828 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 121.326 0.584 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.3 t -42.08 -46.35 4.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.04 -1.437 . . . . 0.0 111.637 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 10' ' ' MET . 1.2 mp 42.76 52.23 5.04 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -95.53 -145.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 170.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -91.65 113.8 59.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.571 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 52.3 Cg_exo -57.63 129.11 32.02 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.878 2.385 . . . . 0.0 112.47 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.08 -131.34 6.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.607 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.57 -36.75 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 54.2 mt-30 -63.11 125.41 23.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.47 0.652 . . . . 0.0 111.556 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -74.8 130.92 40.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.717 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.434 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -68.06 129.64 26.7 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.017 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 65.7 mt -102.14 145.31 29.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.164 0.507 . . . . 0.0 112.009 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 74.5 mt -113.36 144.01 43.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.168 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 2.9 p -78.07 154.47 31.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 50.3 mt-10 -57.53 -26.7 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.901 0.381 . . . . 0.0 111.453 -176.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.6 mmtt -69.15 -24.12 64.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.81 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 m -115.72 25.21 10.93 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.599 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 33.4 t70 -72.49 131.36 42.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.22 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.29 62.68 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.807 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -111.76 131.64 55.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.3 119.16 73.26 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -57.26 -38.3 95.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.266 2.644 . . . . 0.0 113.359 -174.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.498 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 6.9 mm -64.44 -56.8 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 28.1 p -100.82 -19.78 15.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -169.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 33' ' ' CYS . 13.4 t70 68.59 85.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.225 0.536 . . . . 0.0 110.397 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -174.58 145.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.312 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.35 33.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.71 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.4 p -78.62 158.23 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.313 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.531 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 31.3 ttp180 -50.83 126.02 23.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.382 0.673 . . . . 0.0 112.543 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.6 Cg_exo -70.45 -166.62 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.605 2.87 . . . . 0.0 112.169 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 25.7 tptp -166.91 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -143.65 140.2 29.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.059 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 33.8 mtpt -62.03 136.26 57.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 111.117 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 11.5 t -75.85 131.94 34.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.94 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -121.19 128.73 52.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.723 0.296 . . . . 0.0 110.205 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.22 151.26 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.062 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.722 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 9.6 p -59.7 153.77 19.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -54.94 -37.03 65.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 6.8 m120 -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.341 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 m -71.39 -27.01 63.03 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.459 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 89.3 p -77.16 -39.44 49.1 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.942 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 4.0 p90 . . . . . 0 C--N 1.327 -0.392 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.7 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? . . . . . 0 CA--C 1.513 -0.456 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.872 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 6.9 p30 -62.18 142.7 57.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 40.9 t -46.71 111.08 0.34 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.816 -175.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.464 HD11 ' CB ' ' A' ' 70' ' ' ALA . 6.0 pt -60.43 -26.0 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.398 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.64 -42.96 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -117.43 5.76 12.55 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.137 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 5.4 p-10 38.64 43.49 0.69 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -148.76 -58.59 0.22 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.834 -173.298 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -86.76 17.75 3.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -167.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.872 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 2.6 t 59.67 137.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.113 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -82.36 162.23 41.76 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.548 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 68' ' ' ASN . 6.3 p -149.8 -44.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.259 -0.471 . . . . 0.0 110.367 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' N ' HG13 ' A' ' 67' ' ' VAL . 76.6 m-20 -106.03 131.39 53.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.01 133.36 56.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.955 0.407 . . . . 0.0 110.752 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -74.21 150.5 40.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 9.2 m-85 -128.62 131.93 48.12 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.477 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 98.4 m-85 -67.97 127.79 34.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.777 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 8.5 p -73.68 158.78 34.06 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.232 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.512 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.39 -46.2 62.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.138 -178.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.69 -44.51 93.62 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.611 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.797 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 58.6 m -64.72 -43.41 93.51 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.224 -0.297 . . . . 0.0 111.018 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 58.4 m -64.24 -34.59 78.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -58.33 -49.88 75.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.927 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.52 -47.0 24.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.521 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.67 34.55 0.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.556 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' CYS . 18.9 mmtp -76.13 -23.69 54.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.23 0.538 . . . . 0.0 110.531 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.23 -42.13 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.892 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -85.54 -15.24 43.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.597 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.504 ' OD2' HD21 ' A' ' 12' ' ' LEU . 25.2 t0 -56.47 -51.13 69.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.899 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.91 34.43 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.211 -1.471 . . . . 0.0 114.926 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.3 t -72.56 113.5 21.66 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 113.691 -1.254 . . . . 0.0 111.751 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 96.3 Cg_endo -81.98 43.87 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.228 2.619 . . . . 0.0 113.405 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' MET . 6.5 mmm180 -87.97 131.24 34.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.597 177.867 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.981 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 t -51.91 -54.0 34.45 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.478 -167.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.981 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 34.1 mt 44.86 37.86 2.58 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -82.42 170.71 14.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 50.7 tp60 -67.69 119.65 67.69 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 34.6 Cg_exo -62.29 145.47 96.01 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.754 2.303 . . . . 0.0 112.814 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.9 -66.46 1.62 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.977 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p 176.64 -32.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.792 0.329 . . . . 0.0 110.586 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -64.38 133.28 52.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.692 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -74.71 137.26 41.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -75.35 133.48 14.88 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.996 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 80.1 mt -100.12 143.34 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.674 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 63.7 mt -111.93 138.56 48.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 3.5 p -81.88 148.92 28.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 27' ' ' ASP . 46.6 mt-10 -54.39 -27.58 37.62 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.64 -29.98 70.62 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.656 0.265 . . . . 0.0 111.378 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 60' ' ' ILE . 34.6 m -105.37 -12.63 15.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.878 0.37 . . . . 0.0 110.206 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' CB ' ' HA ' ' A' ' 24' ' ' GLU . 11.7 t70 -59.89 115.75 3.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.075 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.02 -33.02 4.19 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 47.2 mttp -77.55 136.75 38.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.63 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.3 t -79.98 121.98 82.69 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' O ' HD11 ' A' ' 89' ' ' ILE . 10.3 Cg_endo -55.82 -41.26 79.21 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.228 2.619 . . . . 0.0 113.648 -174.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 5.8 mm -63.73 -49.09 83.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 p -111.47 -17.09 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 t0 63.04 74.89 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.543 0.687 . . . . 0.0 110.366 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -160.24 146.32 15.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.312 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -87.19 30.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.322 . . . . 0.0 111.159 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 73' ' ' CYS . 3.6 p -76.64 150.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.866 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -49.08 124.64 13.48 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 87.9 Cg_endo -79.62 149.35 21.0 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.526 2.817 . . . . 0.0 112.114 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -132.16 -62.37 0.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.4 mtp-105 -102.39 141.99 34.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -69.18 137.57 53.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.183 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.913 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -78.84 145.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.127 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -131.7 119.48 21.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.83 155.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.893 -173.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p -71.13 160.24 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.599 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -53.57 -39.74 65.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.194 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.01 -35.51 75.22 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.541 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 60.4 m -98.48 33.3 2.28 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.151 -0.343 . . . . 0.0 111.493 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.6 p -156.81 -28.06 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.9 p90 . . . . . 0 N--CA 1.465 0.304 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -170.681 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 51.7 mmtt . . . . . 0 CA--C 1.516 -0.327 0 CA-C-O 121.063 0.458 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 21.4 p30 -66.2 143.37 57.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.4 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -55.23 130.27 41.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.453 -177.299 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.562 HD13 ' HA3' ' A' ' 20' ' ' GLY . 9.9 pt -62.44 -26.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -171.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 26' ' ' CYS . 45.9 mt -80.0 -42.65 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.924 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -109.51 -11.38 14.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.645 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.416 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 54.03 28.52 8.86 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.513 . . . . 0.0 111.264 175.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.26 -64.27 0.61 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.375 -169.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -79.74 140.17 37.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.921 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 21.2 t -64.07 135.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 111.045 -176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.6 141.73 27.97 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.5 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.66 -42.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -115.19 141.58 47.83 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.585 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.87 136.38 57.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.736 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -79.05 160.09 27.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.065 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.546 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 12.8 m-85 -132.21 134.6 45.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.628 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.735 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 74.6 m-85 -68.65 127.81 34.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.4 p -68.22 163.38 22.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.952 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -51.81 -45.88 64.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.234 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 67.2 mm-40 -60.26 -48.25 82.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.544 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.601 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 66.5 m -65.56 -37.91 88.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.411 0.148 . . . . 0.0 111.243 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.18 -43.46 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 110.005 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -66.06 -42.83 88.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 91.6 mt -63.94 -34.48 78.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.47 30.21 14.4 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.857 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.75 -22.44 27.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -66.35 -42.43 88.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.713 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.3 -16.54 60.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.551 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' A' ' 12' ' ' LEU . 5.3 t70 -64.75 -50.35 67.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.82 -139.41 5.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 118.643 -1.742 . . . . 0.0 115.688 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 44.4 t -62.06 119.47 49.05 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 113.104 -1.548 . . . . 0.0 112.687 -170.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.913 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 64.4 Cg_endo -84.16 51.28 3.31 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.691 2.927 . . . . 0.0 113.068 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.541 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.0 mmt180 -99.58 127.27 45.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.54 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 31' ' ' PRO . 46.3 mm . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.458 0.647 . . . . 0.0 109.434 172.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.569 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.8 ptp . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 2.0 t -46.12 -47.02 17.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.603 -1.181 . . . . 0.0 112.812 -174.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.569 HD13 ' HG3' ' A' ' 10' ' ' MET . 1.3 mp 46.35 40.23 7.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 62.4 mttm -80.02 -162.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.819 0.342 . . . . 0.0 110.345 169.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.4 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 70.7 tp60 -85.99 110.58 31.7 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.367 173.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 36.9 Cg_endo -70.75 143.56 46.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.495 2.13 . . . . 0.0 113.018 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.68 -101.5 0.47 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.206 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.49 -31.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.485 ' HB2' HG22 ' A' ' 45' ' ' VAL . 62.9 mt-30 -57.9 132.41 53.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 111.477 -177.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.9 m -83.26 138.53 33.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.714 -176.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.29 133.79 13.35 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.809 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 94.3 mt -96.91 151.47 19.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 0.0 112.084 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.0 141.52 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.17 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.7 p -78.78 154.74 29.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.65 -32.21 50.6 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.262 0.351 . . . . 0.0 111.847 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.0 mmtp -63.65 -43.91 95.36 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.95 -15.93 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -53.59 108.99 0.4 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.471 0.653 . . . . 0.0 110.585 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.3 -35.12 1.69 Allowed Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.02 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -87.96 128.36 35.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.798 -0.201 . . . . 0.0 111.496 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.13 118.58 65.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.86 -39.41 68.3 Favored 'Trans proline' 0 N--CA 1.474 0.357 0 C-N-CA 123.051 2.501 . . . . 0.0 114.169 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mm -63.94 -40.79 90.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.06 -18.85 8.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t0 66.06 76.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.284 0.564 . . . . 0.0 110.013 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.9 t -162.43 147.06 12.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.874 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -90.45 22.72 3.28 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.033 0.444 . . . . 0.0 111.143 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.606 HG13 ' HB2' ' A' ' 73' ' ' CYS . 2.5 p -69.43 148.85 11.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.135 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -40.19 113.07 0.9 Allowed Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.6 Cg_endo -78.71 148.12 22.49 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.202 2.601 . . . . 0.0 112.011 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 74' ' ' TRP . 61.9 mttm -139.17 -53.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 99.5 mtt180 -101.05 138.21 38.39 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -64.8 132.42 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.497 . . . . 0.0 111.04 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.831 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 15.7 t -74.16 125.18 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.354 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.9 136.99 36.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.984 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.81 HG12 HH21 ' A' ' 88' ' ' ARG . 2.1 m -91.84 150.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.6 p -81.29 145.7 30.77 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 1.5 tp10 -58.11 -24.3 58.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -173.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.523 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 41.9 m-80 -66.08 -20.99 66.34 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.383 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.485 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 78.4 m -110.27 39.0 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.119 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB3' HG21 ' A' ' 45' ' ' VAL . 84.8 p -147.78 -49.43 0.17 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.618 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 120.691 0.282 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -68.6 149.75 48.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.372 0.606 . . . . 0.0 110.588 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 11.8 t -54.1 124.12 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.829 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.401 HD11 ' CB ' ' A' ' 70' ' ' ALA . 28.0 pt -69.33 -23.07 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.576 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -78.71 -49.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -95.28 -8.28 36.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.33 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.87 46.67 6.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.702 0.801 . . . . 0.0 111.663 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -61.56 0.13 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.236 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -70.06 141.75 52.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.723 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.8 132.72 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.207 0.317 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.53 176.93 54.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.702 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 68' ' ' ASN . 3.2 p -161.34 -52.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.425 ' N ' HG13 ' A' ' 67' ' ' VAL . 76.2 m-20 -97.4 122.7 40.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.677 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.16 134.08 56.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.993 0.425 . . . . 0.0 110.482 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' CB ' HD11 ' A' ' 59' ' ' ILE . . . -73.26 142.73 47.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.591 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.451 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 7.6 m-85 -124.79 130.09 51.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.271 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.831 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.6 m-85 -66.26 129.94 41.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.0 p -69.75 161.86 28.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.775 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.573 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 26.6 t90 -53.75 -39.82 65.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.603 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -60.99 -48.25 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.723 0.297 . . . . 0.0 110.946 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 84.2 m -67.97 -32.76 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.58 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.12 -44.02 97.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.583 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 -60.77 -46.65 89.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.76 -32.62 72.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.71 38.57 10.43 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.344 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 87.5 mttt -78.76 -9.14 59.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.681 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.07 -35.73 72.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.36 0.6 . . . . 0.0 109.597 173.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -81.74 -9.17 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.061 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 81' ' ' LYS . 23.5 t0 -70.1 -42.9 72.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.76 -175.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA3' ' HG ' ' A' ' 12' ' ' LEU . . . 172.09 178.52 42.39 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.626 -1.273 . . . . 0.0 114.029 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -72.42 110.68 8.62 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 111.326 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.582 ' HG2' HH12 ' A' ' 88' ' ' ARG . 56.6 Cg_endo -78.12 41.44 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.436 2.758 . . . . 0.0 115.279 -172.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.81 HH21 HG12 ' A' ' 45' ' ' VAL . 7.0 mmt-85 -79.98 134.41 36.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 121.217 0.532 . . . . 0.0 112.126 -175.005 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 79.54 -142.39 24.73 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.973 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m 53.56 43.1 31.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.348 0.594 . . . . 0.0 110.61 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -167.13 -121.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.312 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -88.52 51.75 2.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.409 0.623 . . . . 0.0 111.42 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -152.11 36.86 0.54 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.457 ' C ' ' H ' ' A' ' 7' ' ' ASP . 31.3 tt0 -80.26 -34.0 37.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.05 -171.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.533 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 20.2 t80 77.36 -23.21 0.25 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.176 -173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.457 ' H ' ' C ' ' A' ' 5' ' ' GLN . 1.5 m-20 61.5 39.82 14.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.66 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.681 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -73.94 51.99 0.42 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.151 178.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.689 ' HB ' ' HB3' ' A' ' 91' ' ' ASN . 1.7 mp -61.06 98.79 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.281 0.562 . . . . 0.0 109.813 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.501 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.5 ptp -114.24 156.68 23.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.276 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HA ' HD11 ' A' ' 90' ' ' LEU . 42.6 t -53.83 -49.74 67.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.031 -172.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.787 ' HG ' ' HB3' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 51.87 43.06 30.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 172.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 50.2 mttm -95.62 -155.38 0.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.584 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -87.34 111.91 44.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.063 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 32.9 Cg_exo -60.1 138.58 82.68 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.244 2.629 . . . . 0.0 112.926 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.91 -140.25 11.26 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.12 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.612 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 35.3 m -98.44 -29.11 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.64 0.257 . . . . 0.0 111.209 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 59.5 mt-30 -69.23 125.53 26.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.95 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -82.32 142.45 32.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.827 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.8 118.55 6.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.628 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 81.8 mt -92.18 143.75 26.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 112.071 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 70.7 mt -110.33 136.57 49.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.301 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.8 p -72.59 152.39 41.83 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 53.6 mt-10 -54.97 -25.44 29.72 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 0.0 111.558 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HE3' HG22 ' A' ' 107' ' ' VAL . 25.1 mtpp -72.16 -23.29 61.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.747 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 20.6 m -116.32 15.37 15.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 26.1 t70 -68.29 129.8 41.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -21.33 46.59 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.329 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 45.0 mttm -71.82 134.61 46.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.8 t -81.82 121.57 79.47 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HG2' HG11 ' A' ' 43' ' ' VAL . 72.7 Cg_exo -54.11 -34.15 76.95 Favored 'Trans proline' 0 CA--C 1.526 0.093 0 C-N-CA 122.441 2.094 . . . . 0.0 112.771 -175.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 3.8 mm -76.01 -32.72 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.431 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 20.1 p -137.98 -34.46 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t0 64.35 86.86 0.12 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 t -154.36 25.35 0.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.578 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 36.79 50.11 0.82 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.303 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 73' ' ' CYS . 7.9 p -118.19 162.81 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.346 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 ptp85 -42.43 128.5 2.89 Favored Pre-proline 0 N--CA 1.466 0.354 0 O-C-N 123.736 0.648 . . . . 0.0 112.63 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.547 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 2.8 Cg_exo -76.64 -154.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.421 2.747 . . . . 0.0 112.164 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -176.4 -49.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.32 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -150.12 136.08 18.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.494 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.71 134.55 56.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.957 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 16.2 m -74.03 134.42 29.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.612 ' NH2' ' HA ' ' A' ' 17' ' ' VAL . 27.8 mtp85 -108.15 122.15 46.32 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -81.9 143.84 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.166 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.1 p -61.35 149.08 39.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.928 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 89.8 mt-10 -54.55 -34.49 61.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.374 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m120 -53.94 -36.25 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.765 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 66.2 m -83.82 -32.29 25.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.319 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.418 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 4.5 m -67.18 -49.05 66.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.066 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.529 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 -95.36 28.52 2.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.65 38.91 2.02 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.957 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 69.48 -48.8 0.61 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.517 0.727 . . . . 0.0 112.664 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -78.26 70.33 4.6 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.215 0.531 . . . . 0.0 110.956 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -117.21 -54.59 2.39 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.351 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -81.97 -29.81 31.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.931 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 34.7 m-20 -63.92 144.94 56.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.431 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.5 t -47.38 131.73 13.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.719 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 11.0 pt -75.96 -29.53 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.102 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -77.72 -45.7 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.766 ' HA ' HD23 ' A' ' 92' ' ' LEU . 28.6 p -109.4 14.28 23.72 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 44.7 p30 22.26 58.24 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.25 -67.61 0.12 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 0.0 110.458 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -78.19 139.8 38.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.931 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 8.9 p -61.65 139.56 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 110.881 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -84.07 145.21 22.26 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.628 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.0 m -111.1 -41.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.6 135.29 54.3 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -62.12 134.49 56.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -75.47 147.2 40.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.589 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.547 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 9.4 m-85 -117.26 136.24 53.23 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.867 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 80.5 m-85 -67.81 128.59 37.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.58 ' HB2' HG13 ' A' ' 37' ' ' VAL . 1.8 p -72.25 149.08 44.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -51.08 -39.5 56.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.598 0.562 . . . . 0.0 111.7 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.27 -45.62 93.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.606 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 60.7 m -65.61 -36.65 84.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.502 0.191 . . . . 0.0 110.97 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 73.4 m -66.3 -41.81 89.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -62.84 -47.19 84.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.56 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.04 -33.79 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.38 40.21 5.15 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.364 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.02 -30.93 15.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -66.89 -27.59 67.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.852 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -69.03 -8.84 48.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.329 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.787 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 70.6 m-20 -69.08 -51.21 41.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.16 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.42 -137.27 5.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.235 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 26.9 t -54.41 115.87 9.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 124.054 0.942 . . . . 0.0 111.717 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.957 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 66.0 Cg_endo -88.39 26.82 0.56 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.95 2.433 . . . . 0.0 114.177 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.765 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 30.3 mtt-85 -73.45 121.65 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.955 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 mm -74.46 116.89 17.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.233 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.629 HD11 ' HA ' ' A' ' 11' ' ' CYS . 29.6 mt -99.86 -32.82 10.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.021 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.689 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 1.1 p-10 -56.58 -29.82 62.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.963 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.766 HD23 ' HA ' ' A' ' 61' ' ' CYS . 15.1 tp -75.66 96.47 3.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.837 -173.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.84 -40.47 4.64 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -153.22 178.96 9.18 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 99' ' ' ARG . 1.6 m-80 62.42 70.62 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.924 0.393 . . . . 0.0 110.879 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.75 ' HD2' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -48.2 -32.53 7.22 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.774 -176.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.75 ' N ' ' HD2' ' A' ' 96' ' ' ARG . 4.2 pp -162.67 139.66 7.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 55.11 -135.05 1.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.855 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.463 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 1.3 mpt_? -139.11 47.0 1.92 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -136.36 131.36 34.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.423 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.527 ' HA ' HH21 ' A' ' 96' ' ' ARG . 9.8 p90 -105.81 -37.11 6.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 167.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 49.97 68.32 0.77 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.112 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 52.55 49.16 21.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.138 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -145.0 40.13 1.24 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.313 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? 69.18 -60.98 0.44 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.748 0.819 . . . . 0.0 111.847 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? 178.77 -30.77 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.67 HG23 ' HG2' ' A' ' 96' ' ' ARG . 14.3 p . . . . . 0 C--N 1.31 -1.151 0 CA-C-N 113.353 -1.748 . . . . 0.0 108.462 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 156.8 51.2 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.083 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 m -72.19 70.54 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 m 71.27 -47.05 0.65 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.538 0.735 . . . . 0.0 112.284 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.575 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 7.4 tpm_? 63.22 50.56 2.97 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.724 0.774 . . . . 0.0 109.999 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -77.83 137.82 38.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.144 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -173.56 136.73 0.6 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.616 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -99.9 -15.78 18.23 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -73.51 61.24 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.925 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.496 ' HB3' HD12 ' A' ' 89' ' ' ILE . 10.5 mt -80.74 80.18 7.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.97 0.414 . . . . 0.0 110.744 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 1.6 mp -78.93 71.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.522 ' HE1' HD13 ' A' ' 32' ' ' ILE . 4.7 ptp -73.45 149.32 42.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.693 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.714 ' HB2' HD21 ' A' ' 90' ' ' LEU . 45.5 t -52.54 -49.89 63.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.308 -175.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 54.6 mt 50.32 32.22 6.05 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HE2' ' SG ' ' A' ' 11' ' ' CYS . 27.9 mtmt -82.39 166.12 19.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.153 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.3 112.89 5.5 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 123.77 0.668 . . . . 0.0 110.451 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 50.9 Cg_endo -76.65 141.01 21.62 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.095 2.53 . . . . 0.0 113.376 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 -144.08 11.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -89.1 -24.47 5.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.132 0.491 . . . . 0.0 110.667 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -57.4 124.48 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.42 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 m -84.97 137.9 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.117 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -69.01 130.33 24.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.713 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 68' ' ' ASN . 52.5 mt -88.84 142.88 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.338 0.59 . . . . 0.0 112.358 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.712 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 81.4 mt -113.13 137.62 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.963 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 6.5 p -75.94 154.88 35.59 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 27' ' ' ASP . 39.9 mt-10 -51.97 -33.27 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.405 0.44 . . . . 0.0 111.552 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -69.0 -27.96 66.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.775 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 49.4 m -104.48 41.42 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.962 0.411 . . . . 0.0 109.916 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 9.6 t70 -66.66 119.14 11.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.01 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.73 44.67 56.2 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.613 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD3' ' HB3' ' A' ' 26' ' ' CYS . 35.3 mtpt -120.15 139.74 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.538 -0.389 . . . . 0.0 110.992 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 37.1 t -78.67 122.75 85.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.634 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.724 ' HG2' HG21 ' A' ' 43' ' ' VAL . 36.7 Cg_exo -64.49 -36.45 43.6 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.104 2.536 . . . . 0.0 113.323 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.62 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.8 mm -64.43 -41.58 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.992 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.15 -12.5 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 63.91 81.55 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.308 0.575 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 t -171.73 152.9 3.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.957 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -88.32 22.63 2.43 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.663 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 73' ' ' CYS . 10.0 p -68.02 154.92 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.07 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 10.9 ptp180 -44.02 129.35 4.35 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.534 0.734 . . . . 0.0 112.721 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.712 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 Cg_exo -73.98 -164.54 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.37 2.713 . . . . 0.0 112.379 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.786 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -172.17 -42.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.979 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -149.66 136.42 19.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -63.16 139.52 58.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.474 0.654 . . . . 0.0 111.698 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.828 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.2 t -70.47 133.8 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.417 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -123.6 128.34 49.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.831 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG12 ' HD2' ' A' ' 87' ' ' PRO . 28.7 m -100.83 155.88 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.043 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.4 p -67.44 145.95 54.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.93 -28.94 64.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.625 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 16.9 m-80 -59.1 -31.11 68.62 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.833 175.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.443 ' HB3' ' CD ' ' A' ' 88' ' ' ARG . 79.3 m -101.48 29.3 4.9 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 122.155 -0.341 . . . . 0.0 111.798 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 m -111.29 -28.17 8.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 109.837 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 17.0 p90 -97.4 149.19 22.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.56 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.22 -176.49 35.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.166 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -70.41 -48.81 54.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.666 0.386 . . . . 0.0 111.388 -177.167 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -77.28 55.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.428 0.632 . . . . 0.0 110.762 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.24 -53.37 0.74 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.913 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 14.1 mmtp -79.08 -18.2 53.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.778 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.849 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 80.2 m-20 -67.23 150.47 49.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.901 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 36.7 t -50.11 135.1 21.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.608 HG22 ' HG2' ' A' ' 88' ' ' ARG . 11.7 pt -77.65 -35.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.599 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.26 -47.3 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 19.8 p -103.07 2.81 35.29 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.847 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.724 HD21 ' HB ' ' A' ' 89' ' ' ILE . 0.8 OUTLIER 36.36 47.3 0.48 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.117 0.886 . . . . 0.0 113.256 174.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.21 -66.27 0.37 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.044 -174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -81.98 143.39 31.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.235 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 48.5 t -56.92 134.44 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.217 0.323 . . . . 0.0 110.545 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.87 147.29 21.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.775 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.68 -37.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.089 0.471 . . . . 0.0 110.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.712 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 6.4 m120 -82.77 173.33 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.172 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -109.92 134.41 52.12 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.531 ' CB ' HD11 ' A' ' 59' ' ' ILE . . . -77.58 151.54 34.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.28 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.404 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 16.3 m-85 -126.24 135.36 51.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.828 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 76.9 m-85 -71.26 125.11 26.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.6 p -67.58 157.0 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -50.28 -40.82 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.479 0.487 . . . . 0.0 111.479 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 37.2 mt-10 -58.91 -51.96 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.604 0.24 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.62 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 98.7 m -64.38 -36.14 83.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.363 -178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 72' ' ' TYR . 84.9 m -67.87 -42.83 80.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -58.8 -49.24 78.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.959 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 42.3 mt -72.06 -27.43 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.68 47.18 3.26 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.43 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.494 ' CB ' HG21 ' A' ' 32' ' ' ILE . 29.7 mmmt -82.19 -36.43 27.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.205 0.526 . . . . 0.0 109.911 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -66.77 -28.8 68.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.997 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.9 pttp -57.07 -30.91 64.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.31 . . . . 0.0 110.465 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB2' HD22 ' A' ' 12' ' ' LEU . 86.9 m-20 -61.57 -52.55 63.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.691 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.32 -127.72 3.45 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.569 -1.3 . . . . 0.0 114.669 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.4 t -58.84 109.56 1.96 Allowed Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.52 -1.34 . . . . 0.0 113.182 -171.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.461 ' CG ' HG13 ' A' ' 43' ' ' VAL . 72.0 Cg_endo -87.97 39.89 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.992 2.461 . . . . 0.0 113.716 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 59' ' ' ILE . 24.3 mtp85 -85.03 127.68 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.724 ' HB ' HD21 ' A' ' 62' ' ' ASN . 31.5 mm -81.28 126.14 39.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.714 HD21 ' HB2' ' A' ' 11' ' ' CYS . 17.0 mt -89.09 -37.45 15.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.031 -170.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -63.25 125.92 25.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.375 0.607 . . . . 0.0 111.902 -171.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.34 45.75 26.55 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.643 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.21 53.5 4.43 Favored Glycine 0 C--N 1.33 0.217 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 172.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m 74.26 -43.39 0.53 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.844 0.858 . . . . 0.0 110.479 -170.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -66.8 129.75 40.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.957 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 35.25 1.78 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.823 0.821 . . . . 0.0 109.35 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.8 mt -142.08 67.68 1.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.532 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -47.6 -45.98 27.98 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.059 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -111.98 126.79 55.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.417 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -78.82 124.43 28.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.728 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -70.78 -47.85 57.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.363 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 64.93 -59.78 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.122 0.889 . . . . 0.0 111.149 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -83.1 137.93 33.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.776 172.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? 60.95 -144.05 0.48 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.416 0.448 . . . . 0.0 110.689 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.623 ' HB3' HG23 ' A' ' 107' ' ' VAL . 37.1 mtmm -146.92 135.95 22.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.594 0.235 . . . . 0.0 110.591 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -95.84 38.92 1.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.406 0.622 . . . . 0.0 109.667 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 105' ' ' LYS . 71.7 t . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.331 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 65.92 -141.55 41.93 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.14 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 3' ' ' ARG . 50.3 m 67.69 -60.06 0.4 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.503 0.721 . . . . 0.0 112.069 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t 51.34 50.06 19.72 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.263 0.554 . . . . 0.0 109.922 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 1' ' ' SER . 30.2 mmt180 -74.13 126.76 31.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.39 -173.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -126.38 59.91 1.33 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 7' ' ' ASP . 7.5 pt20 -144.92 163.08 35.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.748 -169.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.519 ' HB3' HD21 ' A' ' 8' ' ' LEU . 65.1 t80 -76.1 34.67 0.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.15 0.976 . . . . 0.0 110.096 174.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 5' ' ' GLN . 71.9 m-20 60.18 53.89 4.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.611 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 8' ' ' LEU . 2.0 mt -85.44 74.68 10.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.531 177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 91' ' ' ASN . 1.6 mp -68.94 79.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.729 0.776 . . . . 0.0 109.935 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.544 ' HE1' ' HA ' ' A' ' 32' ' ' ILE . 2.3 ptp -80.8 153.96 27.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.577 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HA ' HD11 ' A' ' 90' ' ' LEU . 44.1 t -56.15 -53.12 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.304 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mp 48.52 37.9 9.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -79.59 177.64 8.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.59 167.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -70.81 116.05 42.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.883 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 31.8 Cg_exo -62.91 145.23 94.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.161 2.574 . . . . 0.0 113.37 -175.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.93 -137.4 9.22 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.53 -23.28 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -72.31 138.75 47.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.487 . . . . 0.0 111.718 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 m -91.7 137.66 32.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.644 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.524 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -66.71 132.33 31.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.268 -0.492 . . . . 0.0 112.798 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 88.1 mt -95.87 143.46 27.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.046 0.451 . . . . 0.0 111.83 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 60.0 mt -113.01 140.42 47.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.263 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.3 p -78.92 154.03 30.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 40.1 mt-10 -54.69 -26.22 32.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.83 0.347 . . . . 0.0 111.67 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 35.1 mmtp -70.11 -29.36 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.432 ' O ' HD13 ' A' ' 22' ' ' LEU . 4.8 m -116.29 17.28 15.67 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.564 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 51.9 t0 -66.77 127.2 31.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.145 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.95 -22.18 42.24 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.491 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -68.26 122.07 17.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.489 0.185 . . . . 0.0 110.99 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -69.19 113.03 13.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.42 -27.37 67.67 Favored 'Trans proline' 0 N--CA 1.473 0.3 0 C-N-CA 123.372 2.715 . . . . 0.0 113.403 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.544 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 4.8 mm -66.8 -36.59 77.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.92 -176.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.58 -15.61 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 67.1 84.05 0.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.373 0.606 . . . . 0.0 109.831 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -164.57 136.02 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.148 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.68 11.76 8.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 73' ' ' CYS . 8.3 p -66.44 160.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.001 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -40.76 130.85 1.85 Allowed Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.66 0.784 . . . . 0.0 112.873 -175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 93.4 Cg_endo -78.83 -161.23 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.388 2.725 . . . . 0.0 112.771 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -171.57 -50.55 0.02 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.359 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -134.88 145.47 48.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.186 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 59.7 mttp -68.18 140.47 56.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.836 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.7 m -74.58 127.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 111.606 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.53 114.99 29.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.52 146.53 6.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.345 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p -67.04 161.23 24.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -47.36 -44.89 24.38 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.042 0.839 . . . . 0.0 111.715 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.731 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.1 m120 -61.69 -39.1 90.24 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.709 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 55.9 m -90.0 43.53 1.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.682 0.277 . . . . 0.0 110.794 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 65.9 m -155.62 -38.68 0.08 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.698 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.731 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -59.68 -23.1 62.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -175.215 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.37 145.58 7.27 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.833 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.3 pttt 52.99 -59.46 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.414 1.886 . . . . 0.0 115.208 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -77.05 44.64 0.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.152 -0.343 . . . . 0.0 111.87 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 50' ' ' SER . . . -134.79 -45.32 0.73 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.989 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -66.13 -46.51 77.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.148 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -65.92 148.47 51.73 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.34 0.59 . . . . 0.0 110.933 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 20.2 t -51.6 125.73 15.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.375 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.5 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 8.7 pt -65.52 -26.86 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.457 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.4 mt -81.12 -41.1 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 32.1 p -113.75 2.61 15.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.348 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.1 p30 29.25 53.1 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.43 1.092 . . . . 0.0 113.476 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.64 -59.49 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.383 -176.315 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -72.48 141.27 48.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.826 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.36 133.01 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.174 0.512 . . . . 0.0 110.957 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.415 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.11 140.09 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.996 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -127.08 -39.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -117.84 137.73 52.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.89 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.3 139.1 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.568 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.699 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -82.39 151.33 26.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.653 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 7.7 m-85 -124.73 134.15 52.93 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.838 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.836 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 68.2 m-85 -66.17 125.15 24.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -66.07 151.54 46.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -52.98 -38.0 61.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.68 -46.26 87.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.473 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 86.0 m -72.39 -38.01 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.722 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.5 t -63.97 -35.9 82.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.302 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -62.9 -41.43 99.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.334 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.03 1.41 21.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.01 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.05 84.78 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.495 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 93.3 mttt -77.72 -20.35 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HB2' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -70.82 -23.47 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.667 175.474 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.47 -25.06 60.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -55.03 -57.82 10.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.61 -140.15 7.11 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.647 -1.263 . . . . 0.0 114.343 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.643 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 47.4 t -64.5 115.91 24.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.189 -1.005 . . . . 0.0 112.275 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.811 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 93.9 Cg_endo -83.17 39.59 0.84 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.211 2.607 . . . . 0.0 113.442 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.709 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 9.5 mmt180 -81.73 121.81 26.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.992 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.443 HG23 ' OD1' ' A' ' 91' ' ' ASN . 36.4 mm -78.42 113.12 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 11' ' ' CYS . 25.0 mt -105.26 -27.69 11.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.78 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 11.9 p-10 -60.3 -27.01 66.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.543 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.56 124.45 22.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.39 . . . . 0.0 110.926 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.4 50.83 3.88 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.649 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 16.9 m 55.23 61.33 2.95 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.679 0.276 . . . . 0.0 110.527 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 94' ' ' SER . 6.2 m120 74.21 -71.91 0.12 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.269 -174.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -174.06 -73.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.371 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.4 mt -156.46 120.38 4.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.82 0.343 . . . . 0.0 110.748 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.573 ' OD1' ' HG3' ' A' ' 99' ' ' ARG . 10.1 t70 -78.81 138.31 38.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.573 ' HG3' ' OD1' ' A' ' 98' ' ' ASP . 56.1 mtm-85 66.82 65.86 0.45 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.108 0.48 . . . . 0.0 110.494 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -51.45 127.94 21.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.492 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -70.22 69.86 0.37 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.316 0.579 . . . . 0.0 110.59 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.12 135.28 4.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.628 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.533 ' HG2' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 178.77 -46.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.005 173.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 65.9 mttm -102.74 39.12 1.58 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.028 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 62.97 69.52 0.58 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.524 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 106' ' ' LYS . 32.8 mmtp 65.98 34.02 7.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.604 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 104' ' ' LYS . 86.7 t . . . . . 0 C--O 1.247 0.935 0 CA-C-O 117.441 -1.266 . . . . 0.0 107.869 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -159.93 126.79 1.69 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.719 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.5 p -169.4 41.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.001 0.429 . . . . 0.0 110.875 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m -86.51 32.02 0.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.924 0.392 . . . . 0.0 111.12 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -90.65 121.03 32.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.805 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -163.18 130.43 3.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.029 0.443 . . . . 0.0 111.258 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.542 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -76.71 -46.01 27.14 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.4 t80 55.42 -108.7 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -139.48 42.97 2.02 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 5' ' ' GLN . 1.4 mt -78.93 46.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.873 -174.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.655 ' HA ' ' HB2' ' A' ' 91' ' ' ASN . 2.3 mp -86.4 43.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 123.248 1.499 . . . . 0.0 108.471 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 1.4 ptp -127.29 143.83 51.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.544 173.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.669 ' HA ' HD11 ' A' ' 90' ' ' LEU . 50.8 t -56.98 -50.4 72.81 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.493 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 84' ' ' ASP . 40.0 mt 49.5 40.65 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.015 1.116 . . . . 0.0 114.015 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HB3' ' H ' ' A' ' 14' ' ' GLN . 47.4 mttm -82.29 -159.8 0.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.821 169.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 15.6 tm0? -85.18 122.94 73.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.12 133.17 48.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.852 2.368 . . . . 0.0 112.75 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -144.16 6.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.247 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG12 ' OE1' ' A' ' 47' ' ' GLU . 11.3 p -99.38 -30.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.754 0.311 . . . . 0.0 111.401 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.499 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 70.6 mt-30 -77.96 136.37 37.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.37 0.605 . . . . 0.0 111.896 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 m -75.86 143.28 41.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.526 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.28 120.45 5.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.213 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 73.5 mt -91.98 147.61 22.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.492 . . . . 0.0 112.14 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.653 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 76.8 mt -110.89 130.11 55.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.139 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.446 ' H ' ' CB ' ' A' ' 58' ' ' CYS . 8.5 p -71.4 160.42 32.79 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.705 ' HG3' HG21 ' A' ' 67' ' ' VAL . 54.8 mt-10 -58.25 -24.55 59.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp -74.44 -31.23 62.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.677 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -110.13 25.07 12.2 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 38.9 t70 -68.03 124.74 24.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.97 77.25 Favored Glycine 0 C--N 1.321 -0.266 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.627 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 51.3 mttm -102.7 134.51 45.97 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.448 -0.442 . . . . 0.0 110.607 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 12.6 t -70.75 117.17 53.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 11.2 Cg_endo -58.89 -31.95 96.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.818 2.346 . . . . 0.0 112.811 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 12.6 mm -66.4 -46.94 85.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.243 -175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -122.21 -6.06 8.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -170.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.98 75.79 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 110.091 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 t -164.33 147.52 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -89.01 41.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.058 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 73' ' ' CYS . 41.9 t -74.43 148.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.87 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.557 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 5.4 mmp_? -35.93 120.17 0.69 Allowed Pre-proline 0 C--O 1.224 -0.287 0 O-C-N 124.495 1.122 . . . . 0.0 112.554 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.58 144.37 44.56 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.597 2.198 . . . . 0.0 112.38 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 12.3 mmmm -131.7 -78.79 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -85.78 132.04 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.07 132.32 44.92 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 21.9 t -71.45 129.08 35.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.405 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -121.83 130.44 53.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.9 m -80.6 144.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.157 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.5 p -62.39 139.78 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.611 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 6.9 tp10 -60.16 -21.18 61.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.094 -174.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.628 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 5.2 m120 -60.48 -31.56 70.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.7 m -87.38 -35.02 18.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.529 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 16.6 p -92.28 -22.08 19.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -57.67 -32.87 67.74 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.01 140.69 5.23 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.642 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.452 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 39.0 ttmt 69.91 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.477 0.711 . . . . 0.0 111.701 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.452 ' HG3' ' HG2' ' A' ' 53' ' ' LYS . 41.4 mt-30 58.98 33.49 23.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.241 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.07 35.09 1.97 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.069 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 -22.4 0.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.796 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 15.6 p30 -62.15 149.26 41.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.815 0.817 . . . . 0.0 112.083 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -64.8 130.92 45.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.265 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' CD1' HG11 ' A' ' 43' ' ' VAL . 8.4 pt -62.57 -40.6 88.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.46 -38.12 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.2 p -101.73 -26.55 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.954 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 57.5 56.47 4.97 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.246 0.546 . . . . 0.0 109.611 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.86 -58.55 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.336 -170.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.4 144.0 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.752 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -64.68 138.13 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.895 0.378 . . . . 0.0 110.978 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -72.13 151.2 46.81 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.297 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.705 HG21 ' HG3' ' A' ' 24' ' ' GLU . 61.1 t -118.74 -60.94 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.887 0.375 . . . . 0.0 111.167 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -113.45 137.55 51.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.892 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -60.3 136.72 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.473 0.483 . . . . 0.0 111.366 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.653 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -82.57 159.39 22.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.904 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -136.54 134.34 37.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.138 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.5 m-85 -66.17 128.12 34.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 1.8 p -71.87 160.15 33.06 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.002 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -49.09 -50.62 36.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.077 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HG3' HG11 ' A' ' 37' ' ' VAL . 46.3 mt-10 -59.92 -43.15 95.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.388 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 91.6 m -68.01 -34.97 77.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.169 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 40' ' ' LYS . 81.7 m -68.63 -37.48 79.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -60.53 -47.16 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.272 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.12 -28.2 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.588 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.54 36.84 10.14 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.967 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 81' ' ' LYS . 21.6 mtpp -87.4 -10.95 50.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.919 0.39 . . . . 0.0 110.243 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -68.82 -24.46 64.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 108.988 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -73.97 -23.49 59.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.757 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' HD13 ' A' ' 12' ' ' LEU . 81.4 m-20 -58.16 -58.93 6.3 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 -135.01 7.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.859 -1.163 . . . . 0.0 114.261 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 24.8 t -55.99 107.35 0.86 Allowed Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 111.929 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 97.3 Cg_endo -87.95 38.25 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.772 2.315 . . . . 0.0 113.563 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 10' ' ' MET . 53.6 mtt180 -87.52 131.42 34.37 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.983 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 32.3 mm -69.71 121.35 19.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.176 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 91' ' ' ASN . 1.5 pp -173.71 -33.4 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.846 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.815 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 13.8 t-20 61.01 106.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.884 0.874 . . . . 0.0 111.18 -173.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 91' ' ' ASN . 3.0 pp 61.82 -40.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.195 1.398 . . . . 0.0 113.28 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.32 15.42 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.781 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.6 m 55.57 52.03 11.75 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.243 0.544 . . . . 0.0 110.799 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -151.96 33.52 0.54 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.491 0.663 . . . . 0.0 109.982 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -153.35 121.44 6.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.427 175.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 82.8 mt 58.35 47.73 13.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.424 0.63 . . . . 0.0 110.019 -173.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 99' ' ' ARG . 30.2 t70 -147.95 -129.43 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.047 -176.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -77.49 74.66 4.05 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 171.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.561 ' HB3' ' HG2' ' A' ' 102' ' ' GLU . 4.0 t-160 -156.78 137.65 13.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.702 -172.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.663 ' HB2' ' HA ' ' A' ' 106' ' ' LYS . 49.0 p90 -61.12 -40.25 93.09 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.901 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.561 ' HG2' ' HB3' ' A' ' 100' ' ' HIS . 55.9 mm-40 52.66 -112.4 0.68 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 175.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -122.12 -48.86 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 111.23 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -87.87 -62.82 1.41 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.432 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -79.67 56.66 2.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.03 -175.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.663 ' HA ' ' HB2' ' A' ' 101' ' ' PHE . 50.9 mtmt -80.55 45.35 0.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.067 0.461 . . . . 0.0 111.392 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.476 177.242 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.864 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 161.45 -43.25 0.39 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.037 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.4 t 61.09 -143.11 0.48 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 122.851 0.46 . . . . 0.0 110.65 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.3 t -171.32 -133.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 59.66 56.46 3.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 110.919 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -126.52 123.63 38.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.478 0.656 . . . . 0.0 111.378 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -106.08 167.33 9.88 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.52 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.8 t80 61.74 -126.07 0.79 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -119.06 32.52 6.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.284 0.564 . . . . 0.0 109.572 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.87 145.72 55.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.368 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.689 HD13 ' H ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -151.81 43.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.934 -164.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.471 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -63.39 136.59 57.73 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.904 -176.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.4 t -48.85 -48.46 41.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.292 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' N ' ' A' ' 86' ' ' CYS . 20.9 mt 41.45 40.5 1.31 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 50.5 mttm -80.0 -160.18 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 34.0 tp60 -82.13 111.01 23.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.381 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 77.2 Cg_endo -80.17 146.54 17.93 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.453 2.102 . . . . 0.0 112.746 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.69 -142.6 13.34 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.298 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.41 -17.87 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.096 0.474 . . . . 0.0 110.717 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -64.33 142.18 58.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.9 m -109.08 126.58 53.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.747 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -63.55 138.2 42.7 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.307 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 56' ' ' LYS . 41.2 mt -78.93 154.34 29.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.869 0.842 . . . . 0.0 113.131 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' A' ' 70' ' ' ALA . 1.7 tp -124.47 127.68 47.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.856 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 1.4 p -81.36 149.4 28.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -52.31 -35.01 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -62.22 -37.95 87.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.32 -17.37 23.66 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.49 -0.131 . . . . 0.0 110.795 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' HA ' HD23 ' A' ' 22' ' ' LEU . 13.0 t70 -54.49 110.79 0.68 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.866 -172.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.78 -31.22 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.775 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.542 ' HB2' HD13 ' A' ' 60' ' ' ILE . 55.1 mttm -78.61 132.58 37.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.479 -0.361 . . . . 0.0 110.892 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 t -80.46 119.05 75.2 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 71.3 Cg_exo -54.59 -37.01 90.74 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 123.059 2.506 . . . . 0.0 113.761 -172.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.604 HG21 ' HD3' ' A' ' 81' ' ' LYS . 3.4 mm -61.47 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.4 p -106.5 -21.75 12.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -171.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 65.42 83.43 0.17 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.394 0.616 . . . . 0.0 110.292 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 t -169.34 138.88 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.39 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -80.13 45.96 0.78 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.242 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 73' ' ' CYS . 4.2 p -94.1 148.38 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.009 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -40.16 123.31 1.67 Allowed Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 77.9 Cg_endo -72.43 152.15 54.39 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.011 2.474 . . . . 0.0 111.261 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HD2' ' HD1' ' A' ' 74' ' ' TRP . 57.6 tttp -128.81 -37.16 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.848 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.46 145.42 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.93 143.07 52.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 111.557 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.779 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 31.6 m -68.39 155.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -116.19 114.81 24.95 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG22 ' HB2' ' A' ' 49' ' ' CYS . 10.0 p -93.88 139.61 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.591 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.5 p -65.79 147.75 52.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.71 -30.47 63.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.679 0.275 . . . . 0.0 110.476 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.685 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.9 m120 -55.94 -40.92 73.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.506 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 91.6 m -80.65 -24.66 38.82 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.597 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -76.95 -41.94 41.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.667 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -79.61 41.05 0.47 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 112.206 -175.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -163.87 159.74 32.52 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -61.68 -11.49 12.05 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -57.94 -40.4 80.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 49' ' ' CYS . . . -63.28 -33.22 75.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.585 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.9 mmpt? -64.18 -30.32 71.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.254 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 34.5 m120 -76.23 140.17 41.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.022 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.9 t -51.68 126.57 18.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.218 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.533 HD11 ' CB ' ' A' ' 70' ' ' ALA . 12.4 pt -68.78 -27.58 36.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.587 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' ' 29' ' ' LYS . 54.0 mt -75.81 -42.8 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.991 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 24.9 p -105.63 -6.99 18.79 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.23 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 42.19 45.85 3.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.981 0.801 . . . . 0.0 112.31 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 -62.43 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.142 0.496 . . . . 0.0 110.188 -177.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -75.87 141.97 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.891 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 9.9 p -68.16 139.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.729 0.3 . . . . 0.0 110.591 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.25 145.1 20.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.8 m -116.33 -38.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.554 0.216 . . . . 0.0 111.478 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -104.73 -174.87 2.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.522 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' HB3' HG21 ' A' ' 19' ' ' THR . 44.3 m-20 -107.78 142.26 38.08 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 22' ' ' LEU . . . -79.42 151.4 30.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -127.39 136.27 51.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.779 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 56.1 m-85 -68.11 127.81 34.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 37' ' ' VAL . 12.4 p -71.42 161.74 30.57 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.746 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.578 ' HD1' ' HD2' ' A' ' 40' ' ' LYS . 27.8 t90 -51.99 -42.2 62.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.161 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -58.63 -55.97 28.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.116 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.78 -39.48 94.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.484 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.7 t -65.31 -41.31 94.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.454 0.169 . . . . 0.0 110.765 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.4 ttp-105 -64.15 -44.53 91.85 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.026 0.441 . . . . 0.0 110.324 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 77.3 mt -65.67 -38.2 88.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.367 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 28.18 4.11 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.308 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.604 ' HD3' HG21 ' A' ' 32' ' ' ILE . 46.6 mttm -88.39 -4.67 58.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.869 0.366 . . . . 0.0 110.571 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 p-10 -66.83 -30.45 70.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.034 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.474 ' HB3' ' NZ ' ' A' ' 83' ' ' LYS . 3.5 mmmp? -96.2 7.82 45.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.27 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -69.69 -59.65 2.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.7 -158.15 30.91 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.355 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.474 ' N ' ' HA ' ' A' ' 12' ' ' LEU . 34.2 t -66.08 115.22 21.18 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.658 0.783 . . . . 0.0 111.54 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.619 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 90.0 Cg_endo -86.76 41.98 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.683 2.922 . . . . 0.0 114.047 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -87.81 130.34 34.9 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.988 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.0 mm -84.29 115.81 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.689 ' H ' HD13 ' A' ' 9' ' ' ILE . 18.1 mt -85.45 -46.63 10.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.816 -174.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.561 ' H ' HD11 ' A' ' 9' ' ' ILE . 12.9 p30 -59.81 -69.82 0.19 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.6 tp 177.54 136.03 0.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.991 ' HA3' ' HA ' ' A' ' 61' ' ' CYS . . . -58.64 151.38 33.08 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.019 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -71.77 47.39 0.14 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.063 0.459 . . . . 0.0 111.858 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -65.92 -41.13 91.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.704 ' HD2' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -110.1 -151.8 0.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.964 173.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.704 ' HG ' ' HD2' ' A' ' 96' ' ' ARG . 96.3 mt 64.59 32.55 11.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.419 0.628 . . . . 0.0 109.712 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.6 -30.21 22.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.942 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -66.74 123.38 19.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.021 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -79.03 76.73 5.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.278 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -76.67 45.27 0.4 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.322 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.9 -37.87 85.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.948 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -56.84 136.08 55.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.235 -176.035 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 68.07 -57.82 0.46 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.22 1.008 . . . . 0.0 113.29 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -170.48 115.56 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.602 ' HD3' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -79.29 -32.32 43.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.009 0.433 . . . . 0.0 111.736 -175.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.567 HG22 ' HG2' ' A' ' 106' ' ' LYS . 11.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.656 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -171.21 161.22 33.75 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.1 m -74.62 45.62 0.25 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.915 0.388 . . . . 0.0 111.933 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.6 m -159.32 -54.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 38.67 62.11 1.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.201 1.0 . . . . 0.0 113.485 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -82.54 49.23 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 109.251 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.497 ' HG3' ' H ' ' A' ' 6' ' ' PHE . 53.6 tp60 -169.68 -121.34 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.777 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' H ' ' HG3' ' A' ' 5' ' ' GLN . 28.6 t80 -171.61 161.67 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -73.73 58.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 111.285 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 9' ' ' ILE . 61.6 mt -77.34 39.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.518 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.666 ' HA ' ' CB ' ' A' ' 91' ' ' ASN . 3.7 mp -131.9 26.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 124.083 1.897 . . . . 0.0 106.275 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.81 ' HG2' HD22 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -109.25 140.45 42.87 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.129 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -41.58 -63.11 0.76 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.328 . . . . 0.0 113.254 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.81 HD22 ' HG2' ' A' ' 10' ' ' MET . 0.0 OUTLIER 51.03 36.77 16.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.873 ' HE2' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -104.29 170.66 7.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 166.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.3 tp-100 -57.33 121.91 50.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 123.551 0.532 . . . . 0.0 110.693 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.9 Cg_exo -71.19 151.03 60.49 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.879 2.386 . . . . 0.0 112.688 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.652 ' H ' ' HA ' ' A' ' 46' ' ' CYS . . . -88.02 -125.98 2.37 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.529 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -105.42 -48.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -62.22 151.02 37.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.522 HG21 ' HD3' ' A' ' 42' ' ' LYS . 98.6 m -82.23 143.56 31.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.451 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.75 126.51 9.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.952 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.2 mt -95.33 136.73 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.674 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 90.7 mt -99.07 148.7 23.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.49 171.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.9 p -89.47 154.99 19.59 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 67' ' ' VAL . 62.5 mm-40 -52.21 -29.54 23.04 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.423 0.452 . . . . 0.0 111.996 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.3 mmtp -69.4 -36.58 76.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.31 -0.244 . . . . 0.0 111.218 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 23.3 m -99.48 33.73 2.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.69 119.23 9.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.115 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.43 31.99 62.7 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.525 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 26' ' ' CYS . 24.5 mtpp -103.76 122.86 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 14.0 t -62.06 115.89 18.56 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.165 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.714 ' HG2' HG11 ' A' ' 43' ' ' VAL . 8.1 Cg_exo -73.29 50.16 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.63 2.887 . . . . 0.0 112.716 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mm -149.86 -48.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.3 p -112.94 -14.84 12.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.085 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 65.82 80.95 0.21 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.599 0.714 . . . . 0.0 109.939 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -165.65 146.91 7.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.99 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.72 14.1 12.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.477 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -65.22 150.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 16.5 ptm180 -37.5 126.98 0.89 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 124.001 0.92 . . . . 0.0 113.383 -174.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.4 Cg_exo -71.55 -163.54 0.13 Allowed 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.429 2.753 . . . . 0.0 112.478 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -169.0 -52.53 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.235 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -140.11 141.89 36.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HD3' HG21 ' A' ' 19' ' ' THR . 39.6 ttmt -69.06 140.13 54.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.948 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.714 HG11 ' HG2' ' A' ' 31' ' ' PRO . 12.4 m -77.95 148.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.799 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.57 129.23 50.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.044 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 m -93.73 146.52 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.025 0.441 . . . . 0.0 111.343 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.665 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p -69.91 165.33 21.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -59.47 -41.06 88.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.176 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.873 ' HB2' ' HE2' ' A' ' 13' ' ' LYS . 63.0 m-20 -74.52 40.3 0.13 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.502 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.498 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 15.6 m -151.35 -52.3 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.75 174.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.507 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 51.5 m -100.21 44.17 1.03 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.737 0.779 . . . . 0.0 110.025 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -72.08 -33.68 68.09 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.202 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.47 -68.85 0.13 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.266 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.41 142.84 39.04 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.768 -0.086 . . . . 0.0 110.768 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HB2' ' ND2' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 40.37 49.42 2.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.809 0.844 . . . . 0.0 111.527 -177.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 50' ' ' SER . . . -92.41 -41.93 10.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.083 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -90.39 27.53 1.67 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.578 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.441 ' ND2' ' HB2' ' A' ' 54' ' ' GLN . 22.9 p30 -93.35 149.74 21.0 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.769 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.719 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.8 t -48.3 129.39 15.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.922 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.619 HG22 ' HD3' ' A' ' 88' ' ' ARG . 8.5 pt -65.89 -31.6 54.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.482 -174.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 26' ' ' CYS . 51.4 mt -77.17 -47.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.74 -4.5 15.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.835 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 40.06 47.91 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.59 0.756 . . . . 0.0 112.651 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.53 -57.25 0.28 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.023 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -76.75 146.69 37.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.716 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.18 131.36 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 110.162 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.17 139.47 25.02 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.991 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 24' ' ' GLU . 16.2 m -131.63 -40.05 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 111.447 0.165 . . . . 0.0 111.447 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.75 138.95 33.53 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.33 129.94 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.674 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -80.28 148.99 30.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 7.9 m-85 -128.01 133.77 49.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.674 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 53.7 m-85 -68.38 132.44 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -68.63 153.02 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -53.19 -38.33 62.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.789 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.82 -45.79 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.611 0.243 . . . . 0.0 111.385 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.6 m -67.68 -37.77 82.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.086 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.5 t -61.85 -42.64 99.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -57.34 -50.23 73.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.889 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.18 -27.59 62.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.576 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.17 30.71 21.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.404 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -78.99 -27.5 43.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -67.21 -41.72 85.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.096 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -85.01 26.58 0.84 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' CG ' ' HG ' ' A' ' 12' ' ' LEU . 49.4 t0 -80.39 -53.65 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . 179.32 -149.64 8.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.451 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 30.3 t -67.26 121.05 76.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.697 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 85.3 Cg_endo -80.91 43.42 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.93 3.087 . . . . 0.0 113.446 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.619 ' HD3' HG22 ' A' ' 59' ' ' ILE . 14.9 mmm180 -102.14 143.7 31.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.999 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.0 mm -94.99 123.62 47.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.483 HD21 ' CB ' ' A' ' 11' ' ' CYS . 1.3 pt? -168.12 -31.77 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.666 ' CB ' ' HA ' ' A' ' 9' ' ' ILE . 6.5 t-20 -23.17 -64.61 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.516 1.127 . . . . 0.0 113.699 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.501 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -164.82 141.64 6.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.13 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.08 122.78 7.71 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.558 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.5 m 71.81 -49.2 0.69 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.633 0.773 . . . . 0.0 111.732 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 92' ' ' LEU . 4.8 m120 -63.29 135.92 57.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.409 ' HB3' ' H ' ' A' ' 97' ' ' LEU . 5.0 mmt85 -124.8 -154.99 0.65 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.16 0.505 . . . . 0.0 111.385 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 32.1 mt -87.52 30.03 0.83 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.516 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -77.25 136.49 38.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.349 174.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.8 ttp-105 62.04 37.08 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.795 0.807 . . . . 0.0 109.628 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 21.3 m80 -123.93 -44.6 2.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.239 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 63.11 -94.45 0.04 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.365 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 59.4 36.39 23.24 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.753 0.787 . . . . 0.0 110.33 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -144.07 -49.26 0.29 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.284 -1.325 . . . . 0.0 107.651 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -123.21 153.15 40.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.173 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 105' ' ' LYS . 12.3 mptt -66.17 124.27 22.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.099 0.476 . . . . 0.0 110.994 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -81.56 139.93 34.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.377 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.943 179.238 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.812 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -69.12 133.25 26.35 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.388 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.4 p -80.29 43.04 0.61 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.995 0.426 . . . . 0.0 111.913 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -75.15 -27.5 59.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.446 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 66.6 44.05 2.35 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.434 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -146.26 9.81 1.11 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.863 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.722 ' HG2' ' HD1' ' A' ' 6' ' ' PHE . 42.4 tt0 -62.49 -70.4 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.306 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.722 ' HD1' ' HG2' ' A' ' 5' ' ' GLN . 3.5 m-85 -103.78 9.67 36.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.814 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 52.68 48.36 22.69 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.586 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.637 ' H ' HD12 ' A' ' 8' ' ' LEU . 3.3 mp -63.72 121.56 14.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.187 -173.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.863 ' HA ' ' HB2' ' A' ' 91' ' ' ASN . 1.3 mp -90.16 50.13 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-O 122.357 1.075 . . . . 0.0 109.386 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 3.8 ptp -143.77 136.77 27.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.522 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HA ' HD11 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -58.32 -37.54 75.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.787 -174.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 53.8 mt 56.16 34.3 23.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 171.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 61.6 mttm -77.53 -169.36 1.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.533 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.24 113.63 45.23 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.514 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.782 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 27.7 Cg_exo -63.91 144.84 89.26 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.442 2.762 . . . . 0.0 112.809 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.08 -142.64 11.06 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.841 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.595 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 8.3 p -82.24 -35.65 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.127 0.489 . . . . 0.0 110.669 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.38 127.27 30.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.902 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.55 140.24 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.275 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.46 121.38 9.88 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.44 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 56' ' ' LYS . 26.2 mt -78.53 153.82 30.95 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.548 0.69 . . . . 0.0 112.548 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.744 HD11 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.81 127.01 28.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.677 -171.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 1.7 p -80.06 144.87 32.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 93.1 mt-10 -55.17 -26.06 36.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -65.51 -36.33 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.581 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.0 m -94.81 -17.98 21.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.4 t0 -52.05 121.6 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.509 -172.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.78 -32.88 5.47 Favored Glycine 0 C--N 1.316 -0.58 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.26 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -71.13 128.39 35.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.447 -0.376 . . . . 0.0 110.866 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.6 t -74.8 119.67 77.88 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 8.8 Cg_endo -54.8 -36.15 90.1 Favored 'Trans proline' 0 N--CA 1.472 0.264 0 C-N-CA 123.174 2.582 . . . . 0.0 113.331 -174.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.495 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.4 mm -65.41 -44.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.7 p -121.55 -11.49 8.68 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 62.79 72.4 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.957 0.408 . . . . 0.0 111.181 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -162.67 141.8 8.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.856 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -83.31 45.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.306 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.66 HG13 ' HB2' ' A' ' 73' ' ' CYS . 5.9 p -92.79 154.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.245 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -35.16 124.81 0.58 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.356 1.062 . . . . 0.0 113.584 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.79 146.89 38.79 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.144 2.563 . . . . 0.0 111.825 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 57.7 tptt -127.45 -49.27 1.41 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.697 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -138.09 138.69 38.97 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.937 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HG2' ' CE2' ' A' ' 71' ' ' PHE . 32.5 mtpt -65.25 136.04 56.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.322 0.582 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 26.0 t -79.92 124.72 38.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.162 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.595 ' NH1' ' HA ' ' A' ' 17' ' ' VAL . 72.7 mtt-85 -107.05 133.34 51.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.059 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.95 147.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.967 0.413 . . . . 0.0 110.118 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.782 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 p -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.17 -42.8 14.49 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.912 0.758 . . . . 0.0 111.721 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.3 m120 -60.28 -41.12 92.65 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 74.0 m -85.8 53.37 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 t -160.72 -46.85 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.427 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 -73.73 136.01 43.67 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.489 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.08 -42.92 1.41 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 116.013 -0.539 . . . . 0.0 114.115 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.77 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -165.74 172.15 12.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.961 0.381 . . . . 0.0 110.933 -174.002 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.77 ' HG3' ' HG2' ' A' ' 53' ' ' LYS . 74.8 mt-30 61.92 46.13 6.94 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.703 0.627 . . . . 0.0 111.307 176.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -118.45 -42.11 2.79 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.354 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 21' ' ' LEU . 35.4 mtmm -84.33 -35.28 23.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.083 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 p30 -65.75 143.34 57.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.402 0.62 . . . . 0.0 111.551 -173.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.5 t -64.05 125.89 25.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.676 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 70' ' ' ALA . 18.4 pt -63.3 -32.43 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.744 HD12 HD11 ' A' ' 22' ' ' LEU . 49.3 mt -73.52 -41.3 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -173.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 6.3 p -93.5 -25.11 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.227 174.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 t30 61.43 44.59 9.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.745 0.784 . . . . 0.0 109.656 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 63' ' ' LEU . 1.4 tm? -164.18 -59.27 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.418 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 74.9 m-80 -71.82 146.22 48.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.4 p -66.93 136.19 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.386 . . . . 0.0 111.09 -177.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -88.51 142.34 17.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.4 m -117.17 -38.53 2.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.685 0.279 . . . . 0.0 111.594 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' LEU . 80.5 m-20 -109.93 -168.52 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -115.02 145.73 41.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.025 0.441 . . . . 0.0 110.513 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . . . -75.86 152.28 37.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.709 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CE2' ' HG2' ' A' ' 42' ' ' LYS . 32.0 m-85 -132.08 131.47 42.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.192 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -70.67 128.75 37.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.66 ' HB2' HG13 ' A' ' 37' ' ' VAL . 7.1 p -73.6 158.4 34.85 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.868 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 27.8 t90 -47.97 -49.74 29.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.536 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 5.5 pt-20 -68.45 -36.5 79.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 34.7 m -63.23 -42.25 99.2 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.584 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 97.4 m -68.1 -41.1 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.701 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -63.26 -42.47 99.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -72.24 -30.13 64.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.248 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.83 4.29 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.033 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -96.24 -32.61 12.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 109.979 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -64.06 -34.99 79.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.614 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 7.47 2.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.953 -176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -76.47 -56.41 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.07 -147.33 12.35 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.433 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 2.0 t -70.59 114.44 26.38 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 124.302 1.041 . . . . 0.0 112.389 -174.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 10' ' ' MET . 96.0 Cg_endo -93.33 42.11 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.073 2.515 . . . . 0.0 114.887 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' ' 10' ' ' MET . 39.9 mtt-85 -74.58 128.42 35.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.024 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 17.8 mm -67.34 118.79 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 0.0 111.225 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 91' ' ' ASN . 2.1 pp -169.75 -40.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.935 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.863 ' HB2' ' HA ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER 65.76 -67.2 0.14 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.772 0.829 . . . . 0.0 110.763 -176.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.34 -60.12 1.77 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.98 -61.44 0.75 Allowed Glycine 0 C--N 1.33 0.209 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.45 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.6 t -173.96 -140.82 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 58.69 37.11 25.21 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 122.714 0.405 . . . . 0.0 111.233 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.2 -28.0 0.74 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.683 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.19 149.33 44.74 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 t70 62.39 46.54 5.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.326 0.584 . . . . 0.0 109.655 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 70.7 -69.04 0.19 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.351 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -170.38 143.88 2.4 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.185 0.594 . . . . 0.0 109.554 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -77.01 72.93 3.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.05 0.452 . . . . 0.0 109.795 175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 5.9 tp10 -161.99 145.17 11.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.02 -174.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 102' ' ' GLU . 34.7 mmtp 72.91 -57.79 0.62 Allowed 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.098 0.874 . . . . 0.0 111.309 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -84.58 126.01 32.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.16 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp 62.23 -134.16 0.52 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.426 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 64.14 48.25 3.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.882 0.849 . . . . 0.0 110.545 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.66 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -70.32 126.06 15.47 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.237 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.8 t 53.33 -130.86 2.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.432 0.293 . . . . 0.0 110.395 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m 71.5 -47.8 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.828 0.851 . . . . 0.0 112.501 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.48 -27.3 66.89 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.3 -50.51 67.16 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.293 0.568 . . . . 0.0 110.398 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 8' ' ' LEU . 12.7 pt20 -96.42 -138.84 0.26 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.538 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.633 ' HE2' ' HD3' ' A' ' 103' ' ' LYS . 1.2 t80 64.2 17.24 10.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.402 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -92.11 25.95 2.68 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 159.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 5' ' ' GLN . 1.6 mt -76.2 95.17 3.65 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.759 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 8' ' ' LEU . 1.9 tp 173.27 178.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -172.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.781 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -55.87 137.73 49.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.72 0.771 . . . . 0.0 112.052 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.4 t -52.84 -39.75 62.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.67 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 10' ' ' MET . 1.1 mp 43.29 46.44 5.38 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -88.89 -152.66 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 46' ' ' CYS . 11.9 tp-100 -86.3 115.17 61.05 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 48.9 Cg_exo -58.94 136.17 71.69 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.084 2.523 . . . . 0.0 112.852 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.69 -112.29 0.89 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.445 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 p -146.26 -26.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.781 0.324 . . . . 0.0 110.881 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.569 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 56.2 mt-30 -66.35 131.7 46.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.324 0.583 . . . . 0.0 111.45 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -76.33 135.52 39.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.888 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.2 118.72 5.66 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.233 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 91.8 mt -90.8 143.67 26.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.144 0.497 . . . . 0.0 111.648 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 80.9 mt -104.04 133.63 48.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.743 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.3 p -71.27 154.26 41.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HG2' HG21 ' A' ' 67' ' ' VAL . 37.1 mt-10 -48.64 -32.27 8.02 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.484 0.49 . . . . 0.0 112.269 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -70.81 -43.21 69.1 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.652 ' HB3' HD12 ' A' ' 60' ' ' ILE . 33.7 m -89.72 -11.32 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -54.86 115.5 2.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.764 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.7 -31.31 5.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.6 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 62.5 mttp -77.32 127.59 32.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.4 t -68.14 118.27 57.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 3.2 Cg_endo -52.93 -41.29 72.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.221 2.614 . . . . 0.0 113.652 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.963 HG21 ' HG2' ' A' ' 81' ' ' LYS . 1.4 mm -68.75 -48.44 71.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -110.5 -7.94 14.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 58.88 71.46 0.58 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.295 0.569 . . . . 0.0 110.266 -177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.7 t -160.04 139.51 11.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.112 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.405 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.3 m-85 -85.62 30.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 73' ' ' CYS . 7.7 p -80.51 148.82 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.444 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -36.93 119.96 0.8 Allowed Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.8 Cg_endo -80.63 150.65 19.1 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.341 2.694 . . . . 0.0 112.207 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 52.2 mtpt -137.59 -69.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.668 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 20.7 tpp180 -78.86 131.62 36.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.022 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -69.03 133.46 48.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.215 0.531 . . . . 0.0 110.613 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.655 HG13 ' HG3' ' A' ' 87' ' ' PRO . 3.1 t -76.88 126.22 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.866 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -125.04 127.95 47.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.779 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 m -85.53 158.44 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 0.0 111.257 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.9 p -65.45 148.79 51.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -54.02 -30.89 49.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.249 0.343 . . . . 0.0 111.686 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.668 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 64.7 m-80 -59.83 -34.2 72.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.476 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.471 ' HA ' HE21 ' A' ' 54' ' ' GLN . 84.5 m -95.89 35.5 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.717 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 14.8 m -140.57 -45.16 0.4 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.304 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -87.69 -18.43 29.55 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.729 178.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.78 -150.16 6.8 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.903 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -82.41 38.07 0.54 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.23 0.538 . . . . 0.0 111.239 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.471 HE21 ' HA ' ' A' ' 49' ' ' CYS . 2.4 pm0 -166.03 142.07 4.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.724 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -174.03 -49.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.379 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.695 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -96.83 -26.63 15.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.178 177.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 72.0 m-20 -61.05 142.54 56.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.3 t -51.03 133.39 27.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.89 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.427 ' CD1' HG11 ' A' ' 43' ' ' VAL . 7.6 pt -78.43 -26.58 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.518 -175.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 26' ' ' CYS . 48.9 mt -78.2 -48.24 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.549 ' C ' ' H ' ' A' ' 63' ' ' LEU . 28.2 p -103.03 -6.75 22.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.764 -0.775 . . . . 0.0 110.834 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 12.9 m-80 70.05 -36.08 0.34 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.745 0.818 . . . . 0.0 111.581 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -78.65 -63.22 1.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.559 -166.379 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -68.23 148.62 50.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.742 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -73.93 137.02 24.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.721 0.295 . . . . 0.0 110.688 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 144.35 27.25 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.875 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' HG2' ' A' ' 24' ' ' GLU . 27.2 m -115.29 -47.63 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -114.75 135.68 53.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.289 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.89 134.62 55.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.781 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -77.37 153.05 34.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.475 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 11.2 m-85 -134.55 135.1 42.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.521 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -66.55 130.29 42.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.9 p -68.97 162.51 26.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -51.18 -44.03 61.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.105 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -59.82 -47.67 84.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.741 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 68.4 m -67.51 -37.92 83.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.298 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 77.0 m -62.55 -42.88 99.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.798 0.332 . . . . 0.0 110.504 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.05 -42.25 99.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 68.6 mt -70.28 -33.44 71.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.5 7.83 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.847 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.963 ' HG2' HG21 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -66.73 -25.58 66.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.796 0.331 . . . . 0.0 111.564 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.668 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . 26.5 p-10 -65.76 -43.52 88.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.756 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -83.94 -9.0 59.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.916 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 6.4 m-20 -60.03 -49.49 77.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.12 7.92 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.041 -1.075 . . . . 0.0 113.706 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 41.4 t -69.38 117.97 57.75 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.412 -0.894 . . . . 0.0 111.85 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.655 ' HG3' HG13 ' A' ' 43' ' ' VAL . 75.6 Cg_endo -86.45 24.94 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 123.201 2.601 . . . . 0.0 113.261 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 10' ' ' MET . 2.0 mmt180 -73.82 124.49 26.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm -77.69 110.6 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 68.2 mt -83.02 -26.2 31.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.491 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 7.3 t-20 -64.64 -143.74 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.797 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -160.25 -141.68 0.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.98 -51.15 57.66 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.579 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.5 m -155.83 124.29 5.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.708 0.254 . . . . 0.0 110.48 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.16 50.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.652 ' HD3' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -160.87 -143.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.838 -176.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.652 ' HG ' ' HD3' ' A' ' 96' ' ' ARG . 91.6 mt 66.79 31.07 7.64 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 122.775 0.43 . . . . 0.0 111.203 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -77.5 130.61 37.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 99' ' ' ARG . 5.3 mmp_? -94.76 -20.17 19.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.865 0.364 . . . . 0.0 110.964 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -125.08 47.98 2.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.136 0.494 . . . . 0.0 110.65 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -65.82 117.23 7.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.806 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -168.96 62.2 0.06 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.633 ' HD3' ' HE2' ' A' ' 6' ' ' PHE . 26.2 mtpp -111.3 76.23 0.96 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.081 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER 74.34 -40.71 0.46 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.292 -175.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -133.35 152.62 51.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.273 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -151.65 131.78 13.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.348 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.979 -0.534 . . . . 0.0 110.025 178.725 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 169.95 60.92 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.4 m 62.3 -131.78 0.57 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.423 0.289 . . . . 0.0 110.315 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.0 m -159.37 140.46 12.72 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 67.37 -85.01 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.875 0.734 . . . . 0.0 110.965 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -97.98 -145.21 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 6' ' ' PHE . 1.9 pt20 -87.65 -11.79 47.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 21.4 t80 79.22 23.5 0.53 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 124.404 1.065 . . . . 0.0 110.032 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.65 54.7 9.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.211 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.648 ' HB2' ' CG2' ' A' ' 89' ' ' ILE . 3.7 mt -58.89 142.27 51.13 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.221 0.534 . . . . 0.0 111.654 -174.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 92' ' ' LEU . 3.8 mp -104.36 45.54 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.12 -162.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.876 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 42.19 -170.33 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.484 -1.235 . . . . 0.0 113.46 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.85 ' HB2' HD21 ' A' ' 90' ' ' LEU . 16.4 t -111.14 -54.75 2.57 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.881 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.556 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 56.8 mt 48.56 33.16 3.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.047 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -86.24 -179.74 6.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mm-40 -67.93 116.05 34.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.2 Cg_exo -72.4 142.57 37.26 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.431 2.754 . . . . 0.0 112.975 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.45 -133.35 4.43 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.925 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.56 -27.08 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.658 0.266 . . . . 0.0 111.329 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -64.6 131.65 47.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 111.163 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.668 HG21 ' HD3' ' A' ' 42' ' ' LYS . 6.6 m -83.13 140.91 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.026 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.4 133.07 14.08 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.687 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 71.7 mt -95.64 143.79 26.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.173 0.511 . . . . 0.0 112.358 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 53.2 mt -113.93 139.28 49.35 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.374 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 8.6 p -72.62 151.62 42.22 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.606 ' HG2' HG21 ' A' ' 67' ' ' VAL . 21.4 mt-10 -49.32 -34.67 16.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.923 0.392 . . . . 0.0 111.595 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -71.46 -26.45 62.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 56.9 m -101.2 -16.08 17.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.453 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -51.94 115.77 1.85 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.258 0.552 . . . . 0.0 111.201 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 36' ' ' TYR . . . 122.29 -30.93 5.05 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.951 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 40.0 mttm -72.12 127.72 33.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.57 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 2.5 t -71.08 120.42 79.42 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HG2' HG11 ' A' ' 43' ' ' VAL . 71.8 Cg_exo -53.1 -35.54 73.05 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.827 2.351 . . . . 0.0 112.964 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mm -67.84 -46.68 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.363 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.7 p -118.46 -2.94 10.97 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.6 t70 59.13 67.8 0.88 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.284 0.564 . . . . 0.0 110.69 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.02 143.34 15.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.022 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.475 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.1 m-85 -83.39 13.31 4.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.091 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 73' ' ' CYS . 13.1 p -60.67 149.64 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.8 ptp85 -38.88 128.77 1.18 Allowed Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.098 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.732 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 Cg_exo -74.83 -161.38 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.437 2.758 . . . . 0.0 112.724 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.836 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -167.78 -43.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.728 178.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 -153.83 142.53 20.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 111.196 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.668 ' HD3' HG21 ' A' ' 19' ' ' THR . 87.0 mttt -62.54 143.08 57.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.473 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.994 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 18.0 m -82.08 146.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -118.98 133.51 55.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.073 0.463 . . . . 0.0 110.78 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.7 m -86.9 146.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.667 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.769 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 10.2 p -66.16 151.39 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -52.02 -37.17 52.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.884 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.495 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 16.9 m-80 -64.67 -20.19 66.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.554 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 19.6 m -90.2 -41.01 11.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.274 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -68.82 -30.27 68.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -63.46 -21.76 66.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -173.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.85 -148.87 18.91 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.169 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.488 ' HE3' ' CZ ' ' A' ' 51' ' ' PHE . 22.3 pttp 52.83 -59.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.173 1.789 . . . . 0.0 114.455 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -162.61 115.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.516 0.598 . . . . 0.0 111.299 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' CYS . . . -165.87 -35.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.647 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -66.76 -29.37 69.32 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.11 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 13.8 p30 -71.62 138.85 49.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.1 t -42.7 126.29 3.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.931 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.432 HG12 HD23 ' A' ' 22' ' ' LEU . 9.5 pt -61.21 -32.03 51.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.986 -1.007 . . . . 0.0 113.128 -171.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.99 -45.16 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -103.94 -7.35 20.46 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.684 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 42.04 51.33 4.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.708 0.803 . . . . 0.0 112.387 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 -66.13 0.13 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.085 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -71.24 139.41 50.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.51 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 13.8 p -66.67 136.4 26.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.432 . . . . 0.0 111.448 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.51 141.66 25.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.381 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 ' HG2' ' A' ' 24' ' ' GLU . 19.1 m -118.87 -46.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -116.91 147.23 42.4 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.648 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.36 142.62 58.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.579 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . . . -81.32 155.59 25.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.904 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 18.3 m-85 -127.84 137.28 52.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 91.1 m-85 -69.76 125.39 26.58 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 1.8 p -71.21 152.75 43.04 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.269 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.534 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.65 -44.19 62.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.092 -177.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -56.15 -46.8 79.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.527 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -72.6 -38.56 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.5 t -67.14 -39.98 86.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 110.397 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.27 -32.27 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.403 0.621 . . . . 0.0 109.905 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 101.82 41.21 2.53 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.106 176.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -94.74 1.26 55.46 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.279 -0.542 . . . . 0.0 110.722 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.48 -23.52 62.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.547 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -96.21 9.54 40.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.136 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -68.05 -65.91 0.63 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.96 -154.4 24.38 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.407 170.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 54.1 t -57.93 115.41 11.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.211 -0.994 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.994 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 71.8 Cg_endo -78.29 17.42 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.286 2.658 . . . . 0.0 113.312 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 14.0 mmm180 -67.98 136.41 53.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.876 ' HA ' ' HA ' ' A' ' 10' ' ' MET . 28.9 mm -92.31 119.55 40.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 118.408 0.549 . . . . 0.0 111.345 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.85 HD21 ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -153.84 -62.59 0.14 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.703 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER 169.97 154.61 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.365 0.666 . . . . 0.0 110.009 -173.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.711 ' HB3' HG22 ' A' ' 9' ' ' ILE . 60.2 tp -159.56 -24.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.57 37.95 39.11 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.5 t -167.98 44.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -69.27 127.85 34.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.279 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' HB2' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -145.14 -122.12 0.08 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.69 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' H ' ' HB2' ' A' ' 96' ' ' ARG . 92.4 mt 73.37 141.12 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.972 0.509 . . . . 0.0 111.282 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.91 59.86 1.61 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.607 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -67.61 138.28 56.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.013 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -156.12 51.9 0.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.462 0.648 . . . . 0.0 110.306 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -99.08 42.28 1.11 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.58 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -96.43 36.02 1.41 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.948 -175.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -95.21 -169.59 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -68.29 -33.07 73.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 25.2 mmmt -79.52 130.07 35.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.438 172.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -159.32 -36.6 0.06 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.623 0.725 . . . . 0.0 109.228 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 48.6 t . . . . . 0 C--N 1.31 -1.116 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.755 173.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 173.0 -35.84 0.13 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.926 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.8 t 60.1 30.67 20.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.793 0.437 . . . . 0.0 111.201 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.533 ' H ' ' HB3' ' A' ' 92' ' ' LEU . 5.0 m 54.63 32.4 17.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.811 176.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -75.84 142.54 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.033 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -75.54 55.43 0.82 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.688 ' HB3' ' HB2' ' A' ' 8' ' ' LEU . 57.4 mt-30 -67.76 144.91 55.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.33 72.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.468 0.651 . . . . 0.0 111.137 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 55.8 28.3 12.13 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.725 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 5' ' ' GLN . 62.4 mt -91.02 46.48 1.32 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.133 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.875 ' HA ' ' HB2' ' A' ' 91' ' ' ASN . 2.5 mp -110.52 13.27 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 123.157 1.456 . . . . 0.0 107.427 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.668 ' HE1' HD13 ' A' ' 32' ' ' ILE . 4.3 ptp -95.07 144.98 25.29 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 111.868 -2.424 . . . . 0.0 111.425 170.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.756 ' HA ' HD11 ' A' ' 90' ' ' LEU . 7.6 t -44.69 -59.9 2.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.383 -1.735 . . . . 0.0 112.625 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 84' ' ' ASP . 81.7 mt 52.48 32.18 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.935 0.894 . . . . 0.0 113.225 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -80.75 -177.92 6.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 9.3 tm0? -66.83 115.52 25.77 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 6.5 Cg_exo -74.99 140.1 25.09 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.991 2.461 . . . . 0.0 112.873 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.07 -145.3 10.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.214 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.6 -5.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.518 -0.401 . . . . 0.0 110.606 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -62.01 130.36 45.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.177 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -79.17 137.83 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.301 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.26 125.66 7.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.341 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 81.9 mt -100.08 145.8 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.241 0.543 . . . . 0.0 112.407 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.614 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 85.8 mt -114.04 133.01 55.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.572 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.5 p -72.14 157.95 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -53.01 -27.44 19.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.884 0.374 . . . . 0.0 111.842 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 50.7 mtpt -75.43 -24.14 57.05 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.321 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.441 ' HB3' HD12 ' A' ' 60' ' ' ILE . 8.9 m -119.05 18.46 13.14 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.9 129.54 40.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.763 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.52 -22.33 37.99 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.664 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 60.3 mttp -74.82 133.03 41.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.643 0.259 . . . . 0.0 111.021 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t -70.9 121.01 82.76 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 12.0 Cg_endo -58.35 -34.33 98.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.976 2.451 . . . . 0.0 113.142 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.668 HD13 ' HE1' ' A' ' 10' ' ' MET . 13.0 mm -69.89 -46.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.212 -175.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.5 p -122.66 -7.57 8.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 60.87 78.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.341 0.591 . . . . 0.0 110.367 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -160.54 143.95 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.398 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 25.5 m-85 -94.63 26.9 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.668 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG22 ' H ' ' A' ' 38' ' ' ARG . 4.4 p -75.96 168.84 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.602 ' NH1' ' HB3' ' A' ' 38' ' ' ARG . 3.2 mtp-105 -50.49 129.23 25.72 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.7 Cg_exo -73.28 158.57 48.43 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.19 2.593 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.512 ' HG3' ' HE3' ' A' ' 74' ' ' TRP . 11.9 tmtt? -142.94 -49.77 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.273 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HD3' ' OD2' ' A' ' 82' ' ' ASP . 67.9 ttt180 -122.31 130.54 53.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.683 0.278 . . . . 0.0 111.071 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.71 136.6 54.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.17 0.509 . . . . 0.0 110.648 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.2 t -75.44 134.68 28.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.984 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -124.46 130.19 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.5 m -92.29 155.68 3.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.047 0.451 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.5 p -66.3 151.34 47.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.222 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -53.06 -39.62 63.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.355 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.624 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 5.1 m120 -55.87 -44.71 78.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.256 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 33.6 m -66.95 -25.06 66.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 t -87.24 -51.01 6.21 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.628 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -65.22 -21.3 66.73 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.306 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.61 155.45 52.94 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.656 172.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -51.51 -37.77 50.84 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.467 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 2.9 pm0 -79.4 48.76 0.92 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.921 0.391 . . . . 0.0 111.467 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.72 -54.71 23.59 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 11.5 mmpt? -97.76 16.83 19.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -171.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 84.6 m-20 -84.35 154.46 22.86 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.733 0.777 . . . . 0.0 111.398 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.0 t -53.2 136.27 36.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.106 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.516 HD11 ' CB ' ' A' ' 70' ' ' ALA . 11.1 pt -77.76 -32.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.768 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 26' ' ' CYS . 46.8 mt -73.26 -48.58 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -108.2 11.8 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.306 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 7.3 p-10 53.79 -37.11 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -93.12 -46.75 7.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 119.665 1.121 . . . . 0.0 113.888 -171.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.742 ' H ' HD12 ' A' ' 63' ' ' LEU . 4.3 m120 -67.73 135.56 52.9 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 11.7 p -59.44 134.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 111.55 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.5 144.66 19.9 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.274 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.01 -42.57 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -113.43 139.21 49.1 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.966 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -64.36 138.16 58.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.215 0.531 . . . . 0.0 111.104 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.614 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -83.33 154.01 24.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.072 176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 11.6 m-85 -131.76 135.13 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.88 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 46.3 m-85 -68.63 127.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 4.9 p -70.87 156.75 39.2 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.569 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.512 ' HE3' ' HG3' ' A' ' 40' ' ' LYS . 9.5 t-105 -41.17 -60.27 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.007 0.817 . . . . 0.0 112.804 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.16 -35.85 78.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.209 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 23.5 m -62.81 -35.94 81.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 111.245 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.3 m -70.99 -37.95 72.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.211 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -49.21 76.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.39 175.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.16 -32.62 71.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.771 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . 79.9 43.92 9.55 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.504 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -95.32 -31.07 13.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.187 0.518 . . . . 0.0 110.068 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.435 ' OD2' ' HD3' ' A' ' 41' ' ' ARG . 43.7 p-10 -65.94 -30.93 71.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.429 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' C ' ' HD2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -64.38 -19.12 65.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.582 -176.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.721 ' HB3' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -64.62 -42.58 95.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.389 -177.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.04 -136.29 6.28 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.876 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 36.8 t -60.38 113.36 7.31 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.362 1.065 . . . . 0.0 112.159 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 69.4 Cg_endo -86.51 43.9 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.033 2.489 . . . . 0.0 113.827 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.643 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 45.9 mtt180 -98.67 127.88 44.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.94 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 9' ' ' ILE . 50.4 mm -74.18 114.27 13.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.756 HD11 ' HA ' ' A' ' 11' ' ' CYS . 0.8 OUTLIER -158.62 -0.72 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -177.201 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.875 ' HB2' ' HA ' ' A' ' 9' ' ' ILE . 91.2 m-20 -78.81 -118.96 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.168 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' HB3' ' H ' ' A' ' 2' ' ' SER . 4.2 tp -172.3 128.17 0.56 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.57 -140.1 4.15 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.016 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.6 m -68.41 115.86 8.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.194 0.521 . . . . 0.0 110.789 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 176.41 -41.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.712 ' HD3' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -142.55 146.07 34.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.609 -1.632 . . . . 0.0 107.44 170.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 96' ' ' ARG . 5.1 mt 172.56 -21.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.17 0.919 . . . . 0.0 110.843 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.7 t70 61.41 47.13 7.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.871 0.843 . . . . 0.0 109.954 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -148.04 -147.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.736 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 102' ' ' GLU . 58.4 t60 56.25 36.78 28.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 100' ' ' HIS . 37.0 t80 72.09 -28.56 0.19 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.144 0.577 . . . . 0.0 112.053 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.535 ' HG2' ' HG2' ' A' ' 103' ' ' LYS . 41.2 tt0 -54.74 132.89 46.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.846 0.459 . . . . 0.0 111.771 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.535 ' HG2' ' HG2' ' A' ' 102' ' ' GLU . 14.5 mmmm 70.84 -50.95 0.68 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.182 0.993 . . . . 0.0 111.98 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -77.93 -134.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.288 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -168.34 179.41 4.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -146.93 127.69 14.34 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.815 -177.601 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -179.44 -133.13 1.9 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.755 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 m -92.13 37.89 0.99 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.126 0.489 . . . . 0.0 110.459 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -82.27 47.16 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.298 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -143.55 128.59 18.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.063 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -87.12 -44.28 11.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.283 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 67.1 127.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.956 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 1.8 t80 -136.05 24.77 3.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.295 1.045 . . . . 0.0 108.798 173.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 1.01 ' HB3' HD11 ' A' ' 9' ' ' ILE . 25.6 m-20 -89.48 -50.86 5.85 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.242 168.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.582 ' CD1' ' HA ' ' A' ' 6' ' ' PHE . 1.1 mp 48.76 73.97 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.685 173.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.01 HD11 ' HB3' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -176.83 -172.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 123.969 0.908 . . . . 0.0 109.389 -177.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.86 ' SD ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -76.15 142.38 41.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 164.009 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.0 t -45.72 -53.84 8.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 111.522 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' HB2' ' HG3' ' A' ' 10' ' ' MET . 2.6 tp 41.99 41.05 1.8 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 170.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 64.0 mttm -79.65 -134.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.93 116.65 53.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD3' ' HA2' ' A' ' 85' ' ' GLY . 52.0 Cg_exo -56.14 135.72 71.4 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.217 -175.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.16 -136.14 8.05 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.393 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.67 -24.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -80.86 137.44 36.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -78.25 137.91 38.35 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.988 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.75 133.22 13.25 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.491 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 64.2 mt -95.29 147.36 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 111.913 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.645 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 79.4 mt -117.12 132.28 56.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.376 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.593 ' HA ' HG23 ' A' ' 67' ' ' VAL . 6.9 p -71.9 158.24 36.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HG3' HG21 ' A' ' 67' ' ' VAL . 39.8 mt-10 -55.75 -28.01 53.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.0 111.561 -176.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 55.0 mttp -71.81 -24.44 61.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.413 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.478 ' HB3' HD12 ' A' ' 60' ' ' ILE . 5.6 m -119.66 18.33 12.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 32.7 t70 -67.51 131.49 45.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.554 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.49 -27.54 6.31 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.83 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 61.9 mttp -66.75 132.02 47.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.584 0.231 . . . . 0.0 111.027 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 t -71.17 118.01 61.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 68.0 Cg_exo -56.41 -39.85 88.51 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.157 2.571 . . . . 0.0 113.383 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.586 HG21 ' HD3' ' A' ' 81' ' ' LYS . 6.8 mm -61.54 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.209 -174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -119.47 -16.51 8.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 66.94 77.97 0.26 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.59 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -171.34 145.86 2.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.996 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -97.45 31.23 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.79 70.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 122.31 1.053 . . . . 0.0 111.83 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.428 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 4.8 mmp_? 60.14 111.63 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.776 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.36 144.03 66.22 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.719 2.279 . . . . 0.0 112.132 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -128.68 -48.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -139.81 144.9 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.439 -0.163 . . . . 0.0 111.202 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 92.9 mttt -63.94 138.31 58.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.316 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.805 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.0 t -73.53 131.84 34.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.687 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.0 OUTLIER -113.18 124.69 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.61 150.92 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.404 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.633 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 11.7 p -62.0 150.14 38.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -51.78 -34.83 41.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.103 -177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.7 m120 -58.24 -45.51 87.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.574 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 99.3 m -74.99 -15.01 60.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -85.49 -45.62 11.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.263 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.645 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER -81.36 -20.88 39.65 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.824 -179.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.5 158.59 53.61 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.278 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.92 -24.96 67.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.395 0.617 . . . . 0.0 110.054 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.479 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 7.0 mp0 -53.83 -30.83 47.02 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.431 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.04 -35.43 11.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.791 -1.095 . . . . 0.0 113.013 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -70.59 -36.33 73.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.01 0.433 . . . . 0.0 110.582 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.804 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 3.1 m120 -78.26 158.82 28.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.3 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.5 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.397 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.615 HG22 ' NE ' ' A' ' 88' ' ' ARG . 7.7 pt -70.62 -38.09 72.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.976 -173.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 26' ' ' CYS . 43.4 mt -69.95 -54.85 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -90.36 -6.47 54.99 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.793 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 48.99 24.29 0.85 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.932 0.893 . . . . 0.0 112.393 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.91 -59.83 0.74 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.319 -170.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -76.14 140.53 41.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.804 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 42.9 t -58.56 137.76 20.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 111.107 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.88 149.17 45.87 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.049 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 23' ' ' CYS . 47.3 t -122.4 -62.19 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.757 0.313 . . . . 0.0 111.28 -177.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.44 143.19 45.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.28 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -60.48 136.78 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -82.71 156.06 23.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.325 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -128.8 133.68 48.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.14 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.805 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.3 m-85 -67.27 130.85 44.4 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.416 ' SG ' ' CG ' ' A' ' 75' ' ' GLU . 11.2 p -73.48 167.97 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -55.69 -49.17 73.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' CG ' ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt-20 -63.26 -39.58 95.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 69.4 m -66.25 -40.03 89.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.899 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 21.3 t -68.07 -36.99 80.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.25 0.548 . . . . 0.0 109.89 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -60.61 -44.24 96.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.05 -31.49 69.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.874 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.76 8.44 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.01 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HD3' HG21 ' A' ' 32' ' ' ILE . 43.1 mttm -87.84 7.51 30.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.708 0.766 . . . . 0.0 110.294 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -92.8 -10.94 35.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.847 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.67 -26.25 7.52 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.081 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -64.98 -54.83 24.34 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.951 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.449 ' HA2' ' HD3' ' A' ' 15' ' ' PRO . . . -158.56 -158.55 9.09 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.999 -1.572 . . . . 0.0 115.152 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 1.6 t -95.17 120.04 64.75 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.792 -1.204 . . . . 0.0 111.47 -173.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.86 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 71.6 Cg_endo -75.5 47.02 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.922 3.081 . . . . 0.0 114.166 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.615 ' NE ' HG22 ' A' ' 59' ' ' ILE . 17.9 mmt180 -101.95 126.67 48.92 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 91' ' ' ASN . 2.8 mm -86.88 118.68 33.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.508 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.53 -44.5 7.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.831 ' HB3' ' N ' ' A' ' 9' ' ' ILE . 3.5 t-20 -126.03 159.4 32.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.3 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -39.33 -38.84 0.58 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.04 -57.18 0.29 Allowed Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.96 174.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m 55.68 37.35 28.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.643 0.735 . . . . 0.0 109.766 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -166.99 25.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.606 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 98' ' ' ASP . 19.7 ttt85 -67.5 135.5 53.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.133 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.1 mt 72.45 -25.38 0.18 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.128 0.571 . . . . 0.0 111.523 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 96' ' ' ARG . 31.0 t70 61.83 22.04 12.71 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.905 0.882 . . . . 0.0 111.493 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -94.8 41.63 1.09 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.309 0.576 . . . . 0.0 110.564 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.57 141.43 31.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.058 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.74 45.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.27 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 103' ' ' LYS . 46.2 tp10 -68.29 122.46 18.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.76 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.425 ' HG3' ' HG3' ' A' ' 102' ' ' GLU . 34.1 mtmm 62.1 -135.29 0.52 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.977 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.71 -35.02 45.55 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 122.208 -0.308 . . . . 0.0 111.371 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -67.18 129.5 40.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.777 0.323 . . . . 0.0 110.53 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.37 10.68 28.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.327 0.584 . . . . 0.0 109.721 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.2 t . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.624 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 77.17 48.57 8.18 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.311 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.7 m -65.13 -38.32 90.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.528 0.204 . . . . 0.0 110.469 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t 55.12 48.34 19.84 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.79 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -95.84 53.52 1.42 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.426 0.632 . . . . 0.0 109.714 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 6' ' ' PHE . 61.7 m170 -84.55 142.54 29.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.168 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.613 ' C ' ' H ' ' A' ' 7' ' ' ASP . 19.7 pt20 -79.76 35.13 0.29 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.333 169.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.75 ' HB2' HD11 ' A' ' 8' ' ' LEU . 34.1 m-85 69.56 -20.36 0.17 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.325 1.05 . . . . 0.0 109.705 -169.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.613 ' H ' ' C ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER 64.73 44.01 3.94 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.783 176.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -85.16 56.15 3.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.168 0.509 . . . . 0.0 110.516 175.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 91' ' ' ASN . 1.8 mp -74.05 69.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.379 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.592 ' SD ' ' HD2' ' A' ' 83' ' ' LYS . 7.1 ptp -50.44 151.69 2.13 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.367 -172.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.759 ' HB2' HD21 ' A' ' 90' ' ' LEU . 53.8 t -42.57 -56.53 3.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.559 -174.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 86.8 mt 52.39 41.0 30.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.508 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 84.4 mttt -77.1 -176.96 4.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 167.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -70.09 116.11 40.99 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.722 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 28.6 Cg_endo -72.15 142.85 38.76 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.386 2.057 . . . . 0.0 112.765 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.57 -157.43 28.7 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.007 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.85 -23.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.11 0.481 . . . . 0.0 110.893 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -63.65 128.49 36.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.034 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.576 HG21 ' HD3' ' A' ' 42' ' ' LYS . 20.2 m -82.58 136.33 34.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.601 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.546 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -66.51 126.16 27.26 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.923 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 63.8 mt -80.96 141.85 34.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 112.14 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 70.2 mt -118.4 143.91 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.186 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 11.5 p -80.14 157.55 26.58 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.4 -26.55 42.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.07 0.462 . . . . 0.0 111.386 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.1 mmtt -71.52 -27.3 63.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.2 m -108.84 26.22 10.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.06 127.46 31.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.4 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.61 32.84 61.32 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.421 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE2' ' HE1' ' A' ' 36' ' ' TYR . 94.4 mttt -111.83 140.22 46.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.675 0.274 . . . . 0.0 110.902 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 10.7 t -82.36 114.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.942 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HG3' HG21 ' A' ' 43' ' ' VAL . 12.0 Cg_endo -58.83 -29.43 89.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.978 2.452 . . . . 0.0 112.957 -176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 81' ' ' LYS . 21.2 mm -65.23 -40.94 90.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.09 -12.28 6.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 t0 62.2 74.38 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -163.25 141.36 7.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.106 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.502 ' HE1' ' HE2' ' A' ' 29' ' ' LYS . 13.2 m-85 -85.75 33.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 73' ' ' CYS . 5.1 p -78.78 158.02 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -41.51 128.85 2.31 Favored Pre-proline 0 N--CA 1.467 0.379 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 96.1 Cg_endo -82.53 154.3 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.32 2.68 . . . . 0.0 112.048 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 20.8 tptm -127.21 -40.62 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -150.45 139.68 21.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.306 -0.246 . . . . 0.0 111.166 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HD3' HG21 ' A' ' 19' ' ' THR . 71.2 mttt -59.96 139.33 57.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 111.714 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.786 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.9 t -71.34 133.37 31.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.114 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' NH1' ' HB2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -109.78 126.85 54.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.918 175.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.4 m -102.07 154.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.733 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -66.84 141.29 57.73 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.26 -22.61 53.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.7 -32.11 73.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.301 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.3 m -92.1 41.58 1.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.602 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -138.69 -41.98 0.49 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.556 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -127.07 28.32 5.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.732 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.44 -148.8 10.69 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.343 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -67.08 -42.63 84.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -130.88 130.27 43.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.94 -44.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.458 -172.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 21.8 mmtp -70.95 -33.32 70.36 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.338 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.877 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.0 m-20 -68.89 140.92 55.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.467 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 10.4 t -48.54 131.53 17.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.016 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 ' HA3' ' A' ' 20' ' ' GLY . 24.1 pt -70.19 -32.88 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.429 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 mt -72.64 -44.32 60.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.3 p -107.12 -3.81 19.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.984 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 41.47 45.02 2.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.415 0.686 . . . . 0.0 112.621 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.9 -60.61 0.26 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.211 0.529 . . . . 0.0 110.654 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -82.32 138.54 34.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.488 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.877 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 46.8 t -61.32 137.27 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.59 -179.41 49.5 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.148 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -174.12 -39.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.597 0.713 . . . . 0.0 109.31 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 8.1 m120 -82.83 176.75 9.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.387 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -118.92 135.48 54.56 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB2' HD21 ' A' ' 22' ' ' LEU . . . -78.38 146.25 34.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -126.55 133.02 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.786 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 64.2 m-85 -69.33 120.8 15.71 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 7.0 p -70.03 162.1 28.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.468 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 4.9 t-105 -43.4 -55.95 3.84 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 124.206 0.941 . . . . 0.0 112.1 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.81 -46.77 88.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.92 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.1 m -66.53 -40.86 89.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.079 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 t -67.51 -40.51 85.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.617 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -62.97 -43.6 98.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.881 0.372 . . . . 0.0 110.505 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.71 -27.12 62.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.067 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.07 44.46 13.81 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.533 ' O ' HD12 ' A' ' 32' ' ' ILE . 29.3 mtpp -93.12 31.41 1.45 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.955 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.39 -1.32 8.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.592 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 94.0 mttt 58.73 30.48 20.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.393 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 23.0 t70 82.42 -36.34 0.09 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.621 174.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.722 ' HA2' ' HG3' ' A' ' 15' ' ' PRO . . . -165.48 -134.15 1.62 Allowed Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 118.448 -1.834 . . . . 0.0 115.468 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 13.3 t -50.63 103.09 0.35 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 113.772 -1.214 . . . . 0.0 113.03 -169.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 57.7 Cg_endo -91.28 44.61 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.563 2.842 . . . . 0.0 113.113 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.1 ptm180 -110.94 136.7 49.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 8' ' ' LEU . 42.9 mm -76.13 139.72 18.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.315 -175.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.759 HD21 ' HB2' ' A' ' 11' ' ' CYS . 1.6 pp -171.5 -37.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER 56.65 -149.95 0.45 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.395 169.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -173.65 134.75 0.5 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.695 -172.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.24 -44.13 4.46 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.8 m -157.78 170.9 21.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.0 m120 70.46 63.48 0.2 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.501 0.5 . . . . 0.0 111.061 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.501 HH22 HG21 ' A' ' 9' ' ' ILE . 18.2 tpp180 -66.35 135.14 53.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.331 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 97' ' ' LEU . 3.0 pp -56.66 141.34 43.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -74.44 118.18 17.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.331 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 102' ' ' GLU . 65.9 mtp180 66.03 -77.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.758 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.427 ' HA ' HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -165.84 -60.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -169.67 35.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.405 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.651 ' HG3' ' HG3' ' A' ' 103' ' ' LYS . 6.9 tp10 -76.54 140.18 41.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.359 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.651 ' HG3' ' HG3' ' A' ' 102' ' ' GLU . 66.0 mttm 61.3 45.82 8.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.988 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -172.22 -38.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.449 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 66.58 -149.85 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.997 -174.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.499 ' HD3' ' HB3' ' A' ' 14' ' ' GLN . 33.2 mtmm -115.0 51.75 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.131 0.491 . . . . 0.0 110.672 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.214 -0.898 . . . . 0.0 109.345 179.477 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.641 ' HA3' ' HZ ' ' A' ' 6' ' ' PHE . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.196 -0.362 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 109.56 23.41 6.28 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.066 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.0 m -158.42 137.09 11.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 m -136.1 121.21 18.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.161 0.505 . . . . 0.0 111.138 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -105.13 -17.82 14.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.658 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -148.73 -137.07 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -80.23 115.95 20.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.641 ' HZ ' ' HA3' ' A' ' -1' ' ' GLY . 47.6 t80 -83.16 29.14 0.49 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.637 -176.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 p30 38.62 53.57 1.88 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.702 0.801 . . . . 0.0 112.529 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.846 HD22 ' H ' ' A' ' 8' ' ' LEU . 1.2 mm? -63.97 -41.68 97.47 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.854 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 91' ' ' ASN . 1.5 mp 58.32 77.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.195 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.664 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -84.44 145.66 28.05 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.402 -171.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 30.9 t -50.53 -54.22 24.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.222 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.664 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 81.1 mt 48.34 40.79 15.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 50.9 mttm -79.97 -156.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -83.16 111.17 28.58 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 59.6 Cg_endo -80.98 138.33 11.43 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.006 1.804 . . . . 0.0 112.417 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.91 -139.42 9.65 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.047 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -89.46 -16.9 8.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 110.284 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.729 ' HB2' HG12 ' A' ' 45' ' ' VAL . 3.7 mm100 -56.93 132.88 54.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.149 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.402 HG21 ' HD3' ' A' ' 42' ' ' LYS . 12.7 m -107.61 127.3 53.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.212 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.744 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -71.7 114.67 5.21 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.256 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.1 mt -87.07 154.03 21.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.688 0.28 . . . . 0.0 110.587 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 76.8 mt -113.74 130.21 56.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p -75.2 157.03 35.18 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 51.2 mt-10 -54.9 -28.39 50.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.964 0.412 . . . . 0.0 111.69 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.7 mtpt -72.43 -27.97 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.165 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.8 31.79 6.49 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.9 t0 -73.76 133.91 43.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.343 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.85 32.29 66.68 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.035 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 22.9 mtpp -119.46 122.04 40.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 25.3 t -63.29 118.66 45.72 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.48 -37.3 97.71 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.762 HG21 ' HG3' ' A' ' 81' ' ' LYS . 10.8 mm -64.08 -46.48 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.36 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 22.5 p -123.78 -8.47 7.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.3 t0 60.91 76.47 0.37 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.812 0.815 . . . . 0.0 110.428 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -151.36 143.25 23.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.477 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 29' ' ' LYS . 5.9 m-85 -96.5 23.98 6.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 110.299 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 73' ' ' CYS . 9.9 p -76.35 161.8 4.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.201 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.599 ' HD2' ' HD2' ' A' ' 39' ' ' PRO . 23.2 tpt180 -47.25 120.24 6.71 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.443 0.697 . . . . 0.0 112.559 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 86.2 Cg_endo -82.56 161.14 16.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.415 2.743 . . . . 0.0 111.815 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HG3' ' CE3' ' A' ' 74' ' ' TRP . 3.3 mmmp? -130.32 -59.25 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -116.41 136.94 52.56 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.839 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HD3' HG21 ' A' ' 19' ' ' THR . 38.9 ttmt -67.73 136.74 54.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.742 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 17.9 m -79.98 151.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.917 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -124.45 127.55 47.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.159 173.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.729 HG12 ' HB2' ' A' ' 18' ' ' GLN . 0.3 OUTLIER -92.54 153.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.608 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 p -72.83 148.32 44.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 86.5 tt0 -56.56 -27.44 57.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.035 0.445 . . . . 0.0 111.068 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.56 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 7.5 m-80 -63.84 -26.69 68.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.112 177.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HB3' ' NE ' ' A' ' 88' ' ' ARG . 87.6 m -102.68 33.1 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.22 -0.3 . . . . 0.0 111.679 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.488 ' OG ' ' HG3' ' A' ' 18' ' ' GLN . 12.0 p -160.9 -50.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.573 -173.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 49.71 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.137 0.975 . . . . 0.0 111.847 -175.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.66 76.07 1.76 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.191 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 18' ' ' GLN . 67.6 mttm 67.51 -74.97 0.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.676 0.79 . . . . 0.0 112.246 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -155.34 28.22 0.4 Allowed 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 44.24 27.47 0.22 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.939 171.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER 41.02 44.81 2.12 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.672 0.789 . . . . 0.0 111.65 -176.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.23 141.17 39.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.376 1.084 . . . . 0.0 113.353 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.0 t -69.93 135.12 49.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.442 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.744 HD13 ' HA3' ' A' ' 20' ' ' GLY . 3.7 pt -71.92 -31.87 42.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -70.28 -51.41 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 21.7 p -91.38 -7.4 50.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.685 176.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 6.7 p-10 47.25 40.2 9.9 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 124.436 1.085 . . . . 0.0 111.57 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -157.41 -60.63 0.09 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.525 -177.071 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.581 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 5.7 m120 -60.21 144.58 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 34.5 t -61.56 119.37 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 111.075 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.22 142.78 26.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.464 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 -45.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -108.2 127.86 54.2 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.87 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.56 136.83 56.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.82 0.448 . . . . 0.0 110.961 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -76.93 146.28 37.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.774 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 6.9 m-85 -127.52 134.55 49.77 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.182 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.487 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 95.2 m-85 -62.98 124.92 22.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.7 p -69.14 161.17 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.856 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.499 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -46.84 -50.29 18.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.067 -177.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.28 -45.65 87.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.697 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 92.3 m -64.82 -33.25 75.54 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.307 -0.246 . . . . 0.0 111.013 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 32.0 t -67.59 -40.6 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.74 -44.64 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.895 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.14 -32.59 72.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.731 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . 89.51 46.93 4.18 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.762 ' HG3' HG21 ' A' ' 32' ' ' ILE . 27.4 mmmt -73.57 -14.96 61.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 110.742 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -64.53 -32.13 73.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -73.21 -21.63 60.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.837 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.437 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.3 m-20 -58.1 -55.4 35.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.58 -137.01 7.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.866 -1.159 . . . . 0.0 114.132 171.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.628 ' SG ' HG22 ' A' ' 45' ' ' VAL . 50.2 t -64.29 113.28 9.88 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.979 0.912 . . . . 0.0 111.835 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.636 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 83.0 Cg_endo -82.58 31.55 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.956 2.437 . . . . 0.0 114.381 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.483 ' NE ' ' HB3' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.22 139.58 38.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.84 HD12 ' HB3' ' A' ' 8' ' ' LEU . 33.5 mm -92.83 132.09 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 123.16 0.288 . . . . 0.0 110.763 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 11' ' ' CYS . 1.2 pt? -165.6 54.69 0.11 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.746 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 9.7 p30 -72.07 -29.98 64.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 171.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' HG ' ' H ' ' A' ' 94' ' ' SER . 64.8 tp -160.78 -58.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.571 174.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.13 22.32 49.21 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.258 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.552 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 t 54.89 40.28 31.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.985 0.514 . . . . 0.0 110.455 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -160.05 -57.97 0.06 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -71.87 127.11 31.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.081 -176.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.9 mt 51.14 37.0 17.03 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.547 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -76.91 -41.68 42.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 45.5 ttt-85 167.31 -37.42 0.0 OUTLIER 'General case' 0 C--O 1.231 0.086 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.843 175.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -63.55 136.93 57.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.583 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.832 ' HB2' ' HA ' ' A' ' 106' ' ' LYS . 40.9 p90 -150.35 122.27 8.18 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 171.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -142.37 -42.23 0.33 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.174 -166.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.683 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 55.4 mtpt -75.32 91.5 2.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.471 -173.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 70.67 -54.2 0.65 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.064 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -138.9 -130.94 0.12 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.625 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.832 ' HA ' ' HB2' ' A' ' 101' ' ' PHE . 12.4 mmmm -80.7 54.27 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.094 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' A' ' 103' ' ' LYS . 36.9 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.042 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 161.41 -32.32 0.35 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t -163.63 139.96 6.82 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 71.25 142.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.789 0.68 . . . . 0.0 111.785 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 3' ' ' ARG . 6.6 ptp180 -66.27 141.6 57.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.665 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -66.21 -49.31 67.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.442 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -78.59 128.22 33.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.6 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -79.67 -110.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -87.28 17.89 4.1 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.401 0.619 . . . . 0.0 110.153 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mt -86.01 55.37 3.5 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.694 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.8 mp -62.37 87.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.67 -173.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.711 ' CG ' HD13 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -66.26 136.0 55.23 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.041 -171.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.48 ' CB ' HD21 ' A' ' 90' ' ' LEU . 1.6 t -37.76 -59.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.673 -172.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD13 ' CG ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 45.77 43.47 9.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.42 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 67.8 mttm -91.74 -147.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.649 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -95.64 111.29 55.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.025 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 71.7 Cg_exo -54.67 134.79 64.28 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.233 2.622 . . . . 0.0 113.296 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.45 -142.12 12.56 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.863 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -96.94 -35.93 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' ' CB ' ' A' ' 50' ' ' SER . 75.4 mt-30 -76.35 138.51 40.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.472 0.653 . . . . 0.0 112.111 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.492 HG21 ' HD3' ' A' ' 42' ' ' LYS . 30.1 m -84.44 131.17 34.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.536 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.36 137.52 35.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 86.2 mt -106.31 161.69 14.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.376 . . . . 0.0 111.658 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.714 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 81.7 mt -123.24 131.2 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 11.5 p -73.36 161.01 30.95 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HG3' HG21 ' A' ' 67' ' ' VAL . 70.6 mt-10 -62.07 -18.16 59.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.203 0.525 . . . . 0.0 111.347 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 56.4 mttm -78.24 -36.68 46.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.609 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 3.9 m -106.42 32.48 4.45 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.584 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 44.2 t0 -70.93 129.66 39.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.596 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.71 28.28 61.42 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.104 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 26' ' ' CYS . 40.0 mtmt -115.91 126.64 54.17 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.658 -0.319 . . . . 0.0 110.375 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.27 117.89 34.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 78.4 Cg_exo -55.61 -37.67 94.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.987 2.458 . . . . 0.0 113.136 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.603 HG21 ' HB3' ' A' ' 81' ' ' LYS . 7.3 mm -63.21 -49.48 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.1 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.9 p -116.27 -8.44 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.6 t0 63.28 68.65 0.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.056 0.455 . . . . 0.0 109.962 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -153.42 142.98 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.459 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -87.45 2.44 50.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.318 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -60.67 152.53 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.659 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -31.08 131.86 0.25 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.434 1.094 . . . . 0.0 113.463 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 88.0 Cg_endo -76.81 -160.84 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.509 . . . . 0.0 112.431 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.566 ' HG2' ' SG ' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -169.75 -50.46 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.261 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -157.35 144.24 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.718 -174.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HD3' HG21 ' A' ' 19' ' ' THR . 94.0 mttt -61.59 141.73 57.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.039 0.447 . . . . 0.0 111.5 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.938 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 25.6 m -77.82 137.78 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.281 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -106.52 119.87 40.44 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.52 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG22 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -80.67 146.39 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.525 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 7.1 p -68.38 160.45 29.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.001 -177.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' CYS . 36.9 tt0 -60.47 -29.63 69.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.056 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.551 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 9.0 m120 -77.68 35.94 0.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.201 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.748 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 58.0 m -157.02 -38.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.339 174.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' A' ' 18' ' ' GLN . 76.3 p -92.31 34.41 1.04 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.933 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -32.44 58.7 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.453 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.25 -71.22 0.27 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.544 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.653 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 1.4 tpmt? -74.17 123.97 25.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 66.13 51.62 1.26 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.588 0.709 . . . . 0.0 110.544 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.37 -32.47 8.13 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.336 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -95.41 14.2 23.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.62 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -73.0 148.68 43.96 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.572 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.7 t -59.47 116.81 4.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' A' ' 43' ' ' VAL . 2.0 pt -57.59 -30.44 36.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.046 -172.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.35 -44.1 63.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.7 p -101.04 -12.97 18.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.346 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 56.38 17.72 3.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.45 1.1 . . . . 0.0 111.723 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 -61.42 0.85 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 -172.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -71.79 142.25 49.68 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.56 133.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -73.62 139.22 26.14 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.714 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.719 HG21 ' HG3' ' A' ' 24' ' ' GLU . 45.3 t -109.94 -57.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.258 0.552 . . . . 0.0 111.07 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.14 136.81 43.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.303 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.439 ' HA ' HD23 ' A' ' 21' ' ' LEU . 2.1 m-20 -64.08 128.87 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.714 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -74.26 144.27 44.69 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.973 0.416 . . . . 0.0 111.753 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -115.87 135.33 54.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.371 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.753 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 86.9 m-85 -64.98 132.62 49.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.5 p -74.65 154.83 38.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.536 ' HA ' ' SG ' ' A' ' 77' ' ' CYS . 56.5 t90 -53.2 -41.41 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.442 0.464 . . . . 0.0 111.659 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 50.0 mt-10 -59.62 -42.99 93.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.976 0.417 . . . . 0.0 110.542 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 59.4 m -67.67 -39.76 84.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.566 ' SG ' ' HG2' ' A' ' 40' ' ' LYS . 21.5 p -72.63 -34.2 67.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -63.38 -45.17 92.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 83.7 mt -73.93 -39.46 63.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.606 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.47 28.54 3.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.749 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.637 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 4.5 mttp -82.98 -25.24 32.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.138 0.494 . . . . 0.0 110.431 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.35 -32.33 73.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.272 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -94.84 8.39 42.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.212 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.637 ' OD2' ' HA ' ' A' ' 81' ' ' LYS . 2.6 m-20 -71.06 -48.15 54.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.99 -143.7 9.71 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.916 173.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 52.6 t -68.93 123.65 88.55 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 123.842 0.857 . . . . 0.0 111.42 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.938 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 69.3 Cg_endo -89.28 25.26 0.61 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.656 2.238 . . . . 0.0 114.945 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.748 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 50.4 mtt180 -80.18 141.4 35.71 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.006 -0.433 . . . . 0.0 111.231 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.8 mm -99.07 104.6 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.066 173.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.48 HD21 ' CB ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -134.35 -6.53 2.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.232 -176.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 3.4 m-20 66.07 -130.89 0.21 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.575 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -148.25 139.73 23.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.0 0.428 . . . . 0.0 111.086 178.184 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.17 46.12 3.49 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.762 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.3 m 59.9 41.79 17.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.031 0.532 . . . . 0.0 111.4 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.717 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 17.6 p-10 -166.2 -52.8 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.108 176.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.717 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 6.3 ppt_? 58.25 -39.75 0.06 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.649 1.58 . . . . 0.0 114.56 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.21 130.78 44.19 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.967 -0.458 . . . . 0.0 110.633 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.86 37.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.67 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 101' ' ' PHE . 99.6 mtt180 -81.85 57.21 3.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 174.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -72.68 31.09 0.06 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.92 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 99' ' ' ARG . 15.8 m-85 -96.45 52.08 1.22 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 172.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.67 -46.37 88.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.945 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -79.33 125.6 29.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.301 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 mttp 56.6 47.74 17.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.373 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.24 -175.99 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 101' ' ' PHE . 3.6 mppt? -83.04 133.76 35.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.977 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.522 -178.171 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 63.91 -116.69 9.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.929 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t -156.65 -146.09 0.16 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -153.97 158.8 41.18 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -63.58 104.07 0.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.801 0.81 . . . . 0.0 110.833 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.0 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.404 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -63.86 160.45 17.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.891 168.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.622 ' HB2' ' CD1' ' A' ' 8' ' ' LEU . 33.5 m-85 -71.86 -134.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -132.23 38.55 3.48 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.678 -0.639 . . . . 0.0 111.939 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.747 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -91.35 55.92 2.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.201 0.524 . . . . 0.0 110.637 174.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.7 mp -77.97 79.94 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . 1.004 ' HG3' HD13 ' A' ' 12' ' ' LEU . 2.2 ptm -109.39 169.74 8.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.547 -167.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.606 ' HA ' HD11 ' A' ' 90' ' ' LEU . 9.1 t -54.14 -53.91 46.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.179 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.004 HD13 ' HG3' ' A' ' 10' ' ' MET . 0.9 OUTLIER 40.23 49.41 2.46 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 174.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 59.7 mttm -91.63 -149.56 0.24 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 170.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -100.3 122.57 49.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.336 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 70.1 Cg_exo -53.93 132.89 52.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.244 2.629 . . . . 0.0 112.535 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.87 -63.6 1.81 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.337 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.53 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HG3' ' CG2' ' A' ' 45' ' ' VAL . 9.3 pt20 -71.25 145.65 49.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.778 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.657 HG21 ' HD3' ' A' ' 42' ' ' LYS . 28.4 m -78.97 139.07 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.778 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.65 129.4 13.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.356 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 95.0 mt -100.14 142.78 31.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.274 0.559 . . . . 0.0 111.717 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -107.5 134.98 49.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.012 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 4.2 p -72.47 150.99 42.8 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 69.4 mt-10 -50.22 -30.63 11.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.17 0.51 . . . . 0.0 111.63 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.4 mttm -69.82 -22.39 63.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.485 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.1 m -116.07 0.91 13.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.159 0.504 . . . . 0.0 109.735 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 31.9 t0 -56.16 136.45 52.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.816 -172.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.18 -28.59 10.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.91 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 36.2 mtmt -74.18 128.11 34.7 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.126 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 1.8 t -66.42 115.54 25.04 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -55.45 -28.96 66.61 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 123.074 2.516 . . . . 0.0 113.159 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.48 HD11 ' HE1' ' A' ' 72' ' ' TYR . 7.2 mm -64.46 -42.29 94.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.881 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 35' ' ' SER . 31.5 p -128.72 -11.84 4.89 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -170.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 65.59 58.28 0.82 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.61 . . . . 0.0 110.645 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.503 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 41.8 t -153.96 141.37 19.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.585 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 3.4 m-85 -91.31 34.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 37' ' ' VAL . 7.4 p -81.7 76.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.178 0.989 . . . . 0.0 111.547 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.445 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 63.5 mtp85 59.73 91.43 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.62 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 39.9 Cg_endo -62.42 145.24 95.72 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.365 2.043 . . . . 0.0 111.366 174.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -132.56 -51.1 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.46 140.82 48.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.744 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.657 ' HD3' HG21 ' A' ' 19' ' ' THR . 72.2 mttt -66.36 136.1 55.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.941 HG11 ' HG3' ' A' ' 87' ' ' PRO . 58.2 t -85.86 133.04 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.851 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -109.29 128.02 54.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' CG2' ' HG3' ' A' ' 18' ' ' GLN . 25.0 m -77.13 155.4 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.334 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.781 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 2.1 p -66.49 164.06 17.23 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.426 0.632 . . . . 0.0 111.744 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HG2' ' CE2' ' A' ' 51' ' ' PHE . 67.8 tt0 -55.05 -50.8 68.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.102 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 2.5 m-80 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.487 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.624 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 96.0 m -70.84 -24.12 62.47 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -78.68 -38.76 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.142 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.541 ' CE2' ' HG2' ' A' ' 47' ' ' GLU . 1.7 p90 -96.63 -26.01 15.37 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -82.76 52.76 4.76 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.782 -174.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 61.5 pttt 52.29 178.23 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.377 1.071 . . . . 0.0 112.533 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' HB2' ' ND2' ' A' ' 57' ' ' ASN . 16.8 pt20 42.74 35.19 0.66 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.074 0.95 . . . . 0.0 112.515 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.79 79.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.109 0.48 . . . . 0.0 111.085 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -66.58 -15.53 63.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.441 -178.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 22.4 m-20 -61.22 136.84 58.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.28 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 29.8 t -55.16 125.9 22.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.126 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.878 HD12 ' HG2' ' A' ' 87' ' ' PRO . 3.5 pt -66.88 -34.39 69.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.672 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -71.63 -37.59 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.78 ' O ' HD12 ' A' ' 63' ' ' LEU . 27.3 p -113.45 -0.35 14.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.421 -0.799 . . . . 0.0 110.482 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 36.56 59.58 0.98 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.432 1.493 . . . . 0.0 114.829 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.006 HD13 ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.88 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.056 171.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 1.006 ' H ' HD13 ' A' ' 63' ' ' LEU . 72.2 m-80 -61.19 142.55 56.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.9 t -75.52 132.45 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.15 148.36 31.29 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.158 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.45 -41.85 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -113.25 131.91 55.73 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 110.956 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.22 138.18 56.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.415 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB2' HD11 ' A' ' 59' ' ' ILE . . . -71.19 144.57 50.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.708 175.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.89 133.05 52.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.697 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.48 ' HE1' HD11 ' A' ' 32' ' ' ILE . 97.6 m-85 -65.45 126.72 29.16 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 3.9 p -74.65 165.21 25.6 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.272 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -47.95 -59.56 3.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.537 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 54.2 mt-10 -58.17 -43.1 87.28 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.216 -171.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.14 -32.51 73.99 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.055 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.7 m -68.7 -36.98 79.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.81 -45.1 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.218 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 94.2 mt -63.0 -33.79 76.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.784 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.08 31.24 9.3 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.041 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.56 26.95 3.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.286 0.565 . . . . 0.0 109.971 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -78.43 -15.96 58.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.695 173.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -4.32 38.85 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.325 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.719 ' HB3' HD11 ' A' ' 12' ' ' LEU . 83.5 m-20 -81.95 77.35 8.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.91 -86.4 0.02 OUTLIER Glycine 0 C--O 1.227 -0.282 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.374 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.781 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 10.8 t -78.37 108.67 8.25 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.715 0.293 . . . . 0.0 110.571 -174.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.941 ' HG3' HG11 ' A' ' 43' ' ' VAL . 43.0 Cg_endo -93.5 36.74 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.523 2.149 . . . . 0.0 113.785 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.624 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 33.3 mtt180 -75.63 114.51 14.3 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.083 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.5 mm -75.43 87.56 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 11' ' ' CYS . 16.0 mt -66.88 -43.42 83.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.903 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -69.1 128.37 36.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.421 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 71.08 -43.47 0.56 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.133 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.34 -126.72 22.89 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' A' ' 61' ' ' CYS . 48.4 t -108.0 18.86 20.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.13 0.491 . . . . 0.0 109.955 173.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -83.43 50.97 1.88 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.625 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.481 ' HB2' ' H ' ' A' ' 97' ' ' LEU . 3.2 ppt_? -163.32 -140.96 0.05 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.638 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.534 ' O ' HD12 ' A' ' 97' ' ' LEU . 4.3 pp -59.04 140.49 55.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.105 0.479 . . . . 0.0 110.935 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -126.14 28.76 5.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.581 0.705 . . . . 0.0 109.334 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.7 mmt-85 -148.13 142.71 26.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.736 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -80.95 114.81 20.08 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 174.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 106' ' ' LYS . 9.2 p90 -66.71 126.38 28.81 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.081 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -170.57 -52.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.267 -172.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -70.08 -59.05 3.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.01 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -177.84 128.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.511 ' HB3' HG22 ' A' ' 107' ' ' VAL . 65.4 mttm 70.35 143.85 0.05 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.871 0.732 . . . . 0.0 111.617 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' A' ' 101' ' ' PHE . 48.0 mtmt -87.17 44.61 1.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.605 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 105' ' ' LYS . 19.6 m . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.66 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -160.84 48.65 0.38 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 m -67.46 -39.01 85.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.692 -0.254 . . . . 0.0 110.972 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m 57.39 45.9 19.15 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.74 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.8 mtm-85 -66.47 138.54 57.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.351 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -76.55 -135.93 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 171.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -76.81 77.39 3.42 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.908 -0.495 . . . . 0.0 110.002 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 22.0 m-85 -120.21 27.39 8.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.557 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -86.48 58.68 5.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 164.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' ' 6' ' ' PHE . 3.7 mt -65.69 -133.12 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.975 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.754 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.9 mp 61.24 49.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 123.499 1.618 . . . . 0.0 107.466 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.722 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 8.1 ptm -72.53 148.32 45.11 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 112.855 -1.975 . . . . 0.0 110.19 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HA ' HD11 ' A' ' 90' ' ' LEU . 15.3 t -48.35 -59.82 3.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.912 -169.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.722 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 81.5 mt 48.58 35.65 6.41 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -81.73 -171.34 3.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.0 tm0? -72.07 117.39 57.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -83.45 138.87 8.79 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.05 2.5 . . . . 0.0 112.773 -178.41 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.3 -138.79 9.02 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.477 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -95.53 -14.54 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.541 0.686 . . . . 0.0 109.749 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.601 ' HB2' HG12 ' A' ' 45' ' ' VAL . 6.2 mm100 -59.49 136.98 58.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.137 -178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -105.42 136.66 44.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.423 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.682 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -77.77 133.69 13.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.714 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 85.7 mt -90.58 145.76 24.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 53.7 mt -109.09 134.92 51.06 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.097 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.5 p -71.61 151.98 43.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HG2' HG11 ' A' ' 67' ' ' VAL . 37.8 mt-10 -48.73 -32.91 9.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 111.789 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -71.81 -27.65 63.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -102.75 1.38 34.24 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.953 -0.467 . . . . 0.0 110.162 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -59.46 112.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.71 -26.8 7.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.851 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -73.45 130.59 40.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.765 0.317 . . . . 0.0 111.329 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.22 122.14 86.72 Favored Pre-proline 0 C--N 1.319 -0.717 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 168.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HG3' HG11 ' A' ' 43' ' ' VAL . 6.1 Cg_endo -53.15 -35.5 73.39 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.663 2.909 . . . . 0.0 113.872 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 14.1 mm -69.5 -44.17 80.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.2 p -112.08 -20.88 11.78 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 68.49 72.82 0.29 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.554 0.693 . . . . 0.0 110.337 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -163.31 145.81 10.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.756 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -82.16 40.18 0.62 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.174 0.511 . . . . 0.0 110.318 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.532 HG13 ' CB ' ' A' ' 73' ' ' CYS . 8.4 p -87.02 153.44 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.078 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -39.79 110.56 0.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -171.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 91.0 Cg_endo -79.6 151.61 22.4 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.286 2.658 . . . . 0.0 111.85 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -140.97 -58.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.694 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -90.15 131.28 36.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.266 -0.174 . . . . 0.0 111.192 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -70.65 136.29 48.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.766 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 32.8 m -71.03 139.73 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.449 0.642 . . . . 0.0 111.728 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -112.74 114.84 27.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.76 175.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -83.94 148.88 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.788 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 3.5 p -68.96 145.89 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -56.45 -27.99 58.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.292 0.567 . . . . 0.0 110.349 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.788 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 52.9 m-80 -60.37 -32.34 71.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.655 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.481 ' HB2' HG22 ' A' ' 45' ' ' VAL . 99.1 m -94.54 36.44 1.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.626 0.25 . . . . 0.0 111.117 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.8 t -139.86 -52.25 0.51 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 -69.21 137.77 53.48 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.624 179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.77 -134.59 7.73 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.156 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -157.32 27.0 0.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -148.8 33.54 0.76 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.394 0.616 . . . . 0.0 110.402 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.96 0.06 45.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.49 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -22.39 54.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 1.003 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 76.0 m-20 -61.15 152.88 27.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.888 0.851 . . . . 0.0 111.59 -176.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -59.42 131.07 49.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.307 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.682 HD13 ' HA3' ' A' ' 20' ' ' GLY . 11.9 pt -73.62 -32.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.975 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.01 -48.66 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 63' ' ' LEU . 29.5 p -102.13 -9.3 20.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.85 -28.25 0.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.581 0.752 . . . . 0.0 112.56 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -75.74 -60.14 2.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.678 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -91.91 150.77 20.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.179 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.003 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 16.7 t -63.37 136.14 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.386 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 23' ' ' CYS . . . -82.19 -167.21 39.45 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.463 HG11 ' HG2' ' A' ' 24' ' ' GLU . 7.4 p -162.06 -50.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.822 0.344 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.449 ' N ' HG13 ' A' ' 67' ' ' VAL . 79.2 m-20 -105.26 138.75 40.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.928 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.53 134.76 51.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -77.72 153.97 32.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.151 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.94 135.66 45.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.982 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.71 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 43.9 m-85 -71.62 133.58 45.8 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 6.1 p -70.76 158.24 36.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.494 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -55.13 -41.06 71.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.907 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' OE2' HG21 ' A' ' 37' ' ' VAL . 48.4 mt-10 -58.42 -51.75 68.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.666 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 97.0 m -65.54 -38.0 88.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.054 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' ' HE3' ' A' ' 74' ' ' TRP . 36.9 t -66.25 -41.41 90.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -67.77 -46.84 70.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' HE2' ' A' ' 81' ' ' LYS . 8.6 mp -64.14 -30.97 72.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.24 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 96.76 45.08 2.75 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.992 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HE2' HD23 ' A' ' 79' ' ' LEU . 67.6 mttm -103.2 -24.5 13.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.533 . . . . 0.0 110.072 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -69.59 -25.18 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 15.9 pttp -63.33 -27.98 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.294 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB3' HD13 ' A' ' 12' ' ' LEU . 76.6 m-20 -52.28 -48.12 65.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.033 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.06 -139.65 8.3 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.851 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.7 t -55.35 117.65 15.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.401 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.766 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 88.9 Cg_endo -82.23 22.02 0.91 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.932 2.421 . . . . 0.0 113.307 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.0 mmt180 -77.54 122.31 25.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.322 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 10' ' ' MET . 12.7 mm -78.98 131.37 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -163.97 45.32 0.11 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.883 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.754 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -38.88 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.533 -175.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 21.6 tp 162.51 120.82 0.0 OUTLIER 'General case' 0 C--O 1.234 0.279 0 O-C-N 124.471 1.107 . . . . 0.0 108.934 175.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.03 -49.91 73.42 Favored Glycine 0 CA--C 1.515 0.079 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.45 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -158.85 127.02 5.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -78.14 106.6 10.14 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.964 ' HG2' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -77.61 172.49 13.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.105 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.964 ' HG ' ' HG2' ' A' ' 96' ' ' ARG . 76.9 mt 63.39 38.39 10.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.198 0.523 . . . . 0.0 110.719 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -93.38 148.57 21.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.042 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -79.43 65.59 4.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.531 0.681 . . . . 0.0 110.704 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' PHE . 74.3 t60 -147.1 -57.52 0.26 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.085 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 100' ' ' HIS . 8.4 m-85 69.86 138.01 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 O-C-N 124.274 0.984 . . . . 0.0 110.681 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -151.55 38.28 0.61 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.304 1.05 . . . . 0.0 108.862 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -103.15 -142.81 0.36 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.842 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -94.01 35.08 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.714 0.768 . . . . 0.0 109.05 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -173.43 122.95 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.124 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -167.07 39.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.429 0.633 . . . . 0.0 110.185 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.293 179.021 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 76.48 -128.15 9.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.117 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.4 p 51.43 46.3 26.7 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.436 0.694 . . . . 0.0 111.28 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.81 136.09 52.2 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.955 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -174.29 159.75 3.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.429 ' O ' HD11 ' A' ' 8' ' ' LEU . 35.5 m80 72.58 152.86 0.13 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.056 0.848 . . . . 0.0 110.341 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -158.99 35.63 0.21 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.223 0.535 . . . . 0.0 110.254 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 45.4 m-85 -59.58 -54.4 46.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 109.656 177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 27.1 t0 167.21 68.52 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.864 ' HB2' HG23 ' A' ' 89' ' ' ILE . 38.3 mt -70.49 64.86 0.29 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.018 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.739 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.3 mp 26.54 78.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 112.263 -2.244 . . . . 0.0 112.53 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.782 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 11.3 ptp -68.89 144.15 54.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.807 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -54.71 -42.13 71.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.646 -173.206 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 93.0 mt 48.99 45.7 22.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 172.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.59 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 34.6 mttm -88.65 -155.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.035 172.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 52.1 mm-40 -77.75 114.6 42.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 110.856 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 8.9 Cg_exo -71.53 142.48 40.49 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.136 2.557 . . . . 0.0 112.741 -177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.73 -139.72 6.4 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.508 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -101.57 -25.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.335 . . . . 0.0 110.438 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -61.19 128.87 38.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.683 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -76.22 140.35 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.39 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -68.21 114.33 5.98 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.256 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 84.3 mt -77.5 149.49 34.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.707 HD21 ' HB2' ' A' ' 70' ' ' ALA . 64.7 mt -122.42 138.41 54.55 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.644 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.608 ' HA ' HG12 ' A' ' 67' ' ' VAL . 7.8 p -76.25 142.68 41.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HG3' HG11 ' A' ' 67' ' ' VAL . 48.6 mt-10 -47.62 -28.25 2.26 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 76.7 mttt -65.54 -39.33 91.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.05 -14.59 27.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 122.113 -0.367 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.91 120.4 5.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.278 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.19 -34.1 3.47 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.966 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HB2' HD13 ' A' ' 60' ' ' ILE . 20.8 mtpp -72.92 131.18 41.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.934 -0.133 . . . . 0.0 110.711 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 44.5 t -71.94 117.53 58.81 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 11.3 Cg_endo -58.69 -31.45 94.87 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.858 2.372 . . . . 0.0 112.74 -173.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.595 HD13 ' SD ' ' A' ' 10' ' ' MET . 1.6 mm -72.15 -43.13 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.322 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.6 -8.24 7.4 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.21 73.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.113 0.482 . . . . 0.0 110.797 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -165.94 139.73 4.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.3 33.56 0.81 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.029 0.442 . . . . 0.0 110.866 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.9 p -76.38 152.88 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.796 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.7 ptp180 -44.05 126.7 4.39 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.8 Cg_exo -77.54 -167.14 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.457 2.771 . . . . 0.0 111.698 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -170.98 -49.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.167 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -116.9 139.18 50.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -71.23 133.64 46.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.315 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.977 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 29.2 m -72.32 143.79 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.704 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -128.63 126.74 40.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -81.46 146.02 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.736 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.3 p -70.94 146.18 49.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 56.6 mt-10 -54.98 -37.25 66.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.432 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.638 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 4.5 m120 -51.38 -39.52 57.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 88.3 m -81.55 -36.36 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.583 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 28.8 p -72.87 -48.79 34.48 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.53 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -74.04 -17.13 61.01 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.089 0.471 . . . . 0.0 110.432 178.128 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.73 -114.63 0.4 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.421 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -147.6 153.91 40.01 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 65.36 55.44 1.07 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.912 0.758 . . . . 0.0 111.358 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' CYS . . . -128.88 -28.57 2.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.769 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 8.9 mptt -74.75 -14.48 60.72 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.625 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 60.9 m-20 -77.09 149.77 35.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.816 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.5 t -53.42 123.02 10.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.602 175.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.453 HD11 ' CB ' ' A' ' 70' ' ' ALA . 13.2 pt -62.44 -29.86 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 29' ' ' LYS . 47.1 mt -73.45 -44.9 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.4 p -100.31 -11.38 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.311 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 44.46 44.92 7.35 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.155 0.982 . . . . 0.0 110.941 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -152.67 -61.36 0.15 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.375 -172.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -73.06 140.14 47.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 6.0 p -66.64 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.108 0.48 . . . . 0.0 111.243 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.77 159.21 53.77 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.054 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 23' ' ' CYS . 2.0 p -157.55 -48.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.289 0.566 . . . . 0.0 110.226 -178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' H ' HG13 ' A' ' 67' ' ' VAL . 3.1 m120 -92.33 -176.25 4.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.357 174.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -124.49 142.89 50.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.57 0.224 . . . . 0.0 110.685 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.749 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -87.88 154.68 20.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.104 0.478 . . . . 0.0 111.13 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.408 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 20.0 m-85 -130.39 134.07 46.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.479 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.723 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.4 m-85 -68.92 122.74 19.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 5.9 p -70.25 149.81 47.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -55.6 -31.21 62.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.041 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 66.8 mm-40 -59.9 -44.91 93.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.867 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.535 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 38.0 m -68.64 -37.06 79.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.46 -40.79 96.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.054 177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.66 96.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.105 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.55 -35.08 72.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.694 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.6 38.46 6.59 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.491 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -93.72 -30.21 15.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.436 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.76 -29.88 71.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.126 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -63.32 -20.65 65.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.076 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.48 ' HB2' HD22 ' A' ' 12' ' ' LEU . 44.7 m-20 -67.19 -44.86 78.57 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.519 ' HA3' ' HG3' ' A' ' 15' ' ' PRO . . . 126.4 -119.9 3.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.562 -1.304 . . . . 0.0 114.664 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 19.3 t -43.14 105.5 0.43 Allowed Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 113.12 -171.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.977 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 75.1 Cg_endo -85.15 22.48 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.204 2.603 . . . . 0.0 112.674 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -73.16 124.0 24.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.864 HG23 ' HB2' ' A' ' 8' ' ' LEU . 12.1 mm -83.12 133.62 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 122.533 0.333 . . . . 0.0 111.816 -176.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 11' ' ' CYS . 1.5 pt? -169.61 38.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.739 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 21.3 p-10 -50.98 142.64 11.59 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.839 0.352 . . . . 0.0 111.148 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.2 tp -50.34 117.9 2.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.157 -173.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -130.08 56.87 0.73 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.1 m 68.96 49.59 0.65 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.377 0.608 . . . . 0.0 110.04 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -130.62 22.25 5.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.932 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.544 HH11 HD23 ' A' ' 97' ' ' LEU . 4.9 tmt_? -67.41 -33.68 75.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.319 0.581 . . . . 0.0 109.803 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.544 HD23 HH11 ' A' ' 96' ' ' ARG . 0.4 OUTLIER -151.28 59.62 0.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.747 177.134 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.93 127.34 31.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.15 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -155.53 55.5 0.62 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -69.23 137.91 53.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.63 -175.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.92 43.16 1.24 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.169 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.57 -35.3 79.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.408 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.888 ' HD3' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -73.78 163.24 28.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.023 174.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -77.44 54.54 1.16 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.592 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HE2' ' HG3' ' A' ' 103' ' ' LYS . 60.9 pttt -167.61 145.4 4.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 110.316 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -142.58 -45.7 0.32 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.415 0.626 . . . . 0.0 110.527 -177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.309 -1.188 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.871 178.594 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -165.46 137.45 4.69 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.85 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.8 m 58.63 40.14 23.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.494 0.664 . . . . 0.0 110.589 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -93.21 -27.69 16.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.579 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 70.99 139.77 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.81 0.694 . . . . 0.0 111.476 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.518 ' NE2' ' HA ' ' A' ' 94' ' ' SER . 49.2 p-80 -177.74 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.756 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -160.69 170.29 21.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.65 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 27.3 t80 -68.33 -20.72 64.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.594 172.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' HB3' ' OD1' ' A' ' 91' ' ' ASN . 11.3 m-20 72.49 74.41 0.15 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.425 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.717 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -74.96 124.04 26.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.095 -170.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.938 HG12 ' HB3' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -169.76 46.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 C-N-CA 123.317 0.647 . . . . 0.0 110.651 174.497 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.828 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -64.31 131.94 48.74 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.75 -174.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' HB2' HD21 ' A' ' 90' ' ' LEU . 53.3 t -42.08 -46.35 4.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.04 -1.437 . . . . 0.0 111.637 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 10' ' ' MET . 1.2 mp 42.76 52.23 5.04 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -95.53 -145.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 170.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -91.65 113.8 59.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.571 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 52.3 Cg_exo -57.63 129.11 32.02 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.878 2.385 . . . . 0.0 112.47 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.08 -131.34 6.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.607 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.57 -36.75 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 54.2 mt-30 -63.11 125.41 23.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.47 0.652 . . . . 0.0 111.556 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -74.8 130.92 40.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.717 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.434 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -68.06 129.64 26.7 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.017 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 65.7 mt -102.14 145.31 29.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.164 0.507 . . . . 0.0 112.009 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 74.5 mt -113.36 144.01 43.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.168 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 2.9 p -78.07 154.47 31.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 50.3 mt-10 -57.53 -26.7 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.901 0.381 . . . . 0.0 111.453 -176.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.6 mmtt -69.15 -24.12 64.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.81 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 m -115.72 25.21 10.93 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.599 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 33.4 t70 -72.49 131.36 42.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.22 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.29 62.68 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.807 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -111.76 131.64 55.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.3 119.16 73.26 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -57.26 -38.3 95.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.266 2.644 . . . . 0.0 113.359 -174.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.498 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 6.9 mm -64.44 -56.8 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 28.1 p -100.82 -19.78 15.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -169.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 33' ' ' CYS . 13.4 t70 68.59 85.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.225 0.536 . . . . 0.0 110.397 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -174.58 145.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.312 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.35 33.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.71 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.4 p -78.62 158.23 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.313 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.531 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 31.3 ttp180 -50.83 126.02 23.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.382 0.673 . . . . 0.0 112.543 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.6 Cg_exo -70.45 -166.62 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.605 2.87 . . . . 0.0 112.169 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 25.7 tptp -166.91 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -143.65 140.2 29.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.059 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 33.8 mtpt -62.03 136.26 57.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 111.117 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 11.5 t -75.85 131.94 34.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.94 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -121.19 128.73 52.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.723 0.296 . . . . 0.0 110.205 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' A' ' 55' ' ' ALA . 35.2 m -75.22 151.26 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.062 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.722 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 9.6 p -59.7 153.77 19.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -54.94 -37.03 65.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 6.8 m120 -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.341 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 33.8 m -71.39 -27.01 63.03 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.459 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 89.3 p -77.16 -39.44 49.1 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.942 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 4.0 p90 -90.43 -31.21 16.92 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.7 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.88 30.42 7.53 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.89 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 3.7 mptp? 60.87 -178.24 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.813 0.445 . . . . 0.0 111.125 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.2 mp0 63.76 56.94 1.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.428 0.633 . . . . 0.0 111.127 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -138.6 -30.67 0.76 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.978 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -78.91 -37.2 40.55 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.404 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.872 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 6.9 p30 -62.18 142.7 57.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 40.9 t -46.71 111.08 0.34 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.816 -175.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.464 HD11 ' CB ' ' A' ' 70' ' ' ALA . 6.0 pt -60.43 -26.0 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.398 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.64 -42.96 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -117.43 5.76 12.55 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.137 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 5.4 p-10 38.64 43.49 0.69 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -148.76 -58.59 0.22 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.834 -173.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -86.76 17.75 3.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -167.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.872 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 2.6 t 59.67 137.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.113 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -82.36 162.23 41.76 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.548 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 68' ' ' ASN . 6.3 p -149.8 -44.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.259 -0.471 . . . . 0.0 110.367 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' N ' HG13 ' A' ' 67' ' ' VAL . 76.6 m-20 -106.03 131.39 53.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.01 133.36 56.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.955 0.407 . . . . 0.0 110.752 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -74.21 150.5 40.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 9.2 m-85 -128.62 131.93 48.12 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.477 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 98.4 m-85 -67.97 127.79 34.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.777 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 8.5 p -73.68 158.78 34.06 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.232 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.512 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.39 -46.2 62.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.138 -178.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.69 -44.51 93.62 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.611 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.797 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 58.6 m -64.72 -43.41 93.51 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.224 -0.297 . . . . 0.0 111.018 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 58.4 m -64.24 -34.59 78.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -58.33 -49.88 75.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.927 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.52 -47.0 24.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.521 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.67 34.55 0.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.556 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' CYS . 18.9 mmtp -76.13 -23.69 54.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.23 0.538 . . . . 0.0 110.531 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.23 -42.13 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.892 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -85.54 -15.24 43.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.597 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.504 ' OD2' HD21 ' A' ' 12' ' ' LEU . 25.2 t0 -56.47 -51.13 69.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.899 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.91 34.43 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.211 -1.471 . . . . 0.0 114.926 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.3 t -72.56 113.5 21.66 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 113.691 -1.254 . . . . 0.0 111.751 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 96.3 Cg_endo -81.98 43.87 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.228 2.619 . . . . 0.0 113.405 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' MET . 6.5 mmm180 -87.97 131.24 34.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.649 HG23 HD11 ' A' ' 9' ' ' ILE . 28.6 mm -91.91 115.84 31.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.597 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.869 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -140.62 50.79 1.66 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.938 ' HB3' HG12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -92.32 -124.23 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.47 -0.769 . . . . 0.0 111.423 169.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.747 ' N ' HD21 ' A' ' 91' ' ' ASN . 2.3 pt? -159.04 14.8 0.16 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.984 0.421 . . . . 0.0 110.056 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.777 ' H ' ' ND2' ' A' ' 91' ' ' ASN . . . 77.0 136.83 0.79 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.154 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.518 ' HA ' ' NE2' ' A' ' 4' ' ' HIS . 51.2 p 54.01 69.9 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.429 0.692 . . . . 0.0 112.405 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.96 132.94 53.75 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 174.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -151.97 -135.68 0.06 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.208 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' H ' ' HB2' ' A' ' 96' ' ' ARG . 98.2 mt 65.96 28.83 10.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.376 0.608 . . . . 0.0 110.801 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.11 -26.02 15.12 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.3 mmm-85 -133.99 119.46 19.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.437 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -169.23 -46.93 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.102 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 1.7 t80 61.41 69.36 0.66 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.525 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -92.17 21.09 5.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 57.66 44.01 21.37 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.845 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -82.97 -51.24 7.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.99 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -149.1 58.72 1.03 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.545 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp 61.49 34.71 17.91 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.6 0.714 . . . . 0.0 109.077 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 9.9 p . . . . . 0 C--O 1.244 0.807 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.183 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 77.58 47.85 8.49 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.736 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.6 t -152.66 47.76 0.73 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.716 0.769 . . . . 0.0 109.353 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 m -81.2 53.15 1.96 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.347 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -61.81 -47.15 86.41 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -84.13 -68.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.863 168.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HG3' HD13 ' A' ' 8' ' ' LEU . 3.8 tp60 178.29 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.92 176.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.594 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 9.8 t80 -146.42 26.44 1.17 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.807 0.813 . . . . 0.0 109.481 174.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -92.23 47.69 1.35 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.959 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.594 ' CD2' ' HA ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -157.56 39.49 0.29 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.745 -171.591 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.497 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -77.57 147.22 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.632 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.981 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -143.57 131.55 21.67 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 t -51.91 -54.0 34.45 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.478 -167.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.981 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 34.1 mt 44.86 37.86 2.58 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -82.42 170.71 14.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 50.7 tp60 -67.69 119.65 67.69 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 34.6 Cg_exo -62.29 145.47 96.01 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.754 2.303 . . . . 0.0 112.814 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.9 -66.46 1.62 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.977 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p 176.64 -32.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.792 0.329 . . . . 0.0 110.586 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -64.38 133.28 52.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.692 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -74.71 137.26 41.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -75.35 133.48 14.88 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.996 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 80.1 mt -100.12 143.34 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.674 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 63.7 mt -111.93 138.56 48.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 3.5 p -81.88 148.92 28.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 27' ' ' ASP . 46.6 mt-10 -54.39 -27.58 37.62 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.64 -29.98 70.62 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.656 0.265 . . . . 0.0 111.378 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 60' ' ' ILE . 34.6 m -105.37 -12.63 15.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.878 0.37 . . . . 0.0 110.206 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' CB ' ' HA ' ' A' ' 24' ' ' GLU . 11.7 t70 -59.89 115.75 3.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.075 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.02 -33.02 4.19 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 47.2 mttp -77.55 136.75 38.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.63 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.3 t -79.98 121.98 82.69 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' O ' HD11 ' A' ' 89' ' ' ILE . 10.3 Cg_endo -55.82 -41.26 79.21 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.228 2.619 . . . . 0.0 113.648 -174.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 5.8 mm -63.73 -49.09 83.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 p -111.47 -17.09 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 t0 63.04 74.89 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.543 0.687 . . . . 0.0 110.366 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -160.24 146.32 15.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.312 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -87.19 30.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.322 . . . . 0.0 111.159 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 73' ' ' CYS . 3.6 p -76.64 150.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.866 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -49.08 124.64 13.48 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 87.9 Cg_endo -79.62 149.35 21.0 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.526 2.817 . . . . 0.0 112.114 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -132.16 -62.37 0.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.4 mtp-105 -102.39 141.99 34.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -69.18 137.57 53.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.183 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.913 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -78.84 145.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.127 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -131.7 119.48 21.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.83 155.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.893 -173.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p -71.13 160.24 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.599 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -53.57 -39.74 65.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.194 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.01 -35.51 75.22 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.541 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 60.4 m -98.48 33.3 2.28 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.151 -0.343 . . . . 0.0 111.493 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.501 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 53.6 p -156.81 -28.06 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -50.98 -41.31 59.44 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.38 157.12 15.08 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.56 -1.305 . . . . 0.0 113.754 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 22.1 pttp 44.21 34.23 0.97 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.124 1.37 . . . . 0.0 113.904 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 19.7 tt0 176.95 46.88 0.0 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.098 0.475 . . . . 0.0 110.438 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 50' ' ' SER . . . -130.5 -29.58 1.96 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.969 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 51.7 mmtt -71.31 -29.76 65.42 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.063 0.458 . . . . 0.0 110.809 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 21.4 p30 -66.2 143.37 57.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.4 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -55.23 130.27 41.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.453 -177.299 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.562 HD13 ' HA3' ' A' ' 20' ' ' GLY . 9.9 pt -62.44 -26.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -171.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 26' ' ' CYS . 45.9 mt -80.0 -42.65 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.924 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -109.51 -11.38 14.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.645 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.416 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 54.03 28.52 8.86 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.513 . . . . 0.0 111.264 175.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.26 -64.27 0.61 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.375 -169.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -79.74 140.17 37.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.921 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 21.2 t -64.07 135.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 111.045 -176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.6 141.73 27.97 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.5 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.66 -42.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -115.19 141.58 47.83 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.585 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.87 136.38 57.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.736 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -79.05 160.09 27.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.065 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.546 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 12.8 m-85 -132.21 134.6 45.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.628 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.735 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 74.6 m-85 -68.65 127.81 34.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.4 p -68.22 163.38 22.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.952 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -51.81 -45.88 64.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.234 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 67.2 mm-40 -60.26 -48.25 82.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.544 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.601 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 66.5 m -65.56 -37.91 88.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.411 0.148 . . . . 0.0 111.243 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.18 -43.46 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 110.005 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -66.06 -42.83 88.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 91.6 mt -63.94 -34.48 78.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.47 30.21 14.4 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.857 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.75 -22.44 27.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -66.35 -42.43 88.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.713 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.3 -16.54 60.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.551 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' A' ' 12' ' ' LEU . 5.3 t70 -64.75 -50.35 67.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.82 -139.41 5.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 118.643 -1.742 . . . . 0.0 115.688 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 44.4 t -62.06 119.47 49.05 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 113.104 -1.548 . . . . 0.0 112.687 -170.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.913 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 64.4 Cg_endo -84.16 51.28 3.31 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.691 2.927 . . . . 0.0 113.068 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.541 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.0 mmt180 -99.58 127.27 45.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.54 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 31' ' ' PRO . 46.3 mm -90.9 88.42 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.458 0.647 . . . . 0.0 109.434 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 9' ' ' ILE . 3.9 mt -66.74 -27.18 67.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.557 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -41.24 142.95 0.47 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.301 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 94' ' ' SER . 30.4 tp -63.23 130.87 46.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.554 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.82 55.84 4.76 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.555 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.489 ' HB2' HD23 ' A' ' 92' ' ' LEU . 11.9 t -65.5 -32.12 73.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.424 0.29 . . . . 0.0 110.666 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 63.96 49.12 2.88 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.304 0.573 . . . . 0.0 110.432 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.415 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 5.9 ppt_? -127.28 28.53 5.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.288 0.566 . . . . 0.0 110.797 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.33 118.89 36.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.198 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 68.99 140.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.948 0.78 . . . . 0.0 110.806 -173.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -78.35 59.42 2.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.952 0.406 . . . . 0.0 111.169 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -66.88 130.15 42.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.375 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.566 ' HB2' ' HG3' ' A' ' 106' ' ' LYS . 37.0 p90 -99.58 -23.67 14.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.868 0.366 . . . . 0.0 110.248 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -75.97 69.47 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.691 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.32 175.23 11.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.861 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -55.32 118.54 4.5 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.473 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 68.05 124.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.13 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.566 ' HG3' ' HB2' ' A' ' 101' ' ' PHE . 4.0 ttmp? -75.58 51.21 0.58 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.588 0.708 . . . . 0.0 110.571 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.301 177.514 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -169.77 130.75 2.1 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.9 m -160.55 -130.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -70.21 -41.56 73.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.934 0.397 . . . . 0.0 110.062 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 58.87 41.22 21.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.752 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -94.81 -38.39 10.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.091 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -135.88 171.8 13.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.314 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.696 ' HD1' HD11 ' A' ' 8' ' ' LEU . 3.5 m-85 -62.3 -22.14 65.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.796 -173.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER 81.54 81.88 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 123.971 0.794 . . . . 0.0 110.039 -171.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.696 HD11 ' HD1' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -123.81 60.05 1.12 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.342 -179.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.05 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.7 mp -78.03 63.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 122.595 1.188 . . . . 0.0 109.589 -171.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.569 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.8 ptp -90.05 149.33 22.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.496 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.451 ' N ' HD21 ' A' ' 90' ' ' LEU . 2.0 t -46.12 -47.02 17.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.603 -1.181 . . . . 0.0 112.812 -174.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.569 HD13 ' HG3' ' A' ' 10' ' ' MET . 1.3 mp 46.35 40.23 7.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 62.4 mttm -80.02 -162.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.819 0.342 . . . . 0.0 110.345 169.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.4 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 70.7 tp60 -85.99 110.58 31.7 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.367 173.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 36.9 Cg_endo -70.75 143.56 46.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.495 2.13 . . . . 0.0 113.018 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.68 -101.5 0.47 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.206 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.49 -31.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.485 ' HB2' HG22 ' A' ' 45' ' ' VAL . 62.9 mt-30 -57.9 132.41 53.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 111.477 -177.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.9 m -83.26 138.53 33.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.714 -176.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.29 133.79 13.35 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.809 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 94.3 mt -96.91 151.47 19.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 0.0 112.084 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.0 141.52 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.17 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.7 p -78.78 154.74 29.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.65 -32.21 50.6 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.262 0.351 . . . . 0.0 111.847 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.0 mmtp -63.65 -43.91 95.36 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.95 -15.93 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -53.59 108.99 0.4 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.471 0.653 . . . . 0.0 110.585 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.3 -35.12 1.69 Allowed Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.02 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -87.96 128.36 35.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.798 -0.201 . . . . 0.0 111.496 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.13 118.58 65.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.86 -39.41 68.3 Favored 'Trans proline' 0 N--CA 1.474 0.357 0 C-N-CA 123.051 2.501 . . . . 0.0 114.169 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mm -63.94 -40.79 90.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.06 -18.85 8.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t0 66.06 76.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.284 0.564 . . . . 0.0 110.013 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.9 t -162.43 147.06 12.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.874 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -90.45 22.72 3.28 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.033 0.444 . . . . 0.0 111.143 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.606 HG13 ' HB2' ' A' ' 73' ' ' CYS . 2.5 p -69.43 148.85 11.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.135 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -40.19 113.07 0.9 Allowed Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.6 Cg_endo -78.71 148.12 22.49 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.202 2.601 . . . . 0.0 112.011 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 74' ' ' TRP . 61.9 mttm -139.17 -53.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 99.5 mtt180 -101.05 138.21 38.39 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -64.8 132.42 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.497 . . . . 0.0 111.04 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.831 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 15.7 t -74.16 125.18 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.354 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.9 136.99 36.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.984 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.81 HG12 HH21 ' A' ' 88' ' ' ARG . 2.1 m -91.84 150.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.6 p -81.29 145.7 30.77 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 1.5 tp10 -58.11 -24.3 58.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -173.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.523 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 41.9 m-80 -66.08 -20.99 66.34 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.383 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.485 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 78.4 m -110.27 39.0 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.119 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.738 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 84.8 p -147.78 -49.43 0.17 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.618 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.03 40.2 0.53 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.01 -51.44 0.13 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.423 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.597 ' HD3' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -132.48 165.0 25.32 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.597 ' HG2' ' HD3' ' A' ' 53' ' ' LYS . 85.9 mm-40 62.32 -138.81 0.45 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.667 0.605 . . . . 0.0 110.41 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 50' ' ' SER . . . 67.61 -60.15 0.39 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.873 0.869 . . . . 0.0 112.204 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -83.11 -46.48 12.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.851 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -68.6 149.75 48.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.372 0.606 . . . . 0.0 110.588 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 11.8 t -54.1 124.12 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.829 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.401 HD11 ' CB ' ' A' ' 70' ' ' ALA . 28.0 pt -69.33 -23.07 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.576 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -78.71 -49.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -95.28 -8.28 36.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.33 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.87 46.67 6.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.702 0.801 . . . . 0.0 111.663 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -61.56 0.13 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.236 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -70.06 141.75 52.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.723 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.8 132.72 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.207 0.317 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.53 176.93 54.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.702 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 68' ' ' ASN . 3.2 p -161.34 -52.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.425 ' N ' HG13 ' A' ' 67' ' ' VAL . 76.2 m-20 -97.4 122.7 40.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.677 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.16 134.08 56.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.993 0.425 . . . . 0.0 110.482 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' CB ' HD11 ' A' ' 59' ' ' ILE . . . -73.26 142.73 47.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.591 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.451 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 7.6 m-85 -124.79 130.09 51.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.271 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.831 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.6 m-85 -66.26 129.94 41.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.0 p -69.75 161.86 28.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.775 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.573 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 26.6 t90 -53.75 -39.82 65.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.603 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -60.99 -48.25 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.723 0.297 . . . . 0.0 110.946 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 84.2 m -67.97 -32.76 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.58 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.12 -44.02 97.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.583 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 -60.77 -46.65 89.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.76 -32.62 72.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.71 38.57 10.43 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.344 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 87.5 mttt -78.76 -9.14 59.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.681 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.07 -35.73 72.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.36 0.6 . . . . 0.0 109.597 173.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -81.74 -9.17 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.061 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 81' ' ' LYS . 23.5 t0 -70.1 -42.9 72.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.76 -175.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA3' ' HG ' ' A' ' 12' ' ' LEU . . . 172.09 178.52 42.39 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.626 -1.273 . . . . 0.0 114.029 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -72.42 110.68 8.62 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 111.326 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.582 ' HG2' HH12 ' A' ' 88' ' ' ARG . 56.6 Cg_endo -78.12 41.44 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.436 2.758 . . . . 0.0 115.279 -172.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.81 HH21 HG12 ' A' ' 45' ' ' VAL . 7.0 mmt-85 -79.98 134.41 36.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.505 HG23 ' OD1' ' A' ' 91' ' ' ASN . 33.7 mm -85.24 126.34 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.217 0.532 . . . . 0.0 112.126 -175.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.451 HD21 ' N ' ' A' ' 11' ' ' CYS . 0.6 OUTLIER -149.4 46.0 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.683 174.474 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 1.05 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 5.7 m120 -57.17 124.24 18.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.513 -173.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.1 tp 173.16 -48.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.828 177.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.3 -75.41 0.39 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.6 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 98' ' ' ASP . 35.3 t 174.08 -67.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.964 -0.618 . . . . 0.0 109.658 172.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 70.17 -31.57 0.22 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.823 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -155.56 160.56 40.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.624 -175.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 94.1 mt 75.81 -56.2 0.6 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.65 0.78 . . . . 0.0 113.057 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.55 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 44.1 m-20 -81.48 43.9 0.77 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.101 0.477 . . . . 0.0 111.283 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -135.36 35.16 2.99 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.84 ' HB3' ' HG3' ' A' ' 102' ' ' GLU . 4.1 m170 -148.86 134.13 18.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.229 -177.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -71.21 -41.85 69.71 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.684 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.84 ' HG3' ' HB3' ' A' ' 100' ' ' HIS . 97.3 mt-10 43.67 60.88 2.47 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.673 0.608 . . . . 0.0 111.768 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.8 mttt 67.34 -130.55 0.14 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.059 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.9 tptm 67.95 -64.55 0.28 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.37 0.668 . . . . 0.0 111.537 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -148.55 39.99 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -67.39 127.27 32.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.007 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.121 177.409 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.501 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.5 ptp . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.149 0.499 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.6 t -53.83 -49.74 67.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.031 -172.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.787 ' HG ' ' HB3' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 51.87 43.06 30.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 172.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 50.2 mttm -95.62 -155.38 0.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.584 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.34 111.91 44.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.063 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 32.9 Cg_exo -60.1 138.58 82.68 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.244 2.629 . . . . 0.0 112.926 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.91 -140.25 11.26 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.12 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.612 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 35.3 m -98.44 -29.11 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.64 0.257 . . . . 0.0 111.209 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 59.5 mt-30 -69.23 125.53 26.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.95 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -82.32 142.45 32.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.827 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.8 118.55 6.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.628 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 81.8 mt -92.18 143.75 26.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 112.071 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 70.7 mt -110.33 136.57 49.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.301 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.8 p -72.59 152.39 41.83 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 53.6 mt-10 -54.97 -25.44 29.72 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 0.0 111.558 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 25.1 mtpp -72.16 -23.29 61.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.747 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 20.6 m -116.32 15.37 15.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 26.1 t70 -68.29 129.8 41.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -21.33 46.59 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.329 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 45.0 mttm -71.82 134.61 46.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.8 t -81.82 121.57 79.47 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HG2' HG11 ' A' ' 43' ' ' VAL . 72.7 Cg_exo -54.11 -34.15 76.95 Favored 'Trans proline' 0 CA--C 1.526 0.093 0 C-N-CA 122.441 2.094 . . . . 0.0 112.771 -175.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 3.8 mm -76.01 -32.72 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.431 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 20.1 p -137.98 -34.46 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t0 64.35 86.86 0.12 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 t -154.36 25.35 0.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.578 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 36.79 50.11 0.82 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.303 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 73' ' ' CYS . 7.9 p -118.19 162.81 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.346 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 ptp85 -42.43 128.5 2.89 Favored Pre-proline 0 N--CA 1.466 0.354 0 O-C-N 123.736 0.648 . . . . 0.0 112.63 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.547 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 2.8 Cg_exo -76.64 -154.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.421 2.747 . . . . 0.0 112.164 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -176.4 -49.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.32 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -150.12 136.08 18.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.494 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.71 134.55 56.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.957 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 16.2 m -74.03 134.42 29.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.612 ' NH2' ' HA ' ' A' ' 17' ' ' VAL . 27.8 mtp85 -108.15 122.15 46.32 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -81.9 143.84 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.166 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.1 p -61.35 149.08 39.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.928 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 89.8 mt-10 -54.55 -34.49 61.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.374 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m120 -53.94 -36.25 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.765 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 66.2 m -83.82 -32.29 25.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.319 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.418 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 4.5 m -67.18 -49.05 66.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.066 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.529 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.578 0.228 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.931 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 34.7 m-20 -63.92 144.94 56.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.431 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.5 t -47.38 131.73 13.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.719 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 11.0 pt -75.96 -29.53 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.102 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -77.72 -45.7 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 28.6 p -109.4 14.28 23.72 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER 22.26 58.24 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.25 -67.61 0.12 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 0.0 110.458 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.19 139.8 38.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.931 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 8.9 p -61.65 139.56 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 110.881 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -84.07 145.21 22.26 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.628 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.0 m -111.1 -41.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.6 135.29 54.3 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -62.12 134.49 56.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -75.47 147.2 40.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.589 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.547 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 9.4 m-85 -117.26 136.24 53.23 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.867 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 80.5 m-85 -67.81 128.59 37.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.58 ' HB2' HG13 ' A' ' 37' ' ' VAL . 1.8 p -72.25 149.08 44.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -51.08 -39.5 56.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.598 0.562 . . . . 0.0 111.7 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.27 -45.62 93.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.606 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 60.7 m -65.61 -36.65 84.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.502 0.191 . . . . 0.0 110.97 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 73.4 m -66.3 -41.81 89.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -62.84 -47.19 84.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.56 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.04 -33.79 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.38 40.21 5.15 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.364 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.02 -30.93 15.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -66.89 -27.59 67.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.852 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -69.03 -8.84 48.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.329 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.787 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 70.6 m-20 -69.08 -51.21 41.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.16 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.42 -137.27 5.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.235 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 26.9 t -54.41 115.87 9.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 124.054 0.942 . . . . 0.0 111.717 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.957 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 66.0 Cg_endo -88.39 26.82 0.56 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.95 2.433 . . . . 0.0 114.177 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.765 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 30.3 mtt-85 -73.45 121.65 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.955 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 mm . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.233 177.705 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.522 ' HE1' HD13 ' A' ' 32' ' ' ILE . 4.7 ptp . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 121.405 0.621 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.478 ' SG ' ' HE2' ' A' ' 13' ' ' LYS . 45.5 t -52.54 -49.89 63.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.308 -175.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 54.6 mt 50.32 32.22 6.05 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HE2' ' SG ' ' A' ' 11' ' ' CYS . 27.9 mtmt -82.39 166.12 19.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.153 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.3 112.89 5.5 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 123.77 0.668 . . . . 0.0 110.451 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 50.9 Cg_endo -76.65 141.01 21.62 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.095 2.53 . . . . 0.0 113.376 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 -144.08 11.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -89.1 -24.47 5.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.132 0.491 . . . . 0.0 110.667 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -57.4 124.48 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.42 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 m -84.97 137.9 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.117 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -69.01 130.33 24.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.713 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 68' ' ' ASN . 52.5 mt -88.84 142.88 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.338 0.59 . . . . 0.0 112.358 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.712 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 81.4 mt -113.13 137.62 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.963 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 6.5 p -75.94 154.88 35.59 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 27' ' ' ASP . 39.9 mt-10 -51.97 -33.27 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.405 0.44 . . . . 0.0 111.552 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -69.0 -27.96 66.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.775 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 49.4 m -104.48 41.42 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.962 0.411 . . . . 0.0 109.916 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 9.6 t70 -66.66 119.14 11.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.01 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.73 44.67 56.2 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.613 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD3' ' HB3' ' A' ' 26' ' ' CYS . 35.3 mtpt -120.15 139.74 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.538 -0.389 . . . . 0.0 110.992 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 37.1 t -78.67 122.75 85.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.634 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.724 ' HG2' HG21 ' A' ' 43' ' ' VAL . 36.7 Cg_exo -64.49 -36.45 43.6 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.104 2.536 . . . . 0.0 113.323 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.62 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.8 mm -64.43 -41.58 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.992 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.15 -12.5 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 63.91 81.55 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.308 0.575 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 t -171.73 152.9 3.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.957 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -88.32 22.63 2.43 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.663 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 73' ' ' CYS . 10.0 p -68.02 154.92 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.07 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 10.9 ptp180 -44.02 129.35 4.35 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.534 0.734 . . . . 0.0 112.721 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.712 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 Cg_exo -73.98 -164.54 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.37 2.713 . . . . 0.0 112.379 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.786 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -172.17 -42.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.979 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -149.66 136.42 19.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -63.16 139.52 58.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.474 0.654 . . . . 0.0 111.698 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.828 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.2 t -70.47 133.8 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.417 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -123.6 128.34 49.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.831 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG12 ' HD2' ' A' ' 87' ' ' PRO . 28.7 m -100.83 155.88 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.043 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.4 p -67.44 145.95 54.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.93 -28.94 64.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.625 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 16.9 m-80 -59.1 -31.11 68.62 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.833 175.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.443 ' HB3' ' CD ' ' A' ' 88' ' ' ARG . 79.3 m -101.48 29.3 4.9 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 122.155 -0.341 . . . . 0.0 111.798 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 m -111.29 -28.17 8.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 109.837 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 17.0 p90 . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.56 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 14.1 mmtp . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.849 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 80.2 m-20 -67.23 150.47 49.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.901 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 36.7 t -50.11 135.1 21.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.608 HG22 ' HG2' ' A' ' 88' ' ' ARG . 11.7 pt -77.65 -35.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.599 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.26 -47.3 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.8 p -103.07 2.81 35.29 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.847 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.541 ' OD1' ' HB ' ' A' ' 89' ' ' ILE . 1.5 p-10 36.36 47.3 0.48 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.117 0.886 . . . . 0.0 113.256 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.21 -66.27 0.37 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.044 -174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -81.98 143.39 31.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.235 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 48.5 t -56.92 134.44 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.217 0.323 . . . . 0.0 110.545 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.87 147.29 21.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.775 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.68 -37.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.089 0.471 . . . . 0.0 110.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.712 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 6.4 m120 -82.77 173.33 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.172 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -109.92 134.41 52.12 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.531 ' CB ' HD11 ' A' ' 59' ' ' ILE . . . -77.58 151.54 34.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.28 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.404 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 16.3 m-85 -126.24 135.36 51.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.828 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 76.9 m-85 -71.26 125.11 26.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.6 p -67.58 157.0 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -50.28 -40.82 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.479 0.487 . . . . 0.0 111.479 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 37.2 mt-10 -58.91 -51.96 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.604 0.24 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.62 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 98.7 m -64.38 -36.14 83.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.363 -178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 72' ' ' TYR . 84.9 m -67.87 -42.83 80.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -58.8 -49.24 78.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.959 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 42.3 mt -72.06 -27.43 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.68 47.18 3.26 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.43 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.494 ' CB ' HG21 ' A' ' 32' ' ' ILE . 29.7 mmmt -82.19 -36.43 27.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.205 0.526 . . . . 0.0 109.911 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -66.77 -28.8 68.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.997 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.9 pttp -57.07 -30.91 64.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.31 . . . . 0.0 110.465 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB2' HD22 ' A' ' 12' ' ' LEU . 86.9 m-20 -61.57 -52.55 63.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.691 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.32 -127.72 3.45 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.569 -1.3 . . . . 0.0 114.669 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.4 t -58.84 109.56 1.96 Allowed Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.52 -1.34 . . . . 0.0 113.182 -171.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.461 ' CG ' HG13 ' A' ' 43' ' ' VAL . 72.0 Cg_endo -87.97 39.89 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.992 2.461 . . . . 0.0 113.716 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 59' ' ' ILE . 24.3 mtp85 -85.03 127.68 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HB ' ' OD1' ' A' ' 62' ' ' ASN . 31.5 mm . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.544 ' HE1' ' HA ' ' A' ' 32' ' ' ILE . 2.3 ptp . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.425 0.631 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.427 ' CB ' ' HB2' ' A' ' 88' ' ' ARG . 44.1 t -56.15 -53.12 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.304 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mp 48.52 37.9 9.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -79.59 177.64 8.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.59 167.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -70.81 116.05 42.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.883 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 31.8 Cg_exo -62.91 145.23 94.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.161 2.574 . . . . 0.0 113.37 -175.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.93 -137.4 9.22 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.53 -23.28 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -72.31 138.75 47.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.487 . . . . 0.0 111.718 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 m -91.7 137.66 32.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.644 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.524 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -66.71 132.33 31.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.268 -0.492 . . . . 0.0 112.798 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 88.1 mt -95.87 143.46 27.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.046 0.451 . . . . 0.0 111.83 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 60.0 mt -113.01 140.42 47.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.263 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.3 p -78.92 154.03 30.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 40.1 mt-10 -54.69 -26.22 32.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.83 0.347 . . . . 0.0 111.67 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 35.1 mmtp -70.11 -29.36 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.432 ' O ' HD13 ' A' ' 22' ' ' LEU . 4.8 m -116.29 17.28 15.67 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.564 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 51.9 t0 -66.77 127.2 31.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.145 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.95 -22.18 42.24 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.491 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -68.26 122.07 17.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.489 0.185 . . . . 0.0 110.99 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -69.19 113.03 13.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.42 -27.37 67.67 Favored 'Trans proline' 0 N--CA 1.473 0.3 0 C-N-CA 123.372 2.715 . . . . 0.0 113.403 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.544 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 4.8 mm -66.8 -36.59 77.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.92 -176.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.58 -15.61 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 67.1 84.05 0.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.373 0.606 . . . . 0.0 109.831 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -164.57 136.02 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.148 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.68 11.76 8.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 73' ' ' CYS . 8.3 p -66.44 160.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.001 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -40.76 130.85 1.85 Allowed Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.66 0.784 . . . . 0.0 112.873 -175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 93.4 Cg_endo -78.83 -161.23 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.388 2.725 . . . . 0.0 112.771 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -171.57 -50.55 0.02 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.359 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -134.88 145.47 48.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.186 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 59.7 mttp -68.18 140.47 56.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.836 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.7 m -74.58 127.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 111.606 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.53 114.99 29.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.52 146.53 6.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.345 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p -67.04 161.23 24.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -47.36 -44.89 24.38 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.042 0.839 . . . . 0.0 111.715 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.731 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.1 m120 -61.69 -39.1 90.24 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.709 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 55.9 m -90.0 43.53 1.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.682 0.277 . . . . 0.0 110.794 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.9 m -155.62 -38.68 0.08 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.698 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.731 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 120.55 0.214 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -65.92 148.47 51.73 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.34 0.59 . . . . 0.0 110.933 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 20.2 t -51.6 125.73 15.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.375 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.5 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 8.7 pt -65.52 -26.86 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.457 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.4 mt -81.12 -41.1 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 32.1 p -113.75 2.61 15.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.348 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 29.25 53.1 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.43 1.092 . . . . 0.0 113.476 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.64 -59.49 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.383 -176.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -72.48 141.27 48.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.826 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.36 133.01 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.174 0.512 . . . . 0.0 110.957 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.415 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.11 140.09 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.996 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -127.08 -39.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -117.84 137.73 52.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.89 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.3 139.1 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.568 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.699 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -82.39 151.33 26.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.653 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 7.7 m-85 -124.73 134.15 52.93 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.838 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.836 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 68.2 m-85 -66.17 125.15 24.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -66.07 151.54 46.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -52.98 -38.0 61.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.68 -46.26 87.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.473 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 86.0 m -72.39 -38.01 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.722 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.5 t -63.97 -35.9 82.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.302 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -62.9 -41.43 99.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.334 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.03 1.41 21.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.01 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.05 84.78 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.495 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 93.3 mttt -77.72 -20.35 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HB2' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -70.82 -23.47 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.667 175.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.47 -25.06 60.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -55.03 -57.82 10.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.61 -140.15 7.11 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.647 -1.263 . . . . 0.0 114.343 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.643 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 47.4 t -64.5 115.91 24.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.189 -1.005 . . . . 0.0 112.275 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.811 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 93.9 Cg_endo -83.17 39.59 0.84 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.211 2.607 . . . . 0.0 113.442 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.709 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 9.5 mmt180 -81.73 121.81 26.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.992 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.4 mm . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.071 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 1.4 ptp . . . . . 0 N--CA 1.444 -0.729 0 CA-C-O 121.171 0.51 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 50.8 t -56.98 -50.4 72.81 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.493 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 84' ' ' ASP . 40.0 mt 49.5 40.65 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.015 1.116 . . . . 0.0 114.015 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HB3' ' H ' ' A' ' 14' ' ' GLN . 47.4 mttm -82.29 -159.8 0.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.821 169.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -85.18 122.94 73.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.12 133.17 48.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.852 2.368 . . . . 0.0 112.75 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -144.16 6.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.247 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG12 ' OE1' ' A' ' 47' ' ' GLU . 11.3 p -99.38 -30.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.754 0.311 . . . . 0.0 111.401 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.499 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 70.6 mt-30 -77.96 136.37 37.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.37 0.605 . . . . 0.0 111.896 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 m -75.86 143.28 41.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.526 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.28 120.45 5.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.213 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 73.5 mt -91.98 147.61 22.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.492 . . . . 0.0 112.14 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.653 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 76.8 mt -110.89 130.11 55.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.139 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.446 ' H ' ' CB ' ' A' ' 58' ' ' CYS . 8.5 p -71.4 160.42 32.79 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.705 ' HG3' HG21 ' A' ' 67' ' ' VAL . 54.8 mt-10 -58.25 -24.55 59.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp -74.44 -31.23 62.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.677 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -110.13 25.07 12.2 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 38.9 t70 -68.03 124.74 24.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.97 77.25 Favored Glycine 0 C--N 1.321 -0.266 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.627 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 51.3 mttm -102.7 134.51 45.97 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.448 -0.442 . . . . 0.0 110.607 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 12.6 t -70.75 117.17 53.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 11.2 Cg_endo -58.89 -31.95 96.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.818 2.346 . . . . 0.0 112.811 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 12.6 mm -66.4 -46.94 85.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.243 -175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -122.21 -6.06 8.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -170.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.98 75.79 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 110.091 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 t -164.33 147.52 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -89.01 41.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.058 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 73' ' ' CYS . 41.9 t -74.43 148.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.87 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.557 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 5.4 mmp_? -35.93 120.17 0.69 Allowed Pre-proline 0 C--O 1.224 -0.287 0 O-C-N 124.495 1.122 . . . . 0.0 112.554 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.58 144.37 44.56 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.597 2.198 . . . . 0.0 112.38 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 12.3 mmmm -131.7 -78.79 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -85.78 132.04 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.07 132.32 44.92 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 21.9 t -71.45 129.08 35.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.405 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -121.83 130.44 53.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.9 m -80.6 144.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.157 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.5 p -62.39 139.78 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.611 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 6.9 tp10 -60.16 -21.18 61.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.094 -174.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.628 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 5.2 m120 -60.48 -31.56 70.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.7 m -87.38 -35.02 18.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.529 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 16.6 p -92.28 -22.08 19.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 N--CA 1.465 0.301 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -172.587 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 15.6 p30 -62.15 149.26 41.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.815 0.817 . . . . 0.0 112.083 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -64.8 130.92 45.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.265 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' CD1' HG11 ' A' ' 43' ' ' VAL . 8.4 pt -62.57 -40.6 88.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.46 -38.12 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.2 p -101.73 -26.55 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.954 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 57.5 56.47 4.97 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.246 0.546 . . . . 0.0 109.611 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.86 -58.55 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.336 -170.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.4 144.0 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.752 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -64.68 138.13 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.895 0.378 . . . . 0.0 110.978 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -72.13 151.2 46.81 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.297 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.705 HG21 ' HG3' ' A' ' 24' ' ' GLU . 61.1 t -118.74 -60.94 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.887 0.375 . . . . 0.0 111.167 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -113.45 137.55 51.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.892 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -60.3 136.72 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.473 0.483 . . . . 0.0 111.366 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.653 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -82.57 159.39 22.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.904 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -136.54 134.34 37.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.138 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.5 m-85 -66.17 128.12 34.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 1.8 p -71.87 160.15 33.06 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.002 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -49.09 -50.62 36.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.077 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HG3' HG11 ' A' ' 37' ' ' VAL . 46.3 mt-10 -59.92 -43.15 95.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.388 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 91.6 m -68.01 -34.97 77.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.169 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 40' ' ' LYS . 81.7 m -68.63 -37.48 79.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -60.53 -47.16 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.272 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.12 -28.2 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.588 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.54 36.84 10.14 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.967 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 81' ' ' LYS . 21.6 mtpp -87.4 -10.95 50.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.919 0.39 . . . . 0.0 110.243 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -68.82 -24.46 64.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 108.988 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -73.97 -23.49 59.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.757 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' HD13 ' A' ' 12' ' ' LEU . 81.4 m-20 -58.16 -58.93 6.3 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 -135.01 7.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.859 -1.163 . . . . 0.0 114.261 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 24.8 t -55.99 107.35 0.86 Allowed Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 111.929 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 97.3 Cg_endo -87.95 38.25 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.772 2.315 . . . . 0.0 113.563 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 10' ' ' MET . 53.6 mtt180 -87.52 131.42 34.37 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.983 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mm . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.176 178.746 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.471 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.405 0 CA-C-O 121.382 0.611 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.4 t -48.85 -48.46 41.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.292 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' N ' ' A' ' 86' ' ' CYS . 20.9 mt 41.45 40.5 1.31 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 50.5 mttm -80.0 -160.18 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 tp-100 -82.13 111.01 23.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.381 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 77.2 Cg_endo -80.17 146.54 17.93 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.453 2.102 . . . . 0.0 112.746 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.69 -142.6 13.34 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.298 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.41 -17.87 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.096 0.474 . . . . 0.0 110.717 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -64.33 142.18 58.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.9 m -109.08 126.58 53.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.747 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -63.55 138.2 42.7 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.307 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 56' ' ' LYS . 41.2 mt -78.93 154.34 29.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.869 0.842 . . . . 0.0 113.131 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' A' ' 70' ' ' ALA . 1.7 tp -124.47 127.68 47.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.856 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 1.4 p -81.36 149.4 28.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -52.31 -35.01 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -62.22 -37.95 87.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.32 -17.37 23.66 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.49 -0.131 . . . . 0.0 110.795 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' HA ' HD23 ' A' ' 22' ' ' LEU . 13.0 t70 -54.49 110.79 0.68 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.866 -172.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.78 -31.22 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.775 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.542 ' HB2' HD13 ' A' ' 60' ' ' ILE . 55.1 mttm -78.61 132.58 37.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.479 -0.361 . . . . 0.0 110.892 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 t -80.46 119.05 75.2 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 71.3 Cg_exo -54.59 -37.01 90.74 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 123.059 2.506 . . . . 0.0 113.761 -172.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.604 HG21 ' HD3' ' A' ' 81' ' ' LYS . 3.4 mm -61.47 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.4 p -106.5 -21.75 12.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -171.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 65.42 83.43 0.17 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.394 0.616 . . . . 0.0 110.292 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 t -169.34 138.88 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.39 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -80.13 45.96 0.78 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.242 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 73' ' ' CYS . 4.2 p -94.1 148.38 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.009 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -40.16 123.31 1.67 Allowed Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 77.9 Cg_endo -72.43 152.15 54.39 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.011 2.474 . . . . 0.0 111.261 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HD2' ' HD1' ' A' ' 74' ' ' TRP . 57.6 tttp -128.81 -37.16 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.848 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.46 145.42 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.93 143.07 52.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 111.557 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.779 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 31.6 m -68.39 155.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -116.19 114.81 24.95 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.536 HG22 ' HB2' ' A' ' 49' ' ' CYS . 10.0 p -93.88 139.61 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.591 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.5 p -65.79 147.75 52.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.71 -30.47 63.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.679 0.275 . . . . 0.0 110.476 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.685 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.9 m120 -55.94 -40.92 73.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.506 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.536 ' HB2' HG22 ' A' ' 45' ' ' VAL . 91.6 m -80.65 -24.66 38.82 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.597 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -76.95 -41.94 41.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.667 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 112.206 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.9 mmpt? . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.078 0.466 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 71.7 m-80 -76.23 140.17 41.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.022 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.9 t -51.68 126.57 18.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.218 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD11 ' CB ' ' A' ' 70' ' ' ALA . 12.4 pt -68.78 -27.58 36.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.587 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' ' 29' ' ' LYS . 54.0 mt -75.81 -42.8 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 24.9 p -105.63 -6.99 18.79 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.23 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 42.19 45.85 3.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.981 0.801 . . . . 0.0 112.31 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 -62.43 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.142 0.496 . . . . 0.0 110.188 -177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -75.87 141.97 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.891 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 9.9 p -68.16 139.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.729 0.3 . . . . 0.0 110.591 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.25 145.1 20.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.8 m -116.33 -38.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.554 0.216 . . . . 0.0 111.478 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -104.73 -174.87 2.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.522 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.411 ' HB3' HG21 ' A' ' 19' ' ' THR . 44.3 m-20 -107.78 142.26 38.08 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 22' ' ' LEU . . . -79.42 151.4 30.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -127.39 136.27 51.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.779 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 56.1 m-85 -68.11 127.81 34.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 37' ' ' VAL . 12.4 p -71.42 161.74 30.57 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.746 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.578 ' HD1' ' HD2' ' A' ' 40' ' ' LYS . 27.8 t90 -51.99 -42.2 62.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.161 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -58.63 -55.97 28.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.116 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.78 -39.48 94.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.484 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.7 t -65.31 -41.31 94.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.454 0.169 . . . . 0.0 110.765 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.4 ttp-105 -64.15 -44.53 91.85 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.026 0.441 . . . . 0.0 110.324 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 77.3 mt -65.67 -38.2 88.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.367 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 28.18 4.11 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.308 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.604 ' HD3' HG21 ' A' ' 32' ' ' ILE . 46.6 mttm -88.39 -4.67 58.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.869 0.366 . . . . 0.0 110.571 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 p-10 -66.83 -30.45 70.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.034 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 3.5 mmmp? -96.2 7.82 45.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.27 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -69.69 -59.65 2.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.7 -158.15 30.91 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.355 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.474 ' N ' ' HA ' ' A' ' 12' ' ' LEU . 34.2 t -66.08 115.22 21.18 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.658 0.783 . . . . 0.0 111.54 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.619 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 90.0 Cg_endo -86.76 41.98 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.683 2.922 . . . . 0.0 114.047 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -87.81 130.34 34.9 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.988 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.0 mm . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 175.153 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.81 ' HG2' HD22 ' A' ' 12' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.437 -1.108 0 CA-C-O 120.869 0.366 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -41.58 -63.11 0.76 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.328 . . . . 0.0 113.254 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.81 HD22 ' HG2' ' A' ' 10' ' ' MET . 0.0 OUTLIER 51.03 36.77 16.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.873 ' HE2' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -104.29 170.66 7.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 166.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.3 tp-100 -57.33 121.91 50.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 123.551 0.532 . . . . 0.0 110.693 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.9 Cg_exo -71.19 151.03 60.49 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.879 2.386 . . . . 0.0 112.688 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.652 ' H ' ' HA ' ' A' ' 46' ' ' CYS . . . -88.02 -125.98 2.37 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.529 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -105.42 -48.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -62.22 151.02 37.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.522 HG21 ' HD3' ' A' ' 42' ' ' LYS . 98.6 m -82.23 143.56 31.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.451 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.75 126.51 9.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.952 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.2 mt -95.33 136.73 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.674 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 90.7 mt -99.07 148.7 23.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.49 171.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.9 p -89.47 154.99 19.59 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 67' ' ' VAL . 62.5 mm-40 -52.21 -29.54 23.04 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.423 0.452 . . . . 0.0 111.996 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.3 mmtp -69.4 -36.58 76.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.31 -0.244 . . . . 0.0 111.218 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 23.3 m -99.48 33.73 2.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.69 119.23 9.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.115 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.43 31.99 62.7 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.525 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 26' ' ' CYS . 24.5 mtpp -103.76 122.86 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 14.0 t -62.06 115.89 18.56 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.165 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.714 ' HG2' HG11 ' A' ' 43' ' ' VAL . 8.1 Cg_exo -73.29 50.16 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.63 2.887 . . . . 0.0 112.716 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mm -149.86 -48.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.3 p -112.94 -14.84 12.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.085 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 65.82 80.95 0.21 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.599 0.714 . . . . 0.0 109.939 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -165.65 146.91 7.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.99 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.72 14.1 12.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.477 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -65.22 150.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 16.5 ptm180 -37.5 126.98 0.89 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 124.001 0.92 . . . . 0.0 113.383 -174.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.4 Cg_exo -71.55 -163.54 0.13 Allowed 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.429 2.753 . . . . 0.0 112.478 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -169.0 -52.53 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.235 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -140.11 141.89 36.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HD3' HG21 ' A' ' 19' ' ' THR . 39.6 ttmt -69.06 140.13 54.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.948 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.714 HG11 ' HG2' ' A' ' 31' ' ' PRO . 12.4 m -77.95 148.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.799 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.57 129.23 50.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.044 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 m -93.73 146.52 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.025 0.441 . . . . 0.0 111.343 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.665 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p -69.91 165.33 21.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -59.47 -41.06 88.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.176 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.873 ' HB2' ' HE2' ' A' ' 13' ' ' LYS . 3.7 m120 -74.52 40.3 0.13 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.502 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.498 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 15.6 m -151.35 -52.3 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.75 174.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.5 m -100.21 44.17 1.03 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.737 0.779 . . . . 0.0 110.025 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.202 -178.799 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -93.35 149.74 21.0 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.769 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.719 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.8 t -48.3 129.39 15.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.922 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.619 HG22 ' HD3' ' A' ' 88' ' ' ARG . 8.5 pt -65.89 -31.6 54.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.482 -174.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 26' ' ' CYS . 51.4 mt -77.17 -47.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.74 -4.5 15.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.835 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 40.06 47.91 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.59 0.756 . . . . 0.0 112.651 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.53 -57.25 0.28 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.023 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -76.75 146.69 37.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.716 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.18 131.36 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 110.162 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.17 139.47 25.02 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.991 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 24' ' ' GLU . 16.2 m -131.63 -40.05 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 111.447 0.165 . . . . 0.0 111.447 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.75 138.95 33.53 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.33 129.94 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.674 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -80.28 148.99 30.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 7.9 m-85 -128.01 133.77 49.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.674 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 53.7 m-85 -68.38 132.44 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -68.63 153.02 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -53.19 -38.33 62.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.789 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.82 -45.79 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.611 0.243 . . . . 0.0 111.385 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.6 m -67.68 -37.77 82.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.086 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.5 t -61.85 -42.64 99.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -57.34 -50.23 73.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.889 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.18 -27.59 62.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.576 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.17 30.71 21.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.404 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -78.99 -27.5 43.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -67.21 -41.72 85.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.096 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -85.01 26.58 0.84 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' CG ' ' HG ' ' A' ' 12' ' ' LEU . 49.4 t0 -80.39 -53.65 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . 179.32 -149.64 8.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.451 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 30.3 t -67.26 121.05 76.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.697 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 85.3 Cg_endo -80.91 43.42 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.93 3.087 . . . . 0.0 113.446 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.619 ' HD3' HG22 ' A' ' 59' ' ' ILE . 14.9 mmm180 -102.14 143.7 31.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.999 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.0 mm . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.807 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 3.8 ptp . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 120.906 0.384 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -37.54 75.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.787 -174.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 53.8 mt 56.16 34.3 23.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 171.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 61.6 mttm -77.53 -169.36 1.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.533 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.24 113.63 45.23 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.514 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.782 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 27.7 Cg_exo -63.91 144.84 89.26 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.442 2.762 . . . . 0.0 112.809 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.08 -142.64 11.06 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.841 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.595 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 8.3 p -82.24 -35.65 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.127 0.489 . . . . 0.0 110.669 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.38 127.27 30.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.902 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.55 140.24 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.275 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.46 121.38 9.88 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.44 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 56' ' ' LYS . 26.2 mt -78.53 153.82 30.95 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.548 0.69 . . . . 0.0 112.548 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.744 HD11 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.81 127.01 28.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.677 -171.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 1.7 p -80.06 144.87 32.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 93.1 mt-10 -55.17 -26.06 36.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -65.51 -36.33 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.581 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.0 m -94.81 -17.98 21.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.4 t0 -52.05 121.6 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.509 -172.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.78 -32.88 5.47 Favored Glycine 0 C--N 1.316 -0.58 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.26 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -71.13 128.39 35.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.447 -0.376 . . . . 0.0 110.866 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.6 t -74.8 119.67 77.88 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 8.8 Cg_endo -54.8 -36.15 90.1 Favored 'Trans proline' 0 N--CA 1.472 0.264 0 C-N-CA 123.174 2.582 . . . . 0.0 113.331 -174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.495 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.4 mm -65.41 -44.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.7 p -121.55 -11.49 8.68 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 62.79 72.4 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.957 0.408 . . . . 0.0 111.181 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -162.67 141.8 8.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.856 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -83.31 45.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.306 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.66 HG13 ' HB2' ' A' ' 73' ' ' CYS . 5.9 p -92.79 154.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.245 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -35.16 124.81 0.58 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.356 1.062 . . . . 0.0 113.584 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.79 146.89 38.79 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.144 2.563 . . . . 0.0 111.825 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 57.7 tptt -127.45 -49.27 1.41 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.697 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -138.09 138.69 38.97 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.937 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HG2' ' CE2' ' A' ' 71' ' ' PHE . 32.5 mtpt -65.25 136.04 56.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.322 0.582 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 26.0 t -79.92 124.72 38.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.162 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.595 ' NH1' ' HA ' ' A' ' 17' ' ' VAL . 72.7 mtt-85 -107.05 133.34 51.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.059 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.95 147.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.967 0.413 . . . . 0.0 110.118 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.782 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 p -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.17 -42.8 14.49 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.912 0.758 . . . . 0.0 111.721 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.3 m120 -60.28 -41.12 92.65 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 74.0 m -85.8 53.37 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 t -160.72 -46.85 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.427 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.489 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 21' ' ' LEU . 35.4 mtmm . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 p30 -65.75 143.34 57.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.402 0.62 . . . . 0.0 111.551 -173.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.5 t -64.05 125.89 25.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.676 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 70' ' ' ALA . 18.4 pt -63.3 -32.43 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.744 HD12 HD11 ' A' ' 22' ' ' LEU . 49.3 mt -73.52 -41.3 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -173.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 6.3 p -93.5 -25.11 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.227 174.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 t30 61.43 44.59 9.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.745 0.784 . . . . 0.0 109.656 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 63' ' ' LEU . 1.4 tm? -164.18 -59.27 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.418 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 74.9 m-80 -71.82 146.22 48.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.4 p -66.93 136.19 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.386 . . . . 0.0 111.09 -177.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -88.51 142.34 17.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.4 m -117.17 -38.53 2.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.685 0.279 . . . . 0.0 111.594 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' LEU . 80.5 m-20 -109.93 -168.52 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -115.02 145.73 41.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.025 0.441 . . . . 0.0 110.513 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . . . -75.86 152.28 37.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.709 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CE2' ' HG2' ' A' ' 42' ' ' LYS . 32.0 m-85 -132.08 131.47 42.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.192 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -70.67 128.75 37.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.66 ' HB2' HG13 ' A' ' 37' ' ' VAL . 7.1 p -73.6 158.4 34.85 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.868 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 27.8 t90 -47.97 -49.74 29.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.536 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 5.5 pt-20 -68.45 -36.5 79.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 34.7 m -63.23 -42.25 99.2 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.584 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 97.4 m -68.1 -41.1 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.701 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -63.26 -42.47 99.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -72.24 -30.13 64.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.248 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.83 4.29 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.033 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -96.24 -32.61 12.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 109.979 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -64.06 -34.99 79.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.614 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 7.47 2.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.953 -176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -76.47 -56.41 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.07 -147.33 12.35 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.433 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 2.0 t -70.59 114.44 26.38 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 124.302 1.041 . . . . 0.0 112.389 -174.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 10' ' ' MET . 96.0 Cg_endo -93.33 42.11 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.073 2.515 . . . . 0.0 114.887 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' ' 10' ' ' MET . 39.9 mtt-85 -74.58 128.42 35.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.024 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 89' ' ' ILE . 17.8 mm . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 0.0 111.225 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.781 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.72 0.771 . . . . 0.0 112.052 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.4 t -52.84 -39.75 62.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.67 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 10' ' ' MET . 1.1 mp 43.29 46.44 5.38 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -88.89 -152.66 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 46' ' ' CYS . 67.3 tp60 -86.3 115.17 61.05 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 48.9 Cg_exo -58.94 136.17 71.69 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.084 2.523 . . . . 0.0 112.852 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.69 -112.29 0.89 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.445 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 p -146.26 -26.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.781 0.324 . . . . 0.0 110.881 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.569 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 56.2 mt-30 -66.35 131.7 46.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.324 0.583 . . . . 0.0 111.45 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -76.33 135.52 39.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.888 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.2 118.72 5.66 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.233 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 91.8 mt -90.8 143.67 26.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.144 0.497 . . . . 0.0 111.648 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 80.9 mt -104.04 133.63 48.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.743 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.3 p -71.27 154.26 41.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HG2' HG21 ' A' ' 67' ' ' VAL . 37.1 mt-10 -48.64 -32.27 8.02 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.484 0.49 . . . . 0.0 112.269 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -70.81 -43.21 69.1 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.652 ' HB3' HD12 ' A' ' 60' ' ' ILE . 33.7 m -89.72 -11.32 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -54.86 115.5 2.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.764 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.7 -31.31 5.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.6 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 62.5 mttp -77.32 127.59 32.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.4 t -68.14 118.27 57.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 3.2 Cg_endo -52.93 -41.29 72.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.221 2.614 . . . . 0.0 113.652 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.963 HG21 ' HG2' ' A' ' 81' ' ' LYS . 1.4 mm -68.75 -48.44 71.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -110.5 -7.94 14.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 58.88 71.46 0.58 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.295 0.569 . . . . 0.0 110.266 -177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.7 t -160.04 139.51 11.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.112 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.405 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.3 m-85 -85.62 30.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 73' ' ' CYS . 7.7 p -80.51 148.82 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.444 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -36.93 119.96 0.8 Allowed Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.8 Cg_endo -80.63 150.65 19.1 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.341 2.694 . . . . 0.0 112.207 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 52.2 mtpt -137.59 -69.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.668 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 20.7 tpp180 -78.86 131.62 36.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.022 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -69.03 133.46 48.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.215 0.531 . . . . 0.0 110.613 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.655 HG13 ' HG3' ' A' ' 87' ' ' PRO . 3.1 t -76.88 126.22 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.866 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -125.04 127.95 47.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.779 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 m -85.53 158.44 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 0.0 111.257 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.9 p -65.45 148.79 51.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -54.02 -30.89 49.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.249 0.343 . . . . 0.0 111.686 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.668 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 64.7 m-80 -59.83 -34.2 72.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.476 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.89 35.5 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.717 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 14.8 m -140.57 -45.16 0.4 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.304 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.729 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.695 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 72.0 m-20 -61.05 142.54 56.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.3 t -51.03 133.39 27.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.89 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' CD1' HG11 ' A' ' 43' ' ' VAL . 7.6 pt -78.43 -26.58 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.518 -175.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 26' ' ' CYS . 48.9 mt -78.2 -48.24 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.549 ' C ' ' H ' ' A' ' 63' ' ' LEU . 28.2 p -103.03 -6.75 22.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.764 -0.775 . . . . 0.0 110.834 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 12.9 m-80 70.05 -36.08 0.34 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.745 0.818 . . . . 0.0 111.581 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -78.65 -63.22 1.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.559 -166.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -68.23 148.62 50.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.742 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -73.93 137.02 24.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.721 0.295 . . . . 0.0 110.688 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 144.35 27.25 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.875 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' HG2' ' A' ' 24' ' ' GLU . 27.2 m -115.29 -47.63 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -114.75 135.68 53.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.289 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.89 134.62 55.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.781 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -77.37 153.05 34.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.475 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 11.2 m-85 -134.55 135.1 42.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.521 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -66.55 130.29 42.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.9 p -68.97 162.51 26.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -51.18 -44.03 61.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.105 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -59.82 -47.67 84.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.741 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 68.4 m -67.51 -37.92 83.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.298 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 77.0 m -62.55 -42.88 99.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.798 0.332 . . . . 0.0 110.504 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.05 -42.25 99.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 68.6 mt -70.28 -33.44 71.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.5 7.83 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.847 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.963 ' HG2' HG21 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -66.73 -25.58 66.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.796 0.331 . . . . 0.0 111.564 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.668 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . 26.5 p-10 -65.76 -43.52 88.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.756 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -83.94 -9.0 59.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.916 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 6.4 m-20 -60.03 -49.49 77.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.12 7.92 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.041 -1.075 . . . . 0.0 113.706 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 41.4 t -69.38 117.97 57.75 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.412 -0.894 . . . . 0.0 111.85 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.655 ' HG3' HG13 ' A' ' 43' ' ' VAL . 75.6 Cg_endo -86.45 24.94 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 123.201 2.601 . . . . 0.0 113.261 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 10' ' ' MET . 2.0 mmt180 -73.82 124.49 26.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm . . . . . 0 C--N 1.32 -0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.546 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.876 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.4 t -111.14 -54.75 2.57 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.881 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.556 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 56.8 mt 48.56 33.16 3.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.047 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -86.24 -179.74 6.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mm-40 -67.93 116.05 34.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.2 Cg_exo -72.4 142.57 37.26 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.431 2.754 . . . . 0.0 112.975 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.45 -133.35 4.43 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.925 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.56 -27.08 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.658 0.266 . . . . 0.0 111.329 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -64.6 131.65 47.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 111.163 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.668 HG21 ' HD3' ' A' ' 42' ' ' LYS . 6.6 m -83.13 140.91 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.026 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.4 133.07 14.08 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.687 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 71.7 mt -95.64 143.79 26.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.173 0.511 . . . . 0.0 112.358 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 53.2 mt -113.93 139.28 49.35 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.374 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 8.6 p -72.62 151.62 42.22 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.606 ' HG2' HG21 ' A' ' 67' ' ' VAL . 21.4 mt-10 -49.32 -34.67 16.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.923 0.392 . . . . 0.0 111.595 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -71.46 -26.45 62.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 56.9 m -101.2 -16.08 17.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.453 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -51.94 115.77 1.85 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.258 0.552 . . . . 0.0 111.201 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 36' ' ' TYR . . . 122.29 -30.93 5.05 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.951 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 40.0 mttm -72.12 127.72 33.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.57 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 2.5 t -71.08 120.42 79.42 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HG2' HG11 ' A' ' 43' ' ' VAL . 71.8 Cg_exo -53.1 -35.54 73.05 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.827 2.351 . . . . 0.0 112.964 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mm -67.84 -46.68 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.363 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.7 p -118.46 -2.94 10.97 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.6 t70 59.13 67.8 0.88 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.284 0.564 . . . . 0.0 110.69 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.02 143.34 15.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.022 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 28' ' ' GLY . 2.1 m-85 -83.39 13.31 4.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.091 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 73' ' ' CYS . 13.1 p -60.67 149.64 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.8 ptp85 -38.88 128.77 1.18 Allowed Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.098 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.732 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 Cg_exo -74.83 -161.38 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.437 2.758 . . . . 0.0 112.724 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.836 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -167.78 -43.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.728 178.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 -153.83 142.53 20.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 111.196 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.668 ' HD3' HG21 ' A' ' 19' ' ' THR . 87.0 mttt -62.54 143.08 57.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.473 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.994 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 18.0 m -82.08 146.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -118.98 133.51 55.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.073 0.463 . . . . 0.0 110.78 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.7 m -86.9 146.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.667 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.769 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 10.2 p -66.16 151.39 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -52.02 -37.17 52.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.884 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.495 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 16.9 m-80 -64.67 -20.19 66.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.554 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 19.6 m -90.2 -41.01 11.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.274 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -68.82 -30.27 68.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.3 mttm . . . . . 0 CA--C 1.515 -0.383 0 CA-C-O 120.858 0.361 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 13.8 p30 -71.62 138.85 49.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.1 t -42.7 126.29 3.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.931 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.432 HG12 HD23 ' A' ' 22' ' ' LEU . 9.5 pt -61.21 -32.03 51.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.986 -1.007 . . . . 0.0 113.128 -171.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.99 -45.16 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -103.94 -7.35 20.46 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.684 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 42.04 51.33 4.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.708 0.803 . . . . 0.0 112.387 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 -66.13 0.13 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.085 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -71.24 139.41 50.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.51 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 13.8 p -66.67 136.4 26.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.432 . . . . 0.0 111.448 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.51 141.66 25.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.381 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 ' HG2' ' A' ' 24' ' ' GLU . 19.1 m -118.87 -46.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -116.91 147.23 42.4 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.648 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.36 142.62 58.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.579 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . . . -81.32 155.59 25.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.904 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 18.3 m-85 -127.84 137.28 52.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 91.1 m-85 -69.76 125.39 26.58 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 1.8 p -71.21 152.75 43.04 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.269 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.534 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.65 -44.19 62.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.092 -177.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -56.15 -46.8 79.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.527 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -72.6 -38.56 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.5 t -67.14 -39.98 86.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 110.397 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.27 -32.27 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.403 0.621 . . . . 0.0 109.905 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 101.82 41.21 2.53 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.106 176.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -94.74 1.26 55.46 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.279 -0.542 . . . . 0.0 110.722 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.48 -23.52 62.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.547 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -96.21 9.54 40.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.136 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -68.05 -65.91 0.63 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.96 -154.4 24.38 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.407 170.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 54.1 t -57.93 115.41 11.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.211 -0.994 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.994 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 71.8 Cg_endo -78.29 17.42 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.286 2.658 . . . . 0.0 113.312 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 14.0 mmm180 -67.98 136.41 53.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.876 ' HA ' ' HA ' ' A' ' 10' ' ' MET . 28.9 mm . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 118.408 0.549 . . . . 0.0 111.345 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.668 ' HE1' HD13 ' A' ' 32' ' ' ILE . 4.3 ptp . . . . . 0 N--CA 1.447 -0.625 0 CA-C-O 121.502 0.668 . . . . 0.0 111.425 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 7.6 t -44.69 -59.9 2.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.383 -1.735 . . . . 0.0 112.625 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 84' ' ' ASP . 81.7 mt 52.48 32.18 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.935 0.894 . . . . 0.0 113.225 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -80.75 -177.92 6.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.83 115.52 25.77 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 6.5 Cg_exo -74.99 140.1 25.09 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.991 2.461 . . . . 0.0 112.873 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.07 -145.3 10.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.214 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.6 -5.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.518 -0.401 . . . . 0.0 110.606 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -62.01 130.36 45.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.177 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -79.17 137.83 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.301 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.26 125.66 7.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.341 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 81.9 mt -100.08 145.8 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.241 0.543 . . . . 0.0 112.407 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.614 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 85.8 mt -114.04 133.01 55.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.572 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.5 p -72.14 157.95 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -53.01 -27.44 19.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.884 0.374 . . . . 0.0 111.842 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 50.7 mtpt -75.43 -24.14 57.05 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.321 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.441 ' HB3' HD12 ' A' ' 60' ' ' ILE . 8.9 m -119.05 18.46 13.14 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.9 129.54 40.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.763 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.52 -22.33 37.99 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.664 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 60.3 mttp -74.82 133.03 41.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.643 0.259 . . . . 0.0 111.021 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t -70.9 121.01 82.76 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 12.0 Cg_endo -58.35 -34.33 98.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.976 2.451 . . . . 0.0 113.142 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.668 HD13 ' HE1' ' A' ' 10' ' ' MET . 13.0 mm -69.89 -46.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.212 -175.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.5 p -122.66 -7.57 8.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 60.87 78.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.341 0.591 . . . . 0.0 110.367 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -160.54 143.95 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.398 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 25.5 m-85 -94.63 26.9 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.668 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG22 ' H ' ' A' ' 38' ' ' ARG . 4.4 p -75.96 168.84 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 3.2 mtp-105 -50.49 129.23 25.72 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.7 Cg_exo -73.28 158.57 48.43 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.19 2.593 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.512 ' HG3' ' HE3' ' A' ' 74' ' ' TRP . 11.9 tmtt? -142.94 -49.77 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.273 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HD3' ' OD2' ' A' ' 82' ' ' ASP . 67.9 ttt180 -122.31 130.54 53.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.683 0.278 . . . . 0.0 111.071 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.71 136.6 54.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.17 0.509 . . . . 0.0 110.648 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.2 t -75.44 134.68 28.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.984 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -124.46 130.19 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.5 m -92.29 155.68 3.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.047 0.451 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.5 p -66.3 151.34 47.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.222 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -53.06 -39.62 63.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.355 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.624 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 5.1 m120 -55.87 -44.71 78.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.256 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.643 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 33.6 m -66.95 -25.06 66.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 t -87.24 -51.01 6.21 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.628 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.306 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 11.5 mmpt? . . . . . 0 CA--C 1.519 -0.238 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 84.6 m-20 -84.35 154.46 22.86 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.733 0.777 . . . . 0.0 111.398 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.0 t -53.2 136.27 36.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.106 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.516 HD11 ' CB ' ' A' ' 70' ' ' ALA . 11.1 pt -77.76 -32.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.768 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 26' ' ' CYS . 46.8 mt -73.26 -48.58 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -108.2 11.8 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.306 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 7.3 p-10 53.79 -37.11 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -93.12 -46.75 7.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 119.665 1.121 . . . . 0.0 113.888 -171.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.742 ' H ' HD12 ' A' ' 63' ' ' LEU . 4.3 m120 -67.73 135.56 52.9 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 11.7 p -59.44 134.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 111.55 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.5 144.66 19.9 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.274 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.01 -42.57 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -113.43 139.21 49.1 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.966 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -64.36 138.16 58.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.215 0.531 . . . . 0.0 111.104 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.614 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -83.33 154.01 24.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.072 176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 11.6 m-85 -131.76 135.13 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.88 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 46.3 m-85 -68.63 127.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 4.9 p -70.87 156.75 39.2 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.569 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.512 ' HE3' ' HG3' ' A' ' 40' ' ' LYS . 9.5 t-105 -41.17 -60.27 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.007 0.817 . . . . 0.0 112.804 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.16 -35.85 78.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.209 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 23.5 m -62.81 -35.94 81.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 111.245 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.3 m -70.99 -37.95 72.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.211 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -49.21 76.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.39 175.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.16 -32.62 71.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.771 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . 79.9 43.92 9.55 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.504 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -95.32 -31.07 13.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.187 0.518 . . . . 0.0 110.068 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.435 ' OD2' ' HD3' ' A' ' 41' ' ' ARG . 43.7 p-10 -65.94 -30.93 71.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.429 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HD2' ' C ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -64.38 -19.12 65.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.582 -176.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.721 ' HB3' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -64.62 -42.58 95.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.389 -177.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.04 -136.29 6.28 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.876 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 36.8 t -60.38 113.36 7.31 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.362 1.065 . . . . 0.0 112.159 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 69.4 Cg_endo -86.51 43.9 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.033 2.489 . . . . 0.0 113.827 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.643 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 45.9 mtt180 -98.67 127.88 44.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.94 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.4 mm . . . . . 0 C--N 1.32 -0.682 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.016 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.86 ' SD ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.0 t -45.72 -53.84 8.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 111.522 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.515 ' HB2' ' HG3' ' A' ' 10' ' ' MET . 2.6 tp 41.99 41.05 1.8 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 170.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 64.0 mttm -79.65 -134.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -109.93 116.65 53.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD3' ' HA2' ' A' ' 85' ' ' GLY . 52.0 Cg_exo -56.14 135.72 71.4 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.217 -175.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.16 -136.14 8.05 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.393 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.67 -24.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -80.86 137.44 36.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -78.25 137.91 38.35 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.988 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.75 133.22 13.25 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.491 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 64.2 mt -95.29 147.36 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 111.913 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.645 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 79.4 mt -117.12 132.28 56.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.376 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.593 ' HA ' HG23 ' A' ' 67' ' ' VAL . 6.9 p -71.9 158.24 36.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HG3' HG21 ' A' ' 67' ' ' VAL . 39.8 mt-10 -55.75 -28.01 53.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.0 111.561 -176.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 55.0 mttp -71.81 -24.44 61.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.413 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.478 ' HB3' HD12 ' A' ' 60' ' ' ILE . 5.6 m -119.66 18.33 12.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 32.7 t70 -67.51 131.49 45.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.554 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.49 -27.54 6.31 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.83 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 61.9 mttp -66.75 132.02 47.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.584 0.231 . . . . 0.0 111.027 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 t -71.17 118.01 61.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 68.0 Cg_exo -56.41 -39.85 88.51 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.157 2.571 . . . . 0.0 113.383 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.586 HG21 ' HD3' ' A' ' 81' ' ' LYS . 6.8 mm -61.54 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.209 -174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -119.47 -16.51 8.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 66.94 77.97 0.26 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.59 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -171.34 145.86 2.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.996 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -97.45 31.23 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.79 70.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 122.31 1.053 . . . . 0.0 111.83 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.8 mmp_? 60.14 111.63 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.776 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.36 144.03 66.22 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.719 2.279 . . . . 0.0 112.132 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -128.68 -48.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -139.81 144.9 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.439 -0.163 . . . . 0.0 111.202 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 92.9 mttt -63.94 138.31 58.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.316 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.805 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.0 t -73.53 131.84 34.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.687 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.0 OUTLIER -113.18 124.69 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.61 150.92 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.404 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.633 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 11.7 p -62.0 150.14 38.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -51.78 -34.83 41.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.103 -177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.7 m120 -58.24 -45.51 87.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.574 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 99.3 m -74.99 -15.01 60.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -85.49 -45.62 11.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.263 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.645 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.824 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.01 0.433 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.804 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.4 m-80 -78.26 158.82 28.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.3 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.5 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.397 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.615 HG22 ' NE ' ' A' ' 88' ' ' ARG . 7.7 pt -70.62 -38.09 72.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.976 -173.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 26' ' ' CYS . 43.4 mt -69.95 -54.85 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -90.36 -6.47 54.99 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.793 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 48.99 24.29 0.85 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.932 0.893 . . . . 0.0 112.393 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.91 -59.83 0.74 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.319 -170.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -76.14 140.53 41.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.804 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 42.9 t -58.56 137.76 20.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 111.107 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.88 149.17 45.87 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.049 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 23' ' ' CYS . 47.3 t -122.4 -62.19 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.757 0.313 . . . . 0.0 111.28 -177.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.44 143.19 45.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.28 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -60.48 136.78 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -82.71 156.06 23.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.325 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -128.8 133.68 48.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.14 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.805 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.3 m-85 -67.27 130.85 44.4 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.416 ' SG ' ' CG ' ' A' ' 75' ' ' GLU . 11.2 p -73.48 167.97 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -55.69 -49.17 73.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' CG ' ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt-20 -63.26 -39.58 95.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 69.4 m -66.25 -40.03 89.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.899 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 21.3 t -68.07 -36.99 80.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.25 0.548 . . . . 0.0 109.89 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -60.61 -44.24 96.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.05 -31.49 69.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.874 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.76 8.44 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.01 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HD3' HG21 ' A' ' 32' ' ' ILE . 43.1 mttm -87.84 7.51 30.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.708 0.766 . . . . 0.0 110.294 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -92.8 -10.94 35.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.847 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.67 -26.25 7.52 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.081 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -64.98 -54.83 24.34 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.951 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.449 ' HA2' ' HD3' ' A' ' 15' ' ' PRO . . . -158.56 -158.55 9.09 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.999 -1.572 . . . . 0.0 115.152 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 1.6 t -95.17 120.04 64.75 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.792 -1.204 . . . . 0.0 111.47 -173.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.86 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 71.6 Cg_endo -75.5 47.02 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.922 3.081 . . . . 0.0 114.166 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.615 ' NE ' HG22 ' A' ' 59' ' ' ILE . 17.9 mmt180 -101.95 126.67 48.92 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 10' ' ' MET . 2.8 mm . . . . . 0 C--N 1.315 -0.918 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.508 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.592 ' SD ' ' HD2' ' A' ' 83' ' ' LYS . 7.1 ptp . . . . . 0 C--O 1.233 0.205 0 CA-C-O 121.37 0.605 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 t -42.57 -56.53 3.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.559 -174.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 86.8 mt 52.39 41.0 30.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.508 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 84.4 mttt -77.1 -176.96 4.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 167.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.44 ' NE2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -70.09 116.11 40.99 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.722 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 28.6 Cg_endo -72.15 142.85 38.76 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.386 2.057 . . . . 0.0 112.765 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.57 -157.43 28.7 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.007 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.85 -23.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.11 0.481 . . . . 0.0 110.893 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -63.65 128.49 36.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.034 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.576 HG21 ' HD3' ' A' ' 42' ' ' LYS . 20.2 m -82.58 136.33 34.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.601 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.546 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -66.51 126.16 27.26 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.923 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 63.8 mt -80.96 141.85 34.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 112.14 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 70.2 mt -118.4 143.91 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.186 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 11.5 p -80.14 157.55 26.58 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.4 -26.55 42.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.07 0.462 . . . . 0.0 111.386 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.1 mmtt -71.52 -27.3 63.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.2 m -108.84 26.22 10.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.06 127.46 31.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.4 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.61 32.84 61.32 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.421 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE2' ' HE1' ' A' ' 36' ' ' TYR . 94.4 mttt -111.83 140.22 46.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.675 0.274 . . . . 0.0 110.902 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 10.7 t -82.36 114.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.942 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HG3' HG21 ' A' ' 43' ' ' VAL . 12.0 Cg_endo -58.83 -29.43 89.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.978 2.452 . . . . 0.0 112.957 -176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 81' ' ' LYS . 21.2 mm -65.23 -40.94 90.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.09 -12.28 6.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 t0 62.2 74.38 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -163.25 141.36 7.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.106 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.502 ' HE1' ' HE2' ' A' ' 29' ' ' LYS . 13.2 m-85 -85.75 33.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 73' ' ' CYS . 5.1 p -78.78 158.02 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -41.51 128.85 2.31 Favored Pre-proline 0 N--CA 1.467 0.379 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 96.1 Cg_endo -82.53 154.3 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.32 2.68 . . . . 0.0 112.048 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 20.8 tptm -127.21 -40.62 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -150.45 139.68 21.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.306 -0.246 . . . . 0.0 111.166 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HD3' HG21 ' A' ' 19' ' ' THR . 71.2 mttt -59.96 139.33 57.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 111.714 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.786 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.9 t -71.34 133.37 31.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.114 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.5 ' HB2' ' NH1' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -109.78 126.85 54.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.918 175.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.4 m -102.07 154.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.733 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -66.84 141.29 57.73 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.26 -22.61 53.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.7 -32.11 73.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.301 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.3 m -92.1 41.58 1.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.602 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -138.69 -41.98 0.49 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.556 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.732 176.627 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 21.8 mmtp . . . . . 0 CA--C 1.512 -0.505 0 CA-C-O 120.925 0.393 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.877 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.0 m-20 -68.89 140.92 55.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.467 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 10.4 t -48.54 131.53 17.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.016 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 ' HA3' ' A' ' 20' ' ' GLY . 24.1 pt -70.19 -32.88 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.429 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 mt -72.64 -44.32 60.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.3 p -107.12 -3.81 19.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.984 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 41.47 45.02 2.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.415 0.686 . . . . 0.0 112.621 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.9 -60.61 0.26 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.211 0.529 . . . . 0.0 110.654 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -82.32 138.54 34.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.488 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.877 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 46.8 t -61.32 137.27 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.59 -179.41 49.5 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.148 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -174.12 -39.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.597 0.713 . . . . 0.0 109.31 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 8.1 m120 -82.83 176.75 9.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.387 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -118.92 135.48 54.56 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB2' HD21 ' A' ' 22' ' ' LEU . . . -78.38 146.25 34.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -126.55 133.02 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.786 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 64.2 m-85 -69.33 120.8 15.71 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 7.0 p -70.03 162.1 28.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.468 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 4.9 t-105 -43.4 -55.95 3.84 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 124.206 0.941 . . . . 0.0 112.1 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.81 -46.77 88.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.92 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.1 m -66.53 -40.86 89.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.079 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 t -67.51 -40.51 85.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.617 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -62.97 -43.6 98.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.881 0.372 . . . . 0.0 110.505 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.71 -27.12 62.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.067 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.07 44.46 13.81 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.533 ' O ' HD12 ' A' ' 32' ' ' ILE . 29.3 mtpp -93.12 31.41 1.45 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.955 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.39 -1.32 8.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.592 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 94.0 mttt 58.73 30.48 20.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.393 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 23.0 t70 82.42 -36.34 0.09 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.621 174.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.722 ' HA2' ' HG3' ' A' ' 15' ' ' PRO . . . -165.48 -134.15 1.62 Allowed Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 118.448 -1.834 . . . . 0.0 115.468 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 13.3 t -50.63 103.09 0.35 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 113.772 -1.214 . . . . 0.0 113.03 -169.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 57.7 Cg_endo -91.28 44.61 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.563 2.842 . . . . 0.0 113.113 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.1 ptm180 -110.94 136.7 49.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.315 -175.418 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.664 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 121.395 0.617 . . . . 0.0 111.402 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 30.9 t -50.53 -54.22 24.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.222 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.664 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 81.1 mt 48.34 40.79 15.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 50.9 mttm -79.97 -156.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -83.16 111.17 28.58 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 59.6 Cg_endo -80.98 138.33 11.43 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.006 1.804 . . . . 0.0 112.417 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.91 -139.42 9.65 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.047 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -89.46 -16.9 8.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 110.284 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.729 ' HB2' HG12 ' A' ' 45' ' ' VAL . 3.7 mm100 -56.93 132.88 54.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.149 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.402 HG21 ' HD3' ' A' ' 42' ' ' LYS . 12.7 m -107.61 127.3 53.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.212 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.744 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -71.7 114.67 5.21 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.256 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.1 mt -87.07 154.03 21.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.688 0.28 . . . . 0.0 110.587 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 76.8 mt -113.74 130.21 56.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p -75.2 157.03 35.18 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 51.2 mt-10 -54.9 -28.39 50.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.964 0.412 . . . . 0.0 111.69 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.7 mtpt -72.43 -27.97 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.165 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.8 31.79 6.49 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.9 t0 -73.76 133.91 43.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.343 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.85 32.29 66.68 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.035 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 22.9 mtpp -119.46 122.04 40.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 25.3 t -63.29 118.66 45.72 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.48 -37.3 97.71 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.762 HG21 ' HG3' ' A' ' 81' ' ' LYS . 10.8 mm -64.08 -46.48 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.36 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 22.5 p -123.78 -8.47 7.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.3 t0 60.91 76.47 0.37 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.812 0.815 . . . . 0.0 110.428 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -151.36 143.25 23.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.477 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 29' ' ' LYS . 5.9 m-85 -96.5 23.98 6.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 110.299 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 73' ' ' CYS . 9.9 p -76.35 161.8 4.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.201 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.599 ' HD2' ' HD2' ' A' ' 39' ' ' PRO . 23.2 tpt180 -47.25 120.24 6.71 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.443 0.697 . . . . 0.0 112.559 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 86.2 Cg_endo -82.56 161.14 16.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.415 2.743 . . . . 0.0 111.815 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HG3' ' CE3' ' A' ' 74' ' ' TRP . 3.3 mmmp? -130.32 -59.25 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -116.41 136.94 52.56 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.839 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HD3' HG21 ' A' ' 19' ' ' THR . 38.9 ttmt -67.73 136.74 54.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.742 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 17.9 m -79.98 151.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.917 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -124.45 127.55 47.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.159 173.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.729 HG12 ' HB2' ' A' ' 18' ' ' GLN . 0.3 OUTLIER -92.54 153.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.608 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 p -72.83 148.32 44.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 86.5 tt0 -56.56 -27.44 57.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.035 0.445 . . . . 0.0 111.068 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.56 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 7.5 m-80 -63.84 -26.69 68.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.112 177.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HB3' ' NE ' ' A' ' 88' ' ' ARG . 87.6 m -102.68 33.1 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.22 -0.3 . . . . 0.0 111.679 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.488 ' OG ' ' HG3' ' A' ' 18' ' ' GLN . 12.0 p -160.9 -50.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.573 -173.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 124.137 0.975 . . . . 0.0 111.847 -175.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.207 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.23 141.17 39.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.376 1.084 . . . . 0.0 113.353 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.0 t -69.93 135.12 49.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.442 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.744 HD13 ' HA3' ' A' ' 20' ' ' GLY . 3.7 pt -71.92 -31.87 42.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -70.28 -51.41 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 21.7 p -91.38 -7.4 50.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.685 176.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 6.7 p-10 47.25 40.2 9.9 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 124.436 1.085 . . . . 0.0 111.57 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -157.41 -60.63 0.09 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.525 -177.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.581 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 5.7 m120 -60.21 144.58 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 34.5 t -61.56 119.37 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 111.075 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.22 142.78 26.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.464 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 -45.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -108.2 127.86 54.2 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.87 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.56 136.83 56.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.82 0.448 . . . . 0.0 110.961 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -76.93 146.28 37.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.774 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 6.9 m-85 -127.52 134.55 49.77 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.182 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.487 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 95.2 m-85 -62.98 124.92 22.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.7 p -69.14 161.17 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.856 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.499 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -46.84 -50.29 18.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.067 -177.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.28 -45.65 87.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.697 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 92.3 m -64.82 -33.25 75.54 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.307 -0.246 . . . . 0.0 111.013 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 32.0 t -67.59 -40.6 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.74 -44.64 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.895 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.14 -32.59 72.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.731 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . 89.51 46.93 4.18 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.762 ' HG3' HG21 ' A' ' 32' ' ' ILE . 27.4 mmmt -73.57 -14.96 61.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 110.742 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -64.53 -32.13 73.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -73.21 -21.63 60.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.837 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.437 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.3 m-20 -58.1 -55.4 35.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.58 -137.01 7.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.866 -1.159 . . . . 0.0 114.132 171.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.628 ' SG ' HG22 ' A' ' 45' ' ' VAL . 50.2 t -64.29 113.28 9.88 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.979 0.912 . . . . 0.0 111.835 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.636 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 83.0 Cg_endo -82.58 31.55 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.956 2.437 . . . . 0.0 114.381 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.483 ' NE ' ' HB3' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.22 139.58 38.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 C--N 1.327 -0.409 0 O-C-N 123.16 0.288 . . . . 0.0 110.763 -179.559 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.711 ' CG ' HD13 ' A' ' 12' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 1.6 t -37.76 -59.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.673 -172.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD13 ' CG ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 45.77 43.47 9.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.42 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 67.8 mttm -91.74 -147.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.649 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -95.64 111.29 55.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.025 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 71.7 Cg_exo -54.67 134.79 64.28 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.233 2.622 . . . . 0.0 113.296 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.45 -142.12 12.56 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.863 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -96.94 -35.93 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' ' CB ' ' A' ' 50' ' ' SER . 75.4 mt-30 -76.35 138.51 40.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.472 0.653 . . . . 0.0 112.111 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.492 HG21 ' HD3' ' A' ' 42' ' ' LYS . 30.1 m -84.44 131.17 34.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.536 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.36 137.52 35.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 86.2 mt -106.31 161.69 14.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.376 . . . . 0.0 111.658 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.714 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 81.7 mt -123.24 131.2 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 11.5 p -73.36 161.01 30.95 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HG3' HG21 ' A' ' 67' ' ' VAL . 70.6 mt-10 -62.07 -18.16 59.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.203 0.525 . . . . 0.0 111.347 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 56.4 mttm -78.24 -36.68 46.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.609 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 3.9 m -106.42 32.48 4.45 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.584 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 44.2 t0 -70.93 129.66 39.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.596 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.71 28.28 61.42 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.104 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 26' ' ' CYS . 40.0 mtmt -115.91 126.64 54.17 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.658 -0.319 . . . . 0.0 110.375 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.27 117.89 34.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 78.4 Cg_exo -55.61 -37.67 94.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.987 2.458 . . . . 0.0 113.136 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.603 HG21 ' HB3' ' A' ' 81' ' ' LYS . 7.3 mm -63.21 -49.48 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.1 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.9 p -116.27 -8.44 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.6 t0 63.28 68.65 0.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.056 0.455 . . . . 0.0 109.962 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -153.42 142.98 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.459 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -87.45 2.44 50.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.318 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -60.67 152.53 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.659 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -31.08 131.86 0.25 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.434 1.094 . . . . 0.0 113.463 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 88.0 Cg_endo -76.81 -160.84 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.509 . . . . 0.0 112.431 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.566 ' HG2' ' SG ' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -169.75 -50.46 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.261 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -157.35 144.24 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.718 -174.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HD3' HG21 ' A' ' 19' ' ' THR . 94.0 mttt -61.59 141.73 57.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.039 0.447 . . . . 0.0 111.5 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.938 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 25.6 m -77.82 137.78 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.281 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -106.52 119.87 40.44 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.52 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.528 HG22 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -80.67 146.39 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.525 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 7.1 p -68.38 160.45 29.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.001 -177.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' CYS . 36.9 tt0 -60.47 -29.63 69.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.056 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.551 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 9.0 m120 -77.68 35.94 0.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.201 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.748 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 58.0 m -157.02 -38.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.339 174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' A' ' 18' ' ' GLN . 76.3 p -92.31 34.41 1.04 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.933 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.453 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -73.0 148.68 43.96 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.572 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.7 t -59.47 116.81 4.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' A' ' 43' ' ' VAL . 2.0 pt -57.59 -30.44 36.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.046 -172.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.35 -44.1 63.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.7 p -101.04 -12.97 18.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.346 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 56.38 17.72 3.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.45 1.1 . . . . 0.0 111.723 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 -61.42 0.85 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 -172.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -71.79 142.25 49.68 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.56 133.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -73.62 139.22 26.14 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.714 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.719 HG21 ' HG3' ' A' ' 24' ' ' GLU . 45.3 t -109.94 -57.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.258 0.552 . . . . 0.0 111.07 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.14 136.81 43.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.303 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.439 ' HA ' HD23 ' A' ' 21' ' ' LEU . 2.1 m-20 -64.08 128.87 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.714 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -74.26 144.27 44.69 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.973 0.416 . . . . 0.0 111.753 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -115.87 135.33 54.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.371 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.753 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 86.9 m-85 -64.98 132.62 49.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.5 p -74.65 154.83 38.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.536 ' HA ' ' SG ' ' A' ' 77' ' ' CYS . 56.5 t90 -53.2 -41.41 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.442 0.464 . . . . 0.0 111.659 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 50.0 mt-10 -59.62 -42.99 93.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.976 0.417 . . . . 0.0 110.542 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 59.4 m -67.67 -39.76 84.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.566 ' SG ' ' HG2' ' A' ' 40' ' ' LYS . 21.5 p -72.63 -34.2 67.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -63.38 -45.17 92.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 83.7 mt -73.93 -39.46 63.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.606 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.47 28.54 3.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.749 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.637 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 4.5 mttp -82.98 -25.24 32.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.138 0.494 . . . . 0.0 110.431 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.35 -32.33 73.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.272 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -94.84 8.39 42.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.212 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.637 ' OD2' ' HA ' ' A' ' 81' ' ' LYS . 2.6 m-20 -71.06 -48.15 54.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.99 -143.7 9.71 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.916 173.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 52.6 t -68.93 123.65 88.55 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 123.842 0.857 . . . . 0.0 111.42 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.938 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 69.3 Cg_endo -89.28 25.26 0.61 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.656 2.238 . . . . 0.0 114.945 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.748 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 50.4 mtt180 -80.18 141.4 35.71 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.006 -0.433 . . . . 0.0 111.231 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.8 mm . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.066 173.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 1.004 ' HG3' HD13 ' A' ' 12' ' ' LEU . 2.2 ptm . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 120.788 0.327 . . . . 0.0 111.547 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 9.1 t -54.14 -53.91 46.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.179 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.004 HD13 ' HG3' ' A' ' 10' ' ' MET . 0.9 OUTLIER 40.23 49.41 2.46 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 174.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 59.7 mttm -91.63 -149.56 0.24 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 170.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -100.3 122.57 49.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.336 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 70.1 Cg_exo -53.93 132.89 52.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.244 2.629 . . . . 0.0 112.535 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.87 -63.6 1.81 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.337 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.53 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HG3' ' CG2' ' A' ' 45' ' ' VAL . 9.3 pt20 -71.25 145.65 49.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.778 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.657 HG21 ' HD3' ' A' ' 42' ' ' LYS . 28.4 m -78.97 139.07 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.778 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.65 129.4 13.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.356 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 95.0 mt -100.14 142.78 31.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.274 0.559 . . . . 0.0 111.717 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -107.5 134.98 49.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.012 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 4.2 p -72.47 150.99 42.8 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 69.4 mt-10 -50.22 -30.63 11.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.17 0.51 . . . . 0.0 111.63 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.4 mttm -69.82 -22.39 63.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.485 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.1 m -116.07 0.91 13.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.159 0.504 . . . . 0.0 109.735 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 31.9 t0 -56.16 136.45 52.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.816 -172.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.18 -28.59 10.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.91 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 36.2 mtmt -74.18 128.11 34.7 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.126 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 1.8 t -66.42 115.54 25.04 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -55.45 -28.96 66.61 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 123.074 2.516 . . . . 0.0 113.159 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.48 HD11 ' HE1' ' A' ' 72' ' ' TYR . 7.2 mm -64.46 -42.29 94.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.881 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 35' ' ' SER . 31.5 p -128.72 -11.84 4.89 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -170.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 65.59 58.28 0.82 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.61 . . . . 0.0 110.645 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.503 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 41.8 t -153.96 141.37 19.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.585 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 3.4 m-85 -91.31 34.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 37' ' ' VAL . 7.4 p -81.7 76.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.178 0.989 . . . . 0.0 111.547 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.445 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 63.5 mtp85 59.73 91.43 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.62 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 39.9 Cg_endo -62.42 145.24 95.72 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.365 2.043 . . . . 0.0 111.366 174.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -132.56 -51.1 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.46 140.82 48.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.744 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.657 ' HD3' HG21 ' A' ' 19' ' ' THR . 72.2 mttt -66.36 136.1 55.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.941 HG11 ' HG3' ' A' ' 87' ' ' PRO . 58.2 t -85.86 133.04 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.851 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -109.29 128.02 54.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' CG2' ' HG3' ' A' ' 18' ' ' GLN . 25.0 m -77.13 155.4 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.334 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.781 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 2.1 p -66.49 164.06 17.23 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.426 0.632 . . . . 0.0 111.744 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HG2' ' CE2' ' A' ' 51' ' ' PHE . 67.8 tt0 -55.05 -50.8 68.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.102 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 2.5 m-80 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.487 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.624 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 96.0 m -70.84 -24.12 62.47 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -78.68 -38.76 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.142 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.541 ' CE2' ' HG2' ' A' ' 47' ' ' GLU . 1.7 p90 . . . . . 0 C--N 1.33 -0.283 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.149 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 1.9 m120 -61.22 136.84 58.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.28 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 29.8 t -55.16 125.9 22.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.126 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.878 HD12 ' HG2' ' A' ' 87' ' ' PRO . 3.5 pt -66.88 -34.39 69.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.672 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -71.63 -37.59 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.78 ' O ' HD12 ' A' ' 63' ' ' LEU . 27.3 p -113.45 -0.35 14.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.421 -0.799 . . . . 0.0 110.482 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 36.56 59.58 0.98 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.432 1.493 . . . . 0.0 114.829 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.006 HD13 ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.88 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.056 171.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 1.006 ' H ' HD13 ' A' ' 63' ' ' LEU . 72.2 m-80 -61.19 142.55 56.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.9 t -75.52 132.45 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.15 148.36 31.29 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.158 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.45 -41.85 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -113.25 131.91 55.73 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 110.956 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.22 138.18 56.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.415 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB2' HD11 ' A' ' 59' ' ' ILE . . . -71.19 144.57 50.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.708 175.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.89 133.05 52.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.697 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.48 ' HE1' HD11 ' A' ' 32' ' ' ILE . 97.6 m-85 -65.45 126.72 29.16 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 3.9 p -74.65 165.21 25.6 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.272 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -47.95 -59.56 3.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.537 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 54.2 mt-10 -58.17 -43.1 87.28 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.216 -171.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.14 -32.51 73.99 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.055 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.7 m -68.7 -36.98 79.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.81 -45.1 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.218 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 94.2 mt -63.0 -33.79 76.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.784 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.08 31.24 9.3 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.041 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.56 26.95 3.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.286 0.565 . . . . 0.0 109.971 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -78.43 -15.96 58.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.695 173.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -4.32 38.85 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.325 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.719 ' HB3' HD11 ' A' ' 12' ' ' LEU . 83.5 m-20 -81.95 77.35 8.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.91 -86.4 0.02 OUTLIER Glycine 0 C--O 1.227 -0.282 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.374 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.781 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 10.8 t -78.37 108.67 8.25 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.715 0.293 . . . . 0.0 110.571 -174.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.941 ' HG3' HG11 ' A' ' 43' ' ' VAL . 43.0 Cg_endo -93.5 36.74 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.523 2.149 . . . . 0.0 113.785 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.624 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 33.3 mtt180 -75.63 114.51 14.3 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.083 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 -178.179 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.722 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 8.1 ptm . . . . . 0 N--CA 1.442 -0.842 0 CA-C-O 120.801 0.334 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.3 t -48.35 -59.82 3.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.912 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.722 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 81.5 mt 48.58 35.65 6.41 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -81.73 -171.34 3.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.07 117.39 57.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -83.45 138.87 8.79 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.05 2.5 . . . . 0.0 112.773 -178.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.3 -138.79 9.02 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.477 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -95.53 -14.54 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.541 0.686 . . . . 0.0 109.749 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.601 ' HB2' HG12 ' A' ' 45' ' ' VAL . 6.2 mm100 -59.49 136.98 58.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.137 -178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -105.42 136.66 44.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.423 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.682 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -77.77 133.69 13.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.714 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 85.7 mt -90.58 145.76 24.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 53.7 mt -109.09 134.92 51.06 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.097 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.5 p -71.61 151.98 43.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HG2' HG11 ' A' ' 67' ' ' VAL . 37.8 mt-10 -48.73 -32.91 9.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 111.789 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -71.81 -27.65 63.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -102.75 1.38 34.24 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.953 -0.467 . . . . 0.0 110.162 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -59.46 112.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.71 -26.8 7.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.851 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -73.45 130.59 40.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.765 0.317 . . . . 0.0 111.329 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.22 122.14 86.72 Favored Pre-proline 0 C--N 1.319 -0.717 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 168.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HG3' HG11 ' A' ' 43' ' ' VAL . 6.1 Cg_endo -53.15 -35.5 73.39 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.663 2.909 . . . . 0.0 113.872 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 14.1 mm -69.5 -44.17 80.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.2 p -112.08 -20.88 11.78 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 68.49 72.82 0.29 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.554 0.693 . . . . 0.0 110.337 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -163.31 145.81 10.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.756 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -82.16 40.18 0.62 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.174 0.511 . . . . 0.0 110.318 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.532 HG13 ' CB ' ' A' ' 73' ' ' CYS . 8.4 p -87.02 153.44 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.078 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -39.79 110.56 0.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -171.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 91.0 Cg_endo -79.6 151.61 22.4 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.286 2.658 . . . . 0.0 111.85 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -140.97 -58.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.694 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -90.15 131.28 36.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.266 -0.174 . . . . 0.0 111.192 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -70.65 136.29 48.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.766 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 32.8 m -71.03 139.73 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.449 0.642 . . . . 0.0 111.728 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -112.74 114.84 27.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.76 175.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -83.94 148.88 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.788 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 3.5 p -68.96 145.89 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -56.45 -27.99 58.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.292 0.567 . . . . 0.0 110.349 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.788 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 52.9 m-80 -60.37 -32.34 71.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.655 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.481 ' HB2' HG22 ' A' ' 45' ' ' VAL . 99.1 m -94.54 36.44 1.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.626 0.25 . . . . 0.0 111.117 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.8 t -139.86 -52.25 0.51 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 . . . . . 0 C--O 1.235 0.324 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.624 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.102 0 CA-C-O 120.546 0.212 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 1.003 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 76.0 m-20 -61.15 152.88 27.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.888 0.851 . . . . 0.0 111.59 -176.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -59.42 131.07 49.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.307 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.682 HD13 ' HA3' ' A' ' 20' ' ' GLY . 11.9 pt -73.62 -32.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.975 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.01 -48.66 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 63' ' ' LEU . 29.5 p -102.13 -9.3 20.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.85 -28.25 0.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.581 0.752 . . . . 0.0 112.56 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -75.74 -60.14 2.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -91.91 150.77 20.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.179 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.003 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 16.7 t -63.37 136.14 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.386 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 23' ' ' CYS . . . -82.19 -167.21 39.45 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.463 HG11 ' HG2' ' A' ' 24' ' ' GLU . 7.4 p -162.06 -50.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.822 0.344 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.449 ' N ' HG13 ' A' ' 67' ' ' VAL . 79.2 m-20 -105.26 138.75 40.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.928 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.53 134.76 51.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -77.72 153.97 32.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.151 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.94 135.66 45.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.982 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.71 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 43.9 m-85 -71.62 133.58 45.8 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 6.1 p -70.76 158.24 36.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.494 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -55.13 -41.06 71.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.907 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' OE2' HG21 ' A' ' 37' ' ' VAL . 48.4 mt-10 -58.42 -51.75 68.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.666 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 97.0 m -65.54 -38.0 88.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.054 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' ' HE3' ' A' ' 74' ' ' TRP . 36.9 t -66.25 -41.41 90.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -67.77 -46.84 70.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' HE2' ' A' ' 81' ' ' LYS . 8.6 mp -64.14 -30.97 72.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.24 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 96.76 45.08 2.75 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.992 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HE2' HD23 ' A' ' 79' ' ' LEU . 67.6 mttm -103.2 -24.5 13.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.533 . . . . 0.0 110.072 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -69.59 -25.18 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 15.9 pttp -63.33 -27.98 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.294 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB3' HD13 ' A' ' 12' ' ' LEU . 76.6 m-20 -52.28 -48.12 65.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.033 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.06 -139.65 8.3 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.851 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.7 t -55.35 117.65 15.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.401 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.766 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 88.9 Cg_endo -82.23 22.02 0.91 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.932 2.421 . . . . 0.0 113.307 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.0 mmt180 -77.54 122.31 25.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.322 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 10' ' ' MET . 12.7 mm . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.782 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 11.3 ptp . . . . . 0 N--CA 1.447 -0.613 0 CA-C-O 121.307 0.575 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -54.71 -42.13 71.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.646 -173.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 93.0 mt 48.99 45.7 22.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 172.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.59 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 34.6 mttm -88.65 -155.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.035 172.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 52.1 mm-40 -77.75 114.6 42.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 110.856 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 8.9 Cg_exo -71.53 142.48 40.49 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.136 2.557 . . . . 0.0 112.741 -177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.73 -139.72 6.4 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.508 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -101.57 -25.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.335 . . . . 0.0 110.438 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -61.19 128.87 38.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.683 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -76.22 140.35 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.39 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -68.21 114.33 5.98 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.256 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 84.3 mt -77.5 149.49 34.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.707 HD21 ' HB2' ' A' ' 70' ' ' ALA . 64.7 mt -122.42 138.41 54.55 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.644 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.608 ' HA ' HG12 ' A' ' 67' ' ' VAL . 7.8 p -76.25 142.68 41.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HG3' HG11 ' A' ' 67' ' ' VAL . 48.6 mt-10 -47.62 -28.25 2.26 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 76.7 mttt -65.54 -39.33 91.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.05 -14.59 27.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 122.113 -0.367 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.91 120.4 5.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.278 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.19 -34.1 3.47 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.966 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HB2' HD13 ' A' ' 60' ' ' ILE . 20.8 mtpp -72.92 131.18 41.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.934 -0.133 . . . . 0.0 110.711 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 44.5 t -71.94 117.53 58.81 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 11.3 Cg_endo -58.69 -31.45 94.87 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.858 2.372 . . . . 0.0 112.74 -173.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.595 HD13 ' SD ' ' A' ' 10' ' ' MET . 1.6 mm -72.15 -43.13 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.322 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.6 -8.24 7.4 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.21 73.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.113 0.482 . . . . 0.0 110.797 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -165.94 139.73 4.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.3 33.56 0.81 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.029 0.442 . . . . 0.0 110.866 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.9 p -76.38 152.88 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.796 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.7 ptp180 -44.05 126.7 4.39 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.8 Cg_exo -77.54 -167.14 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.457 2.771 . . . . 0.0 111.698 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -170.98 -49.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.167 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -116.9 139.18 50.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -71.23 133.64 46.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.315 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.977 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 29.2 m -72.32 143.79 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.704 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -128.63 126.74 40.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -81.46 146.02 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.736 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.3 p -70.94 146.18 49.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 56.6 mt-10 -54.98 -37.25 66.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.432 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.638 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 4.5 m120 -51.38 -39.52 57.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.3 m -81.55 -36.36 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.583 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 28.8 p -72.87 -48.79 34.48 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.53 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 121.089 0.471 . . . . 0.0 110.432 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 8.9 mptt . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 60.9 m-20 -77.09 149.77 35.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.816 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.5 t -53.42 123.02 10.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.602 175.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.453 HD11 ' CB ' ' A' ' 70' ' ' ALA . 13.2 pt -62.44 -29.86 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 29' ' ' LYS . 47.1 mt -73.45 -44.9 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.4 p -100.31 -11.38 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.311 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 44.46 44.92 7.35 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.155 0.982 . . . . 0.0 110.941 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -152.67 -61.36 0.15 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.375 -172.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -73.06 140.14 47.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 6.0 p -66.64 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.108 0.48 . . . . 0.0 111.243 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.77 159.21 53.77 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.054 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 23' ' ' CYS . 2.0 p -157.55 -48.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.289 0.566 . . . . 0.0 110.226 -178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' H ' HG13 ' A' ' 67' ' ' VAL . 3.1 m120 -92.33 -176.25 4.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.357 174.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -124.49 142.89 50.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.57 0.224 . . . . 0.0 110.685 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.749 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -87.88 154.68 20.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.104 0.478 . . . . 0.0 111.13 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.408 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 20.0 m-85 -130.39 134.07 46.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.479 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.723 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.4 m-85 -68.92 122.74 19.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 5.9 p -70.25 149.81 47.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -55.6 -31.21 62.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.041 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 66.8 mm-40 -59.9 -44.91 93.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.867 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.535 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 38.0 m -68.64 -37.06 79.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.46 -40.79 96.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.054 177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.66 96.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.105 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.55 -35.08 72.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.694 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.6 38.46 6.59 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.491 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -93.72 -30.21 15.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.436 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.76 -29.88 71.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.126 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -63.32 -20.65 65.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.076 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.48 ' HB2' HD22 ' A' ' 12' ' ' LEU . 44.7 m-20 -67.19 -44.86 78.57 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.519 ' HA3' ' HG3' ' A' ' 15' ' ' PRO . . . 126.4 -119.9 3.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.562 -1.304 . . . . 0.0 114.664 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 19.3 t -43.14 105.5 0.43 Allowed Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 113.12 -171.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.977 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 75.1 Cg_endo -85.15 22.48 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.204 2.603 . . . . 0.0 112.674 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -73.16 124.0 24.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.1 mm . . . . . 0 C--N 1.32 -0.709 0 C-N-CA 122.533 0.333 . . . . 0.0 111.816 -176.734 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.828 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 121.326 0.584 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.3 t -42.08 -46.35 4.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.04 -1.437 . . . . 0.0 111.637 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 10' ' ' MET . 1.2 mp 42.76 52.23 5.04 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -95.53 -145.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 170.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -91.65 113.8 59.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.571 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 52.3 Cg_exo -57.63 129.11 32.02 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.878 2.385 . . . . 0.0 112.47 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.08 -131.34 6.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.607 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.57 -36.75 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 54.2 mt-30 -63.11 125.41 23.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.47 0.652 . . . . 0.0 111.556 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -74.8 130.92 40.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.717 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.434 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -68.06 129.64 26.7 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.017 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 65.7 mt -102.14 145.31 29.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.164 0.507 . . . . 0.0 112.009 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 74.5 mt -113.36 144.01 43.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.168 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 2.9 p -78.07 154.47 31.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 50.3 mt-10 -57.53 -26.7 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.901 0.381 . . . . 0.0 111.453 -176.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.6 mmtt -69.15 -24.12 64.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.81 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 m -115.72 25.21 10.93 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.599 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 33.4 t70 -72.49 131.36 42.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.22 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.29 62.68 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.807 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -111.76 131.64 55.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.3 119.16 73.26 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -57.26 -38.3 95.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.266 2.644 . . . . 0.0 113.359 -174.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.498 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 6.9 mm -64.44 -56.8 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 28.1 p -100.82 -19.78 15.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -169.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 33' ' ' CYS . 13.4 t70 68.59 85.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.225 0.536 . . . . 0.0 110.397 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -174.58 145.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.312 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.35 33.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.71 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.4 p -78.62 158.23 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.313 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.531 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 31.3 ttp180 -50.83 126.02 23.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.382 0.673 . . . . 0.0 112.543 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.6 Cg_exo -70.45 -166.62 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.605 2.87 . . . . 0.0 112.169 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 25.7 tptp -166.91 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -143.65 140.2 29.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.059 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 33.8 mtpt -62.03 136.26 57.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 111.117 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 11.5 t -75.85 131.94 34.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.94 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -121.19 128.73 52.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.723 0.296 . . . . 0.0 110.205 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -75.22 151.26 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.062 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.722 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 9.6 p -59.7 153.77 19.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -54.94 -37.03 65.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 6.8 m120 -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.341 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 m -71.39 -27.01 63.03 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.459 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 89.3 p -77.16 -39.44 49.1 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.942 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 4.0 p90 . . . . . 0 C--N 1.327 -0.392 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.7 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? . . . . . 0 CA--C 1.513 -0.456 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.872 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 6.9 p30 -62.18 142.7 57.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 40.9 t -46.71 111.08 0.34 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.816 -175.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.464 HD11 ' CB ' ' A' ' 70' ' ' ALA . 6.0 pt -60.43 -26.0 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.398 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.64 -42.96 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -117.43 5.76 12.55 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.137 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 5.4 p-10 38.64 43.49 0.69 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -148.76 -58.59 0.22 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.834 -173.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -86.76 17.75 3.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -167.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.872 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 2.6 t 59.67 137.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.113 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -82.36 162.23 41.76 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.548 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 68' ' ' ASN . 6.3 p -149.8 -44.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.259 -0.471 . . . . 0.0 110.367 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' N ' HG13 ' A' ' 67' ' ' VAL . 76.6 m-20 -106.03 131.39 53.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.01 133.36 56.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.955 0.407 . . . . 0.0 110.752 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -74.21 150.5 40.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 9.2 m-85 -128.62 131.93 48.12 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.477 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 98.4 m-85 -67.97 127.79 34.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.777 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 8.5 p -73.68 158.78 34.06 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.232 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.512 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.39 -46.2 62.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.138 -178.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.69 -44.51 93.62 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.611 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.797 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 58.6 m -64.72 -43.41 93.51 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.224 -0.297 . . . . 0.0 111.018 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 58.4 m -64.24 -34.59 78.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -58.33 -49.88 75.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.927 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.52 -47.0 24.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.521 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.67 34.55 0.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.556 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' CYS . 18.9 mmtp -76.13 -23.69 54.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.23 0.538 . . . . 0.0 110.531 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.23 -42.13 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.892 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -85.54 -15.24 43.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.597 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.504 ' OD2' HD21 ' A' ' 12' ' ' LEU . 25.2 t0 -56.47 -51.13 69.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.899 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.91 34.43 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.211 -1.471 . . . . 0.0 114.926 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.3 t -72.56 113.5 21.66 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 113.691 -1.254 . . . . 0.0 111.751 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 96.3 Cg_endo -81.98 43.87 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.228 2.619 . . . . 0.0 113.405 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' MET . 6.5 mmm180 -87.97 131.24 34.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.597 177.867 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.981 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 t -51.91 -54.0 34.45 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.478 -167.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.981 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 34.1 mt 44.86 37.86 2.58 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -82.42 170.71 14.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 7.1 tp-100 -67.69 119.65 67.69 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 34.6 Cg_exo -62.29 145.47 96.01 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.754 2.303 . . . . 0.0 112.814 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.9 -66.46 1.62 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.977 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p 176.64 -32.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.792 0.329 . . . . 0.0 110.586 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 26.1 mt-30 -64.38 133.28 52.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.692 -175.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -74.71 137.26 41.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -75.35 133.48 14.88 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.996 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 80.1 mt -100.12 143.34 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.674 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 63.7 mt -111.93 138.56 48.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 3.5 p -81.88 148.92 28.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 27' ' ' ASP . 46.6 mt-10 -54.39 -27.58 37.62 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.64 -29.98 70.62 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.656 0.265 . . . . 0.0 111.378 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 60' ' ' ILE . 34.6 m -105.37 -12.63 15.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.878 0.37 . . . . 0.0 110.206 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' CB ' ' HA ' ' A' ' 24' ' ' GLU . 11.7 t70 -59.89 115.75 3.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.075 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.02 -33.02 4.19 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 47.2 mttp -77.55 136.75 38.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.63 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.3 t -79.98 121.98 82.69 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' O ' HD11 ' A' ' 89' ' ' ILE . 10.3 Cg_endo -55.82 -41.26 79.21 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.228 2.619 . . . . 0.0 113.648 -174.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 5.8 mm -63.73 -49.09 83.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 p -111.47 -17.09 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 t0 63.04 74.89 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.543 0.687 . . . . 0.0 110.366 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -160.24 146.32 15.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.312 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -87.19 30.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.322 . . . . 0.0 111.159 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 73' ' ' CYS . 3.6 p -76.64 150.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.866 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -49.08 124.64 13.48 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 87.9 Cg_endo -79.62 149.35 21.0 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.526 2.817 . . . . 0.0 112.114 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -132.16 -62.37 0.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.4 mtp-105 -102.39 141.99 34.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -69.18 137.57 53.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.183 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.913 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -78.84 145.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.127 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -131.7 119.48 21.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.83 155.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.893 -173.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p -71.13 160.24 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.599 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -53.57 -39.74 65.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.194 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.01 -35.51 75.22 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.541 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 60.4 m -98.48 33.3 2.28 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.151 -0.343 . . . . 0.0 111.493 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.544 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 53.6 p -156.81 -28.06 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.9 p90 . . . . . 0 N--CA 1.465 0.304 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -170.681 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 51.7 mmtt . . . . . 0 CA--C 1.516 -0.327 0 CA-C-O 121.063 0.458 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 21.4 p30 -66.2 143.37 57.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.4 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -55.23 130.27 41.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.453 -177.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.562 HD13 ' HA3' ' A' ' 20' ' ' GLY . 9.9 pt -62.44 -26.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -171.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 26' ' ' CYS . 45.9 mt -80.0 -42.65 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.924 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -109.51 -11.38 14.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.645 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.416 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 54.03 28.52 8.86 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.513 . . . . 0.0 111.264 175.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.26 -64.27 0.61 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.375 -169.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -79.74 140.17 37.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.921 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 21.2 t -64.07 135.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 111.045 -176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.6 141.73 27.97 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.5 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.66 -42.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -115.19 141.58 47.83 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.585 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.87 136.38 57.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.736 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -79.05 160.09 27.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.065 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.546 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 12.8 m-85 -132.21 134.6 45.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.628 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.735 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 74.6 m-85 -68.65 127.81 34.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.4 p -68.22 163.38 22.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.952 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -51.81 -45.88 64.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.234 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 67.2 mm-40 -60.26 -48.25 82.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.544 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.601 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 66.5 m -65.56 -37.91 88.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.411 0.148 . . . . 0.0 111.243 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.18 -43.46 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 110.005 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -66.06 -42.83 88.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 91.6 mt -63.94 -34.48 78.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.47 30.21 14.4 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.857 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.75 -22.44 27.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -66.35 -42.43 88.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.713 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.3 -16.54 60.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.551 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' A' ' 12' ' ' LEU . 5.3 t70 -64.75 -50.35 67.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.82 -139.41 5.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 118.643 -1.742 . . . . 0.0 115.688 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 44.4 t -62.06 119.47 49.05 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 113.104 -1.548 . . . . 0.0 112.687 -170.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.913 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 64.4 Cg_endo -84.16 51.28 3.31 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.691 2.927 . . . . 0.0 113.068 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.541 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.0 mmt180 -99.58 127.27 45.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.54 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 31' ' ' PRO . 46.3 mm . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.458 0.647 . . . . 0.0 109.434 172.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.569 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.8 ptp . . . . . 0 N--CA 1.445 -0.68 0 CA-C-O 120.87 0.367 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 2.0 t -46.12 -47.02 17.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.603 -1.181 . . . . 0.0 112.812 -174.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.569 HD13 ' HG3' ' A' ' 10' ' ' MET . 1.3 mp 46.35 40.23 7.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 62.4 mttm -80.02 -162.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.819 0.342 . . . . 0.0 110.345 169.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.4 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 70.7 tp60 -85.99 110.58 31.7 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.367 173.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 36.9 Cg_endo -70.75 143.56 46.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.495 2.13 . . . . 0.0 113.018 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.68 -101.5 0.47 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.206 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.49 -31.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.485 ' HB2' HG22 ' A' ' 45' ' ' VAL . 62.9 mt-30 -57.9 132.41 53.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 111.477 -177.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.9 m -83.26 138.53 33.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.714 -176.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.29 133.79 13.35 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.809 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 94.3 mt -96.91 151.47 19.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 0.0 112.084 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.0 141.52 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.17 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.7 p -78.78 154.74 29.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.65 -32.21 50.6 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.262 0.351 . . . . 0.0 111.847 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.0 mmtp -63.65 -43.91 95.36 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.95 -15.93 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -53.59 108.99 0.4 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.471 0.653 . . . . 0.0 110.585 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.3 -35.12 1.69 Allowed Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.02 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -87.96 128.36 35.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.798 -0.201 . . . . 0.0 111.496 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.13 118.58 65.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.86 -39.41 68.3 Favored 'Trans proline' 0 N--CA 1.474 0.357 0 C-N-CA 123.051 2.501 . . . . 0.0 114.169 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mm -63.94 -40.79 90.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.06 -18.85 8.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t0 66.06 76.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.284 0.564 . . . . 0.0 110.013 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.9 t -162.43 147.06 12.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.874 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -90.45 22.72 3.28 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.033 0.444 . . . . 0.0 111.143 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.606 HG13 ' HB2' ' A' ' 73' ' ' CYS . 2.5 p -69.43 148.85 11.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.135 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -40.19 113.07 0.9 Allowed Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.6 Cg_endo -78.71 148.12 22.49 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.202 2.601 . . . . 0.0 112.011 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 74' ' ' TRP . 61.9 mttm -139.17 -53.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 99.5 mtt180 -101.05 138.21 38.39 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -64.8 132.42 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.497 . . . . 0.0 111.04 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.831 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 15.7 t -74.16 125.18 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.354 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.9 136.99 36.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.984 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.81 HG12 HH21 ' A' ' 88' ' ' ARG . 2.1 m -91.84 150.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.6 p -81.29 145.7 30.77 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 1.5 tp10 -58.11 -24.3 58.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -173.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.523 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 41.9 m-80 -66.08 -20.99 66.34 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.383 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.485 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 78.4 m -110.27 39.0 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.119 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.486 ' HB3' HG21 ' A' ' 45' ' ' VAL . 84.8 p -147.78 -49.43 0.17 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.618 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 120.691 0.282 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.523 HD22 ' C ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.6 149.75 48.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.372 0.606 . . . . 0.0 110.588 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 11.8 t -54.1 124.12 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.829 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.401 HD11 ' CB ' ' A' ' 70' ' ' ALA . 28.0 pt -69.33 -23.07 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.576 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -78.71 -49.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -95.28 -8.28 36.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.33 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.87 46.67 6.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.702 0.801 . . . . 0.0 111.663 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -61.56 0.13 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.236 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -70.06 141.75 52.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.723 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.8 132.72 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.207 0.317 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.53 176.93 54.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.702 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 68' ' ' ASN . 3.2 p -161.34 -52.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.425 ' N ' HG13 ' A' ' 67' ' ' VAL . 76.2 m-20 -97.4 122.7 40.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.677 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.16 134.08 56.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.993 0.425 . . . . 0.0 110.482 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' CB ' HD11 ' A' ' 59' ' ' ILE . . . -73.26 142.73 47.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.591 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.451 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 7.6 m-85 -124.79 130.09 51.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.271 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.831 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.6 m-85 -66.26 129.94 41.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.0 p -69.75 161.86 28.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.775 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.573 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 26.6 t90 -53.75 -39.82 65.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.603 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -60.99 -48.25 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.723 0.297 . . . . 0.0 110.946 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 84.2 m -67.97 -32.76 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.58 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.12 -44.02 97.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.583 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 -60.77 -46.65 89.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.76 -32.62 72.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.71 38.57 10.43 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.344 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 87.5 mttt -78.76 -9.14 59.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.681 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.07 -35.73 72.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.36 0.6 . . . . 0.0 109.597 173.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -81.74 -9.17 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.061 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 81' ' ' LYS . 23.5 t0 -70.1 -42.9 72.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.76 -175.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA3' ' HG ' ' A' ' 12' ' ' LEU . . . 172.09 178.52 42.39 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.626 -1.273 . . . . 0.0 114.029 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -72.42 110.68 8.62 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 111.326 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.582 ' HG2' HH12 ' A' ' 88' ' ' ARG . 56.6 Cg_endo -78.12 41.44 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.436 2.758 . . . . 0.0 115.279 -172.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.81 HH21 HG12 ' A' ' 45' ' ' VAL . 7.0 mmt-85 -79.98 134.41 36.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 121.217 0.532 . . . . 0.0 112.126 -175.005 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 79.54 -142.39 24.73 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.973 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m 53.56 43.1 31.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.348 0.594 . . . . 0.0 110.61 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 p -167.13 -121.31 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.312 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -88.52 51.75 2.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.409 0.623 . . . . 0.0 111.42 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -152.11 36.86 0.54 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.457 ' C ' ' H ' ' A' ' 7' ' ' ASP . 31.3 tt0 -80.26 -34.0 37.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.05 -171.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.533 ' CD2' ' HB3' ' A' ' 8' ' ' LEU . 20.2 t80 77.36 -23.21 0.25 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.176 -173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.457 ' H ' ' C ' ' A' ' 5' ' ' GLN . 1.5 m-20 61.5 39.82 14.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.66 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.681 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -73.94 51.99 0.42 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.151 178.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.689 ' HB ' ' HB3' ' A' ' 91' ' ' ASN . 1.7 mp -61.06 98.79 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.281 0.562 . . . . 0.0 109.813 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.501 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.5 ptp -114.24 156.68 23.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.276 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.629 ' HA ' HD11 ' A' ' 90' ' ' LEU . 42.6 t -53.83 -49.74 67.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.031 -172.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.787 ' HG ' ' HB3' ' A' ' 84' ' ' ASP . 0.8 OUTLIER 51.87 43.06 30.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 172.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 50.2 mttm -95.62 -155.38 0.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.584 171.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -87.34 111.91 44.49 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.063 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 32.9 Cg_exo -60.1 138.58 82.68 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.244 2.629 . . . . 0.0 112.926 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.91 -140.25 11.26 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.12 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.612 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 35.3 m -98.44 -29.11 3.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.64 0.257 . . . . 0.0 111.209 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 59.5 mt-30 -69.23 125.53 26.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.06 0.457 . . . . 0.0 110.95 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -82.32 142.45 32.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.827 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.8 118.55 6.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.628 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 81.8 mt -92.18 143.75 26.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 112.071 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 70.7 mt -110.33 136.57 49.31 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.301 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.8 p -72.59 152.39 41.83 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 170.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 53.6 mt-10 -54.97 -25.44 29.72 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.06 0.457 . . . . 0.0 111.558 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HE3' HG22 ' A' ' 107' ' ' VAL . 25.1 mtpp -72.16 -23.29 61.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.747 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 20.6 m -116.32 15.37 15.84 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 26.1 t70 -68.29 129.8 41.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 -21.33 46.59 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.329 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 45.0 mttm -71.82 134.61 46.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.955 0.407 . . . . 0.0 110.863 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.8 t -81.82 121.57 79.47 Favored Pre-proline 0 C--N 1.319 -0.755 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HG2' HG11 ' A' ' 43' ' ' VAL . 72.7 Cg_exo -54.11 -34.15 76.95 Favored 'Trans proline' 0 CA--C 1.526 0.093 0 C-N-CA 122.441 2.094 . . . . 0.0 112.771 -175.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 3.8 mm -76.01 -32.72 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.431 -174.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 20.1 p -137.98 -34.46 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.9 t0 64.35 86.86 0.12 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.2 t -154.36 25.35 0.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.578 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 36.79 50.11 0.82 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.303 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.58 HG13 ' HB2' ' A' ' 73' ' ' CYS . 7.9 p -118.19 162.81 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.346 -176.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.522 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.1 ptp85 -42.43 128.5 2.89 Favored Pre-proline 0 N--CA 1.466 0.354 0 O-C-N 123.736 0.648 . . . . 0.0 112.63 -173.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.547 ' HB3' ' CB ' ' A' ' 71' ' ' PHE . 2.8 Cg_exo -76.64 -154.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 123.421 2.747 . . . . 0.0 112.164 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -176.4 -49.04 0.01 OUTLIER 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.32 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -150.12 136.08 18.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.494 -173.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -61.71 134.55 56.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.204 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.957 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 16.2 m -74.03 134.42 29.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.612 ' NH2' ' HA ' ' A' ' 17' ' ' VAL . 27.8 mtp85 -108.15 122.15 46.32 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.4 m -81.9 143.84 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.166 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.1 p -61.35 149.08 39.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.928 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 89.8 mt-10 -54.55 -34.49 61.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.374 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 3.5 m120 -53.94 -36.25 62.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.312 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.765 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 66.2 m -83.82 -32.29 25.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.319 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.418 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 4.5 m -67.18 -49.05 66.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.006 0.432 . . . . 0.0 110.066 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.529 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 -95.36 28.52 2.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.65 38.91 2.02 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.957 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 69.48 -48.8 0.61 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.517 0.727 . . . . 0.0 112.664 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.9 mp0 -78.26 70.33 4.6 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.215 0.531 . . . . 0.0 110.956 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -117.21 -54.59 2.39 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.351 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -81.97 -29.81 31.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.931 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 34.7 m-20 -63.92 144.94 56.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.93 0.395 . . . . 0.0 110.431 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.5 t -47.38 131.73 13.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.746 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.719 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 11.0 pt -75.96 -29.53 19.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.102 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.1 mt -77.72 -45.7 28.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.766 ' HA ' HD23 ' A' ' 92' ' ' LEU . 28.6 p -109.4 14.28 23.72 Favored 'General case' 0 C--N 1.334 -0.091 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.868 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER 22.26 58.24 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.25 -67.61 0.12 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.093 0.473 . . . . 0.0 110.458 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -78.19 139.8 38.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.831 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.931 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 8.9 p -61.65 139.56 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.918 0.389 . . . . 0.0 110.881 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -84.07 145.21 22.26 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.628 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.0 m -111.1 -41.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.6 135.29 54.3 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -62.12 134.49 56.65 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -75.47 147.2 40.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.589 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.547 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 9.4 m-85 -117.26 136.24 53.23 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.867 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 80.5 m-85 -67.81 128.59 37.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 170.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.58 ' HB2' HG13 ' A' ' 37' ' ' VAL . 1.8 p -72.25 149.08 44.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -51.08 -39.5 56.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.598 0.562 . . . . 0.0 111.7 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.27 -45.62 93.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.606 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 60.7 m -65.61 -36.65 84.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.502 0.191 . . . . 0.0 110.97 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 73.4 m -66.3 -41.81 89.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -62.84 -47.19 84.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.56 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.04 -33.79 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.38 40.21 5.15 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.364 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.02 -30.93 15.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.436 0.636 . . . . 0.0 109.83 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -66.89 -27.59 67.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.852 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 64.0 pttt -69.03 -8.84 48.77 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.329 -176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.787 ' HB3' ' HG ' ' A' ' 12' ' ' LEU . 70.6 m-20 -69.08 -51.21 41.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.16 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.42 -137.27 5.92 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 119.852 -1.166 . . . . 0.0 114.235 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.654 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 26.9 t -54.41 115.87 9.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 124.054 0.942 . . . . 0.0 111.717 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.957 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 66.0 Cg_endo -88.39 26.82 0.56 Allowed 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.95 2.433 . . . . 0.0 114.177 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.765 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 30.3 mtt-85 -73.45 121.65 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.955 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.545 HG23 ' ND2' ' A' ' 91' ' ' ASN . 27.3 mm -74.46 116.89 17.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.233 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.629 HD11 ' HA ' ' A' ' 11' ' ' CYS . 29.6 mt -99.86 -32.82 10.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.021 -177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.689 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 15.4 p30 -56.58 -29.82 62.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.963 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.766 HD23 ' HA ' ' A' ' 61' ' ' CYS . 15.1 tp -75.66 96.47 3.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.837 -173.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.84 -40.47 4.64 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 170.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.8 t -153.22 178.96 9.18 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.604 ' ND2' ' HA ' ' A' ' 99' ' ' ARG . 2.7 m120 62.42 70.62 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.924 0.393 . . . . 0.0 110.879 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.75 ' HD2' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -48.2 -32.53 7.22 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.774 -176.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.75 ' N ' ' HD2' ' A' ' 96' ' ' ARG . 4.2 pp -162.67 139.66 7.83 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 55.11 -135.05 1.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.855 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.604 ' HA ' ' ND2' ' A' ' 95' ' ' ASN . 1.3 mpt_? -139.11 47.0 1.92 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -136.36 131.36 34.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.423 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.527 ' HA ' HH21 ' A' ' 96' ' ' ARG . 9.8 p90 -105.81 -37.11 6.81 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 167.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 49.97 68.32 0.77 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.112 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 52.55 49.16 21.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.138 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -145.0 40.13 1.24 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.313 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? 69.18 -60.98 0.44 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.748 0.819 . . . . 0.0 111.847 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? 178.77 -30.77 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.67 HG23 ' HG2' ' A' ' 96' ' ' ARG . 14.3 p . . . . . 0 C--N 1.31 -1.151 0 CA-C-N 113.353 -1.748 . . . . 0.0 108.462 176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 156.8 51.2 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.083 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.1 m -72.19 70.54 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 m 71.27 -47.05 0.65 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.538 0.735 . . . . 0.0 112.284 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.575 ' HB3' ' HB2' ' A' ' 61' ' ' CYS . 7.4 tpm_? 63.22 50.56 2.97 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.724 0.774 . . . . 0.0 109.999 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -77.83 137.82 38.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.144 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -173.56 136.73 0.6 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.616 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -99.9 -15.78 18.23 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -73.51 61.24 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.925 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.496 ' HB3' HD12 ' A' ' 89' ' ' ILE . 10.5 mt -80.74 80.18 7.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.97 0.414 . . . . 0.0 110.744 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 1.6 mp -78.93 71.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.522 ' HE1' HD13 ' A' ' 32' ' ' ILE . 4.7 ptp -73.45 149.32 42.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.035 -1.439 . . . . 0.0 111.693 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.714 ' HB2' HD21 ' A' ' 90' ' ' LEU . 45.5 t -52.54 -49.89 63.98 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.308 -175.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 54.6 mt 50.32 32.22 6.05 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HE2' ' SG ' ' A' ' 11' ' ' CYS . 27.9 mtmt -82.39 166.12 19.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.153 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.3 112.89 5.5 Favored Pre-proline 0 C--N 1.327 -0.395 0 O-C-N 123.77 0.668 . . . . 0.0 110.451 -177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 50.9 Cg_endo -76.65 141.01 21.62 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.095 2.53 . . . . 0.0 113.376 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 -144.08 11.79 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 p -89.1 -24.47 5.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.132 0.491 . . . . 0.0 110.667 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -57.4 124.48 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.42 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.0 m -84.97 137.9 32.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.117 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -69.01 130.33 24.59 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.713 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 68' ' ' ASN . 52.5 mt -88.84 142.88 27.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.338 0.59 . . . . 0.0 112.358 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.712 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 81.4 mt -113.13 137.62 51.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.963 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 6.5 p -75.94 154.88 35.59 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 27' ' ' ASP . 39.9 mt-10 -51.97 -33.27 37.04 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.405 0.44 . . . . 0.0 111.552 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -69.0 -27.96 66.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.775 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 49.4 m -104.48 41.42 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.962 0.411 . . . . 0.0 109.916 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 9.6 t70 -66.66 119.14 11.25 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.01 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.73 44.67 56.2 Favored Glycine 0 CA--C 1.518 0.22 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.613 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD3' ' HB3' ' A' ' 26' ' ' CYS . 35.3 mtpt -120.15 139.74 52.15 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.538 -0.389 . . . . 0.0 110.992 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 37.1 t -78.67 122.75 85.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.634 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.724 ' HG2' HG21 ' A' ' 43' ' ' VAL . 36.7 Cg_exo -64.49 -36.45 43.6 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.104 2.536 . . . . 0.0 113.323 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.62 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.8 mm -64.43 -41.58 92.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.992 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.15 -12.5 10.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t70 63.91 81.55 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.308 0.575 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 t -171.73 152.9 3.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.957 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -88.32 22.63 2.43 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.663 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 73' ' ' CYS . 10.0 p -68.02 154.92 7.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.07 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 10.9 ptp180 -44.02 129.35 4.35 Favored Pre-proline 0 N--CA 1.469 0.505 0 C-N-CA 123.534 0.734 . . . . 0.0 112.721 -175.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.712 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.9 Cg_exo -73.98 -164.54 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.37 2.713 . . . . 0.0 112.379 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.786 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -172.17 -42.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.979 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -149.66 136.42 19.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.649 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.3 mttt -63.16 139.52 58.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.474 0.654 . . . . 0.0 111.698 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.828 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.2 t -70.47 133.8 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.417 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -123.6 128.34 49.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.831 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG12 ' HD2' ' A' ' 87' ' ' PRO . 28.7 m -100.83 155.88 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.043 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.4 p -67.44 145.95 54.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.93 -28.94 64.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.617 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.625 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 16.9 m-80 -59.1 -31.11 68.62 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.833 175.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.443 ' HB3' ' CD ' ' A' ' 88' ' ' ARG . 79.3 m -101.48 29.3 4.9 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 122.155 -0.341 . . . . 0.0 111.798 177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 m -111.29 -28.17 8.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.265 0.555 . . . . 0.0 109.837 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 17.0 p90 -97.4 149.19 22.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.56 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.22 -176.49 35.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.166 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -70.41 -48.81 54.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.666 0.386 . . . . 0.0 111.388 -177.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -77.28 55.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.428 0.632 . . . . 0.0 110.762 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -136.24 -53.37 0.74 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.913 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 14.1 mmtp -79.08 -18.2 53.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.778 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.849 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 80.2 m-20 -67.23 150.47 49.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.901 176.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 36.7 t -50.11 135.1 21.36 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.517 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.608 HG22 ' HG2' ' A' ' 88' ' ' ARG . 11.7 pt -77.65 -35.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.599 -173.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.4 mt -74.26 -47.3 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 3' ' ' ARG . 19.8 p -103.07 2.81 35.29 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.847 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.787 HD22 ' HA2' ' A' ' 93' ' ' GLY . 1.5 p-10 36.36 47.3 0.48 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.117 0.886 . . . . 0.0 113.256 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.21 -66.27 0.37 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.044 -174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -81.98 143.39 31.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.235 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 48.5 t -56.92 134.44 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 123.217 0.323 . . . . 0.0 110.545 177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.87 147.29 21.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.775 -177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.68 -37.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.089 0.471 . . . . 0.0 110.655 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.712 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 6.4 m120 -82.77 173.33 11.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.172 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -109.92 134.41 52.12 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 172.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.531 ' CB ' HD11 ' A' ' 59' ' ' ILE . . . -77.58 151.54 34.4 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.28 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.404 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 16.3 m-85 -126.24 135.36 51.49 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.828 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 76.9 m-85 -71.26 125.11 26.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.6 p -67.58 157.0 35.44 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -50.28 -40.82 49.39 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.479 0.487 . . . . 0.0 111.479 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 37.2 mt-10 -58.91 -51.96 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.604 0.24 . . . . 0.0 111.541 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.62 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 98.7 m -64.38 -36.14 83.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.363 -178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 72' ' ' TYR . 84.9 m -67.87 -42.83 80.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.979 0.419 . . . . 0.0 110.426 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -58.8 -49.24 78.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.959 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 42.3 mt -72.06 -27.43 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.927 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 92.68 47.18 3.26 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.047 -0.596 . . . . 0.0 112.43 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.494 ' CB ' HG21 ' A' ' 32' ' ' ILE . 29.7 mmmt -82.19 -36.43 27.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.205 0.526 . . . . 0.0 109.911 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -66.77 -28.8 68.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.997 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.9 pttp -57.07 -30.91 64.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.31 . . . . 0.0 110.465 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.423 ' HB2' HD22 ' A' ' 12' ' ' LEU . 86.9 m-20 -61.57 -52.55 63.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.691 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.32 -127.72 3.45 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.569 -1.3 . . . . 0.0 114.669 169.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.595 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.4 t -58.84 109.56 1.96 Allowed Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.52 -1.34 . . . . 0.0 113.182 -171.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.461 ' CG ' HG13 ' A' ' 43' ' ' VAL . 72.0 Cg_endo -87.97 39.89 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.992 2.461 . . . . 0.0 113.716 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 59' ' ' ILE . 24.3 mtp85 -85.03 127.68 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.541 ' HB ' ' OD1' ' A' ' 62' ' ' ASN . 31.5 mm -81.28 126.14 39.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.714 HD21 ' HB2' ' A' ' 11' ' ' CYS . 17.0 mt -89.09 -37.45 15.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.031 -170.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -63.25 125.92 25.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.375 0.607 . . . . 0.0 111.902 -171.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.34 45.75 26.55 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.643 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.787 ' HA2' HD22 ' A' ' 62' ' ' ASN . . . -80.21 53.5 4.43 Favored Glycine 0 C--N 1.33 0.217 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.1 m 74.26 -43.39 0.53 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.844 0.858 . . . . 0.0 110.479 -170.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -66.8 129.75 40.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.957 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 35.25 1.78 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.823 0.821 . . . . 0.0 109.35 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.8 mt -142.08 67.68 1.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.532 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -47.6 -45.98 27.98 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.059 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -111.98 126.79 55.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.417 174.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -78.82 124.43 28.21 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.728 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -70.78 -47.85 57.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.363 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 64.93 -59.78 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.122 0.889 . . . . 0.0 111.149 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -83.1 137.93 33.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.776 172.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? 60.95 -144.05 0.48 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.416 0.448 . . . . 0.0 110.689 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.623 ' HB3' HG23 ' A' ' 107' ' ' VAL . 37.1 mtmm -146.92 135.95 22.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.594 0.235 . . . . 0.0 110.591 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -95.84 38.92 1.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.406 0.622 . . . . 0.0 109.667 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.623 HG23 ' HB3' ' A' ' 105' ' ' LYS . 71.7 t . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.331 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 65.92 -141.55 41.93 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.14 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 3' ' ' ARG . 50.3 m 67.69 -60.06 0.4 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.503 0.721 . . . . 0.0 112.069 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t 51.34 50.06 19.72 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.263 0.554 . . . . 0.0 109.922 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 1' ' ' SER . 30.2 mmt180 -74.13 126.76 31.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.39 -173.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -126.38 59.91 1.33 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 7' ' ' ASP . 7.5 pt20 -144.92 163.08 35.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.748 -169.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.519 ' HB3' HD21 ' A' ' 8' ' ' LEU . 65.1 t80 -76.1 34.67 0.13 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.15 0.976 . . . . 0.0 110.096 174.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 5' ' ' GLN . 71.9 m-20 60.18 53.89 4.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.611 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 8' ' ' LEU . 2.0 mt -85.44 74.68 10.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.531 177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 91' ' ' ASN . 1.6 mp -68.94 79.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.729 0.776 . . . . 0.0 109.935 -174.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.544 ' HE1' ' HA ' ' A' ' 32' ' ' ILE . 2.3 ptp -80.8 153.96 27.44 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.577 -175.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HA ' HD11 ' A' ' 90' ' ' LEU . 44.1 t -56.15 -53.12 60.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.304 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mp 48.52 37.9 9.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -79.59 177.64 8.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.59 167.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -70.81 116.05 42.09 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.883 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.737 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 31.8 Cg_exo -62.91 145.23 94.43 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.161 2.574 . . . . 0.0 113.37 -175.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.93 -137.4 9.22 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -105.53 -23.28 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -72.31 138.75 47.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.124 0.487 . . . . 0.0 111.718 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 m -91.7 137.66 32.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.644 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.524 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -66.71 132.33 31.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.268 -0.492 . . . . 0.0 112.798 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 88.1 mt -95.87 143.46 27.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.046 0.451 . . . . 0.0 111.83 -178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.599 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 60.0 mt -113.01 140.42 47.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.263 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 3.3 p -78.92 154.03 30.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 40.1 mt-10 -54.69 -26.22 32.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.83 0.347 . . . . 0.0 111.67 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 35.1 mmtp -70.11 -29.36 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.432 ' O ' HD13 ' A' ' 22' ' ' LEU . 4.8 m -116.29 17.28 15.67 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.564 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 51.9 t0 -66.77 127.2 31.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.145 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.95 -22.18 42.24 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.491 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -68.26 122.07 17.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.489 0.185 . . . . 0.0 110.99 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -69.19 113.03 13.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 170.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.42 -27.37 67.67 Favored 'Trans proline' 0 N--CA 1.473 0.3 0 C-N-CA 123.372 2.715 . . . . 0.0 113.403 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.544 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 4.8 mm -66.8 -36.59 77.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.92 -176.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.58 -15.61 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -172.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 67.1 84.05 0.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.373 0.606 . . . . 0.0 109.831 -173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.8 t -164.57 136.02 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.148 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.68 11.76 8.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 73' ' ' CYS . 8.3 p -66.44 160.73 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.001 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -40.76 130.85 1.85 Allowed Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.66 0.784 . . . . 0.0 112.873 -175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 93.4 Cg_endo -78.83 -161.23 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 123.388 2.725 . . . . 0.0 112.771 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -171.57 -50.55 0.02 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.359 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -134.88 145.47 48.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.186 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 59.7 mttp -68.18 140.47 56.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 173.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.836 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.7 m -74.58 127.57 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.231 0.539 . . . . 0.0 111.606 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.53 114.99 29.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.52 146.53 6.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.345 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.737 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 7.9 p -67.04 161.23 24.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -47.36 -44.89 24.38 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.042 0.839 . . . . 0.0 111.715 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.731 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.1 m120 -61.69 -39.1 90.24 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.709 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 55.9 m -90.0 43.53 1.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.682 0.277 . . . . 0.0 110.794 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 65.9 m -155.62 -38.68 0.08 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.698 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.731 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -59.68 -23.1 62.82 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -175.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.37 145.58 7.27 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.833 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.3 pttt 52.99 -59.46 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.414 1.886 . . . . 0.0 115.208 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -77.05 44.64 0.41 Allowed 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.152 -0.343 . . . . 0.0 111.87 -173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 50' ' ' SER . . . -134.79 -45.32 0.73 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.989 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -66.13 -46.51 77.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.148 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -65.92 148.47 51.73 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.34 0.59 . . . . 0.0 110.933 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 20.2 t -51.6 125.73 15.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.375 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.5 ' HA ' ' NH1' ' A' ' 88' ' ' ARG . 8.7 pt -65.52 -26.86 40.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.457 -174.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.4 mt -81.12 -41.1 18.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 32.1 p -113.75 2.61 15.24 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.348 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 29.25 53.1 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.43 1.092 . . . . 0.0 113.476 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -155.64 -59.49 0.1 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.383 -176.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -72.48 141.27 48.57 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.826 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.36 133.01 31.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.174 0.512 . . . . 0.0 110.957 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.415 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.11 140.09 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.996 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -127.08 -39.7 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -117.84 137.73 52.57 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.89 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.3 139.1 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.568 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.699 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -82.39 151.33 26.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.653 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 7.7 m-85 -124.73 134.15 52.93 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.838 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.836 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 68.2 m-85 -66.17 125.15 24.63 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -66.07 151.54 46.64 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -52.98 -38.0 61.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.184 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -58.68 -46.26 87.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.473 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 86.0 m -72.39 -38.01 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.722 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.5 t -63.97 -35.9 82.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.302 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.1 ttt85 -62.9 -41.43 99.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.334 175.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.03 1.41 21.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.01 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.24 33.05 84.78 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.495 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 93.3 mttt -77.72 -20.35 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.953 0.406 . . . . 0.0 110.516 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.449 ' HB2' ' CD2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -70.82 -23.47 62.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.667 175.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -73.47 -25.06 60.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.035 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -55.03 -57.82 10.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.639 -177.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.61 -140.15 7.11 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 119.647 -1.263 . . . . 0.0 114.343 173.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.643 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 47.4 t -64.5 115.91 24.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.189 -1.005 . . . . 0.0 112.275 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.811 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 93.9 Cg_endo -83.17 39.59 0.84 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.211 2.607 . . . . 0.0 113.442 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.709 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 9.5 mmt180 -81.73 121.81 26.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.992 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.443 HG23 ' OD1' ' A' ' 91' ' ' ASN . 36.4 mm -78.42 113.12 17.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 11' ' ' CYS . 25.0 mt -105.26 -27.69 11.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.78 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 11.9 p-10 -60.3 -27.01 66.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.543 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.56 124.45 22.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.918 0.39 . . . . 0.0 110.926 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.4 50.83 3.88 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.649 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 16.9 m 55.23 61.33 2.95 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.679 0.276 . . . . 0.0 110.527 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 94' ' ' SER . 6.2 m120 74.21 -71.91 0.12 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.269 -174.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -174.06 -73.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.371 174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.4 mt -156.46 120.38 4.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.82 0.343 . . . . 0.0 110.748 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.573 ' OD1' ' HG3' ' A' ' 99' ' ' ARG . 10.1 t70 -78.81 138.31 38.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 175.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.573 ' HG3' ' OD1' ' A' ' 98' ' ' ASP . 56.1 mtm-85 66.82 65.86 0.45 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.108 0.48 . . . . 0.0 110.494 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -51.45 127.94 21.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.492 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -70.22 69.86 0.37 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.316 0.579 . . . . 0.0 110.59 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.12 135.28 4.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.628 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.533 ' HG2' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER 178.77 -46.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.005 173.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 65.9 mttm -102.74 39.12 1.58 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.028 177.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 62.97 69.52 0.58 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.524 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 106' ' ' LYS . 32.8 mmtp 65.98 34.02 7.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.604 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 104' ' ' LYS . 86.7 t . . . . . 0 C--O 1.247 0.935 0 CA-C-O 117.441 -1.266 . . . . 0.0 107.869 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -159.93 126.79 1.69 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.719 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.5 p -169.4 41.96 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.001 0.429 . . . . 0.0 110.875 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m -86.51 32.02 0.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.924 0.392 . . . . 0.0 111.12 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -90.65 121.03 32.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.805 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -163.18 130.43 3.52 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.029 0.443 . . . . 0.0 111.258 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.542 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -76.71 -46.01 27.14 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.4 t80 55.42 -108.7 0.45 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -139.48 42.97 2.02 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 5' ' ' GLN . 1.4 mt -78.93 46.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.873 -174.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.655 ' HA ' ' HB2' ' A' ' 91' ' ' ASN . 2.3 mp -86.4 43.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 123.248 1.499 . . . . 0.0 108.471 175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 1.4 ptp -127.29 143.83 51.16 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.544 173.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.669 ' HA ' HD11 ' A' ' 90' ' ' LEU . 50.8 t -56.98 -50.4 72.81 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.493 -173.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 84' ' ' ASP . 40.0 mt 49.5 40.65 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.015 1.116 . . . . 0.0 114.015 174.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HB3' ' H ' ' A' ' 14' ' ' GLN . 47.4 mttm -82.29 -159.8 0.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.821 169.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -85.18 122.94 73.89 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.12 133.17 48.38 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.852 2.368 . . . . 0.0 112.75 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -144.16 6.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.247 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG12 ' OE1' ' A' ' 47' ' ' GLU . 11.3 p -99.38 -30.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.754 0.311 . . . . 0.0 111.401 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.499 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 70.6 mt-30 -77.96 136.37 37.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.37 0.605 . . . . 0.0 111.896 -175.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 m -75.86 143.28 41.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.526 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.28 120.45 5.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.213 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 73.5 mt -91.98 147.61 22.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.492 . . . . 0.0 112.14 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.653 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 76.8 mt -110.89 130.11 55.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.139 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.446 ' H ' ' CB ' ' A' ' 58' ' ' CYS . 8.5 p -71.4 160.42 32.79 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.705 ' HG3' HG21 ' A' ' 67' ' ' VAL . 54.8 mt-10 -58.25 -24.55 59.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.1 mmtp -74.44 -31.23 62.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.677 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 4.5 m -110.13 25.07 12.2 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 38.9 t70 -68.03 124.74 24.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.558 -173.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.97 77.25 Favored Glycine 0 C--N 1.321 -0.266 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.627 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 51.3 mttm -102.7 134.51 45.97 Favored 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.448 -0.442 . . . . 0.0 110.607 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 12.6 t -70.75 117.17 53.2 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 11.2 Cg_endo -58.89 -31.95 96.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.818 2.346 . . . . 0.0 112.811 -175.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.503 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 12.6 mm -66.4 -46.94 85.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.243 -175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -122.21 -6.06 8.87 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -170.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.0 t70 59.98 75.79 0.39 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.236 0.541 . . . . 0.0 110.091 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.4 t -164.33 147.52 9.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.209 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -89.01 41.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.058 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.585 ' HB ' ' HB2' ' A' ' 73' ' ' CYS . 41.9 t -74.43 148.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.87 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.557 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 5.4 mmp_? -35.93 120.17 0.69 Allowed Pre-proline 0 C--O 1.224 -0.287 0 O-C-N 124.495 1.122 . . . . 0.0 112.554 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.58 144.37 44.56 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.597 2.198 . . . . 0.0 112.38 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 12.3 mmmm -131.7 -78.79 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.975 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -85.78 132.04 34.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.042 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.07 132.32 44.92 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.554 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 21.9 t -71.45 129.08 35.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.405 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -121.83 130.44 53.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.9 m -80.6 144.23 11.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.157 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.5 p -62.39 139.78 58.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.611 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 6.9 tp10 -60.16 -21.18 61.34 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.094 -174.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.628 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 5.2 m120 -60.48 -31.56 70.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.7 m -87.38 -35.02 18.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.529 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.611 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 16.6 p -92.28 -22.08 19.95 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -57.67 -32.87 67.74 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.01 140.69 5.23 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.642 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.452 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 39.0 ttmt 69.91 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.477 0.711 . . . . 0.0 111.701 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.483 HE21 ' HB2' ' A' ' 54' ' ' GLN . 6.3 mt-30 58.98 33.49 23.06 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.241 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -99.07 35.09 1.97 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.069 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.52 -22.4 0.38 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.796 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 15.6 p30 -62.15 149.26 41.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.815 0.817 . . . . 0.0 112.083 -176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -64.8 130.92 45.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.265 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' CD1' HG11 ' A' ' 43' ' ' VAL . 8.4 pt -62.57 -40.6 88.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.46 -38.12 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 19.2 p -101.73 -26.55 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.954 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.3 t30 57.5 56.47 4.97 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.246 0.546 . . . . 0.0 109.611 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.86 -58.55 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.336 -170.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.4 144.0 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.752 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -64.68 138.13 23.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.895 0.378 . . . . 0.0 110.978 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -72.13 151.2 46.81 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.297 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.705 HG21 ' HG3' ' A' ' 24' ' ' GLU . 61.1 t -118.74 -60.94 2.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.887 0.375 . . . . 0.0 111.167 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -113.45 137.55 51.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.892 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -60.3 136.72 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.473 0.483 . . . . 0.0 111.366 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.653 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -82.57 159.39 22.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.904 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -136.54 134.34 37.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.138 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.5 m-85 -66.17 128.12 34.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 1.8 p -71.87 160.15 33.06 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.002 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -49.09 -50.62 36.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.077 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' HG3' HG11 ' A' ' 37' ' ' VAL . 46.3 mt-10 -59.92 -43.15 95.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.388 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 91.6 m -68.01 -34.97 77.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.169 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 40' ' ' LYS . 81.7 m -68.63 -37.48 79.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.827 0.346 . . . . 0.0 110.364 176.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -60.53 -47.16 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.272 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.12 -28.2 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.588 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.54 36.84 10.14 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.967 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 81' ' ' LYS . 21.6 mtpp -87.4 -10.95 50.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.919 0.39 . . . . 0.0 110.243 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -68.82 -24.46 64.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.558 -0.747 . . . . 0.0 108.988 170.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -73.97 -23.49 59.48 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.757 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' HD13 ' A' ' 12' ' ' LEU . 81.4 m-20 -58.16 -58.93 6.3 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 -135.01 7.46 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.859 -1.163 . . . . 0.0 114.261 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 24.8 t -55.99 107.35 0.86 Allowed Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 124.686 1.194 . . . . 0.0 111.929 -175.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 97.3 Cg_endo -87.95 38.25 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.772 2.315 . . . . 0.0 113.563 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 10' ' ' MET . 53.6 mtt180 -87.52 131.42 34.37 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.983 175.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.629 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 32.3 mm -69.71 121.35 19.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.176 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 91' ' ' ASN . 1.5 pp -173.71 -33.4 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.846 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.815 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 13.8 t-20 61.01 106.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.884 0.874 . . . . 0.0 111.18 -173.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 91' ' ' ASN . 3.0 pp 61.82 -40.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.195 1.398 . . . . 0.0 113.28 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.32 15.42 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.781 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.6 m 55.57 52.03 11.75 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.243 0.544 . . . . 0.0 110.799 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -151.96 33.52 0.54 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.491 0.663 . . . . 0.0 109.982 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 0.1 OUTLIER -153.35 121.44 6.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.427 175.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 82.8 mt 58.35 47.73 13.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.424 0.63 . . . . 0.0 110.019 -173.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 99' ' ' ARG . 30.2 t70 -147.95 -129.43 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.047 -176.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -77.49 74.66 4.05 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 171.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.561 ' HB3' ' HG2' ' A' ' 102' ' ' GLU . 4.0 t-160 -156.78 137.65 13.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.702 -172.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.663 ' HB2' ' HA ' ' A' ' 106' ' ' LYS . 49.0 p90 -61.12 -40.25 93.09 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.901 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.561 ' HG2' ' HB3' ' A' ' 100' ' ' HIS . 55.9 mm-40 52.66 -112.4 0.68 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.031 175.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -122.12 -48.86 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 111.23 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -87.87 -62.82 1.41 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.432 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -79.67 56.66 2.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.03 -175.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.663 ' HA ' ' HB2' ' A' ' 101' ' ' PHE . 50.9 mtmt -80.55 45.35 0.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.067 0.461 . . . . 0.0 111.392 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.476 177.242 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.864 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 161.45 -43.25 0.39 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.037 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.4 t 61.09 -143.11 0.48 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 122.851 0.46 . . . . 0.0 110.65 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.3 t -171.32 -133.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 59.66 56.46 3.59 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.154 0.502 . . . . 0.0 110.919 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -126.52 123.63 38.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.478 0.656 . . . . 0.0 111.378 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -106.08 167.33 9.88 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.52 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.8 t80 61.74 -126.07 0.79 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -119.06 32.52 6.08 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.284 0.564 . . . . 0.0 109.572 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.87 145.72 55.16 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.368 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.689 HD13 ' H ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -151.81 43.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.934 -164.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.471 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -63.39 136.59 57.73 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.904 -176.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.4 t -48.85 -48.46 41.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.292 -173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' N ' ' A' ' 86' ' ' CYS . 20.9 mt 41.45 40.5 1.31 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 50.5 mttm -80.0 -160.18 0.26 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 169.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 tp-100 -82.13 111.01 23.88 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.381 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 77.2 Cg_endo -80.17 146.54 17.93 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.453 2.102 . . . . 0.0 112.746 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.69 -142.6 13.34 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.298 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.41 -17.87 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.096 0.474 . . . . 0.0 110.717 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -64.33 142.18 58.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 43' ' ' VAL . 7.9 m -109.08 126.58 53.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.747 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -63.55 138.2 42.7 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.307 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 56' ' ' LYS . 41.2 mt -78.93 154.34 29.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.869 0.842 . . . . 0.0 113.131 -175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' A' ' 70' ' ' ALA . 1.7 tp -124.47 127.68 47.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.856 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 1.4 p -81.36 149.4 28.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -52.31 -35.01 49.51 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -62.22 -37.95 87.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.32 -17.37 23.66 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.49 -0.131 . . . . 0.0 110.795 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' HA ' HD23 ' A' ' 22' ' ' LEU . 13.0 t70 -54.49 110.79 0.68 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.529 0.68 . . . . 0.0 110.866 -172.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.78 -31.22 2.86 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.775 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.542 ' HB2' HD13 ' A' ' 60' ' ' ILE . 55.1 mttm -78.61 132.58 37.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.479 -0.361 . . . . 0.0 110.892 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 t -80.46 119.05 75.2 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 71.3 Cg_exo -54.59 -37.01 90.74 Favored 'Trans proline' 0 N--CA 1.473 0.297 0 C-N-CA 123.059 2.506 . . . . 0.0 113.761 -172.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.604 HG21 ' HD3' ' A' ' 81' ' ' LYS . 3.4 mm -61.47 -52.9 55.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.4 p -106.5 -21.75 12.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -171.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 65.42 83.43 0.17 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.394 0.616 . . . . 0.0 110.292 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 t -169.34 138.88 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.39 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -80.13 45.96 0.78 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.242 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 73' ' ' CYS . 4.2 p -94.1 148.38 4.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.009 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -40.16 123.31 1.67 Allowed Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -171.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 77.9 Cg_endo -72.43 152.15 54.39 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.011 2.474 . . . . 0.0 111.261 173.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HD2' ' HD1' ' A' ' 74' ' ' TRP . 57.6 tttp -128.81 -37.16 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.848 -176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.46 145.42 21.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -59.93 143.07 52.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.924 0.392 . . . . 0.0 111.557 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.779 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 31.6 m -68.39 155.14 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.746 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -116.19 114.81 24.95 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG22 ' HB2' ' A' ' 49' ' ' CYS . 10.0 p -93.88 139.61 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.591 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 5.5 p -65.79 147.75 52.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.71 -30.47 63.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.679 0.275 . . . . 0.0 110.476 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.685 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 2.9 m120 -55.94 -40.92 73.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.506 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 91.6 m -80.65 -24.66 38.82 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.597 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -76.95 -41.94 41.17 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.667 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER -79.61 41.05 0.47 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 112.206 -175.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -163.87 159.74 32.52 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -61.68 -11.49 12.05 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -57.94 -40.4 80.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.02 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 49' ' ' CYS . . . -63.28 -33.22 75.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.585 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' A' ' 21' ' ' LEU . 10.9 mmpt? -64.18 -30.32 71.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.254 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 71.7 m-80 -76.23 140.17 41.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.022 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.9 t -51.68 126.57 18.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.218 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.533 HD11 ' CB ' ' A' ' 70' ' ' ALA . 12.4 pt -68.78 -27.58 36.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.587 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' ' 29' ' ' LYS . 54.0 mt -75.81 -42.8 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.991 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 24.9 p -105.63 -6.99 18.79 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 119.971 -0.692 . . . . 0.0 112.23 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 42.19 45.85 3.65 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.981 0.801 . . . . 0.0 112.31 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.21 -62.43 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.142 0.496 . . . . 0.0 110.188 -177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -75.87 141.97 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.891 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 9.9 p -68.16 139.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.729 0.3 . . . . 0.0 110.591 -177.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.25 145.1 20.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.578 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.8 m -116.33 -38.5 2.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.554 0.216 . . . . 0.0 111.478 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -104.73 -174.87 2.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.522 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' HB3' HG21 ' A' ' 19' ' ' THR . 44.3 m-20 -107.78 142.26 38.08 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.844 ' HB2' HD13 ' A' ' 22' ' ' LEU . . . -79.42 151.4 30.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -127.39 136.27 51.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.593 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.779 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 56.1 m-85 -68.11 127.81 34.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 37' ' ' VAL . 12.4 p -71.42 161.74 30.57 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.746 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.578 ' HD1' ' HD2' ' A' ' 40' ' ' LYS . 27.8 t90 -51.99 -42.2 62.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.161 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -58.63 -55.97 28.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.116 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.78 -39.48 94.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.484 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.7 t -65.31 -41.31 94.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.454 0.169 . . . . 0.0 110.765 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.4 ttp-105 -64.15 -44.53 91.85 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.026 0.441 . . . . 0.0 110.324 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 77.3 mt -65.67 -38.2 88.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.367 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 28.18 4.11 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.308 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.604 ' HD3' HG21 ' A' ' 32' ' ' ILE . 46.6 mttm -88.39 -4.67 58.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.869 0.366 . . . . 0.0 110.571 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 p-10 -66.83 -30.45 70.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.034 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.474 ' NZ ' ' HB3' ' A' ' 83' ' ' LYS . 3.5 mmmp? -96.2 7.82 45.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.27 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -69.69 -59.65 2.82 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.7 -158.15 30.91 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.355 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.474 ' N ' ' HA ' ' A' ' 12' ' ' LEU . 34.2 t -66.08 115.22 21.18 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.658 0.783 . . . . 0.0 111.54 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.619 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 90.0 Cg_endo -86.76 41.98 0.84 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.683 2.922 . . . . 0.0 114.047 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -87.81 130.34 34.9 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.988 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.0 mm -84.29 115.81 26.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.845 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.689 ' H ' HD13 ' A' ' 9' ' ' ILE . 18.1 mt -85.45 -46.63 10.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.816 -174.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.561 ' H ' HD11 ' A' ' 9' ' ' ILE . 12.9 p30 -59.81 -69.82 0.19 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.6 tp 177.54 136.03 0.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.991 ' HA3' ' HA ' ' A' ' 61' ' ' CYS . . . -58.64 151.38 33.08 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.019 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.2 m -71.77 47.39 0.14 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.063 0.459 . . . . 0.0 111.858 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.664 HD21 ' HB2' ' A' ' 61' ' ' CYS . 70.0 m-80 -65.92 -41.13 91.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.704 ' HD2' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -110.1 -151.8 0.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.964 173.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.704 ' HG ' ' HD2' ' A' ' 96' ' ' ARG . 96.3 mt 64.59 32.55 11.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.419 0.628 . . . . 0.0 109.712 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -86.6 -30.21 22.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.942 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -66.74 123.38 19.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.021 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -79.03 76.73 5.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.278 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -76.67 45.27 0.4 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.322 -179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.9 -37.87 85.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.948 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -56.84 136.08 55.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.235 -176.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 68.07 -57.82 0.46 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.22 1.008 . . . . 0.0 113.29 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -170.48 115.56 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.602 ' HD3' ' H ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -79.29 -32.32 43.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.009 0.433 . . . . 0.0 111.736 -175.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.567 HG22 ' HG2' ' A' ' 106' ' ' LYS . 11.9 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.656 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -171.21 161.22 33.75 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.1 m -74.62 45.62 0.25 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.915 0.388 . . . . 0.0 111.933 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.6 m -159.32 -54.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 38.67 62.11 1.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.201 1.0 . . . . 0.0 113.485 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -82.54 49.23 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 109.251 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.497 ' HG3' ' H ' ' A' ' 6' ' ' PHE . 53.6 tp60 -169.68 -121.34 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.777 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' H ' ' HG3' ' A' ' 5' ' ' GLN . 28.6 t80 -171.61 161.67 6.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -73.73 58.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 111.285 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 9' ' ' ILE . 61.6 mt -77.34 39.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.518 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.666 ' HA ' ' CB ' ' A' ' 91' ' ' ASN . 3.7 mp -131.9 26.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 124.083 1.897 . . . . 0.0 106.275 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.81 ' HG2' HD22 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -109.25 140.45 42.87 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.129 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 86' ' ' CYS . 0.5 OUTLIER -41.58 -63.11 0.76 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.277 -1.328 . . . . 0.0 113.254 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.81 HD22 ' HG2' ' A' ' 10' ' ' MET . 0.0 OUTLIER 51.03 36.77 16.06 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.873 ' HE2' ' HB2' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -104.29 170.66 7.78 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 166.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.3 tp-100 -57.33 121.91 50.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 123.551 0.532 . . . . 0.0 110.693 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.9 Cg_exo -71.19 151.03 60.49 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.879 2.386 . . . . 0.0 112.688 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.652 ' H ' ' HA ' ' A' ' 46' ' ' CYS . . . -88.02 -125.98 2.37 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.529 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.6 t -105.42 -48.73 9.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -62.22 151.02 37.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.522 HG21 ' HD3' ' A' ' 42' ' ' LYS . 98.6 m -82.23 143.56 31.29 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.451 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.75 126.51 9.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.952 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.2 mt -95.33 136.73 35.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.674 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 90.7 mt -99.07 148.7 23.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.49 171.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.9 p -89.47 154.99 19.59 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 170.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 67' ' ' VAL . 62.5 mm-40 -52.21 -29.54 23.04 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.423 0.452 . . . . 0.0 111.996 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.3 mmtp -69.4 -36.58 76.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.31 -0.244 . . . . 0.0 111.218 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 23.3 m -99.48 33.73 2.4 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -63.69 119.23 9.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.115 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.43 31.99 62.7 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.525 174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 26' ' ' CYS . 24.5 mtpp -103.76 122.86 45.97 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 173.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 14.0 t -62.06 115.89 18.56 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.165 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.714 ' HG2' HG11 ' A' ' 43' ' ' VAL . 8.1 Cg_exo -73.29 50.16 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.63 2.887 . . . . 0.0 112.716 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.3 mm -149.86 -48.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.3 p -112.94 -14.84 12.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.085 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.6 t70 65.82 80.95 0.21 Allowed 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.599 0.714 . . . . 0.0 109.939 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.2 t -165.65 146.91 7.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.99 -176.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.72 14.1 12.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.913 0.387 . . . . 0.0 110.477 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -65.22 150.47 10.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 16.5 ptm180 -37.5 126.98 0.89 Allowed Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 124.001 0.92 . . . . 0.0 113.383 -174.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.4 Cg_exo -71.55 -163.54 0.13 Allowed 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.429 2.753 . . . . 0.0 112.478 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -169.0 -52.53 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.686 -0.233 . . . . 0.0 111.235 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -140.11 141.89 36.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.91 0.386 . . . . 0.0 111.478 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HD3' HG21 ' A' ' 19' ' ' THR . 39.6 ttmt -69.06 140.13 54.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.948 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.714 HG11 ' HG2' ' A' ' 31' ' ' PRO . 12.4 m -77.95 148.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.799 -176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.57 129.23 50.88 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.044 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 m -93.73 146.52 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.025 0.441 . . . . 0.0 111.343 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.665 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.6 p -69.91 165.33 21.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -59.47 -41.06 88.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.176 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.873 ' HB2' ' HE2' ' A' ' 13' ' ' LYS . 3.7 m120 -74.52 40.3 0.13 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.502 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.498 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 15.6 m -151.35 -52.3 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.75 174.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.507 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 51.5 m -100.21 44.17 1.03 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.737 0.779 . . . . 0.0 110.025 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -72.08 -33.68 68.09 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.202 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.47 -68.85 0.13 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.266 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.41 142.84 39.04 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.768 -0.086 . . . . 0.0 110.768 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' HB2' ' ND2' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 40.37 49.42 2.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.809 0.844 . . . . 0.0 111.527 -177.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 50' ' ' SER . . . -92.41 -41.93 10.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.083 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -90.39 27.53 1.67 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.578 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.441 ' ND2' ' HB2' ' A' ' 54' ' ' GLN . 22.9 p30 -93.35 149.74 21.0 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.769 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.719 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 15.8 t -48.3 129.39 15.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.922 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.619 HG22 ' HD3' ' A' ' 88' ' ' ARG . 8.5 pt -65.89 -31.6 54.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.482 -174.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 26' ' ' CYS . 51.4 mt -77.17 -47.31 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.74 -4.5 15.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.835 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 40.06 47.91 2.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.59 0.756 . . . . 0.0 112.651 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.53 -57.25 0.28 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.023 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -76.75 146.69 37.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.716 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.3 t -65.18 131.36 30.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.799 0.333 . . . . 0.0 110.162 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.17 139.47 25.02 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.991 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.451 HG21 ' HG2' ' A' ' 24' ' ' GLU . 16.2 m -131.63 -40.05 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 111.447 0.165 . . . . 0.0 111.447 -177.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.75 138.95 33.53 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.33 129.94 39.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.674 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -80.28 148.99 30.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.274 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 7.9 m-85 -128.01 133.77 49.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.032 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.674 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 53.7 m-85 -68.38 132.44 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.714 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.8 p -68.63 153.02 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -53.19 -38.33 62.74 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.789 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -60.82 -45.79 93.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.611 0.243 . . . . 0.0 111.385 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.6 m -67.68 -37.77 82.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.086 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.5 t -61.85 -42.64 99.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.56 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -57.34 -50.23 73.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.889 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.18 -27.59 62.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.576 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.17 30.71 21.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.404 -175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -78.99 -27.5 43.36 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -67.21 -41.72 85.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.096 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -85.01 26.58 0.84 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.371 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' CG ' ' HG ' ' A' ' 12' ' ' LEU . 49.4 t0 -80.39 -53.65 6.42 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 12' ' ' LEU . . . 179.32 -149.64 8.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.451 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 30.3 t -67.26 121.05 76.87 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.697 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 85.3 Cg_endo -80.91 43.42 1.54 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.93 3.087 . . . . 0.0 113.446 -177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.619 ' HD3' HG22 ' A' ' 59' ' ' ILE . 14.9 mmm180 -102.14 143.7 31.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.999 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.0 mm -94.99 123.62 47.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.483 HD21 ' CB ' ' A' ' 11' ' ' CYS . 1.3 pt? -168.12 -31.77 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.666 ' CB ' ' HA ' ' A' ' 9' ' ' ILE . 6.5 t-20 -23.17 -64.61 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.516 1.127 . . . . 0.0 113.699 -172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.501 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -164.82 141.64 6.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.13 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.08 122.78 7.71 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.558 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.5 m 71.81 -49.2 0.69 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.633 0.773 . . . . 0.0 111.732 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 92' ' ' LEU . 4.8 m120 -63.29 135.92 57.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 170.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.409 ' HB3' ' H ' ' A' ' 97' ' ' LEU . 5.0 mmt85 -124.8 -154.99 0.65 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.16 0.505 . . . . 0.0 111.385 -176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 100' ' ' HIS . 32.1 mt -87.52 30.03 0.83 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.516 -178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -77.25 136.49 38.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.349 174.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.8 ttp-105 62.04 37.08 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.795 0.807 . . . . 0.0 109.628 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 97' ' ' LEU . 21.3 m80 -123.93 -44.6 2.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.239 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 63.11 -94.45 0.04 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.365 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 59.4 36.39 23.24 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.753 0.787 . . . . 0.0 110.33 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -144.07 -49.26 0.29 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.284 -1.325 . . . . 0.0 107.651 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -123.21 153.15 40.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.173 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 105' ' ' LYS . 12.3 mptt -66.17 124.27 22.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.099 0.476 . . . . 0.0 110.994 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -81.56 139.93 34.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.377 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.943 179.238 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.812 0 N-CA-C 112.273 -0.331 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -69.12 133.25 26.35 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.388 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.4 p -80.29 43.04 0.61 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.995 0.426 . . . . 0.0 111.913 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -75.15 -27.5 59.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.446 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 66.6 44.05 2.35 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.434 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -146.26 9.81 1.11 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.863 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.722 ' HG2' ' HD1' ' A' ' 6' ' ' PHE . 42.4 tt0 -62.49 -70.4 0.2 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.306 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.722 ' HD1' ' HG2' ' A' ' 5' ' ' GLN . 3.5 m-85 -103.78 9.67 36.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.814 174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 52.68 48.36 22.69 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.586 -172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.637 ' H ' HD12 ' A' ' 8' ' ' LEU . 3.3 mp -63.72 121.56 14.26 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.187 -173.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.863 ' HA ' ' HB2' ' A' ' 91' ' ' ASN . 1.3 mp -90.16 50.13 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-O 122.357 1.075 . . . . 0.0 109.386 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' ' 88' ' ' ARG . 3.8 ptp -143.77 136.77 27.53 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.522 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HA ' HD11 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -58.32 -37.54 75.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.787 -174.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 53.8 mt 56.16 34.3 23.64 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 171.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 61.6 mttm -77.53 -169.36 1.43 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.533 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -82.24 113.63 45.23 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.514 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.782 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 27.7 Cg_exo -63.91 144.84 89.26 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.442 2.762 . . . . 0.0 112.809 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.08 -142.64 11.06 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.841 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.595 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 8.3 p -82.24 -35.65 13.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.127 0.489 . . . . 0.0 110.669 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -61.38 127.27 30.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.902 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.55 140.24 30.8 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.275 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.46 121.38 9.88 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.44 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 56' ' ' LYS . 26.2 mt -78.53 153.82 30.95 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.548 0.69 . . . . 0.0 112.548 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.744 HD11 HD12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -135.81 127.01 28.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.419 -1.264 . . . . 0.0 111.677 -171.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 1.7 p -80.06 144.87 32.79 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 93.1 mt-10 -55.17 -26.06 36.4 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -173.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -65.51 -36.33 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.581 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.0 m -94.81 -17.98 21.63 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.4 t0 -52.05 121.6 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.509 -172.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.78 -32.88 5.47 Favored Glycine 0 C--N 1.316 -0.58 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.26 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -71.13 128.39 35.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.447 -0.376 . . . . 0.0 110.866 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 4.6 t -74.8 119.67 77.88 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 8.8 Cg_endo -54.8 -36.15 90.1 Favored 'Trans proline' 0 N--CA 1.472 0.264 0 C-N-CA 123.174 2.582 . . . . 0.0 113.331 -174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.495 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 8.4 mm -65.41 -44.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.7 p -121.55 -11.49 8.68 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 62.79 72.4 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.957 0.408 . . . . 0.0 111.181 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -162.67 141.8 8.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.856 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -83.31 45.48 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.306 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.66 HG13 ' HB2' ' A' ' 73' ' ' CYS . 5.9 p -92.79 154.91 3.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.245 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -35.16 124.81 0.58 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 124.356 1.062 . . . . 0.0 113.584 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.79 146.89 38.79 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.144 2.563 . . . . 0.0 111.825 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 57.7 tptt -127.45 -49.27 1.41 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.697 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -138.09 138.69 38.97 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.937 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HG2' ' CE2' ' A' ' 71' ' ' PHE . 32.5 mtpt -65.25 136.04 56.13 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.322 0.582 . . . . 0.0 110.952 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 26.0 t -79.92 124.72 38.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.162 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.595 ' NH1' ' HA ' ' A' ' 17' ' ' VAL . 72.7 mtt-85 -107.05 133.34 51.82 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.059 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.0 m -80.95 147.3 6.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.967 0.413 . . . . 0.0 110.118 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.782 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 2.8 p -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.17 -42.8 14.49 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.912 0.758 . . . . 0.0 111.721 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.3 m120 -60.28 -41.12 92.65 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 74.0 m -85.8 53.37 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 t -160.72 -46.85 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.427 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 -73.73 136.01 43.67 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.489 -177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.08 -42.92 1.41 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 116.013 -0.539 . . . . 0.0 114.115 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.77 ' HG2' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -165.74 172.15 12.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.961 0.381 . . . . 0.0 110.933 -174.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.77 ' HG3' ' HG2' ' A' ' 53' ' ' LYS . 17.1 mt-30 61.92 46.13 6.94 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.703 0.627 . . . . 0.0 111.307 176.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -118.45 -42.11 2.79 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.354 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 21' ' ' LEU . 35.4 mtmm -84.33 -35.28 23.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.083 -177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.7 p30 -65.75 143.34 57.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.402 0.62 . . . . 0.0 111.551 -173.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.5 t -64.05 125.89 25.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.676 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 70' ' ' ALA . 18.4 pt -63.3 -32.43 56.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.744 HD12 HD11 ' A' ' 22' ' ' LEU . 49.3 mt -73.52 -41.3 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -173.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 6.3 p -93.5 -25.11 17.75 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.227 174.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.4 t30 61.43 44.59 9.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.745 0.784 . . . . 0.0 109.656 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 63' ' ' LEU . 1.4 tm? -164.18 -59.27 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.418 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 74.9 m-80 -71.82 146.22 48.14 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.213 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.4 p -66.93 136.19 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.386 . . . . 0.0 111.09 -177.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -88.51 142.34 17.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.697 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.4 m -117.17 -38.53 2.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.685 0.279 . . . . 0.0 111.594 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 21' ' ' LEU . 80.5 m-20 -109.93 -168.52 1.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -115.02 145.73 41.98 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.025 0.441 . . . . 0.0 110.513 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . . . -75.86 152.28 37.24 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.709 175.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.576 ' CE2' ' HG2' ' A' ' 42' ' ' LYS . 32.0 m-85 -132.08 131.47 42.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.192 176.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -70.67 128.75 37.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 171.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.66 ' HB2' HG13 ' A' ' 37' ' ' VAL . 7.1 p -73.6 158.4 34.85 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.868 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 27.8 t90 -47.97 -49.74 29.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.536 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' LEU . 5.5 pt-20 -68.45 -36.5 79.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 34.7 m -63.23 -42.25 99.2 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.584 175.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 97.4 m -68.1 -41.1 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.701 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -63.26 -42.47 99.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -72.24 -30.13 64.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.248 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.83 4.29 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.033 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -96.24 -32.61 12.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 109.979 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -64.06 -34.99 79.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.614 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 7.47 2.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.953 -176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -76.47 -56.41 4.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.07 -147.33 12.35 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.749 -1.215 . . . . 0.0 114.433 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.571 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 2.0 t -70.59 114.44 26.38 Favored Pre-proline 0 C--N 1.326 -0.423 0 C-N-CA 124.302 1.041 . . . . 0.0 112.389 -174.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 10' ' ' MET . 96.0 Cg_endo -93.33 42.11 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.073 2.515 . . . . 0.0 114.887 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.65 ' O ' ' HA ' ' A' ' 10' ' ' MET . 39.9 mtt-85 -74.58 128.42 35.52 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.024 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 17.8 mm -67.34 118.79 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.371 0.605 . . . . 0.0 111.225 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 91' ' ' ASN . 2.1 pp -169.75 -40.38 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.935 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.863 ' HB2' ' HA ' ' A' ' 9' ' ' ILE . 20.9 t-20 65.76 -67.2 0.14 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.772 0.829 . . . . 0.0 110.763 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.34 -60.12 1.77 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 175.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.98 -61.44 0.75 Allowed Glycine 0 C--N 1.33 0.209 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.45 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.6 t -173.96 -140.82 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.5 m120 58.69 37.11 25.21 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 122.714 0.405 . . . . 0.0 111.233 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.2 -28.0 0.74 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.683 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.19 149.33 44.74 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 t70 62.39 46.54 5.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.326 0.584 . . . . 0.0 109.655 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 70.7 -69.04 0.19 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.351 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -170.38 143.88 2.4 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.185 0.594 . . . . 0.0 109.554 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -77.01 72.93 3.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.05 0.452 . . . . 0.0 109.795 175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.571 ' HG3' ' HG2' ' A' ' 103' ' ' LYS . 5.9 tp10 -161.99 145.17 11.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.02 -174.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.571 ' HG2' ' HG3' ' A' ' 102' ' ' GLU . 34.7 mmtp 72.91 -57.79 0.62 Allowed 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.098 0.874 . . . . 0.0 111.309 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -84.58 126.01 32.95 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.16 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp 62.23 -134.16 0.52 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.426 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.3 tttt 64.14 48.25 3.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.882 0.849 . . . . 0.0 110.545 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.66 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -70.32 126.06 15.47 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.237 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.8 t 53.33 -130.86 2.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.432 0.293 . . . . 0.0 110.395 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m 71.5 -47.8 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.828 0.851 . . . . 0.0 112.501 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.48 -27.3 66.89 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.3 -50.51 67.16 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.293 0.568 . . . . 0.0 110.398 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 8' ' ' LEU . 3.2 pt20 -96.42 -138.84 0.26 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.538 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.633 ' HE2' ' HD3' ' A' ' 103' ' ' LYS . 1.2 t80 64.2 17.24 10.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.402 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -92.11 25.95 2.68 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 159.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 5' ' ' GLN . 1.6 mt -76.2 95.17 3.65 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 112.975 -1.921 . . . . 0.0 109.759 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 8' ' ' LEU . 1.9 tp 173.27 178.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -172.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.781 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -55.87 137.73 49.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.72 0.771 . . . . 0.0 112.052 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.4 t -52.84 -39.75 62.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.888 -1.506 . . . . 0.0 111.67 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 10' ' ' MET . 1.1 mp 43.29 46.44 5.38 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 171.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -88.89 -152.66 0.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 46' ' ' CYS . 67.3 tp60 -86.3 115.17 61.05 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.119 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 48.9 Cg_exo -58.94 136.17 71.69 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.084 2.523 . . . . 0.0 112.852 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.69 -112.29 0.89 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.445 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 p -146.26 -26.65 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.781 0.324 . . . . 0.0 110.881 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.569 ' NE2' ' HB3' ' A' ' 50' ' ' SER . 56.2 mt-30 -66.35 131.7 46.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.324 0.583 . . . . 0.0 111.45 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.1 m -76.33 135.52 39.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.888 -176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.2 118.72 5.66 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.233 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 91.8 mt -90.8 143.67 26.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.144 0.497 . . . . 0.0 111.648 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 80.9 mt -104.04 133.63 48.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.743 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.668 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.3 p -71.27 154.26 41.77 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HG2' HG21 ' A' ' 67' ' ' VAL . 37.1 mt-10 -48.64 -32.27 8.02 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 123.484 0.49 . . . . 0.0 112.269 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -70.81 -43.21 69.1 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.652 ' HB3' HD12 ' A' ' 60' ' ' ILE . 33.7 m -89.72 -11.32 42.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -54.86 115.5 2.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.764 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.7 -31.31 5.79 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.6 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 62.5 mttp -77.32 127.59 32.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.493 -0.188 . . . . 0.0 110.493 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 35.4 t -68.14 118.27 57.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 171.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 3.2 Cg_endo -52.93 -41.29 72.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.221 2.614 . . . . 0.0 113.652 -171.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.963 HG21 ' HG2' ' A' ' 81' ' ' LYS . 1.4 mm -68.75 -48.44 71.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -110.5 -7.94 14.7 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 58.88 71.46 0.58 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.295 0.569 . . . . 0.0 110.266 -177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.7 t -160.04 139.51 11.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.112 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.405 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.3 m-85 -85.62 30.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.231 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 73' ' ' CYS . 7.7 p -80.51 148.82 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.444 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -36.93 119.96 0.8 Allowed Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.8 Cg_endo -80.63 150.65 19.1 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.341 2.694 . . . . 0.0 112.207 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 52.2 mtpt -137.59 -69.08 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.668 ' HG2' ' HB2' ' A' ' 82' ' ' ASP . 20.7 tpp180 -78.86 131.62 36.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.022 -175.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -69.03 133.46 48.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.215 0.531 . . . . 0.0 110.613 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.655 HG13 ' HG3' ' A' ' 87' ' ' PRO . 3.1 t -76.88 126.22 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.866 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -125.04 127.95 47.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.779 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 m -85.53 158.44 3.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.107 0.48 . . . . 0.0 111.257 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.703 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.9 p -65.45 148.79 51.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -54.02 -30.89 49.44 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.249 0.343 . . . . 0.0 111.686 -176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.668 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 64.7 m-80 -59.83 -34.2 72.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.476 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.89 35.5 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.717 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 14.8 m -140.57 -45.16 0.4 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.304 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' CE1' ' HA ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -87.69 -18.43 29.55 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.729 178.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.78 -150.16 6.8 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.903 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -82.41 38.07 0.54 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.23 0.538 . . . . 0.0 111.239 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.547 ' HB3' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -166.03 142.07 4.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.724 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -174.03 -49.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.379 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.695 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -96.83 -26.63 15.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.178 177.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 72.0 m-20 -61.05 142.54 56.56 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 42.3 t -51.03 133.39 27.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.89 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.427 ' CD1' HG11 ' A' ' 43' ' ' VAL . 7.6 pt -78.43 -26.58 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.518 -175.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 26' ' ' CYS . 48.9 mt -78.2 -48.24 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -176.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.549 ' C ' ' H ' ' A' ' 63' ' ' LEU . 28.2 p -103.03 -6.75 22.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 119.764 -0.775 . . . . 0.0 110.834 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 12.9 m-80 70.05 -36.08 0.34 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.745 0.818 . . . . 0.0 111.581 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER -78.65 -63.22 1.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.229 -1.35 . . . . 0.0 112.559 -166.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -68.23 148.62 50.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.742 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.2 p -73.93 137.02 24.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.721 0.295 . . . . 0.0 110.688 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.08 144.35 27.25 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.875 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' HG2' ' A' ' 24' ' ' GLU . 27.2 m -115.29 -47.63 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -114.75 135.68 53.9 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 111.289 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.89 134.62 55.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.781 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -77.37 153.05 34.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.475 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 11.2 m-85 -134.55 135.1 42.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.521 174.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 85.4 m-85 -66.55 130.29 42.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.9 p -68.97 162.51 26.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.721 0.296 . . . . 0.0 110.895 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -51.18 -44.03 61.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.105 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 5.5 mm-40 -59.82 -47.67 84.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.741 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 68.4 m -67.51 -37.92 83.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.854 -0.157 . . . . 0.0 111.298 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 77.0 m -62.55 -42.88 99.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.798 0.332 . . . . 0.0 110.504 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.05 -42.25 99.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 68.6 mt -70.28 -33.44 71.57 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.724 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.73 21.5 7.83 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.847 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.963 ' HG2' HG21 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -66.73 -25.58 66.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.796 0.331 . . . . 0.0 111.564 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.668 ' HB2' ' HG2' ' A' ' 41' ' ' ARG . 26.5 p-10 -65.76 -43.52 88.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.756 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -83.94 -9.0 59.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.916 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 81' ' ' LYS . 6.4 m-20 -60.03 -49.49 77.45 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.12 7.92 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.041 -1.075 . . . . 0.0 113.706 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.703 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 41.4 t -69.38 117.97 57.75 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.412 -0.894 . . . . 0.0 111.85 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.655 ' HG3' HG13 ' A' ' 43' ' ' VAL . 75.6 Cg_endo -86.45 24.94 0.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 123.201 2.601 . . . . 0.0 113.261 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 10' ' ' MET . 2.0 mmt180 -73.82 124.49 26.19 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.0 mm -77.69 110.6 13.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 68.2 mt -83.02 -26.2 31.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.491 ' HA ' ' HB3' ' A' ' 8' ' ' LEU . 7.3 t-20 -64.64 -143.74 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.797 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -160.25 -141.68 0.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -62.98 -51.15 57.66 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.579 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.5 m -155.83 124.29 5.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.708 0.254 . . . . 0.0 110.48 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 179.16 50.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.652 ' HD3' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -160.87 -143.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.838 -176.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.652 ' HG ' ' HD3' ' A' ' 96' ' ' ARG . 91.6 mt 66.79 31.07 7.64 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 122.775 0.43 . . . . 0.0 111.203 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -77.5 130.61 37.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 99' ' ' ARG . 5.3 mmp_? -94.76 -20.17 19.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.865 0.364 . . . . 0.0 110.964 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -125.08 47.98 2.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.136 0.494 . . . . 0.0 110.65 177.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -65.82 117.23 7.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.806 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -168.96 62.2 0.06 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.633 ' HD3' ' HE2' ' A' ' 6' ' ' PHE . 26.2 mtpp -111.3 76.23 0.96 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.081 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER 74.34 -40.71 0.46 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.292 -175.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -133.35 152.62 51.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.273 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -151.65 131.78 13.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.348 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.979 -0.534 . . . . 0.0 110.025 178.725 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 169.95 60.92 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.4 m 62.3 -131.78 0.57 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.423 0.289 . . . . 0.0 110.315 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.0 m -159.37 140.46 12.72 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 67.37 -85.01 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.875 0.734 . . . . 0.0 110.965 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -97.98 -145.21 0.31 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 6' ' ' PHE . 1.9 pt20 -87.65 -11.79 47.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 5' ' ' GLN . 21.4 t80 79.22 23.5 0.53 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 124.404 1.065 . . . . 0.0 110.032 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 47.65 54.7 9.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.289 -1.323 . . . . 0.0 111.211 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.648 ' HB2' ' CG2' ' A' ' 89' ' ' ILE . 3.7 mt -58.89 142.27 51.13 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.221 0.534 . . . . 0.0 111.654 -174.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 92' ' ' LEU . 3.8 mp -104.36 45.54 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.12 -162.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.876 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER 42.19 -170.33 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.484 -1.235 . . . . 0.0 113.46 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.85 ' HB2' HD21 ' A' ' 90' ' ' LEU . 16.4 t -111.14 -54.75 2.57 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.881 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.556 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 56.8 mt 48.56 33.16 3.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.07 -1.423 . . . . 0.0 113.047 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -86.24 -179.74 6.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mm-40 -67.93 116.05 34.46 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 11.2 Cg_exo -72.4 142.57 37.26 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.431 2.754 . . . . 0.0 112.975 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.45 -133.35 4.43 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.925 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.56 -27.08 3.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.658 0.266 . . . . 0.0 111.329 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -64.6 131.65 47.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.249 0.547 . . . . 0.0 111.163 -175.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.668 HG21 ' HD3' ' A' ' 42' ' ' LYS . 6.6 m -83.13 140.91 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.026 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.4 133.07 14.08 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.687 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 71.7 mt -95.64 143.79 26.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.173 0.511 . . . . 0.0 112.358 -178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 53.2 mt -113.93 139.28 49.35 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.374 175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.524 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 8.6 p -72.62 151.62 42.22 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 171.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.606 ' HG2' HG21 ' A' ' 67' ' ' VAL . 21.4 mt-10 -49.32 -34.67 16.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.923 0.392 . . . . 0.0 111.595 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -71.46 -26.45 62.72 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 56.9 m -101.2 -16.08 17.12 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.453 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -51.94 115.77 1.85 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.258 0.552 . . . . 0.0 111.201 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 36' ' ' TYR . . . 122.29 -30.93 5.05 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.951 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 40.0 mttm -72.12 127.72 33.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.57 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 2.5 t -71.08 120.42 79.42 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HG2' HG11 ' A' ' 43' ' ' VAL . 71.8 Cg_exo -53.1 -35.54 73.05 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.827 2.351 . . . . 0.0 112.964 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.8 mm -67.84 -46.68 81.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.363 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.7 p -118.46 -2.94 10.97 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.6 t70 59.13 67.8 0.88 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.284 0.564 . . . . 0.0 110.69 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.02 143.34 15.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.022 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.475 ' HB2' ' HA ' ' A' ' 107' ' ' VAL . 2.1 m-85 -83.39 13.31 4.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.091 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 73' ' ' CYS . 13.1 p -60.67 149.64 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.058 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 5.8 ptp85 -38.88 128.77 1.18 Allowed Pre-proline 0 N--CA 1.469 0.489 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.098 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.732 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 6.7 Cg_exo -74.83 -161.38 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.437 2.758 . . . . 0.0 112.724 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.836 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -167.78 -43.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.728 178.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 -153.83 142.53 20.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.341 . . . . 0.0 111.196 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.668 ' HD3' HG21 ' A' ' 19' ' ' THR . 87.0 mttt -62.54 143.08 57.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.473 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.994 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 18.0 m -82.08 146.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.956 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -118.98 133.51 55.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.073 0.463 . . . . 0.0 110.78 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.7 m -86.9 146.0 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.667 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.769 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 10.2 p -66.16 151.39 47.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.324 -179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -52.02 -37.17 52.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.884 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.495 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 16.9 m-80 -64.67 -20.19 66.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.554 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 19.6 m -90.2 -41.01 11.85 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.274 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.6 p -68.82 -30.27 68.79 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -63.46 -21.76 66.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -173.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.85 -148.87 18.91 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.169 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.488 ' HE3' ' CZ ' ' A' ' 51' ' ' PHE . 22.3 pttp 52.83 -59.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.173 1.789 . . . . 0.0 114.455 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -162.61 115.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.516 0.598 . . . . 0.0 111.299 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' CYS . . . -165.87 -35.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.647 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -66.76 -29.37 69.32 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.11 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 13.8 p30 -71.62 138.85 49.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 23' ' ' CYS . 2.1 t -42.7 126.29 3.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.931 -177.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.432 HG12 HD23 ' A' ' 22' ' ' LEU . 9.5 pt -61.21 -32.03 51.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.986 -1.007 . . . . 0.0 113.128 -171.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.2 mt -75.99 -45.16 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -103.94 -7.35 20.46 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.684 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 42.04 51.33 4.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.708 0.803 . . . . 0.0 112.387 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 -66.13 0.13 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.085 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -71.24 139.41 50.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.51 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 13.8 p -66.67 136.4 26.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.008 0.432 . . . . 0.0 111.448 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.51 141.66 25.96 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.381 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.606 HG21 ' HG2' ' A' ' 24' ' ' GLU . 19.1 m -118.87 -46.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -116.91 147.23 42.4 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.648 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.36 142.62 58.16 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.579 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . . . -81.32 155.59 25.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.904 175.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 18.3 m-85 -127.84 137.28 52.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.57 176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 91.1 m-85 -69.76 125.39 26.58 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 1.8 p -71.21 152.75 43.04 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.269 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.534 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.65 -44.19 62.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.092 -177.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -56.15 -46.8 79.12 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.527 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.1 m -72.6 -38.56 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.141 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 33.5 t -67.14 -39.98 86.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.904 0.383 . . . . 0.0 110.397 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.27 -32.27 70.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.403 0.621 . . . . 0.0 109.905 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 101.82 41.21 2.53 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.106 176.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -94.74 1.26 55.46 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.279 -0.542 . . . . 0.0 110.722 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -70.48 -23.52 62.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.547 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -96.21 9.54 40.69 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.136 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -68.05 -65.91 0.63 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.96 -154.4 24.38 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.168 -1.015 . . . . 0.0 113.407 170.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 54.1 t -57.93 115.41 11.06 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.211 -0.994 . . . . 0.0 111.356 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.994 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 71.8 Cg_endo -78.29 17.42 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.286 2.658 . . . . 0.0 113.312 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 14.0 mmm180 -67.98 136.41 53.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.876 ' HA ' ' HA ' ' A' ' 10' ' ' MET . 28.9 mm -92.31 119.55 40.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 118.408 0.549 . . . . 0.0 111.345 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.85 HD21 ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -153.84 -62.59 0.14 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.703 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER 169.97 154.61 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.365 0.666 . . . . 0.0 110.009 -173.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.711 ' HB3' HG22 ' A' ' 9' ' ' ILE . 60.2 tp -159.56 -24.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.57 37.95 39.11 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.5 t -167.98 44.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -69.27 127.85 34.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.279 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' HB2' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -145.14 -122.12 0.08 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.69 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' H ' ' HB2' ' A' ' 96' ' ' ARG . 92.4 mt 73.37 141.12 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.972 0.509 . . . . 0.0 111.282 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.91 59.86 1.61 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.607 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -67.61 138.28 56.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.013 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -156.12 51.9 0.54 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.462 0.648 . . . . 0.0 110.306 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -99.08 42.28 1.11 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.58 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -96.43 36.02 1.41 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.948 -175.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -95.21 -169.59 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -68.29 -33.07 73.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 25.2 mmmt -79.52 130.07 35.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.438 172.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -159.32 -36.6 0.06 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.623 0.725 . . . . 0.0 109.228 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 36' ' ' TYR . 48.6 t . . . . . 0 C--N 1.31 -1.116 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.755 173.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 173.0 -35.84 0.13 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.926 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.8 t 60.1 30.67 20.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.793 0.437 . . . . 0.0 111.201 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.533 ' H ' ' HB3' ' A' ' 92' ' ' LEU . 5.0 m 54.63 32.4 17.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.811 176.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -75.84 142.54 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.033 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -75.54 55.43 0.82 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.688 ' HB3' ' HB2' ' A' ' 8' ' ' LEU . 57.4 mt-30 -67.76 144.91 55.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.33 72.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.468 0.651 . . . . 0.0 111.137 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 55.8 28.3 12.13 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.725 -175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 5' ' ' GLN . 62.4 mt -91.02 46.48 1.32 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.133 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.875 ' HA ' ' HB2' ' A' ' 91' ' ' ASN . 2.5 mp -110.52 13.27 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 123.157 1.456 . . . . 0.0 107.427 178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.668 ' HE1' HD13 ' A' ' 32' ' ' ILE . 4.3 ptp -95.07 144.98 25.29 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 111.868 -2.424 . . . . 0.0 111.425 170.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.756 ' HA ' HD11 ' A' ' 90' ' ' LEU . 7.6 t -44.69 -59.9 2.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.383 -1.735 . . . . 0.0 112.625 -174.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 84' ' ' ASP . 81.7 mt 52.48 32.18 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.935 0.894 . . . . 0.0 113.225 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -80.75 -177.92 6.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.83 115.52 25.77 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 6.5 Cg_exo -74.99 140.1 25.09 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.991 2.461 . . . . 0.0 112.873 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.07 -145.3 10.41 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.214 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.6 -5.58 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.518 -0.401 . . . . 0.0 110.606 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -62.01 130.36 45.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.177 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -79.17 137.83 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.301 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.26 125.66 7.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.341 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 81.9 mt -100.08 145.8 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.241 0.543 . . . . 0.0 112.407 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.614 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 85.8 mt -114.04 133.01 55.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.572 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.5 p -72.14 157.95 36.81 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -53.01 -27.44 19.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.884 0.374 . . . . 0.0 111.842 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 50.7 mtpt -75.43 -24.14 57.05 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.321 -178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.441 ' HB3' HD12 ' A' ' 60' ' ' ILE . 8.9 m -119.05 18.46 13.14 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -67.9 129.54 40.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.763 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.52 -22.33 37.99 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.664 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 60.3 mttp -74.82 133.03 41.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.643 0.259 . . . . 0.0 111.021 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t -70.9 121.01 82.76 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 12.0 Cg_endo -58.35 -34.33 98.57 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.976 2.451 . . . . 0.0 113.142 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.668 HD13 ' HE1' ' A' ' 10' ' ' MET . 13.0 mm -69.89 -46.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.212 -175.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.5 p -122.66 -7.57 8.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 60.87 78.77 0.27 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.341 0.591 . . . . 0.0 110.367 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -160.54 143.95 13.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.398 -175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 25.5 m-85 -94.63 26.9 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.668 179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG22 ' H ' ' A' ' 38' ' ' ARG . 4.4 p -75.96 168.84 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.602 ' HB3' ' NH1' ' A' ' 38' ' ' ARG . 3.2 mtp-105 -50.49 129.23 25.72 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -172.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.7 Cg_exo -73.28 158.57 48.43 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.19 2.593 . . . . 0.0 110.614 173.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.512 ' HG3' ' HE3' ' A' ' 74' ' ' TRP . 11.9 tmtt? -142.94 -49.77 0.34 Allowed 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.273 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HD3' ' OD2' ' A' ' 82' ' ' ASP . 67.9 ttt180 -122.31 130.54 53.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.683 0.278 . . . . 0.0 111.071 -177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -67.71 136.6 54.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.17 0.509 . . . . 0.0 110.648 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 27.2 t -75.44 134.68 28.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.984 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -124.46 130.19 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.5 m -92.29 155.68 3.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.047 0.451 . . . . 0.0 111.249 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 4.5 p -66.3 151.34 47.28 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.222 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -53.06 -39.62 63.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.355 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.624 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 5.1 m120 -55.87 -44.71 78.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.256 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.643 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 33.6 m -66.95 -25.06 66.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.3 t -87.24 -51.01 6.21 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.628 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -65.22 -21.3 66.73 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.306 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.61 155.45 52.94 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.656 172.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -51.51 -37.77 50.84 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.467 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 2.9 pm0 -79.4 48.76 0.92 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.921 0.391 . . . . 0.0 111.467 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.72 -54.71 23.59 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 11.5 mmpt? -97.76 16.83 19.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -171.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 84.6 m-20 -84.35 154.46 22.86 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.733 0.777 . . . . 0.0 111.398 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.0 t -53.2 136.27 36.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.924 -1.489 . . . . 0.0 111.106 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.516 HD11 ' CB ' ' A' ' 70' ' ' ALA . 11.1 pt -77.76 -32.63 18.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.768 -176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 26' ' ' CYS . 46.8 mt -73.26 -48.58 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.7 p -108.2 11.8 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.306 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 7.3 p-10 53.79 -37.11 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 171.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 64' ' ' ASN . 0.3 OUTLIER -93.12 -46.75 7.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 119.665 1.121 . . . . 0.0 113.888 -171.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.742 ' H ' HD12 ' A' ' 63' ' ' LEU . 4.3 m120 -67.73 135.56 52.9 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 11.7 p -59.44 134.96 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 111.55 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -86.5 144.66 19.9 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.274 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.01 -42.57 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -113.43 139.21 49.1 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.966 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -64.36 138.16 58.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.215 0.531 . . . . 0.0 111.104 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.614 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -83.33 154.01 24.3 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.072 176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 11.6 m-85 -131.76 135.13 46.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.88 173.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.593 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 46.3 m-85 -68.63 127.62 33.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 4.9 p -70.87 156.75 39.2 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.569 -176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.512 ' HE3' ' HG3' ' A' ' 40' ' ' LYS . 9.5 t-105 -41.17 -60.27 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 O-C-N 124.007 0.817 . . . . 0.0 112.804 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.16 -35.85 78.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.209 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 23.5 m -62.81 -35.94 81.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 111.245 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.3 m -70.99 -37.95 72.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.211 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -49.21 76.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.39 175.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.16 -32.62 71.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.771 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' O ' ' HE3' ' A' ' 83' ' ' LYS . . . 79.9 43.92 9.55 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.504 -175.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -95.32 -31.07 13.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.187 0.518 . . . . 0.0 110.068 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.435 ' OD2' ' HD3' ' A' ' 41' ' ' ARG . 43.7 p-10 -65.94 -30.93 71.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.429 178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HD2' ' C ' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -64.38 -19.12 65.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.582 -176.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.721 ' HB3' HD22 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -64.62 -42.58 95.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.389 -177.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.04 -136.29 6.28 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.876 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 36.8 t -60.38 113.36 7.31 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.362 1.065 . . . . 0.0 112.159 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 69.4 Cg_endo -86.51 43.9 1.13 Allowed 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.033 2.489 . . . . 0.0 113.827 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.643 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 45.9 mtt180 -98.67 127.88 44.75 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.94 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 9' ' ' ILE . 50.4 mm -74.18 114.27 13.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.756 HD11 ' HA ' ' A' ' 11' ' ' CYS . 0.8 OUTLIER -158.62 -0.72 0.09 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -177.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.875 ' HB2' ' HA ' ' A' ' 9' ' ' ILE . 91.2 m-20 -78.81 -118.96 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 120.344 -0.542 . . . . 0.0 110.168 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.533 ' HB3' ' H ' ' A' ' 2' ' ' SER . 4.2 tp -172.3 128.17 0.56 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.57 -140.1 4.15 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.016 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.6 m -68.41 115.86 8.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.194 0.521 . . . . 0.0 110.789 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 176.41 -41.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.712 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -142.55 146.07 34.26 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.609 -1.632 . . . . 0.0 107.44 170.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 96' ' ' ARG . 5.1 mt 172.56 -21.3 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.17 0.919 . . . . 0.0 110.843 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.7 t70 61.41 47.13 7.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.871 0.843 . . . . 0.0 109.954 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -148.04 -147.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.736 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 102' ' ' GLU . 58.4 t60 56.25 36.78 28.04 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 100' ' ' HIS . 37.0 t80 72.09 -28.56 0.19 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.144 0.577 . . . . 0.0 112.053 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.535 ' HG2' ' HG2' ' A' ' 103' ' ' LYS . 41.2 tt0 -54.74 132.89 46.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.846 0.459 . . . . 0.0 111.771 -177.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.535 ' HG2' ' HG2' ' A' ' 102' ' ' GLU . 14.5 mmmm 70.84 -50.95 0.68 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.182 0.993 . . . . 0.0 111.98 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -77.93 -134.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.288 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.541 ' HB3' ' NZ ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -168.34 179.41 4.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -146.93 127.69 14.34 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.815 -177.601 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -179.44 -133.13 1.9 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.755 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 m -92.13 37.89 0.99 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.126 0.489 . . . . 0.0 110.459 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -82.27 47.16 1.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.298 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -143.55 128.59 18.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.063 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -87.12 -44.28 11.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.283 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 67.1 127.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.956 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 1.8 t80 -136.05 24.77 3.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.295 1.045 . . . . 0.0 108.798 173.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.01 ' HB3' HD11 ' A' ' 9' ' ' ILE . 25.6 m-20 -89.48 -50.86 5.85 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.99 -1.459 . . . . 0.0 108.242 168.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.582 ' CD1' ' HA ' ' A' ' 6' ' ' PHE . 1.1 mp 48.76 73.97 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.689 -1.596 . . . . 0.0 112.685 173.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.01 HD11 ' HB3' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -176.83 -172.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 123.969 0.908 . . . . 0.0 109.389 -177.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.86 ' SD ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -76.15 142.38 41.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 164.009 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.0 t -45.72 -53.84 8.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.658 0.383 . . . . 0.0 111.522 -171.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' HB2' ' HG3' ' A' ' 10' ' ' MET . 2.6 tp 41.99 41.05 1.8 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 170.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 64.0 mttm -79.65 -134.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -109.93 116.65 53.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 173.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD3' ' HA2' ' A' ' 85' ' ' GLY . 52.0 Cg_exo -56.14 135.72 71.4 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.978 2.452 . . . . 0.0 113.217 -175.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.16 -136.14 8.05 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.393 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.67 -24.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -80.86 137.44 36.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.235 0.54 . . . . 0.0 112.333 -174.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.2 m -78.25 137.91 38.35 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.988 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.75 133.22 13.25 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.491 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 64.2 mt -95.29 147.36 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 111.913 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.645 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 79.4 mt -117.12 132.28 56.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.376 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.593 ' HA ' HG23 ' A' ' 67' ' ' VAL . 6.9 p -71.9 158.24 36.39 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HG3' HG21 ' A' ' 67' ' ' VAL . 39.8 mt-10 -55.75 -28.01 53.7 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.997 0.427 . . . . 0.0 111.561 -176.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 55.0 mttp -71.81 -24.44 61.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.413 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.478 ' HB3' HD12 ' A' ' 60' ' ' ILE . 5.6 m -119.66 18.33 12.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 32.7 t70 -67.51 131.49 45.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.554 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.49 -27.54 6.31 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.83 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 61.9 mttp -66.75 132.02 47.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.584 0.231 . . . . 0.0 111.027 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 t -71.17 118.01 61.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 68.0 Cg_exo -56.41 -39.85 88.51 Favored 'Trans proline' 0 N--CA 1.475 0.404 0 C-N-CA 123.157 2.571 . . . . 0.0 113.383 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.586 HG21 ' HD3' ' A' ' 81' ' ' LYS . 6.8 mm -61.54 -45.3 98.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.209 -174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -119.47 -16.51 8.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 66.94 77.97 0.26 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 109.59 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -171.34 145.86 2.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.996 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -97.45 31.23 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.79 70.12 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 122.31 1.053 . . . . 0.0 111.83 -173.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.8 mmp_? 60.14 111.63 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 114.073 -1.421 . . . . 0.0 112.776 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.36 144.03 66.22 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.719 2.279 . . . . 0.0 112.132 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -128.68 -48.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -139.81 144.9 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.439 -0.163 . . . . 0.0 111.202 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 92.9 mttt -63.94 138.31 58.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.316 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.805 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.0 t -73.53 131.84 34.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.687 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 1.0 OUTLIER -113.18 124.69 53.13 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -91.61 150.92 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.404 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.633 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 11.7 p -62.0 150.14 38.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -51.78 -34.83 41.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.103 -177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 5.7 m120 -58.24 -45.51 87.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.041 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.574 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 99.3 m -74.99 -15.01 60.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.321 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -85.49 -45.62 11.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.263 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.645 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.0 OUTLIER -81.36 -20.88 39.65 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.824 -179.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.5 158.59 53.61 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.278 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.92 -24.96 67.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.395 0.617 . . . . 0.0 110.054 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.488 ' HA ' ' ND2' ' A' ' 57' ' ' ASN . 7.0 mp0 -53.83 -30.83 47.02 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.431 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.04 -35.43 11.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.791 -1.095 . . . . 0.0 113.013 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -70.59 -36.33 73.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.01 0.433 . . . . 0.0 110.582 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.804 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.4 m-80 -78.26 158.82 28.79 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.3 -176.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 8.5 t -60.0 136.42 58.01 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.397 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.615 HG22 ' NE ' ' A' ' 88' ' ' ARG . 7.7 pt -70.62 -38.09 72.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.976 -173.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 26' ' ' CYS . 43.4 mt -69.95 -54.85 17.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -90.36 -6.47 54.99 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.793 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 48.99 24.29 0.85 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.932 0.893 . . . . 0.0 112.393 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.91 -59.83 0.74 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.349 -0.541 . . . . 0.0 111.319 -170.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -76.14 140.53 41.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.804 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 42.9 t -58.56 137.76 20.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.0 111.107 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.88 149.17 45.87 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.88 -0.6 . . . . 0.0 113.049 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 23' ' ' CYS . 47.3 t -122.4 -62.19 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.757 0.313 . . . . 0.0 111.28 -177.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.44 143.19 45.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.28 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -60.48 136.78 58.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.981 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -82.71 156.06 23.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.325 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -128.8 133.68 48.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.14 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.805 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 63.3 m-85 -67.27 130.85 44.4 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 170.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.416 ' SG ' ' CG ' ' A' ' 75' ' ' GLU . 11.2 p -73.48 167.97 20.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -55.69 -49.17 73.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' CG ' ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt-20 -63.26 -39.58 95.01 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 69.4 m -66.25 -40.03 89.9 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.899 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 21.3 t -68.07 -36.99 80.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.25 0.548 . . . . 0.0 109.89 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -60.61 -44.24 96.52 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.13 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.05 -31.49 69.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.874 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.05 28.76 8.44 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.01 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HD3' HG21 ' A' ' 32' ' ' ILE . 43.1 mttm -87.84 7.51 30.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.708 0.766 . . . . 0.0 110.294 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -92.8 -10.94 35.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.847 172.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.67 -26.25 7.52 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.081 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -64.98 -54.83 24.34 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.951 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.449 ' HA2' ' HD3' ' A' ' 15' ' ' PRO . . . -158.56 -158.55 9.09 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.999 -1.572 . . . . 0.0 115.152 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 1.6 t -95.17 120.04 64.75 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 113.792 -1.204 . . . . 0.0 111.47 -173.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.86 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 71.6 Cg_endo -75.5 47.02 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.922 3.081 . . . . 0.0 114.166 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.615 ' NE ' HG22 ' A' ' 59' ' ' ILE . 17.9 mmt180 -101.95 126.67 48.92 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 170.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.559 HD12 ' O ' ' A' ' 91' ' ' ASN . 2.8 mm -86.88 118.68 33.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.508 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.9 mt -95.53 -44.5 7.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.831 ' HB3' ' N ' ' A' ' 9' ' ' ILE . 4.0 t30 -126.03 159.4 32.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 113.977 -1.465 . . . . 0.0 108.3 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -39.33 -38.84 0.58 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.04 -57.18 0.29 Allowed Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.96 174.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m 55.68 37.35 28.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.643 0.735 . . . . 0.0 109.766 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -166.99 25.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.606 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 98' ' ' ASP . 19.7 ttt85 -67.5 135.5 53.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.133 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 64.1 mt 72.45 -25.38 0.18 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.128 0.571 . . . . 0.0 111.523 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 96' ' ' ARG . 31.0 t70 61.83 22.04 12.71 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.905 0.882 . . . . 0.0 111.493 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -94.8 41.63 1.09 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.309 0.576 . . . . 0.0 110.564 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.57 141.43 31.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.058 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -172.74 45.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.27 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HG3' ' HG3' ' A' ' 103' ' ' LYS . 46.2 tp10 -68.29 122.46 18.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.76 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.425 ' HG3' ' HG3' ' A' ' 102' ' ' GLU . 34.1 mtmm 62.1 -135.29 0.52 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.977 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -78.71 -35.02 45.55 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 122.208 -0.308 . . . . 0.0 111.371 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -67.18 129.5 40.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.777 0.323 . . . . 0.0 110.53 178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.37 10.68 28.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.327 0.584 . . . . 0.0 109.721 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 52.2 t . . . . . 0 C--O 1.245 0.829 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.624 -179.89 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 77.17 48.57 8.18 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.311 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.7 m -65.13 -38.32 90.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.528 0.204 . . . . 0.0 110.469 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 t 55.12 48.34 19.84 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.79 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -95.84 53.52 1.42 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.426 0.632 . . . . 0.0 109.714 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.434 ' C ' ' H ' ' A' ' 6' ' ' PHE . 61.7 m170 -84.55 142.54 29.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.168 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.613 ' C ' ' H ' ' A' ' 7' ' ' ASP . 19.7 pt20 -79.76 35.13 0.29 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.333 169.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.75 ' HB2' HD11 ' A' ' 8' ' ' LEU . 34.1 m-85 69.56 -20.36 0.17 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.325 1.05 . . . . 0.0 109.705 -169.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.613 ' H ' ' C ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER 64.73 44.01 3.94 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.783 176.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -85.16 56.15 3.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.168 0.509 . . . . 0.0 110.516 175.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 91' ' ' ASN . 1.8 mp -74.05 69.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.379 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.592 ' SD ' ' HD2' ' A' ' 83' ' ' LYS . 7.1 ptp -50.44 151.69 2.13 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.367 -172.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.759 ' HB2' HD21 ' A' ' 90' ' ' LEU . 53.8 t -42.57 -56.53 3.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.122 -1.399 . . . . 0.0 112.559 -174.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.589 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 86.8 mt 52.39 41.0 30.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.508 ' HB2' ' CB ' ' A' ' 46' ' ' CYS . 84.4 mttt -77.1 -176.96 4.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 167.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -70.09 116.11 40.99 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.722 ' HG3' ' HA2' ' A' ' 85' ' ' GLY . 28.6 Cg_endo -72.15 142.85 38.76 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.386 2.057 . . . . 0.0 112.765 -175.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.57 -157.43 28.7 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.007 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -77.85 -23.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.11 0.481 . . . . 0.0 110.893 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -63.65 128.49 36.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.034 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.576 HG21 ' HD3' ' A' ' 42' ' ' LYS . 20.2 m -82.58 136.33 34.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.601 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.546 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -66.51 126.16 27.26 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.923 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 63.8 mt -80.96 141.85 34.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 112.14 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . 70.2 mt -118.4 143.91 46.32 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.186 173.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 11.5 p -80.14 157.55 26.58 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -55.4 -26.55 42.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.07 0.462 . . . . 0.0 111.386 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.1 mmtt -71.52 -27.3 63.1 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.2 m -108.84 26.22 10.83 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.06 127.46 31.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.4 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 72.61 32.84 61.32 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.421 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE2' ' HE1' ' A' ' 36' ' ' TYR . 94.4 mttt -111.83 140.22 46.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.675 0.274 . . . . 0.0 110.902 176.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 10.7 t -82.36 114.6 52.5 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.521 -0.763 . . . . 0.0 108.942 170.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.411 ' HG3' HG21 ' A' ' 43' ' ' VAL . 12.0 Cg_endo -58.83 -29.43 89.99 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.978 2.452 . . . . 0.0 112.957 -176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 81' ' ' LYS . 21.2 mm -65.23 -40.94 90.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.92 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.2 p -126.09 -12.28 6.38 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 t0 62.2 74.38 0.44 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.907 0.384 . . . . 0.0 110.462 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.7 t -163.25 141.36 7.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.106 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.502 ' HE1' ' HE2' ' A' ' 29' ' ' LYS . 13.2 m-85 -85.75 33.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 73' ' ' CYS . 5.1 p -78.78 158.02 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -41.51 128.85 2.31 Favored Pre-proline 0 N--CA 1.467 0.379 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.675 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 96.1 Cg_endo -82.53 154.3 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.32 2.68 . . . . 0.0 112.048 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 74' ' ' TRP . 20.8 tptm -127.21 -40.62 1.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -150.45 139.68 21.24 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.306 -0.246 . . . . 0.0 111.166 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HD3' HG21 ' A' ' 19' ' ' THR . 71.2 mttt -59.96 139.33 57.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 111.714 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.786 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 2.9 t -71.34 133.37 31.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.114 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.5 ' HB2' ' NH1' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -109.78 126.85 54.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.918 175.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.4 m -102.07 154.51 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.552 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.733 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -66.84 141.29 57.73 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.26 -22.61 53.13 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.7 -32.11 73.63 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.301 175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.3 m -92.1 41.58 1.08 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.602 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -138.69 -41.98 0.49 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.556 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -127.07 28.32 5.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.732 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.44 -148.8 10.69 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.343 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -67.08 -42.63 84.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -130.88 130.27 43.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.94 -44.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.458 -172.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 21.8 mmtp -70.95 -33.32 70.36 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.338 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.877 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.0 m-20 -68.89 140.92 55.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.467 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 10.4 t -48.54 131.53 17.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.016 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 ' HA3' ' A' ' 20' ' ' GLY . 24.1 pt -70.19 -32.88 52.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.429 -173.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 mt -72.64 -44.32 60.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.3 p -107.12 -3.81 19.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.984 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 41.47 45.02 2.66 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.415 0.686 . . . . 0.0 112.621 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.9 -60.61 0.26 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.211 0.529 . . . . 0.0 110.654 -174.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -82.32 138.54 34.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.488 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.877 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 46.8 t -61.32 137.27 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -77.59 -179.41 49.5 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 121.252 -0.499 . . . . 0.0 113.148 -177.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -174.12 -39.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.597 0.713 . . . . 0.0 109.31 -177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 22' ' ' LEU . 8.1 m120 -82.83 176.75 9.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.387 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -118.92 135.48 54.56 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB2' HD21 ' A' ' 22' ' ' LEU . . . -78.38 146.25 34.73 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -126.55 133.02 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.143 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.786 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 64.2 m-85 -69.33 120.8 15.71 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 169.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 7.0 p -70.03 162.1 28.81 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.468 -175.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.417 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 4.9 t-105 -43.4 -55.95 3.84 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 124.206 0.941 . . . . 0.0 112.1 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -61.81 -46.77 88.08 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.92 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.1 m -66.53 -40.86 89.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.079 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 t -67.51 -40.51 85.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.617 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 -62.97 -43.6 98.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.881 0.372 . . . . 0.0 110.505 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.71 -27.12 62.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.067 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.07 44.46 13.81 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.533 ' O ' HD12 ' A' ' 32' ' ' ILE . 29.3 mtpp -93.12 31.41 1.45 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.782 -0.209 . . . . 0.0 110.955 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.39 -1.32 8.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.005 0.431 . . . . 0.0 110.309 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.592 ' HD2' ' SD ' ' A' ' 10' ' ' MET . 94.0 mttt 58.73 30.48 20.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.393 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 23.0 t70 82.42 -36.34 0.09 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.621 174.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.722 ' HA2' ' HG3' ' A' ' 15' ' ' PRO . . . -165.48 -134.15 1.62 Allowed Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 118.448 -1.834 . . . . 0.0 115.468 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 13.3 t -50.63 103.09 0.35 Allowed Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 113.772 -1.214 . . . . 0.0 113.03 -169.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.483 ' HA ' ' SD ' ' A' ' 10' ' ' MET . 57.7 Cg_endo -91.28 44.61 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.563 2.842 . . . . 0.0 113.113 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 2.1 ptm180 -110.94 136.7 49.56 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 174.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 8' ' ' LEU . 42.9 mm -76.13 139.72 18.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.315 -175.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.759 HD21 ' HB2' ' A' ' 11' ' ' CYS . 1.6 pp -171.5 -37.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER 56.65 -149.95 0.45 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.395 169.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.1 tp -173.65 134.75 0.5 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.695 -172.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.24 -44.13 4.46 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.8 m -157.78 170.9 21.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.0 m120 70.46 63.48 0.2 Allowed 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.501 0.5 . . . . 0.0 111.061 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.501 HH22 HG21 ' A' ' 9' ' ' ILE . 18.2 tpp180 -66.35 135.14 53.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.331 177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 97' ' ' LEU . 3.0 pp -56.66 141.34 43.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -74.44 118.18 17.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.331 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 102' ' ' GLU . 65.9 mtp180 66.03 -77.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.758 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.427 ' HA ' HD13 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -165.84 -60.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -169.67 35.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.405 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.651 ' HG3' ' HG3' ' A' ' 103' ' ' LYS . 6.9 tp10 -76.54 140.18 41.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.359 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.651 ' HG3' ' HG3' ' A' ' 102' ' ' GLU . 66.0 mttm 61.3 45.82 8.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.988 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -172.22 -38.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.449 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 66.58 -149.85 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.997 -174.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.499 ' HD3' ' HB3' ' A' ' 14' ' ' GLN . 33.2 mtmm -115.0 51.75 0.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.131 0.491 . . . . 0.0 110.672 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.214 -0.898 . . . . 0.0 109.345 179.477 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.641 ' HA3' ' HZ ' ' A' ' 6' ' ' PHE . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.196 -0.362 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 109.56 23.41 6.28 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.066 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.0 m -158.42 137.09 11.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.6 m -136.1 121.21 18.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.161 0.505 . . . . 0.0 111.138 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -105.13 -17.82 14.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.658 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -148.73 -137.07 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -80.23 115.95 20.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.641 ' HZ ' ' HA3' ' A' ' -1' ' ' GLY . 47.6 t80 -83.16 29.14 0.49 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.637 -176.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 p30 38.62 53.57 1.88 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.702 0.801 . . . . 0.0 112.529 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.846 ' H ' HD22 ' A' ' 8' ' ' LEU . 1.2 mm? -63.97 -41.68 97.47 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.854 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 91' ' ' ASN . 1.5 mp 58.32 77.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 113.638 -1.619 . . . . 0.0 109.195 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.664 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -84.44 145.66 28.05 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.515 -1.675 . . . . 0.0 111.402 -171.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 30.9 t -50.53 -54.22 24.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.222 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.664 ' HG ' ' HB2' ' A' ' 10' ' ' MET . 81.1 mt 48.34 40.79 15.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.242 0.831 . . . . 0.0 113.242 173.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 50.9 mttm -79.97 -156.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -83.16 111.17 28.58 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 59.6 Cg_endo -80.98 138.33 11.43 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.006 1.804 . . . . 0.0 112.417 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.91 -139.42 9.65 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.047 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.9 p -89.46 -16.9 8.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 110.284 177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.729 ' HB2' HG12 ' A' ' 45' ' ' VAL . 3.7 mm100 -56.93 132.88 54.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.149 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.402 HG21 ' HD3' ' A' ' 42' ' ' LYS . 12.7 m -107.61 127.3 53.53 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.861 0.363 . . . . 0.0 111.212 -176.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.744 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -71.7 114.67 5.21 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.256 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 92.1 mt -87.07 154.03 21.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.688 0.28 . . . . 0.0 110.587 178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 76.8 mt -113.74 130.21 56.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p -75.2 157.03 35.18 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 51.2 mt-10 -54.9 -28.39 50.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.964 0.412 . . . . 0.0 111.69 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.7 mtpt -72.43 -27.97 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.165 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.0 m -115.8 31.79 6.49 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.593 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 46.9 t0 -73.76 133.91 43.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.343 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.85 32.29 66.68 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.217 -0.901 . . . . 0.0 113.035 174.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 22.9 mtpp -119.46 122.04 40.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 25.3 t -63.29 118.66 45.72 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.48 -37.3 97.71 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.756 2.304 . . . . 0.0 112.783 -175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.762 HG21 ' HG3' ' A' ' 81' ' ' LYS . 10.8 mm -64.08 -46.48 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.36 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 22.5 p -123.78 -8.47 7.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.3 t0 60.91 76.47 0.37 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.812 0.815 . . . . 0.0 110.428 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -151.36 143.25 23.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.477 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 29' ' ' LYS . 5.9 m-85 -96.5 23.98 6.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 110.299 -178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 73' ' ' CYS . 9.9 p -76.35 161.8 4.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.201 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.599 ' HD2' ' HD2' ' A' ' 39' ' ' PRO . 23.2 tpt180 -47.25 120.24 6.71 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.443 0.697 . . . . 0.0 112.559 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 86.2 Cg_endo -82.56 161.14 16.89 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.415 2.743 . . . . 0.0 111.815 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HG3' ' CE3' ' A' ' 74' ' ' TRP . 3.3 mmmp? -130.32 -59.25 1.04 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -116.41 136.94 52.56 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.839 -172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.402 ' HD3' HG21 ' A' ' 19' ' ' THR . 38.9 ttmt -67.73 136.74 54.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.742 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.636 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 17.9 m -79.98 151.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.917 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 mtm-85 -124.45 127.55 47.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.159 173.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.729 HG12 ' HB2' ' A' ' 18' ' ' GLN . 0.3 OUTLIER -92.54 153.59 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.608 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.8 p -72.83 148.32 44.6 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 86.5 tt0 -56.56 -27.44 57.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.035 0.445 . . . . 0.0 111.068 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.56 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 7.5 m-80 -63.84 -26.69 68.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.112 177.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HB3' ' NE ' ' A' ' 88' ' ' ARG . 87.6 m -102.68 33.1 3.32 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.22 -0.3 . . . . 0.0 111.679 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.488 ' OG ' ' HG3' ' A' ' 18' ' ' GLN . 12.0 p -160.9 -50.85 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.573 -173.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 49.71 -82.73 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.137 0.975 . . . . 0.0 111.847 -175.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.66 76.07 1.76 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.191 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 18' ' ' GLN . 67.6 mttm 67.51 -74.97 0.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.676 0.79 . . . . 0.0 112.246 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -155.34 28.22 0.4 Allowed 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 44.24 27.47 0.22 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.939 171.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER 41.02 44.81 2.12 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.672 0.789 . . . . 0.0 111.65 -176.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.23 141.17 39.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.376 1.084 . . . . 0.0 113.353 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 3.0 t -69.93 135.12 49.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.442 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.744 HD13 ' HA3' ' A' ' 20' ' ' GLY . 3.7 pt -71.92 -31.87 42.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -70.28 -51.41 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 64' ' ' ASN . 21.7 p -91.38 -7.4 50.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.685 176.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 6.7 p-10 47.25 40.2 9.9 Favored 'General case' 0 CA--C 1.509 -0.598 0 O-C-N 124.436 1.085 . . . . 0.0 111.57 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.528 HD22 ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -157.41 -60.63 0.09 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.525 -177.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.581 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 5.7 m120 -60.21 144.58 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 34.5 t -61.56 119.37 5.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.072 0.463 . . . . 0.0 111.075 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.22 142.78 26.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.464 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -123.87 -45.22 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -108.2 127.86 54.2 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.87 -178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.56 136.83 56.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.82 0.448 . . . . 0.0 110.961 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -76.93 146.28 37.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.774 177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 6.9 m-85 -127.52 134.55 49.77 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.182 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.487 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 95.2 m-85 -62.98 124.92 22.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.7 p -69.14 161.17 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.856 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.499 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -46.84 -50.29 18.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.067 -177.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.28 -45.65 87.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.697 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 92.3 m -64.82 -33.25 75.54 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.307 -0.246 . . . . 0.0 111.013 174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 32.0 t -67.59 -40.6 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -61.74 -44.64 96.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.895 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.14 -32.59 72.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.731 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 83' ' ' LYS . . . 89.51 46.93 4.18 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.953 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.762 ' HG3' HG21 ' A' ' 32' ' ' ILE . 27.4 mmmt -73.57 -14.96 61.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.227 0.537 . . . . 0.0 110.742 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -64.53 -32.13 73.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.171 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -73.21 -21.63 60.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.837 -177.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.437 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.3 m-20 -58.1 -55.4 35.4 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.891 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.58 -137.01 7.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.866 -1.159 . . . . 0.0 114.132 171.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.628 ' SG ' HG22 ' A' ' 45' ' ' VAL . 50.2 t -64.29 113.28 9.88 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.979 0.912 . . . . 0.0 111.835 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.636 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 83.0 Cg_endo -82.58 31.55 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.956 2.437 . . . . 0.0 114.381 -176.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.483 ' NE ' ' HB3' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -78.22 139.58 38.93 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.84 HD12 ' HB3' ' A' ' 8' ' ' LEU . 33.5 mm -92.83 132.09 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 O-C-N 123.16 0.288 . . . . 0.0 110.763 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 11' ' ' CYS . 1.2 pt? -165.6 54.69 0.11 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.746 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 9.7 p30 -72.07 -29.98 64.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 171.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' HG ' ' H ' ' A' ' 94' ' ' SER . 64.8 tp -160.78 -58.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.571 174.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.13 22.32 49.21 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.258 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.552 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 t 54.89 40.28 31.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.985 0.514 . . . . 0.0 110.455 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -160.05 -57.97 0.06 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -71.87 127.11 31.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.081 -176.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.9 mt 51.14 37.0 17.03 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.547 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -76.91 -41.68 42.61 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 98' ' ' ASP . 45.5 ttt-85 167.31 -37.42 0.0 OUTLIER 'General case' 0 C--O 1.231 0.086 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.843 175.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -63.55 136.93 57.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.583 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.832 ' HB2' ' HA ' ' A' ' 106' ' ' LYS . 40.9 p90 -150.35 122.27 8.18 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 171.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -142.37 -42.23 0.33 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.174 -166.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.683 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 55.4 mtpt -75.32 91.5 2.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.471 -173.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 70.67 -54.2 0.65 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.064 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -138.9 -130.94 0.12 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.776 0.322 . . . . 0.0 110.625 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.832 ' HA ' ' HB2' ' A' ' 101' ' ' PHE . 12.4 mmmm -80.7 54.27 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.094 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' A' ' 103' ' ' LYS . 36.9 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.042 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 111.851 -0.499 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 161.41 -32.32 0.35 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t -163.63 139.96 6.82 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 71.25 142.69 0.06 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.789 0.68 . . . . 0.0 111.785 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 3' ' ' ARG . 6.6 ptp180 -66.27 141.6 57.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.665 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -66.21 -49.31 67.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.442 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -78.59 128.22 33.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.6 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -79.67 -110.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -87.28 17.89 4.1 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.401 0.619 . . . . 0.0 110.153 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mt -86.01 55.37 3.5 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.694 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.8 mp -62.37 87.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.67 -173.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.711 ' CG ' HD13 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -66.26 136.0 55.23 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.041 -171.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.48 ' CB ' HD21 ' A' ' 90' ' ' LEU . 1.6 t -37.76 -59.88 0.77 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.673 -172.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD13 ' CG ' ' A' ' 10' ' ' MET . 0.3 OUTLIER 45.77 43.47 9.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 176.42 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 67.8 mttm -91.74 -147.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.649 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -95.64 111.29 55.13 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.025 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 71.7 Cg_exo -54.67 134.79 64.28 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.233 2.622 . . . . 0.0 113.296 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.45 -142.12 12.56 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.863 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -96.94 -35.93 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.473 ' HB2' ' CB ' ' A' ' 50' ' ' SER . 75.4 mt-30 -76.35 138.51 40.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.472 0.653 . . . . 0.0 112.111 -173.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.492 HG21 ' HD3' ' A' ' 42' ' ' LYS . 30.1 m -84.44 131.17 34.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.536 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.36 137.52 35.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 86.2 mt -106.31 161.69 14.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.891 0.376 . . . . 0.0 111.658 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.714 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 81.7 mt -123.24 131.2 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 176.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 25' ' ' LYS . 11.5 p -73.36 161.01 30.95 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.719 ' HG3' HG21 ' A' ' 67' ' ' VAL . 70.6 mt-10 -62.07 -18.16 59.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.203 0.525 . . . . 0.0 111.347 -177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 56.4 mttm -78.24 -36.68 46.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.609 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 3.9 m -106.42 32.48 4.45 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.584 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 44.2 t0 -70.93 129.66 39.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.596 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.71 28.28 61.42 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.104 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 26' ' ' CYS . 40.0 mtmt -115.91 126.64 54.17 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.658 -0.319 . . . . 0.0 110.375 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.1 t -62.27 117.89 34.65 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.593 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 78.4 Cg_exo -55.61 -37.67 94.98 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.987 2.458 . . . . 0.0 113.136 -174.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.603 HG21 ' HB3' ' A' ' 81' ' ' LYS . 7.3 mm -63.21 -49.48 82.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.1 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.9 p -116.27 -8.44 11.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -170.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.6 t0 63.28 68.65 0.6 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.056 0.455 . . . . 0.0 109.962 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -153.42 142.98 21.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.459 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -87.45 2.44 50.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.318 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.6 p -60.67 152.53 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.659 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -31.08 131.86 0.25 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.434 1.094 . . . . 0.0 113.463 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 88.0 Cg_endo -76.81 -160.84 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.509 . . . . 0.0 112.431 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.566 ' HG2' ' SG ' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -169.75 -50.46 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.261 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -157.35 144.24 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.718 -174.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HD3' HG21 ' A' ' 19' ' ' THR . 94.0 mttt -61.59 141.73 57.58 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.039 0.447 . . . . 0.0 111.5 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.938 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 25.6 m -77.82 137.78 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.281 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -106.52 119.87 40.44 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.52 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG22 ' SG ' ' A' ' 86' ' ' CYS . 0.3 OUTLIER -80.67 146.39 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.525 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.748 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 7.1 p -68.38 160.45 29.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.001 -177.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' CYS . 36.9 tt0 -60.47 -29.63 69.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.056 178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.551 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 9.0 m120 -77.68 35.94 0.2 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.201 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.748 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 58.0 m -157.02 -38.28 0.07 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.339 174.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.473 ' CB ' ' HB2' ' A' ' 18' ' ' GLN . 76.3 p -92.31 34.41 1.04 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.933 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -32.44 58.7 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.453 -178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.25 -71.22 0.27 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.544 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.653 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 1.4 tpmt? -74.17 123.97 25.46 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 66.13 51.62 1.26 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.588 0.709 . . . . 0.0 110.544 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -106.37 -32.47 8.13 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.336 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -95.41 14.2 23.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.62 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -73.0 148.68 43.96 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.572 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.7 t -59.47 116.81 4.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.968 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' A' ' 43' ' ' VAL . 2.0 pt -57.59 -30.44 36.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.046 -172.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.35 -44.1 63.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.7 p -101.04 -12.97 18.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.346 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 56.38 17.72 3.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.45 1.1 . . . . 0.0 111.723 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 -61.42 0.85 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 -172.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -71.79 142.25 49.68 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.56 133.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.97 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -73.62 139.22 26.14 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.714 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.719 HG21 ' HG3' ' A' ' 24' ' ' GLU . 45.3 t -109.94 -57.76 3.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.258 0.552 . . . . 0.0 111.07 -177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.14 136.81 43.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.303 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.439 ' HA ' HD23 ' A' ' 21' ' ' LEU . 2.1 m-20 -64.08 128.87 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.714 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -74.26 144.27 44.69 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.973 0.416 . . . . 0.0 111.753 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -115.87 135.33 54.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.371 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.753 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 86.9 m-85 -64.98 132.62 49.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 170.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 3.5 p -74.65 154.83 38.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.536 ' HA ' ' SG ' ' A' ' 77' ' ' CYS . 56.5 t90 -53.2 -41.41 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.442 0.464 . . . . 0.0 111.659 -176.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 50.0 mt-10 -59.62 -42.99 93.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.976 0.417 . . . . 0.0 110.542 -176.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 59.4 m -67.67 -39.76 84.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.852 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.566 ' SG ' ' HG2' ' A' ' 40' ' ' LYS . 21.5 p -72.63 -34.2 67.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -63.38 -45.17 92.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.439 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 83.7 mt -73.93 -39.46 63.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.606 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.47 28.54 3.22 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.749 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.637 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 4.5 mttp -82.98 -25.24 32.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.138 0.494 . . . . 0.0 110.431 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.35 -32.33 73.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.272 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -94.84 8.39 42.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.212 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.637 ' OD2' ' HA ' ' A' ' 81' ' ' LYS . 2.6 m-20 -71.06 -48.15 54.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.99 -143.7 9.71 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.916 173.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.748 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 52.6 t -68.93 123.65 88.55 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 123.842 0.857 . . . . 0.0 111.42 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.938 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 69.3 Cg_endo -89.28 25.26 0.61 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.656 2.238 . . . . 0.0 114.945 -173.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.748 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 50.4 mtt180 -80.18 141.4 35.71 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.006 -0.433 . . . . 0.0 111.231 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.8 mm -99.07 104.6 16.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.066 173.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.48 HD21 ' CB ' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -134.35 -6.53 2.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.232 -176.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.649 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 66.07 -130.89 0.21 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -174.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.575 ' O ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -148.25 139.73 23.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.0 0.428 . . . . 0.0 111.086 178.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.17 46.12 3.49 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.762 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.3 m 59.9 41.79 17.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.031 0.532 . . . . 0.0 111.4 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.717 ' O ' ' HG3' ' A' ' 96' ' ' ARG . 17.6 p-10 -166.2 -52.8 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.108 176.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.717 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 6.3 ppt_? 58.25 -39.75 0.06 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.649 1.58 . . . . 0.0 114.56 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.21 130.78 44.19 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.967 -0.458 . . . . 0.0 110.633 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.86 37.91 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.67 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.476 ' C ' ' H ' ' A' ' 101' ' ' PHE . 99.6 mtt180 -81.85 57.21 3.35 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 174.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -72.68 31.09 0.06 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.92 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 99' ' ' ARG . 15.8 m-85 -96.45 52.08 1.22 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 172.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.67 -46.37 88.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.945 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -79.33 125.6 29.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.301 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 mttp 56.6 47.74 17.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.373 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt 59.24 -175.99 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG3' ' HB2' ' A' ' 101' ' ' PHE . 3.6 mppt? -83.04 133.76 35.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.977 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.522 -178.171 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 63.91 -116.69 9.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.929 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.3 t -156.65 -146.09 0.16 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -153.97 158.8 41.18 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -63.58 104.07 0.61 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.801 0.81 . . . . 0.0 110.833 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.0 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.404 -176.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -63.86 160.45 17.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.891 168.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.622 ' HB2' ' CD1' ' A' ' 8' ' ' LEU . 33.5 m-85 -71.86 -134.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -132.23 38.55 3.48 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.678 -0.639 . . . . 0.0 111.939 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.747 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -91.35 55.92 2.94 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.201 0.524 . . . . 0.0 110.637 174.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.7 mp -77.97 79.94 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 1.004 ' HG3' HD13 ' A' ' 12' ' ' LEU . 2.2 ptm -109.39 169.74 8.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.547 -167.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.606 ' HA ' HD11 ' A' ' 90' ' ' LEU . 9.1 t -54.14 -53.91 46.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.179 -174.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.004 HD13 ' HG3' ' A' ' 10' ' ' MET . 0.9 OUTLIER 40.23 49.41 2.46 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 174.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 59.7 mttm -91.63 -149.56 0.24 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 170.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -100.3 122.57 49.62 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.336 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 70.1 Cg_exo -53.93 132.89 52.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.244 2.629 . . . . 0.0 112.535 -178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.87 -63.6 1.81 Allowed Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.337 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 p -176.53 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HG3' ' CG2' ' A' ' 45' ' ' VAL . 9.3 pt20 -71.25 145.65 49.46 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.778 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.657 HG21 ' HD3' ' A' ' 42' ' ' LYS . 28.4 m -78.97 139.07 38.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.778 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.65 129.4 13.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.356 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 95.0 mt -100.14 142.78 31.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.274 0.559 . . . . 0.0 111.717 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -107.5 134.98 49.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.012 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 4.2 p -72.47 150.99 42.8 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 69.4 mt-10 -50.22 -30.63 11.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.17 0.51 . . . . 0.0 111.63 -175.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 52.4 mttm -69.82 -22.39 63.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.485 -178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.1 m -116.07 0.91 13.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.159 0.504 . . . . 0.0 109.735 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 31.9 t0 -56.16 136.45 52.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.816 -172.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.18 -28.59 10.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.91 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 36.2 mtmt -74.18 128.11 34.7 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.126 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 73' ' ' CYS . 1.8 t -66.42 115.54 25.04 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -55.45 -28.96 66.61 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 123.074 2.516 . . . . 0.0 113.159 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.48 HD11 ' HE1' ' A' ' 72' ' ' TYR . 7.2 mm -64.46 -42.29 94.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.881 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 35' ' ' SER . 31.5 p -128.72 -11.84 4.89 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -170.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 65.59 58.28 0.82 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.38 0.61 . . . . 0.0 110.645 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.503 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 41.8 t -153.96 141.37 19.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.585 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 3.4 m-85 -91.31 34.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.188 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 37' ' ' VAL . 7.4 p -81.7 76.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 122.178 0.989 . . . . 0.0 111.547 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.445 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 63.5 mtp85 59.73 91.43 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.62 176.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 38' ' ' ARG . 39.9 Cg_endo -62.42 145.24 95.72 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.365 2.043 . . . . 0.0 111.366 174.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -132.56 -51.1 0.92 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.46 140.82 48.56 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.744 -172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.657 ' HD3' HG21 ' A' ' 19' ' ' THR . 72.2 mttt -66.36 136.1 55.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.448 0.642 . . . . 0.0 111.85 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.941 HG11 ' HG3' ' A' ' 87' ' ' PRO . 58.2 t -85.86 133.04 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.851 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -109.29 128.02 54.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' CG2' ' HG3' ' A' ' 18' ' ' GLN . 25.0 m -77.13 155.4 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.334 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.781 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 2.1 p -66.49 164.06 17.23 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.426 0.632 . . . . 0.0 111.744 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HG2' ' CE2' ' A' ' 51' ' ' PHE . 67.8 tt0 -55.05 -50.8 68.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.102 -177.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 2.5 m-80 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.487 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.624 ' SG ' ' HD2' ' A' ' 88' ' ' ARG . 96.0 m -70.84 -24.12 62.47 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -78.68 -38.76 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.142 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.541 ' CE2' ' HG2' ' A' ' 47' ' ' GLU . 1.7 p90 -96.63 -26.01 15.37 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -82.76 52.76 4.76 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.782 -174.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 61.5 pttt 52.29 178.23 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.377 1.071 . . . . 0.0 112.533 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 2.5 pt20 42.74 35.19 0.66 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.074 0.95 . . . . 0.0 112.515 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.79 79.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.109 0.48 . . . . 0.0 111.085 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -66.58 -15.53 63.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.441 -178.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 1.9 m120 -61.22 136.84 58.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.308 0.575 . . . . 0.0 111.28 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 29.8 t -55.16 125.9 22.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.126 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.878 HD12 ' HG2' ' A' ' 87' ' ' PRO . 3.5 pt -66.88 -34.39 69.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.672 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.9 mt -71.63 -37.59 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.78 ' O ' HD12 ' A' ' 63' ' ' LEU . 27.3 p -113.45 -0.35 14.48 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.421 -0.799 . . . . 0.0 110.482 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 0.0 OUTLIER 36.56 59.58 0.98 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.432 1.493 . . . . 0.0 114.829 179.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.006 HD13 ' H ' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -166.88 -59.37 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.056 171.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 1.006 ' H ' HD13 ' A' ' 63' ' ' LEU . 72.2 m-80 -61.19 142.55 56.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 12.9 t -75.52 132.45 33.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.881 0.372 . . . . 0.0 110.857 -177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.15 148.36 31.29 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.158 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.45 -41.85 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -113.25 131.91 55.73 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 120.674 0.273 . . . . 0.0 110.956 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.22 138.18 56.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.415 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.495 ' HB2' HD11 ' A' ' 59' ' ' ILE . . . -71.19 144.57 50.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.708 175.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.89 133.05 52.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.697 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.48 ' HE1' HD11 ' A' ' 32' ' ' ILE . 97.6 m-85 -65.45 126.72 29.16 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 170.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 3.9 p -74.65 165.21 25.6 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.272 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -47.95 -59.56 3.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.537 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 54.2 mt-10 -58.17 -43.1 87.28 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.216 -171.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.5 m -66.14 -32.51 73.99 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.055 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.7 m -68.7 -36.98 79.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.17 0.51 . . . . 0.0 109.981 174.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.81 -45.1 79.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.218 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 94.2 mt -63.0 -33.79 76.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.784 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.08 31.24 9.3 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.041 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -95.56 26.95 3.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.286 0.565 . . . . 0.0 109.971 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -78.43 -15.96 58.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.695 173.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -4.32 38.85 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.325 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.719 ' HB3' HD11 ' A' ' 12' ' ' LEU . 83.5 m-20 -81.95 77.35 8.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 172.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.501 ' O ' ' HD3' ' A' ' 87' ' ' PRO . . . -55.91 -86.4 0.02 OUTLIER Glycine 0 C--O 1.227 -0.282 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.374 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.781 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 10.8 t -78.37 108.67 8.25 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.715 0.293 . . . . 0.0 110.571 -174.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.941 ' HG3' HG11 ' A' ' 43' ' ' VAL . 43.0 Cg_endo -93.5 36.74 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.523 2.149 . . . . 0.0 113.785 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.624 ' HD2' ' SG ' ' A' ' 49' ' ' CYS . 33.3 mtt180 -75.63 114.51 14.3 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.083 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 50.5 mm -75.43 87.56 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 11' ' ' CYS . 16.0 mt -66.88 -43.42 83.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.903 -176.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -69.1 128.37 36.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.421 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 71.08 -43.47 0.56 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.133 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.34 -126.72 22.89 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' A' ' 61' ' ' CYS . 48.4 t -108.0 18.86 20.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.13 0.491 . . . . 0.0 109.955 173.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -83.43 50.97 1.88 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.625 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.481 ' HB2' ' H ' ' A' ' 97' ' ' LEU . 3.2 ppt_? -163.32 -140.96 0.05 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.638 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.534 ' O ' HD12 ' A' ' 97' ' ' LEU . 4.3 pp -59.04 140.49 55.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.105 0.479 . . . . 0.0 110.935 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -126.14 28.76 5.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.581 0.705 . . . . 0.0 109.334 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.7 mmt-85 -148.13 142.71 26.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.736 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -80.95 114.81 20.08 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 174.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 106' ' ' LYS . 9.2 p90 -66.71 126.38 28.81 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.081 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -170.57 -52.35 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.267 -172.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -70.08 -59.05 3.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.01 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -177.84 128.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.511 ' HB3' HG22 ' A' ' 107' ' ' VAL . 65.4 mttm 70.35 143.85 0.05 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.871 0.732 . . . . 0.0 111.617 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.724 ' HA ' ' HB3' ' A' ' 101' ' ' PHE . 48.0 mtmt -87.17 44.61 1.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.605 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 105' ' ' LYS . 19.6 m . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.66 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 112.166 -0.374 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -160.84 48.65 0.38 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 m -67.46 -39.01 85.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.692 -0.254 . . . . 0.0 110.972 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m 57.39 45.9 19.15 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.74 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 84.8 mtm-85 -66.47 138.54 57.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.351 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -76.55 -135.93 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 171.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -76.81 77.39 3.42 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.908 -0.495 . . . . 0.0 110.002 174.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 22.0 m-85 -120.21 27.39 8.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.557 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -86.48 58.68 5.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 164.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 91' ' ' ASN . 3.7 mt -65.69 -133.12 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.975 -173.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.754 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.9 mp 61.24 49.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 123.499 1.618 . . . . 0.0 107.466 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.722 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 8.1 ptm -72.53 148.32 45.11 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 112.855 -1.975 . . . . 0.0 110.19 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HA ' HD11 ' A' ' 90' ' ' LEU . 15.3 t -48.35 -59.82 3.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.912 -169.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.722 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 81.5 mt 48.58 35.65 6.41 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -81.73 -171.34 3.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -72.07 117.39 57.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 1.0 OUTLIER -83.45 138.87 8.79 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.05 2.5 . . . . 0.0 112.773 -178.41 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.3 -138.79 9.02 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.477 174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -95.53 -14.54 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.541 0.686 . . . . 0.0 109.749 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.601 ' HB2' HG12 ' A' ' 45' ' ' VAL . 6.2 mm100 -59.49 136.98 58.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.137 -178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -105.42 136.66 44.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.423 -178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.682 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -77.77 133.69 13.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.714 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 85.7 mt -90.58 145.76 24.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 53.7 mt -109.09 134.92 51.06 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.097 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 7.5 p -71.61 151.98 43.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 172.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HG2' HG11 ' A' ' 67' ' ' VAL . 37.8 mt-10 -48.73 -32.91 9.25 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.958 0.409 . . . . 0.0 111.789 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -71.81 -27.65 63.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.2 m -102.75 1.38 34.24 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.953 -0.467 . . . . 0.0 110.162 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -59.46 112.63 1.84 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.71 -26.8 7.85 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.851 -178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -73.45 130.59 40.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.765 0.317 . . . . 0.0 111.329 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.22 122.14 86.72 Favored Pre-proline 0 C--N 1.319 -0.717 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 168.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HG3' HG11 ' A' ' 43' ' ' VAL . 6.1 Cg_endo -53.15 -35.5 73.39 Favored 'Trans proline' 0 N--CA 1.473 0.279 0 C-N-CA 123.663 2.909 . . . . 0.0 113.872 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.666 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 14.1 mm -69.5 -44.17 80.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.2 p -112.08 -20.88 11.78 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.8 t70 68.49 72.82 0.29 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.554 0.693 . . . . 0.0 110.337 -177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -163.31 145.81 10.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.756 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -82.16 40.18 0.62 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.174 0.511 . . . . 0.0 110.318 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.532 HG13 ' CB ' ' A' ' 73' ' ' CYS . 8.4 p -87.02 153.44 3.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.078 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -39.79 110.56 0.65 Allowed Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -171.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 91.0 Cg_endo -79.6 151.61 22.4 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 123.286 2.658 . . . . 0.0 111.85 175.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -140.97 -58.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.694 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -90.15 131.28 36.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.266 -0.174 . . . . 0.0 111.192 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -70.65 136.29 48.99 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.766 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 32.8 m -71.03 139.73 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.449 0.642 . . . . 0.0 111.728 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -112.74 114.84 27.6 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.76 175.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -83.94 148.88 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.788 ' SG ' ' HB2' ' A' ' 48' ' ' ASN . 3.5 p -68.96 145.89 53.22 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -56.45 -27.99 58.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.292 0.567 . . . . 0.0 110.349 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.788 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 52.9 m-80 -60.37 -32.34 71.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.655 176.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.481 ' HB2' HG22 ' A' ' 45' ' ' VAL . 99.1 m -94.54 36.44 1.16 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.626 0.25 . . . . 0.0 111.117 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.8 t -139.86 -52.25 0.51 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 1.1 p90 -69.21 137.77 53.48 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.624 179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 131.77 -134.59 7.73 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.156 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -157.32 27.0 0.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -148.8 33.54 0.76 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.394 0.616 . . . . 0.0 110.402 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.96 0.06 45.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.49 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -22.39 54.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 1.003 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 76.0 m-20 -61.15 152.88 27.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.888 0.851 . . . . 0.0 111.59 -176.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 44.2 t -59.42 131.07 49.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.307 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.682 HD13 ' HA3' ' A' ' 20' ' ' GLY . 11.9 pt -73.62 -32.44 35.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.975 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.3 mt -72.01 -48.66 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 63' ' ' LEU . 29.5 p -102.13 -9.3 20.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.688 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.85 -28.25 0.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.581 0.752 . . . . 0.0 112.56 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -75.74 -60.14 2.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -170.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -91.91 150.77 20.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.179 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.003 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 16.7 t -63.37 136.14 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.386 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 23' ' ' CYS . . . -82.19 -167.21 39.45 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.463 HG11 ' HG2' ' A' ' 24' ' ' GLU . 7.4 p -162.06 -50.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.822 0.344 . . . . 0.0 111.314 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.449 ' N ' HG13 ' A' ' 67' ' ' VAL . 79.2 m-20 -105.26 138.75 40.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.928 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -67.53 134.76 51.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.017 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -77.72 153.97 32.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.151 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -132.94 135.66 45.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.982 174.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.71 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 43.9 m-85 -71.62 133.58 45.8 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.689 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 6.1 p -70.76 158.24 36.64 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.494 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -55.13 -41.06 71.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.907 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' OE2' HG21 ' A' ' 37' ' ' VAL . 48.4 mt-10 -58.42 -51.75 68.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.666 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 97.0 m -65.54 -38.0 88.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.054 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' ' HE3' ' A' ' 74' ' ' TRP . 36.9 t -66.25 -41.41 90.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.559 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -67.77 -46.84 70.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' HE2' ' A' ' 81' ' ' LYS . 8.6 mp -64.14 -30.97 72.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.24 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 83' ' ' LYS . . . 96.76 45.08 2.75 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.992 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HE2' HD23 ' A' ' 79' ' ' LEU . 67.6 mttm -103.2 -24.5 13.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.218 0.533 . . . . 0.0 110.072 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -69.59 -25.18 63.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.884 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 15.9 pttp -63.33 -27.98 69.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.294 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB3' HD13 ' A' ' 12' ' ' LEU . 76.6 m-20 -52.28 -48.12 65.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.033 -173.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 146.06 -139.65 8.3 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.851 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.7 t -55.35 117.65 15.58 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.401 -177.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.766 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 88.9 Cg_endo -82.23 22.02 0.91 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.932 2.421 . . . . 0.0 113.307 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.536 ' HB2' ' SG ' ' A' ' 86' ' ' CYS . 2.0 mmt180 -77.54 122.31 25.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.322 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 10' ' ' MET . 12.7 mm -78.98 131.37 34.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 172.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -163.97 45.32 0.11 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.883 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.754 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 21.5 t-20 -38.88 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.533 -175.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 91' ' ' ASN . 21.6 tp 162.51 120.82 0.0 OUTLIER 'General case' 0 C--O 1.234 0.279 0 O-C-N 124.471 1.107 . . . . 0.0 108.934 175.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.03 -49.91 73.42 Favored Glycine 0 CA--C 1.515 0.079 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.45 -176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -158.85 127.02 5.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.14 106.6 10.14 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.964 ' HG2' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -77.61 172.49 13.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.105 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.964 ' HG ' ' HG2' ' A' ' 96' ' ' ARG . 76.9 mt 63.39 38.39 10.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.198 0.523 . . . . 0.0 110.719 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -93.38 148.57 21.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.042 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -79.43 65.59 4.64 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.531 0.681 . . . . 0.0 110.704 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' PHE . 74.3 t60 -147.1 -57.52 0.26 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.085 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 100' ' ' HIS . 8.4 m-85 69.86 138.01 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 O-C-N 124.274 0.984 . . . . 0.0 110.681 -174.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -151.55 38.28 0.61 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.304 1.05 . . . . 0.0 108.862 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -103.15 -142.81 0.36 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.842 176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -94.01 35.08 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.714 0.768 . . . . 0.0 109.05 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -173.43 122.95 0.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.124 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -167.07 39.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.429 0.633 . . . . 0.0 110.185 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.293 179.021 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 76.48 -128.15 9.11 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.117 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.4 p 51.43 46.3 26.7 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.436 0.694 . . . . 0.0 111.28 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.81 136.09 52.2 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.955 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' A' ' 4' ' ' HIS . 11.6 ptm180 -174.29 159.75 3.17 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -177.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.429 ' O ' HD11 ' A' ' 8' ' ' LEU . 84.1 m-70 72.58 152.86 0.13 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.056 0.848 . . . . 0.0 110.341 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -158.99 35.63 0.21 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.223 0.535 . . . . 0.0 110.254 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 45.4 m-85 -59.58 -54.4 46.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.635 0.731 . . . . 0.0 109.656 177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 27.1 t0 167.21 68.52 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.864 ' HB2' HG23 ' A' ' 89' ' ' ILE . 38.3 mt -70.49 64.86 0.29 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.018 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.739 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.3 mp 26.54 78.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 112.263 -2.244 . . . . 0.0 112.53 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.782 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 11.3 ptp -68.89 144.15 54.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.807 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' SG ' ' HG3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -54.71 -42.13 71.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.646 -173.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 93.0 mt 48.99 45.7 22.64 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 172.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.59 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 34.6 mttm -88.65 -155.56 0.34 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.035 172.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 52.1 mm-40 -77.75 114.6 42.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 0.0 110.856 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 8.9 Cg_exo -71.53 142.48 40.49 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.136 2.557 . . . . 0.0 112.741 -177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.73 -139.72 6.4 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.508 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -101.57 -25.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.802 0.335 . . . . 0.0 110.438 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -61.19 128.87 38.51 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.683 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 m -76.22 140.35 41.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.39 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -68.21 114.33 5.98 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.256 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 84.3 mt -77.5 149.49 34.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.707 HD21 ' HB2' ' A' ' 70' ' ' ALA . 64.7 mt -122.42 138.41 54.55 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.644 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.608 ' HA ' HG12 ' A' ' 67' ' ' VAL . 7.8 p -76.25 142.68 41.33 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HG3' HG11 ' A' ' 67' ' ' VAL . 48.6 mt-10 -47.62 -28.25 2.26 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -173.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 76.7 mttt -65.54 -39.33 91.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.05 -14.59 27.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 122.113 -0.367 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -52.91 120.4 5.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.278 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.19 -34.1 3.47 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.966 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HB2' HD13 ' A' ' 60' ' ' ILE . 20.8 mtpp -72.92 131.18 41.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.934 -0.133 . . . . 0.0 110.711 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 44.5 t -71.94 117.53 58.81 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 11.3 Cg_endo -58.69 -31.45 94.87 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.858 2.372 . . . . 0.0 112.74 -173.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.595 HD13 ' SD ' ' A' ' 10' ' ' MET . 1.6 mm -72.15 -43.13 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.322 -176.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.6 -8.24 7.4 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -168.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.21 73.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.113 0.482 . . . . 0.0 110.797 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -165.94 139.73 4.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -89.3 33.56 0.81 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.029 0.442 . . . . 0.0 110.866 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.9 p -76.38 152.88 5.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.796 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 12.7 ptp180 -44.05 126.7 4.39 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 5.8 Cg_exo -77.54 -167.14 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.457 2.771 . . . . 0.0 111.698 178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -170.98 -49.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.167 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -116.9 139.18 50.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -71.23 133.64 46.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.315 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.977 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 29.2 m -72.32 143.79 13.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.704 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 57.7 mtm-85 -128.63 126.74 40.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -81.46 146.02 7.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.706 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.736 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 1.3 p -70.94 146.18 49.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 56.6 mt-10 -54.98 -37.25 66.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.432 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.638 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 4.5 m120 -51.38 -39.52 57.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 88.3 m -81.55 -36.36 29.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.583 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.583 ' OG ' ' HA ' ' A' ' 47' ' ' GLU . 28.8 p -72.87 -48.79 34.48 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.53 -173.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 0.6 OUTLIER -74.04 -17.13 61.01 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.089 0.471 . . . . 0.0 110.432 178.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.73 -114.63 0.4 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.421 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -147.6 153.91 40.01 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 54' ' ' GLN . 18.0 mt-30 65.36 55.44 1.07 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 123.912 0.758 . . . . 0.0 111.358 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 49' ' ' CYS . . . -128.88 -28.57 2.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.769 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 56' ' ' LYS . 8.9 mptt -74.75 -14.48 60.72 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.625 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 60.9 m-20 -77.09 149.77 35.7 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.816 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 4.5 t -53.42 123.02 10.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.602 175.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.453 HD11 ' CB ' ' A' ' 70' ' ' ALA . 13.2 pt -62.44 -29.86 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.548 HD13 ' HB2' ' A' ' 29' ' ' LYS . 47.1 mt -73.45 -44.9 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.4 p -100.31 -11.38 20.36 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.311 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 44.46 44.92 7.35 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.155 0.982 . . . . 0.0 110.941 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -152.67 -61.36 0.15 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.375 -172.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -73.06 140.14 47.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 6.0 p -66.64 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.108 0.48 . . . . 0.0 111.243 -175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -70.77 159.21 53.77 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.054 -176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 23' ' ' CYS . 2.0 p -157.55 -48.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.289 0.566 . . . . 0.0 110.226 -178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' H ' HG13 ' A' ' 67' ' ' VAL . 3.1 m120 -92.33 -176.25 4.28 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.357 174.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -124.49 142.89 50.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.57 0.224 . . . . 0.0 110.685 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.749 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -87.88 154.68 20.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.104 0.478 . . . . 0.0 111.13 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.408 ' CB ' ' HB3' ' A' ' 39' ' ' PRO . 20.0 m-85 -130.39 134.07 46.86 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.479 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.723 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.4 m-85 -68.92 122.74 19.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.761 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 5.9 p -70.25 149.81 47.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 t90 -55.6 -31.21 62.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.041 -177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 66.8 mm-40 -59.9 -44.91 93.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.867 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.535 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 38.0 m -68.64 -37.06 79.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.142 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.46 -40.79 96.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.964 0.411 . . . . 0.0 110.054 177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -40.66 96.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.105 178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.55 -35.08 72.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.694 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.6 38.46 6.59 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.491 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -93.72 -30.21 15.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.436 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -63.76 -29.88 71.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.126 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -63.32 -20.65 65.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.076 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.48 ' HB2' HD22 ' A' ' 12' ' ' LEU . 44.7 m-20 -67.19 -44.86 78.57 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.474 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.519 ' HA3' ' HG3' ' A' ' 15' ' ' PRO . . . 126.4 -119.9 3.54 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.562 -1.304 . . . . 0.0 114.664 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 19.3 t -43.14 105.5 0.43 Allowed Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.521 1.128 . . . . 0.0 113.12 -171.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.977 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 75.1 Cg_endo -85.15 22.48 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.204 2.603 . . . . 0.0 112.674 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 10' ' ' MET . 0.1 OUTLIER -73.16 124.0 24.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 176.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.864 HG23 ' HB2' ' A' ' 8' ' ' LEU . 12.1 mm -83.12 133.62 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 122.533 0.333 . . . . 0.0 111.816 -176.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 11' ' ' CYS . 1.5 pt? -169.61 38.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.739 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -50.98 142.64 11.59 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.839 0.352 . . . . 0.0 111.148 177.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.2 tp -50.34 117.9 2.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.157 -173.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -130.08 56.87 0.73 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.1 m 68.96 49.59 0.65 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.377 0.608 . . . . 0.0 110.04 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -130.62 22.25 5.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.932 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.544 HH11 HD23 ' A' ' 97' ' ' LEU . 4.9 tmt_? -67.41 -33.68 75.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.319 0.581 . . . . 0.0 109.803 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.544 HD23 HH11 ' A' ' 96' ' ' ARG . 0.4 OUTLIER -151.28 59.62 0.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.747 177.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -60.93 127.34 31.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.15 -175.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -155.53 55.5 0.62 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -69.23 137.91 53.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.63 -175.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.92 43.16 1.24 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.169 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.57 -35.3 79.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.408 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.888 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -73.78 163.24 28.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.023 174.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -77.44 54.54 1.16 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.592 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HE2' ' HG3' ' A' ' 103' ' ' LYS . 60.9 pttt -167.61 145.4 4.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 110.316 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -142.58 -45.7 0.32 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.415 0.626 . . . . 0.0 110.527 -177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.309 -1.188 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.871 178.594 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -165.46 137.45 4.69 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.85 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.8 m 58.63 40.14 23.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.494 0.664 . . . . 0.0 110.589 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -93.21 -27.69 16.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.579 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 70.99 139.77 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.81 0.694 . . . . 0.0 111.476 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.518 ' NE2' ' HA ' ' A' ' 94' ' ' SER . 49.2 p-80 -177.74 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.756 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -160.69 170.29 21.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.65 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 27.3 t80 -68.33 -20.72 64.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.594 172.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.025 ' HB3' HD21 ' A' ' 91' ' ' ASN . 11.3 m-20 72.49 74.41 0.15 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.425 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.717 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -74.96 124.04 26.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.095 -170.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.938 HG12 ' HB3' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -169.76 46.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 C-N-CA 123.317 0.647 . . . . 0.0 110.651 174.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.828 ' HB2' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -64.31 131.94 48.74 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.75 -174.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.589 ' HB2' HD21 ' A' ' 90' ' ' LEU . 53.3 t -42.08 -46.35 4.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.04 -1.437 . . . . 0.0 111.637 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 10' ' ' MET . 1.2 mp 42.76 52.23 5.04 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 172.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -95.53 -145.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 170.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -91.65 113.8 59.86 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.571 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 52.3 Cg_exo -57.63 129.11 32.02 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.878 2.385 . . . . 0.0 112.47 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.08 -131.34 6.1 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.607 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.57 -36.75 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 54.2 mt-30 -63.11 125.41 23.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.47 0.652 . . . . 0.0 111.556 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 m -74.8 130.92 40.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.717 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.434 ' HA3' HD13 ' A' ' 59' ' ' ILE . . . -68.06 129.64 26.7 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.017 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 65.7 mt -102.14 145.31 29.55 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.164 0.507 . . . . 0.0 112.009 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 74.5 mt -113.36 144.01 43.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.168 176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 2.9 p -78.07 154.47 31.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 172.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 27' ' ' ASP . 50.3 mt-10 -57.53 -26.7 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.901 0.381 . . . . 0.0 111.453 -176.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 75.6 mmtt -69.15 -24.12 64.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.81 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.3 m -115.72 25.21 10.93 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 174.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.599 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 33.4 t70 -72.49 131.36 42.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.22 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.29 62.68 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.807 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -111.76 131.64 55.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -72.3 119.16 73.26 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 9.6 Cg_endo -57.26 -38.3 95.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.266 2.644 . . . . 0.0 113.359 -174.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.498 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 6.9 mm -64.44 -56.8 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 28.1 p -100.82 -19.78 15.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -169.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 33' ' ' CYS . 13.4 t70 68.59 85.34 0.14 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.225 0.536 . . . . 0.0 110.397 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -174.58 145.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.312 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -84.35 33.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.71 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' A' ' 73' ' ' CYS . 14.4 p -78.62 158.23 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.313 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.531 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 31.3 ttp180 -50.83 126.02 23.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.382 0.673 . . . . 0.0 112.543 -176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 12.6 Cg_exo -70.45 -166.62 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.605 2.87 . . . . 0.0 112.169 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . 25.7 tptp -166.91 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -143.65 140.2 29.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.059 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 71' ' ' PHE . 33.8 mtpt -62.03 136.26 57.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 111.117 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 11.5 t -75.85 131.94 34.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.94 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -121.19 128.73 52.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.723 0.296 . . . . 0.0 110.205 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' A' ' 55' ' ' ALA . 35.2 m -75.22 151.26 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.062 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.722 ' HB3' ' HB2' ' A' ' 86' ' ' CYS . 9.6 p -59.7 153.77 19.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -54.94 -37.03 65.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 6.8 m120 -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.341 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 33.8 m -71.39 -27.01 63.03 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.459 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 89.3 p -77.16 -39.44 49.1 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.942 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' A' ' 48' ' ' ASN . 4.0 p90 -90.43 -31.21 16.92 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.7 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.88 30.42 7.53 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.89 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 3.7 mptp? 60.87 -178.24 0.11 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.813 0.445 . . . . 0.0 111.125 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.76 56.94 1.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.428 0.633 . . . . 0.0 111.127 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' A' ' 45' ' ' VAL . . . -138.6 -30.67 0.76 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.978 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -78.91 -37.2 40.55 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.404 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.872 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 6.9 p30 -62.18 142.7 57.5 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 40.9 t -46.71 111.08 0.34 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.816 -175.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.464 HD11 ' CB ' ' A' ' 70' ' ' ALA . 6.0 pt -60.43 -26.0 35.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.398 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.64 -42.96 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -117.43 5.76 12.55 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 119.89 -0.724 . . . . 0.0 112.137 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 5.4 p-10 38.64 43.49 0.69 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.413 HD22 ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -148.76 -58.59 0.22 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.834 -173.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -86.76 17.75 3.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -167.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.872 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 2.6 t 59.67 137.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.113 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -82.36 162.23 41.76 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.548 -173.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 68' ' ' ASN . 6.3 p -149.8 -44.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.259 -0.471 . . . . 0.0 110.367 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' N ' HG13 ' A' ' 67' ' ' VAL . 76.6 m-20 -106.03 131.39 53.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 176.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -60.01 133.36 56.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.955 0.407 . . . . 0.0 110.752 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . . . -74.21 150.5 40.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 42' ' ' LYS . 9.2 m-85 -128.62 131.93 48.12 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.477 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.547 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 98.4 m-85 -67.97 127.79 34.15 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 171.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.777 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 8.5 p -73.68 158.78 34.06 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.232 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.512 ' HA ' ' HE3' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -51.39 -46.2 62.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.138 -178.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -59.69 -44.51 93.62 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.611 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.797 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 58.6 m -64.72 -43.41 93.51 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.224 -0.297 . . . . 0.0 111.018 176.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.422 ' SG ' ' HB3' ' A' ' 40' ' ' LYS . 58.4 m -64.24 -34.59 78.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -58.33 -49.88 75.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.927 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.52 -47.0 24.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.521 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.67 34.55 0.3 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.556 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 76' ' ' CYS . 18.9 mmtp -76.13 -23.69 54.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.23 0.538 . . . . 0.0 110.531 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.23 -42.13 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.892 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -85.54 -15.24 43.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.597 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.504 ' OD2' HD21 ' A' ' 12' ' ' LEU . 25.2 t0 -56.47 -51.13 69.61 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.899 -176.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.66 -160.91 34.43 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.211 -1.471 . . . . 0.0 114.926 170.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 42.3 t -72.56 113.5 21.66 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 113.691 -1.254 . . . . 0.0 111.751 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . 96.3 Cg_endo -81.98 43.87 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.228 2.619 . . . . 0.0 113.405 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' MET . 6.5 mmm180 -87.97 131.24 34.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.227 174.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.649 HG23 HD11 ' A' ' 9' ' ' ILE . 28.6 mm -91.91 115.84 31.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.597 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.869 ' H ' HD13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -140.62 50.79 1.66 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 1.025 HD21 ' HB3' ' A' ' 7' ' ' ASP . 22.5 p30 -92.32 -124.23 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.47 -0.769 . . . . 0.0 111.423 169.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 91' ' ' ASN . 2.3 pt? -159.04 14.8 0.16 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.984 0.421 . . . . 0.0 110.056 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 77.0 136.83 0.79 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.154 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.518 ' HA ' ' NE2' ' A' ' 4' ' ' HIS . 51.2 p 54.01 69.9 0.66 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.429 0.692 . . . . 0.0 112.405 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.467 HD21 ' ND2' ' A' ' 91' ' ' ASN . 78.7 m-20 -62.96 132.94 53.75 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 174.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -151.97 -135.68 0.06 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.208 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' H ' ' HB2' ' A' ' 96' ' ' ARG . 98.2 mt 65.96 28.83 10.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.376 0.608 . . . . 0.0 110.801 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.11 -26.02 15.12 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.3 mmm-85 -133.99 119.46 19.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.437 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -169.23 -46.93 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.102 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 1.7 t80 61.41 69.36 0.66 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.525 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -92.17 21.09 5.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 57.66 44.01 21.37 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.845 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.6 tttm -82.97 -51.24 7.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.99 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -149.1 58.72 1.03 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.545 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp 61.49 34.71 17.91 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.6 0.714 . . . . 0.0 109.077 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 9.9 p . . . . . 0 C--O 1.244 0.807 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.183 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 77.58 47.85 8.49 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.736 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.6 t -152.66 47.76 0.73 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.716 0.769 . . . . 0.0 109.353 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 m -81.2 53.15 1.96 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.347 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -61.81 -47.15 86.41 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -84.13 -68.81 0.69 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.863 168.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HG3' HD13 ' A' ' 8' ' ' LEU . 3.8 tp60 178.29 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.92 176.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.594 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 9.8 t80 -146.42 26.44 1.17 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.807 0.813 . . . . 0.0 109.481 174.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -92.23 47.69 1.35 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.959 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.594 ' CD2' ' HA ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -157.56 39.49 0.29 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.745 -171.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.497 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -77.57 147.22 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.632 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.981 ' HG3' ' HG ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -143.57 131.55 21.67 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.6 t -51.91 -54.0 34.45 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.478 -167.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.981 ' HG ' ' HG3' ' A' ' 10' ' ' MET . 34.1 mt 44.86 37.86 2.58 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -82.42 170.71 14.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 172.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 7.1 tp-100 -67.69 119.65 67.69 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 34.6 Cg_exo -62.29 145.47 96.01 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.754 2.303 . . . . 0.0 112.814 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.9 -66.46 1.62 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.977 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p 176.64 -32.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.792 0.329 . . . . 0.0 110.586 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 50' ' ' SER . 26.1 mt-30 -64.38 133.28 52.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.692 -175.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 m -74.71 137.26 41.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.867 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 43' ' ' VAL . . . -75.35 133.48 14.88 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.996 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 80.1 mt -100.12 143.34 30.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.674 ' HG ' ' HB2' ' A' ' 70' ' ' ALA . 63.7 mt -111.93 138.56 48.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.942 177.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' N ' ' HB2' ' A' ' 58' ' ' CYS . 3.5 p -81.88 148.92 28.53 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 170.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 27' ' ' ASP . 46.6 mt-10 -54.39 -27.58 37.62 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -65.64 -29.98 70.62 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.656 0.265 . . . . 0.0 111.378 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 60' ' ' ILE . 34.6 m -105.37 -12.63 15.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.878 0.37 . . . . 0.0 110.206 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' CB ' ' HA ' ' A' ' 24' ' ' GLU . 11.7 t70 -59.89 115.75 3.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.075 -175.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.02 -33.02 4.19 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 26' ' ' CYS . 47.2 mttp -77.55 136.75 38.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.63 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.3 t -79.98 121.98 82.69 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' O ' HD11 ' A' ' 89' ' ' ILE . 10.3 Cg_endo -55.82 -41.26 79.21 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 123.228 2.619 . . . . 0.0 113.648 -174.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 5.8 mm -63.73 -49.09 83.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.2 p -111.47 -17.09 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -169.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.2 t0 63.04 74.89 0.42 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.543 0.687 . . . . 0.0 110.366 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.6 t -160.24 146.32 15.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.312 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -87.19 30.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.775 0.322 . . . . 0.0 111.159 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' A' ' 73' ' ' CYS . 3.6 p -76.64 150.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.866 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -49.08 124.64 13.48 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 87.9 Cg_endo -79.62 149.35 21.0 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.526 2.817 . . . . 0.0 112.114 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -132.16 -62.37 0.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.4 mtp-105 -102.39 141.99 34.33 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -173.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.0 mttp -69.18 137.57 53.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.967 0.413 . . . . 0.0 111.183 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.913 ' HB ' ' HG3' ' A' ' 87' ' ' PRO . 35.3 m -78.84 145.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.127 -176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -131.7 119.48 21.43 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.5 m -86.83 155.91 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.893 -173.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.742 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 6.2 p -71.13 160.24 33.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.599 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -53.57 -39.74 65.03 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.194 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.01 -35.51 75.22 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.541 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 60.4 m -98.48 33.3 2.28 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.151 -0.343 . . . . 0.0 111.493 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.544 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 53.6 p -156.81 -28.06 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -50.98 -41.31 59.44 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -170.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.38 157.12 15.08 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.56 -1.305 . . . . 0.0 113.754 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 54' ' ' GLN . 22.1 pttp 44.21 34.23 0.97 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.124 1.37 . . . . 0.0 113.904 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 2.7 tt0 176.95 46.88 0.0 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.098 0.475 . . . . 0.0 110.438 176.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.501 ' HB2' ' HA ' ' A' ' 50' ' ' SER . . . -130.5 -29.58 1.96 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.969 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 51.7 mmtt -71.31 -29.76 65.42 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.063 0.458 . . . . 0.0 110.809 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 21.4 p30 -66.2 143.37 57.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.4 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -55.23 130.27 41.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.453 -177.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.562 HD13 ' HA3' ' A' ' 20' ' ' GLY . 9.9 pt -62.44 -26.6 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -171.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 26' ' ' CYS . 45.9 mt -80.0 -42.65 22.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.924 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -109.51 -11.38 14.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.645 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.416 ' HA ' ' OD1' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 54.03 28.52 8.86 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.513 . . . . 0.0 111.264 175.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.26 -64.27 0.61 Allowed 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.375 -169.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -79.74 140.17 37.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.921 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 57' ' ' ASN . 21.2 t -64.07 135.31 28.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 111.045 -176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -75.6 141.73 27.97 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.5 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.66 -42.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -115.19 141.58 47.83 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.585 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -61.87 136.38 57.95 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.736 ' HB3' HG21 ' A' ' 43' ' ' VAL . . . -79.05 160.09 27.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.9 0.381 . . . . 0.0 111.065 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.546 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 12.8 m-85 -132.21 134.6 45.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.628 177.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.735 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 74.6 m-85 -68.65 127.81 34.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 11.4 p -68.22 163.38 22.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.996 0.427 . . . . 0.0 110.952 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -51.81 -45.88 64.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.234 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 67.2 mm-40 -60.26 -48.25 82.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.544 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.601 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 66.5 m -65.56 -37.91 88.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.411 0.148 . . . . 0.0 111.243 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.18 -43.46 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 110.005 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -66.06 -42.83 88.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.862 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 75' ' ' GLU . 91.6 mt -63.94 -34.48 78.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.147 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.47 30.21 14.4 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.857 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.75 -22.44 27.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -66.35 -42.43 88.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.713 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -75.3 -16.54 60.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.551 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' HD22 ' A' ' 12' ' ' LEU . 5.3 t70 -64.75 -50.35 67.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.82 -139.41 5.81 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 118.643 -1.742 . . . . 0.0 115.688 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 46' ' ' CYS . 44.4 t -62.06 119.47 49.05 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 113.104 -1.548 . . . . 0.0 112.687 -170.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.913 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 64.4 Cg_endo -84.16 51.28 3.31 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.691 2.927 . . . . 0.0 113.068 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.541 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.0 mmt180 -99.58 127.27 45.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.54 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 31' ' ' PRO . 46.3 mm -90.9 88.42 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.458 0.647 . . . . 0.0 109.434 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 9' ' ' ILE . 3.9 mt -66.74 -27.18 67.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.557 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -41.24 142.95 0.47 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.301 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 94' ' ' SER . 30.4 tp -63.23 130.87 46.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.554 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.82 55.84 4.76 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.555 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.489 ' HB2' HD23 ' A' ' 92' ' ' LEU . 11.9 t -65.5 -32.12 73.55 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.424 0.29 . . . . 0.0 110.666 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.96 49.12 2.88 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.304 0.573 . . . . 0.0 110.432 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.415 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 5.9 ppt_? -127.28 28.53 5.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.288 0.566 . . . . 0.0 110.797 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 69.6 mt -112.33 118.89 36.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.198 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 68.99 140.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.948 0.78 . . . . 0.0 110.806 -173.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -78.35 59.42 2.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.952 0.406 . . . . 0.0 111.169 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -66.88 130.15 42.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.375 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.566 ' HB2' ' HG3' ' A' ' 106' ' ' LYS . 37.0 p90 -99.58 -23.67 14.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.868 0.366 . . . . 0.0 110.248 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -75.97 69.47 2.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.691 -178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.32 175.23 11.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.861 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -55.32 118.54 4.5 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.473 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 68.05 124.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.13 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.566 ' HG3' ' HB2' ' A' ' 101' ' ' PHE . 4.0 ttmp? -75.58 51.21 0.58 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.588 0.708 . . . . 0.0 110.571 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.301 177.514 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -169.77 130.75 2.1 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.9 m -160.55 -130.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -70.21 -41.56 73.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.934 0.397 . . . . 0.0 110.062 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 58.87 41.22 21.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.752 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -94.81 -38.39 10.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.091 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -135.88 171.8 13.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.314 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.696 ' HD1' HD11 ' A' ' 8' ' ' LEU . 3.5 m-85 -62.3 -22.14 65.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.796 -173.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER 81.54 81.88 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 123.971 0.794 . . . . 0.0 110.039 -171.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.696 HD11 ' HD1' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -123.81 60.05 1.12 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.342 -179.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.05 ' HB ' ' HA ' ' A' ' 91' ' ' ASN . 1.7 mp -78.03 63.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 122.595 1.188 . . . . 0.0 109.589 -171.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.569 ' HG3' HD13 ' A' ' 12' ' ' LEU . 4.8 ptp -90.05 149.33 22.56 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.496 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.451 ' N ' HD21 ' A' ' 90' ' ' LEU . 2.0 t -46.12 -47.02 17.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.603 -1.181 . . . . 0.0 112.812 -174.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.569 HD13 ' HG3' ' A' ' 10' ' ' MET . 1.3 mp 46.35 40.23 7.51 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 175.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 62.4 mttm -80.02 -162.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.819 0.342 . . . . 0.0 110.345 169.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.4 ' H ' ' HB3' ' A' ' 13' ' ' LYS . 70.7 tp60 -85.99 110.58 31.7 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.367 173.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 46' ' ' CYS . 36.9 Cg_endo -70.75 143.56 46.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.495 2.13 . . . . 0.0 113.018 -175.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.68 -101.5 0.47 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.206 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.49 -31.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.485 ' HB2' HG22 ' A' ' 45' ' ' VAL . 62.9 mt-30 -57.9 132.41 53.31 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.955 0.407 . . . . 0.0 111.477 -177.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 5.9 m -83.26 138.53 33.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.714 -176.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.29 133.79 13.35 Favored Glycine 0 C--N 1.331 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.809 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 94.3 mt -96.91 151.47 19.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 0.0 112.084 -177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.0 141.52 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.17 177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 58' ' ' CYS . 5.7 p -78.78 154.74 29.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.65 -32.21 50.6 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.262 0.351 . . . . 0.0 111.847 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 34.0 mmtp -63.65 -43.91 95.36 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 38.8 m -89.95 -15.93 30.98 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -53.59 108.99 0.4 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.471 0.653 . . . . 0.0 110.585 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.3 -35.12 1.69 Allowed Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.02 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -87.96 128.36 35.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.798 -0.201 . . . . 0.0 111.496 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.6 t -70.13 118.58 65.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.86 -39.41 68.3 Favored 'Trans proline' 0 N--CA 1.474 0.357 0 C-N-CA 123.051 2.501 . . . . 0.0 114.169 -171.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mm -63.94 -40.79 90.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.06 -18.85 8.01 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -171.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 t0 66.06 76.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.284 0.564 . . . . 0.0 110.013 -175.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.9 t -162.43 147.06 12.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.874 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -90.45 22.72 3.28 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.033 0.444 . . . . 0.0 111.143 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.606 HG13 ' HB2' ' A' ' 73' ' ' CYS . 2.5 p -69.43 148.85 11.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.135 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -40.19 113.07 0.9 Allowed Pre-proline 0 N--CA 1.473 0.683 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 73' ' ' CYS . 72.6 Cg_endo -78.71 148.12 22.49 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.202 2.601 . . . . 0.0 112.011 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HE2' ' HB2' ' A' ' 74' ' ' TRP . 61.9 mttm -139.17 -53.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 99.5 mtt180 -101.05 138.21 38.39 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -174.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -64.8 132.42 49.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.497 . . . . 0.0 111.04 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.831 ' HA ' ' CE2' ' A' ' 72' ' ' TYR . 15.7 t -74.16 125.18 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.354 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.9 136.99 36.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.929 0.395 . . . . 0.0 110.984 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.81 HG12 HH21 ' A' ' 88' ' ' ARG . 2.1 m -91.84 150.31 3.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 15' ' ' PRO . 1.6 p -81.29 145.7 30.77 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 169.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' OG ' ' A' ' 50' ' ' SER . 1.5 tp10 -58.11 -24.3 58.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -173.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.523 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 41.9 m-80 -66.08 -20.99 66.34 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.383 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.485 ' SG ' ' HG3' ' A' ' 88' ' ' ARG . 78.4 m -110.27 39.0 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.119 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.738 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 84.8 p -147.78 -49.43 0.17 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.618 -178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.03 40.2 0.53 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.01 -51.44 0.13 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.423 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.597 ' HD3' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -132.48 165.0 25.32 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.597 ' HG2' ' HD3' ' A' ' 53' ' ' LYS . 85.9 mm-40 62.32 -138.81 0.45 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.667 0.605 . . . . 0.0 110.41 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 50' ' ' SER . . . 67.61 -60.15 0.39 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.873 0.869 . . . . 0.0 112.204 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -83.11 -46.48 12.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.851 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.523 HD22 ' C ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -68.6 149.75 48.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.372 0.606 . . . . 0.0 110.588 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 11.8 t -54.1 124.12 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.829 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.401 HD11 ' CB ' ' A' ' 70' ' ' ALA . 28.0 pt -69.33 -23.07 26.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.576 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.4 mt -78.71 -49.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -95.28 -8.28 36.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.33 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.87 46.67 6.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.702 0.801 . . . . 0.0 111.663 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -61.56 0.13 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.236 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -70.06 141.75 52.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.723 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.8 132.72 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.207 0.317 . . . . 0.0 110.477 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.53 176.93 54.53 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.702 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 68' ' ' ASN . 3.2 p -161.34 -52.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.006 0.431 . . . . 0.0 110.752 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.425 ' N ' HG13 ' A' ' 67' ' ' VAL . 76.2 m-20 -97.4 122.7 40.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.677 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.16 134.08 56.67 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.993 0.425 . . . . 0.0 110.482 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' CB ' HD11 ' A' ' 59' ' ' ILE . . . -73.26 142.73 47.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.591 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.451 ' CB ' ' HB2' ' A' ' 39' ' ' PRO . 7.6 m-85 -124.79 130.09 51.72 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.271 177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.831 ' CE2' ' HA ' ' A' ' 43' ' ' VAL . 58.6 m-85 -66.26 129.94 41.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 39' ' ' PRO . 12.0 p -69.75 161.86 28.95 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.775 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.573 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 26.6 t90 -53.75 -39.82 65.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.603 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -60.99 -48.25 82.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.723 0.297 . . . . 0.0 110.946 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 32' ' ' ILE . 84.2 m -67.97 -32.76 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.58 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.8 t -62.12 -44.02 97.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.583 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 -60.77 -46.65 89.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.76 -32.62 72.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.71 38.57 10.43 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.344 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 87.5 mttt -78.76 -9.14 59.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.681 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -71.07 -35.73 72.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.36 0.6 . . . . 0.0 109.597 173.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -81.74 -9.17 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.061 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 81' ' ' LYS . 23.5 t0 -70.1 -42.9 72.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.76 -175.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' HA3' ' HG ' ' A' ' 12' ' ' LEU . . . 172.09 178.52 42.39 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.626 -1.273 . . . . 0.0 114.029 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -72.42 110.68 8.62 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 111.326 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.582 ' HG2' HH12 ' A' ' 88' ' ' ARG . 56.6 Cg_endo -78.12 41.44 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.436 2.758 . . . . 0.0 115.279 -172.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.81 HH21 HG12 ' A' ' 45' ' ' VAL . 7.0 mmt-85 -79.98 134.41 36.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.505 HG23 ' OD1' ' A' ' 91' ' ' ASN . 33.7 mm -85.24 126.34 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.217 0.532 . . . . 0.0 112.126 -175.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.451 HD21 ' N ' ' A' ' 11' ' ' CYS . 0.6 OUTLIER -149.4 46.0 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.683 174.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 1.05 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 5.7 m120 -57.17 124.24 18.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.513 -173.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 65.1 tp 173.16 -48.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.828 177.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.3 -75.41 0.39 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.6 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 98' ' ' ASP . 35.3 t 174.08 -67.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.964 -0.618 . . . . 0.0 109.658 172.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m120 70.17 -31.57 0.22 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.823 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -155.56 160.56 40.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.624 -175.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 94.1 mt 75.81 -56.2 0.6 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.65 0.78 . . . . 0.0 113.057 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.55 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 44.1 m-20 -81.48 43.9 0.77 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.101 0.477 . . . . 0.0 111.283 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -135.36 35.16 2.99 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.84 ' HB3' ' HG3' ' A' ' 102' ' ' GLU . 4.1 m170 -148.86 134.13 18.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.229 -177.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -71.21 -41.85 69.71 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.684 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.84 ' HG3' ' HB3' ' A' ' 100' ' ' HIS . 97.3 mt-10 43.67 60.88 2.47 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.673 0.608 . . . . 0.0 111.768 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.8 mttt 67.34 -130.55 0.14 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.059 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.9 tptm 67.95 -64.55 0.28 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.37 0.668 . . . . 0.0 111.537 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -148.55 39.99 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -67.39 127.27 32.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.007 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.121 177.409 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_